Ethan Nadelmann, Controlling medical pot is not such an out-of-control idea
Mark Honigsbaum, Headache sufferers flout new drug law
Benson JA et.al., From Marijuana to Medicine
Fendrich M, Vaughn CM, Diminished Lifetime Substance Use Over Time: An Inquiry Into Differential Underreporting
Mensch BS, Kandel DB, Underreporting of substance Use in a Nation; Longitudinal Youth Cohort: Individual and Interveiwer Effects
Small E et.al., A Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation
Grinspoon L et.al., Marijuana, the AIDS Wasting Syndrome, and the U.S. Government
Roberto Cardosoa Eduardo de Souzaa Luiz Camanoa Jose´ Roberto Leite, Meditation in health: an operational definition
Jane M. Sullivan, Mechanisms of Cannabinoid-Receptor-Mediated Inhibition of Synaptic Transmission in Cultured Hippocampal Pyramidal Neurons
B. R. Martin, R. Jefferson, R. Winckler, J. L. Wiley, J. W. Huffman, P. J. Crocker, B. Saha and R. K. Razdan, Manipulation of the Tetrahydrocannabinol Side Chain Delineates Agonists, Partial Agonists, and Antagonists1
John P. Roche, Sid Bounds, Sean Brown, and Ken Mackie, A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization
Benson JA, Re: Marijuana and Medicine, edited by Gabriel G. Nahas
David Fulton, John Quilley, Evidence against Anandamide as the Hyperpolarizing Factor Mediating the Nitric Oxide-Independent Coronary Vasodilator Effect of Bradykinin in the Rat
Sandra P. Welch, John W. Huffman, John Lowe, Differential Blockade of the Antinociceptive Effects of Centrally Administered Cannabinoids by SR141716A1.
M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, and K. Nicolay, Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
Jerome L, Doblin R, MIthoefer M, Ecstasy use-Parkinson's disease link tenuous
Smigel K, Cancer Problems Lead List for potential Medical Marijuana Research Studies
Rowe PM, Cannabinoid analgesia explained
M. van der Stelt, W. B. Veldhuis, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, K. Nicolay, Neuroprotection by 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
Muscat, News Briefs; Study Finds Marijuana Safe for AIDS Patients
W Zhu, C Newton, Y Daaka, H Friedman, TW Klein, delta 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages
Model KE, The effect of Marijuana Decriminalization on Hospital Emergency Room Drug Episodes: 1975-1978
Judge Francis L. Young, Administrative Law Judge, UNITED STATES DEPARTMENT OF JUSTICE, Drug Enforcement Administration, In The Matter Of Marijuana Rescheduling Petition; Docket No. 86-22 Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of, Administrative Law Judge. Francis L. Young, Administrative Law Judge,
Hammond CT, Mahlberg PG, Morphogenesis of Capitate Glandular Hairs of Cannabis Sativa (Cannabacceae)
Borthwick HA, Scully, NJ, Photoperiodic Responses of Hemp
Rawitch AB; et.al., Competition of Delta-9-Tetrahydrocannabinol with Estrogen in Rat Uterine Estrogen receptor Binding
Lanyon VS et.al., Quantitative Analysis of Cannabinoids in the Secretory Product from Capitate-Stalked Glands of Cannabis sativa L. (Cannabaceae)
O'Suilleabhain P, Giller C, Ecstasy use-Parkinson's disease link tenuous
Cosentino C, Ecstasy and acute dystonia
Greer George, Tolbert Requa, A Method of Conducting Therapeutic Sessions with MDMA
Maurizio Bifulco, Chiara Laezza, Giuseppe Portella, Mario Vitale, Pierangelo Orlando, Luciano De Petrocellis, and Vincenzo Di Marzo, Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
Taco J. De Vries, Yavin Shaham, Judith R. Homberg, Hans Crombag, Karianne Schuurman, Jeanine Dieben, Louk J.M.J. Vanderschuren, Anton N.M. Schoffelmeer, A cannabinoid mechanism in relapse to cocaine seeking
Daniele Piomelli, Cannabinoid activity curtails cocaine craving
David Panikashvili, Constantina Simeonidou, Shimon Ben-Shabat,. Lumar Hanusi, Aviva Breuer, Raphael Mechoulam, Esther Shohami, An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Jenny L. Wiley, Cannabis: Discrimination of ''Internal Bliss''?
Z. H. Song, Carole-Anne Slowey, Dow P. Hurst, Patricia H. Reggio, The Difference between the CB1 and CB2 Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
Liana Fattore, M. Cristina Martellotta, Gregorio Cossu, M. Stefania Mascia, Walter Fratta, CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in rats
T. Bisogno, I. Delton-Vandenbroucke, A. Milone, M. Lagarde, V. Di Marzo, Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N- Docosahexaenoylethanolamine in Bovine Retina
Heyman RB et.al., American Academy of Pediatrics, Marijuana: a continuing concern for pediatricians,
William J. Martin, Andrea G. Hohmann, and J. Michael Walker, Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects
Transform Drug Policy Foundation, After the War on Drugs Options for Control
J. Michael Walker, Susan M. Huang, Nicole M. Strangman, Kang Tsou, and M. Clara Sanudo-Pena, Pain modulation by release of the endogenous cannabinoid anandamide
Natsuo Ueda, Yuko Kurahashi, Shozo Yamamoto, Takashi Tokunaga, Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide
Gray R, Marijuana the Forbidden Medicine, book review
Kozak KR et.al., Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2
Scripture EW, Consciousness under the Influence of Cannabis Indica
Schwartz RH, Voth EA, Sheridan MJ, Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists
Hall W, Book Review; Marijuana Myths, Marijuana Fact: A Review of the Scientific Evidence
Kim ES, Mahlberg PG, Glandular Cuticle Formation in Cannabis (Cannabcceae)
Siegel BZ, Mercury in Marijuna: Some of the problems arising from marijuana use might result from the intake of bioaccumulated mercury
Jeffrey G. Netzeband, Shannon M. Conroy, Kathy L. Parsons, Donna L. Gruol, Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture
Paria BC et.al., The preimplantation Mouse Embryo is a Target for Cannabinoid Ligand-Receptor Signalling
Sadovsky R, driving impact from marijuana and alcohol
Sharon Begley, Scans of Monks' Brains Show Meditation Alters Structure, Functioning
Zoltan Jarai, Jens A. Wagner, Karoly Varga, Kristy D. Lake, David R. Compton, Billy R. Martin, Anne M. Zimmer, Tom I. Bonner, Nancy E. Buckley, Eva Mezey, Raj K. Razdan, Andreas Zimmer, George Kunos, Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
Sean D. McAllister, Graeme Griffin, Leslie S. Satin, Mary E. Abood, Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System
Jian Mu, Shou-yuan Zhuang, M. Todd Kirby, Robert E. Hampson, Sam A. Deadwyler, Cannabinoid Receptors Differentially Modulate Potassium A and D Currents in Hippocampal Neurons in Culture
Mariam H.M. Yousif, Mabayoje A. Oriowo, Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments
Chen-ni Chin, James W. Murphy, John W. Huffman, Debra A. Kendall, The Third Transmembrane Helix of the Cannabinoid Receptor Plays a Role in the Selectivity of Aminoalkylindoles for CB2, Peripheral Cannabinoid Receptor
Jenny L. Wiley, Billy R. Martin, Effects of SR141716A on Diazepam Substitution for 9-Tetrahydrocannabinol in Rat Drug Discrimination.
Sandra P. Welch, Micah Eads, Synergistic interactions of endogenous opioids and cannabinoid systems
Angelo A. Izzo, Nicola Mascolo b, Luisa Pinto, Raffaele Capasso, Francesco Capasso, The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Giovanna Carta, Gian Luigi Gessa, Felice Nava, Dopamine D2 receptor antagonists prevent 9-tetrahydrocannabinol-induced antinociception in rats
Cristina Sanchez, Ismael Galve-Roperh, Daniel Rueda, and Manuel Guzman, Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the 9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes
Gayle Cocita Baldwin, Donald P.Tashkin, Dawn M. Buckley, Alice N. Park, Steven M. Dubinett, Michael D. Roth, Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production
Grinspoon L, Marijuana
The Lancet, Editorial, Deglamorising cannabis
Maugh TH, Marijuana: New Support for Immune and Reproductive Hazards
Ben-Zvi Z, Mechoulam R, 6 beta-Hydroxy-Delta (1)- Tetrahydrocannabinol Synthesis and biological activity
Gaetani S, Cuomo V, Piomelli D., Anandamide hydrolysis: a new target for anti-anxiety drugs?
Eberhard Schlicker, Markus Kathmann, Modulation of transmitter release via presynaptic cannabinoid receptors
M. van der Stelt, W. B. Veldhuis, G. W. van Haaften, F. Fezza, T. Bisogno, P. R. Bar, G. A. Veldink, J. F. G. Vliegenthart, V. Di Marzo, K. Nicolay, Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo
Clemente Vásquez, Deborah L. Lewis, The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors
Wagner JA, Varga K, Kunos G, Cardiovascular actions of cannabinoids and their generation during shock
Kaufman PL, Marijuana and glaucoma [editorial; comment]
Green K, Marijuana smoking vs cannabinoids for glaucoma therapy [see comments]
U.S. Department of Health and Human Services, NTP Technical Report on the Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344/N Rats and B6C3F(1) Mice (Gavage Studies);
NE Kaminski, ME Abood, FK Kessler, BR Martin, AR Schatz, Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
Turner JC et.al., Trichomes and Cannabinoid Content of Developing Leaves and Bracts of Cannabis sativa L. (Cannabaceae)
Turner JC et.al., Quantitative Determination of Cannabinoids in Individual Glandular Trichomes of Cannabis sativa L. (Cannabaceae)
Johnson WT et.al., Arrest Probabilities for Marijuana Users as Indicators of Selective Law Enforcement
Wilson DG, Plant Remains from the Gravency Boat and the Early History of Humulus lupulus L. in W. Europe
Mackay EL, Sex Chromosomes of Cannabis sativa
McPhee HC, Meiotic Cytokinesis of Cannabis
Lutz A, Greischar LL, Rawlings NB, Ricard M, Davidson RJ., Long-term meditators self-induce high-amplitude gamma synchrony during mental practice.
Jingjiang Nie, Deborah L. Lewis, Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration
Dale L. Boger, Haruhiko Sato, Aaron E. Lerner, Michael P. Hedrick, Robert A. Fecik, Hiroshi Miyauchi, Gordon D. Wilkie, Bryce J. Austin , Matthew P. Patricelli, Benjamin F. Cravatt, Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
Das SK et.al., Cannabinoid Ligand-Receptor Signaling in the Mouse Uterous.
Monika Fellermeier, Meinhart H. Zenk, Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol
Sharon Begley with Anne Underwood, Religion And The Brain
Sharon Begley, Religion and the brain
Xiang-Qun Xie, Lawrence S. Melvin, Alexandros Makriyannis, The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940
Galanter M et.al., Effects on Humans of Delta-9-Tetrathydrocannabinol Administration by Smoking
Lau JR; et.al., Phytohemagglutinin-Induced Lynphocyte Transformation in Humans Receiving Delta-9-Tetrahydrocannabinol
King County Bar Association, Drug-Related Crime and Disorder: Practical Policy Options
Timmen L. Cermak, MD, Update on Marijuana: Why It Works And Why It Doesn't
Marcus Roberts, Axel Klein, Mike Trace, TOWARDS A REVIEW OF GLOBAL POLICIES ON ILLEGAL DRUGS
Sandra W. Jacobson, PhD; Lisa M. Chiodo, PhD; Robert J. Sokol MD, Joseph L. Jacobson, PhD, Validity of Maternal Report of Prenatal Alcohol, Cocaine, and Smoking in Relation to Neurobehavioral Outcome
Alvin Berger, Gayle Crozier, Tiziana Bisogno, Paolo Cavaliere, Sheila Innis, Vincenzo Di Marzo, Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets
Takayuki Sugiura, Naoki Yoshinaga, Sachiko Kondo, Keizo Waku, Yoshio Ishima, Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Picrotoxinin-Administered Rat Brain
Cotton P, Government Extinguishes Marijuana Access, Advocates Smell Politics
Muscat, News Breifs; Institute of Medicine Report Backs Medical Use of Marijuana
Qing Tao, Mary E. Abood, Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling 1
Gurwitz D, Kloog Y, Do endogenous cannabinoids contribute to HIV-mediated immune failure?
Robin Condie, Amy Herring, Woo S. Koh, Michael Lee, Norbert E. Kaminski, Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2
Beebe D K, Walley E, Substance Abuse: The Designer Drugs.
Tamaguchi K, Kandel DB, On the Resolution of Role Incompatability: A Life Event History Analysis of Family Roles and Marijuana Use
Menzel MY, Meiotic Chromosomes of Monoecious Kentucky Hemp (Cannabis sativa)
Grotenhermen, Franjo, How to prevent cannabis-induced psychological distress . . . in politicians
Takako Ohno-Shosaku, Hiroshi Tsubokawa, Ichiro Mizushima, Norihide Yoneda, Andreas Zimmer, Masanobu Kano, Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses
Wenzhen Jin, Sean Brown, John P. Roche, Candace Hsieh, Jeremy P. Celver, Abraham Kovoor, Charles Chavkin, and Ken Mackie, Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
D. Piomelli, M. Beltramo, S. Glasnapp, S. Y. Lin, A. Goutopoulos, Xiang-Qun Xie, and A. Makriyannis, Structural determinants for recognition and translocation by the anandamide transporter
Heinz Steiner, Tom I. Bonner, Anne M. Zimmer, Stephen T. Kitai, Andreas Zimmer, Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
Rafael Maldonado and Fernando Rodrı´guez de Fonseca, Cannabinoid Addiction: Behavioral Models and Neural Correlates
Rafael Maldonado, Fernando Rodriguez de Fonseca, Cannabinoid Addiction: Behavioral Models and Neural Correlates
Green BE, Ritter, C;, Marijuana Use and Depression
Rachel I. Wilson, Roger A. Nicoll, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Piomelli D, Pot of Gold for Glioma Therapy.
Monsif Bouaboula, Nathalie Desnoyer, Pierre Carayon, Thérèse Combes, Pierre Casellas, Gi Protein Modulation Induced by a Selective Inverse Agonist for the Peripheral Cannabinoid Receptor CB2: Implication for Intracellular Signalization Cross-Regulation
Qing Tao, Sean D. McAllister, John Andreassi, Katharine W. Nowell, Guy A. Cabral, Dow P. Hurst, Kevin Bachtel, Marie C. Ekman, Patricia H. Reggio, Mary E. Abood, Role of a Conserved Lysine Residue in the Peripheral Cannabinoid Receptor (CB2): Evidence for Subtype Specificity
Yaakov Waksman, John M. Olson, Steven J. Carlisle, Guy A. Cabral, The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells1
Kirsten R. Muller-Vahl, M.D., Udo Schneider, M.D., Hans Kolbe, M.D., Hinderk M. Emrich, M.D, Treatment of Tourette's Syndrome With Delta-9-Tetrahydrocannabinol
Michael D. Roth, Ashim Arora, Sanford H. Barsky, Eric C. Kleerup, Michael Simmons, Donald P. Tashkin, Airway Inflammation in Young Marijuana and Tobacco Smokers
I. B. Adams, D. R. Compton B. R. Martin, Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain
Allyn C. Howlett, Chao Song,1 Barbara A. Berglund, Gerald H. Wilken, J. Jill Pigg, Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies
Shafer RG, Presidents and Pot, Or, Were Washington and Jefferson Stoned?
Deutsch DG et.al, The Cellular Uptake of Anandamide is Coupled to its Breakdown by Fatty-acid Amide Hydrolase
Franck Desarnaud, Hugues Cadas, Daniele Piomelli., Anandamide Amidohydrolase Activity in Rat Brain Microsomes identification and partial characterization
Scott Gottlieb, Cannabinoids might reduce spasticity in multiple sclerosis
Takayuki Yoshida, Kouichi Hashimoto, Andreas Zimmer, Takashi Maejima, Kenji Araishi, Masanobu Kano, The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells
Okey AB et.al., Is Delta-9-tetrahydrocannabinol Estrogenic?
Miczek KA, Delta-9-Tetrahydrocannabinol: Antiaggressive Effects in Mice, Rats, and Squirrel Monkeys
Hanus L et.al., 2-Arachidonyl glycerol ether, an endogenous agonist of the cannabinoid CB1 receptor
Strassman RJ, Book Reveiw, Marijuana: The Forbidden Medicine,
Smith CG et.al., Tolerance Develops to the Disruptive Effects of Delta-9-Tetrahydrocannabinol on Primate Menstrual Cycle
Baker D et.al., Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Rafaelsen OJ et.al, Cannabis and Alcohol: Effects on Simulated Car Driving
Bachman JG et.al., Explaining the Recent Decline in Marijuana Use: Differentiating the Effects of Perceived Risks, Disapproval, and General Lifestyle Factors
French CN, Moore PD, Deforestation, Cannabis Cultivation and Schwingmoor Formation at Cors Llyn (Llyn Mire), Central Wales
The American Public Health Association,, Access to Therapeutic Marijuana/Cannabis
AB Lynn and M Herkenham, Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids
Zablocki B et.al., Marijuana Use, Introspectiveness, and Mental Health
Herkenham M et.al., Cannabinoid localization in Brain
AC Howlett, MR Johnson, LS Melvin, GM Milne, Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model
Kaplan HB et.al., Escalation of Marijuana Use: Application of a General Theory of Deviant Behavior
Turner JC, A Temporal Study of Cannabinoid Composition in Continual Clones of Cannabis sativa L. (Cannabacceae),
Mahlberg PG, Hemphill JK, Effect of Light on Cannabinoid Content of Cannabis sativa L. (Cannabacceae)
Ginsberg IJ, Greenly JR, Competing Theories of Marijuana Use: A Longitudinal Study
KN Dwivedi VM Gupta KN Udupa, A preliminary report on some physiological changes due to Vipashyana Meditation
Stefanis CN, Issidorides MR, Marihuana Effects
Knight RC et.al., College Student Marijuana Use and Societal Alienation
Schaffner JH, Influence of Environment on Sexual Expression in Hemp
Maugh TH, Marijuana "Justifies Serious Concern"
de FAUBERT, MAUNDER, A field test for hallucinogens: further improvements
Dr. Ben Sessa, Can Psychedelics Have A Role In Psychiatry Again?
Thomas W. Klein, Catherine A. Newton, Noryia Nakachi, Herman Friedman, 9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-, IL-12, and IL-12 Receptor 2 Responses to Legionella pneumophila Infection
Cecilia J. Hillard, Sukumar Manna, Marcie J. Greenberg, Ralph DiCamelli, Ruth A. Ross, Lesley A. Stevenson, Vicki Murphy, Roger G. Pertwee and William B. Campbell, Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1)1
François Petitet, Bernadette Jeantaud, Philippe Bertrand, Assunta Imperato, Cannabinoid penetration into mouse brain as determined by ex vivo binding
Kathleen L. McCoy, Marina Matveyeva, Steven J. Carlisle, Guy A. Cabral, Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation1
Stacie A. Cook, John A. Lowe and Billy R. Martin, CB1 Receptor Antagonist Precipitates Withdrawal in Mice Exposed to 9-Tetrahydrocannabinol1
Jenny L. Wiley, David R. Compton, Dong Dai, Julia A. H. Lainton, Michelle Phillips, John W. Huffman, Billy R. Martin, Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids
JONATHAN LEAKE, SCIENCE EDITOR, Get a better mind from the chemist
Hugues Cadas, Sylvie Gaillet, Massimiliano Beltramo, Laurent Venance, Daniele Piomelli, Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP,
SIMON JENKINS, If you want to cut gun crime, first you have to license drugs
Mechoulam R, Marihuana Chemistry
Nilsson IM et.al., Delta-9-tetrahydrocannabinol: Sructure of a major Metabolite
Scheckel CL et.al., Behavioral Effects in Monkeys of racemates of Two Biologically Active Marijuana Constituents
Stockings GT, A New Euphoriant for Depressive Mental States
S. Dalterio, A. Bartke, S. Burstein, Cannabinoids Inhibit Testosterone Secretion by Mouse Testes in vitro
Matthew P. Patricelli, Benjamin F. Cravatt, Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family
Grinspoon L, Marijuana as Medicine: A Plea for Reconsideration
Peter M. Zygmunt, David A. Andersson, Edward D. Hogestatt, 9 - Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism
Gianluigi Tanda, Francesco E. Pontieri, Gaetano Di Chiara, Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism
Ng Lky, Delta-9-tetrahydrocannabinol and Ethanol: Differential Effects on Sympathetic Activity in Differing Environmental Settings,
Kohn PM, Mercer GW, Drug Use, Drug-Use Attitudes, and Authoritarian-Rebellion Dimension
Goode E, Marijuana and the Politics of Reality
Bessey EA, Sex problems in hemp
David Robbe, Manfred Kopf, Anne Remaury, Joel Bockaert, Olivier J. Manzoni, Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Istvan Katona, Beata Sperlagh, Attila Sik, Attila Kafalvi, E. Sylvester Vizi, Ken Mackie, and Tamas F. Freund, Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
A. J. Hampson, M. Grimaldi, J. Axelrod, D. Wink, Cannabidiol and ()9-tetrahydrocannabinol are neuroprotective antioxidants
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli, Michael H. Bracey, Dan K. Giang, Billy R. Martin, Aron H. Lichtman, Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
Bradbury J, Small part of cannabis puzzle solved by animal studies
Kondro W, Medicinal marijuana users in Canada must carry identification cards.
Mike Trace, Marcus Roberts, Axel Klein, ASSESSING DRUG POLICY PRINCIPLES & PRACTICE
Vincenzo Di Marzo, Tiziana Bisogno and Luciano De Petrocellis, Anandamide: some like it hot
Sandor Batkai, Zoltan Jarai, Jens A. Wagner, Sravan K. Goparaju, Karoly Varga, Jie Liu, Lei Wang, Faridoddin Mirshahi, Atmaram D. Khanolkar, Alexandros Makriyannis, Renata Urbaschek, Nelson Garcia Jr, Arun J. Sanyal, George Kunos, Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
Tramer MR et.al., Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Litscher G, Wenzel G, Niederwieser G, Schwarz G., Effects of QiGong on Brain Function
Li X. Zhu, Sherven Sharma, Marina Stolina, Brian Gardner, Michael D. Roth, Donald P. Tashkin and Steven M. Dubinett, Delta-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
Cimons M, US to make research marijuana more accessible
McPartland JM, Dide Effects of Pharmaceuticals not Elicited by Comparable Herbal Medicines: The case of Tetrahydrocannabinol and Marijuana
William S. Edgemond, Marcie J. Greenberg, P. J. Mcginley, Shanmugam Muthian, William B. Campbell and Cecilia J. Hillard, Synthesis and Characterization of Diazomethylarachidonyl Ketone: An Irreversible Inhibitor of N- Arachidonylethanolamine Amidohydrolase1
T. Bisogno, D. Melck, L. De Petrocellis, M. Yu. Bobrov, N. M. Gretskaya, V. V. Bezuglov, N. Sitachitta, W. H. Gerwick, V. Di Marzo, Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
A.J. HAMPSON, M. GRIMALDI, M. LOLIC, D. WINK, R. ROSENTHAL,, Neuroprotective Antioxidants from Marijuana
W. Twitchell, S. Brown, K. Mackie,, 2 Cannabinoids Inhibit N- and P/Q-Type Calcium Channels in Cultured Rat Hippocampal Neurons
Enrique M. Ostrea, Jr, MD, Anthony R. Ostrea, BS, Pippa M. Simpson, PhD, Mortality Within the First 2 Years in Infants Exposed to Cocaine, Opiate, or Cannabinoid During Gestation
Fink M, Marijuana the Forbidden Medicine, book review,
Futoshi Taura, Satoshi Morimoto, Yukihiro Shoyama, Purification and Characterization of Cannabidiolic-acid Synthase from Cannabis sativa L. biochemical analysis of a novel enzyme that catalyzes the oxidocyclization of cannabigerolic acid to cannabidiolic acid
Kirsten Kempe, Fong-Fu Hsu, Alan Bohrer, John Turk, Isotope Dilution Mass Spectrometric Measurements Indicate That Arachidonylethanolamide, the Proposed Endogenous Ligand of the Cannabinoid Receptor, Accumulates in Rat Brain Tissue Post Mortem but Is Contained at Low Levels in or Is Absent from Fresh Tissue
M. Navarro, M. R. A. Carrera, W. Fratta, O. Valverde, G. Cossu, L. Fattore, J. A. Chowen, R. Gomez, I. del Arco, M. A. Villanua, R. Maldonado, G. F. Koob, and F. Rodriguez de Fonseca, Functional Interaction between Opioid and Cannabinoid Receptors in Drug Self-Administration
Maoxing Shen, Timothy M. Piser, Virginia S. Seybold, Stanley A. Thayer, Cannabinoid Receptor Agonists Inhibit Glutamatergic Synaptic Transmission in Rat Hippocampal Cultures
Dalterio S et.al., Delta-9 tetrahydrocannabinol Increases Plasma testoterone Concentrations in Mice
Lemberger L et.al., delta-9-Tetrahydrocannabinol: metabolism and Disposition in Long-Term Marihuana Smokers
Walsh GW, Mann RE, On the High Road: Driving Under the Influence of Cannabis in Ontario
SP Welch, DL Stevens, Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice
Guy Chiu-Kai Chan, Thomas R. Hinds, Soren Impey, Daniel R. Storm, Hippocampal Neurotoxicity of 9-Tetrahydrocannabinol
PB Smith, DR Compton, SP Welch, RK Razdan, R Mechoulam, BR Martin,, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice
Turner JC et.al., Gland Distribution and Cannabinoid Content in Clones of cannabis sativa L
Sharma GK, Altitudinal Variation in Leaf Epidermal Patterns of Cannabis sativa
Hammond CT, Mahlberg PG, Morphology of Glandular Hairs of Cannabis Sativa from Scanning Electron Microscopy
Takayuki Sugiura, Sachiko Kondo, Seishi Kishimoto, Tomoyuki Miyashita, Shinji Nakane, Tomoko Kodaka, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor Comparison of the agonistic activities of various cannabinoid receptor ligands in hl-60 cells
Kassirer JP,, Federal Foolishness and Marijuana
Liliana B. Menalled, Marie-Françoise Chesselet, Mouse models of Huntington's disease
Crawford Vivienne, The Homelie Herbe
Somnath Mukhopadhyay, Helen H. McIntosh, Devin B. Houston, Allyn C. Howlett, The CB1 Cannabinoid Receptor Juxtamembrane C-Terminal Peptide Confers Activation to Specific G proteins in Brain
Zhao-Hui Song, Carole-Anne Slowey, Involvement of Cannabinoid Receptors in the Intraocular Pressure-Lowering Effects of WIN55212-21
Cimmons M, Opposition to new marijuana research rules
Maoxing Shen, Stanley A. Thayer, 9-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture
Marc A. Schuckit, M.D., Jean-Bernard Daeppen, M.D., George P. Danko, Ph.D., Megan L. Tripp, B.A., Tom L. Smith, Ph.D., Ti.-K. Li, M.D., Victor M. Hesselbrock, Ph.D. and Kathleen K. Bucholz, Ph.D, Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component
Marco A. Diana, Carole Levenes, Ken Mackie, Alain Marty, Short-Term Retrograde Inhibition of GABAergic Synaptic Currents in Rat Purkinje Cells Is Mediated by Endogenous Cannabinoids
Stella N, How might cannabinoids influence sexual behavior?
Mani SK et.al., Progesterone receptor and dopamine receptors are required in delta-9-tetrahydrocannabinol modulation of sexual receptivity in female rats.
Sharon Begley, Searching for the God within
Takayuki Sugiura, Tomoko Kodaka, Shinji Nakane, Tomoyuki Miyashita, Sachiko Kondo, Yoshitomo Suhara, Hiroaki Takayama, Keizo Waku, Chiyo Seki, Naomichi Baba, Yoshio Ishima, Evidence That the Cannabinoid CB1 Receptor Is a 2- Arachidonoylglycerol Receptor structure-activity relationship of 2- arachidonoylglycerol, ether-linked analogues, and related compounds
Morris K, "Neural love triangle" leads to sexual receptivity
Haagen-Smit AJ et.al., A Physiologically Active Principle from Cannabis Sativa (Marijuana)
Paul Schweitzer, Cannabinoids Decrease the K+ M-Current in Hippocampal CA1 Neurons
Struempler RE, Nelson G, Urry FM, A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil
Lehmann T, Sager F, Brenneisen R, Excretion of cannabinoids in urine after ingestion of cannabis seed oil
DP Tashkin, MS Simmons, DL Sherrill, AH Coulson, Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age
Bennet WM, Legalization of marijuana for medical use
Warner R et.al., Substance Use Among the Mentally Ill; Prevalence, reasons for Use, and Effects on Illness
Haney A, Kutscheid BB, An Ecological Study of Naturalized Hemp (Cannabis sativa L.) in East-Central Illinois
Schaffner JH, The Fluctuation Curve of Sex Reversal in Staminate Hemp Plants Induced by Photoperiodicity
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
Robbe D et.al., Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens
Tiziana Bisogno et.al., The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors
Dave Bewley-Taylor and Mike Trace, THE INTERNATIONAL NARCOTICS CONTROL BOARD: WATCHDOG OR GUARDIAN OF THE UN DRUG CONTROL CONVENTIONS?
Transform Drug Policy Foundation, After the War on Drugs Options for Control
Marielle Portier, Murielle Rinaldi-Carmona, Florence Pecceu, Therese Combes, Caroline Poinot-Chazel, Bernard Calandra, Francis Barth, Gerard Le Fur and Pierre Casellas, SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist
Andrea G. Hohmann, Kang Tsou, and J. Michael Walker, Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat
Hugues Cadas, Emmanuelle di Tomaso, Daniele Piomelli, Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor, N-Arachidonoyl Phosphatidylethanolamine, in Rat Brain
Harrigan P, Are cannabis and psychosis linked?
David Shire, Christine Carillon, Mourad Kaghad, Bernard Calandra, Murielle Rinaldi-Carmona, Gerard Le Fur, Daniel Caput, Pascual Ferrara, An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*)
Rodriguez JJ et.al., Ultrastructural Localization of the CB1 Cannabinoid Receptor in m-Opioid Receptor Patches of the Rat Caudate Putamen Nucleus
Pulmgreen P et.al., Television Campaigns and Adolescent Marijuana Use: Tests of Sensation Seeking Targeting
Lester BM et.al, The maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report
Chaperon F, Soubrie P, Puech AJ, Thiebot MH, Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
Mahlberg PG, Kim ES, Secretory Visicle Formation in Glandular Trichomes of Cannabis sativa (Cannabacceae)
Kim ES, Mahlberg PG, Secretory Cavity Development in Glandular Thrichomes of Cannabis sativa L. (Cannabacceae),
Casswell S, Marks DF, Cannabis and temporal Disintegration in Experienced and naive Subjects,
Miller FA, The Propagation of Medicinal Plants
Tognetto M et.al., Anandamide Excites Central Terminals of Dorsal Root Ganglion Neurons via Vanilloid Receptor-1 Activation
French ED. Dillon K. Wu X, Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
Sandy Ghozland, Hans W. D. Matthes, Frederic Simonin, Dominique Filliol, Brigitte L. Kieffer, and Rafael Maldonado, Motivational Effects of Cannabinoids Are Mediated by -Opioid and -Opioid Receptors
Nahas GG et.al., Inhibition of Cellular Mediated Immunity in Marihuana Smokers
Hammond CT, Mahlberg PG, Ultrastructural Development of Capitate Glandular Hairs of Cannabis Sativa L. (Cannabaceae)
Alting Von Geusau N, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR, Impaired executive function in male MDMA ("ecstasy") users.
L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R. G. Pertwee, R. A. Ross, R. Mechoulam, E. Fride, HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
Cochran, T., Mindful Writing
Sara Kelly, Victoria Chapman, rapid communication: Selective Cannabinoid CB 1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo
Michelle Glass, John K. Northup, Agonist Selective Regulation of G Proteins by Cannabinoid CB1 and CB2 Receptors
Alex Straiker, Nephi Stella, Daniele Piomelli, Ken Mackie, Harvey J. Karten, Greg Maguire, Vertebrate retina: Localization and function of an endogenous signaling system
Amy C. Herring, Norbert E. Kaminski, Cannabinol-Mediated Inhibition of Nuclear Factor-B, cAMP Response Element-Binding Protein, and Interleukin-2 Secretion by Activated Thymocytes,
B.Y. Zeng, B. Dass, A. Owen, S. Rose, C. Cannizzaro, B.C. Tel, P. Jenner, Chronic l-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats
Swartz JA, Lurigio AJ, Psychotic illness and comorbidity among adult male detainess in drug treatment
D. W. Bonhaus, L. K. Chang, J. Kwan and G. R. Martin, Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses. Journal of Pharmacology
Daniele Piomelli, Massimiliano Beltramo, Andrea Giuffrida, Nephi Stella, Endogenous Cannabinoid Signaling
Christopher S. Breivogel, Steven R. Childers, The Functional Neuroanatomy of Brain Cannabinoid Receptors
D. W. Bonhaus, L. K. Chang, J. Kwan, G. R. Martin, Dual Activation and Inhibition of Adenylyl Cyclase by Cannabinoid Receptor Agonists: Evidence for Agonist-Specific Trafficking of Intracellular Responses
Smith R, Editorial: The war on drugs, Prohibition isn't working some legalisation will help
Hampson RE, Deadwyler SA, Role of cannabinoid receptors in memory storage.
Pros George Ireland, 2-amino-5-aryloxazoline products Patent Number 3,161,650
Heslop-Harrison, Suppressive Effects of 2-Thiouracil on Differentiation and Flowering in Cannabis sativa
Jonas S., Is Substance Abuse a Medical Problem?
Shu-Sen Cui, Rudy C. Bowen, Gui-Bao Gu, Darren K. Hannesson, Peter H. Yu, Xia Zhang, Prevention of Cannabinoid Withdrawal Syndrome by Lithium: Involvement of Oxytocinergic Neuronal Activation
Gardner EL, Vorel SR, Cannabinoid transmission and reward-related events. [Review] [314 refs]
Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J, Maldonado R, Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol
Frank Porreca, Josephine Lai, T. Philip Malan, Can inflammation relieve pain?
K Fischer-Stenger, DA Dove Pettit, GA Cabral,, Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events
Rettori V et.al., In Vitro Effect of Delta-9-Tetrahydrocannabinol to Stimulate Somatostatin Release and Block that of leutinizing Hormane-Releasing Hormone by Suppression of the Release of Prostaglandin E-2,
Vogelmann AF et.al., Cannabinoid Occurence in Seedlings of Cannabis sativa L.: Quantitation in Seedlings of Known Age and Primary Leaf Length
Kandel DB, Adler I, Socialization into Marijuana Use among French Aolescents: A Cross-Cultural Comparison with the United States
Manheimer DI et.al., Marijuana Use Among Urban Adults
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R, Isolation and structure of a brain constituent that binds to the cannabinoid receptor [see comments]
Lemberger L et.al., Marihuana: Studies on the Disposition and metabolism of Delta-9-Tetrahydrocannabinol in man
Valverde O et.al., Cannabinoid Withdrawl Syndrome Is reduced in Pre-Proenkephalin Knock-Out Mice
Laura J. Sim, Robert E. Hampson, Sam A. Deadwyler, and Steven R. Childers, Effects of Chronic Treatment with 9-Tetrahydrocannabinol on Cannabinoid- Stimulated [35S]GTPS Autoradiography in Rat Brain
Strassman RJ, Book Reveiw, Marijuna: The Forbidden Medicine
Weil AT et.al., Clinical and Psychological Effects of Marihuana in Man
Istvan Katona, Ede A. Rancz, Laszlo Acsady, Catherine Ledent, Ken Mackie, Norbert Hajos, Tamas F. Freund, Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission
William S. Aquilino, Leonard A. Lo Sciuto, Effects of Interview Mode on Self-Reported Drug Use
Annas GJ, Reefer Madness- The Federal Response to California's Medical-Marijuana Law
Professor Barry Chevannes, Chairman, Reverend Dr. Webster Edwards, Mr. Anthony Freckleton, Ms. Norma Linton, QC, Mr. DiMario McDowell, Dr. Aileen Standard-Goldson, Mrs. Barbara Smith, A Report of the National Commission on Ganja. To Rt. Hon. P.J. Patterson, Q.C., M.P. Prime Minister of Jamaica
Doblin R, The Media Does MDMA.
Marsicano, G., Wotjak, C. T., Azad, S. C., et al, The endogenous cannabinoid system controls extinction of aversive memories. Nature
Nathalie Niederhoffer, Bela Szabo, Cannabinoids Cause Central Sympathoexcitation and Bradycardia in Rabbits1
David J. Mason Jr, John Loweb and Sandra P. Welcha, Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception
Weigang Zhu, Herman Friedman and Thomas W. Klein, delta 9-Tetrahydrocannabinol Induces Apoptosis in Macrophages and Lymphocytes: Involvement of Bcl-2 and Caspase-11
Jeffrey A. Vivian, Shiroh Kishioka3, Eduardo R. Butelman4, Jillian Broadbear, Katherine O. Lee, James H. Woods, Analgesic, Respiratory and Heart Rate Effects of Cannabinoid and Opioid Agonists in Rhesus Monkeys: Antagonist Effects of SR 141716A
Mao L, Oh L, Does Marijuana or Crack Cocaine Case Cancer?
Ralf P. Brandes, Friedrich-Hubertus Schmitz-Winnenthal, Michel Feletou, Axel Godecke, Paul L. Huang, Paul M. Vanhoutte, Ingrid Fleming, and Rudi Busse, An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice
SAM LISTER, HEALTH CORRESPONDENT, Cannabis hope for bowel disease
Marx J, Marijuana Receptor Gene Cloned
Adams, R, Marihuana
Mechoulam M et.al., Chemical Basis of hashish Activity
Maugh TH, Marihuana (II): Does It Damage The Brain?
Petcoff DG et.al., Marihuana: Idnetification of Cannabinoids by Centrifugal Chromatography
Maugh TH, Marihuana: the grass May No Longer Be Greener
Ferraro L. et.al., The Cannabinoid Receptor Agonist WIN 55,212-2 Regulates Glutamate Transmissiion in Rat Cerebral Cortex: an In Vivo and In Vitro Study.
Stephen E. Straus, Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents
Kaplan J, Lasagna L, Academy Marijuana Report
YJ Jeon, KH Yang, JT Pulaski, NE Kaminski,, Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation
George B. Stefano, Yu Liu, Michael S. Goligorsky, Cannabinoid Receptors Are Coupled to Nitric Oxide Release in Invertebrate Immunocytes, Microglia, and Human Monocytes,
Gorsky J, Marijuana Test: No Ibuprofen Interference
Barsky SH et.al., histopathis and Molecular Alterations in Bronchial Epithelium in Habitual Smokers of Marijuana, Cocaine, and/or tobacco
Marco Diana, Miriam Melis, Anna Lisa Muntoni, and Gian Luigi Gessa, Mesolimbic dopaminergic decline after cannabinoid withdrawal
Kevin R. Kozak, Jeffery J. Prusakiewicz, Scott W. Rowlinson , Claus Schneider, Lawrence J. Marnett, Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol*
Robert J. McKallip, Catherine Lombard, Michael Fisher, Billy R. Martin, Seongho Ryu, Steven Grant, Prakash S. Nagarkatti, Mitzi Nagarkatti, Targeting CB2 Cannabinoid Receptors as a Novel Therapy to Treat Malignant Lymphoblastic Disease 1
S. D. Skaper, A. Buriani, R. Dal Toso, L. Petrelli, S. Romanello, L. Facci, A. Leon, The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
Rachel I. Wilson, Roger A. Nicoll, Endocannabinoid Signaling in the Brain
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss, Aviva Breuer, Raphael Mechoulam, Zvi Vogel, Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase
Coutts AA et.al., Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons
Norio Ishioka, Richard D. Bukoski, A Role for N-Arachidonylethanolamine (Anandamide) as the Mediator of Sensory Nerve-Dependent Ca2+-Induced Relaxation
Zbigniew K. Krowicki, Joseph M. Moerschbaecher, Peter J. Winsauer, Sivarao V. Digavalli, Pamela J. Hornby, 9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
A. Giuffrida, L. H. Parsons, T. M. Kerr, F. Rodríguez deFonseca, M. Navarro, D. Piomelli, Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Brian F. Thomas, Anne F. Gilliam, David F. Burch, Michael J. Roche Herbert H. Seltzman, Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists
Patricia C. Schmid, B. C. Paria, Randy J. Krebsbach, Harald H. O. Schmid, and S. K. Dey,, receptivity for embryo implantation
Michael Bayewitch, Man-Hee Rhee, Tomer Avidor-Reiss , Aviva Breuer, Raphael Mechoulam , Zvi Vogel, ()--Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl Cyclase
Dalterio S et.al., Cannabinoids in Male Mice: Effects on Fertility and Spermatogenesis
Liskow BI, Review of "Marijuana Deceptive Weed" by Gabriel Nahas
Steele T P, Nichols D E, Yim G K W, Stereoselective Effects of MDMA on Inhibition of Monoamine Uptake.
Levin J A, Schmidt C J, Lovenberg W, Release of [3H]-Monoamines from Superfused Rat Striatal Slices by Methylenedioxymethamphetamine (MDMA).
Stone D M, Stahl D C, Hanson G R, Gibb J W, Effects of 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA) on Tyrosine Hydroxylase and Tryptophane Hydroxylase Activity in the Rat Brain.
Mitka M, Therapeutic Marijuana use Supported While Proposed Study Done
Okey AB, Bondy GP, Delta-9-Tetrahydrocannabinol and 17 beta-Estradiol Bind to Different Macromolecules in Estrogen Target Tissues
S. Gonzlez, T. Bisogno, T. Wenger, J. Manzanares, A. Milone, F. Berrendero, V. Di Marzo, J. A. Ramos, J. J. Fernndez-Ruiz, Sex Steroid Influence on Cannabinoid CB1 Receptor mRNA and Endocannabinoid Levels in the Anterior Pituitary Gland
Andrea Giuffrida, Fernando Rodrguez de Fonseca, Daniele Piomelli, Quantification of Bioactive Acylethanolamides in Rat Plasma by Electrospray Mass Spectrometry
DePetrocellis D et.al., The activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and is Limited by Intracellular Metabolism
Peter Fried, Barbara Watkinson, Deborah James, Robert Gray, Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults
Hollister LE, Marihuana in Man: Three Years Later
Tetsuya Nagayama, Amy D. Sinor, 2, Roger P. Simon, Jun Chen, Steven H. Graham, Kunlin Jin, David A. Greenberg, Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures
J.-M. Derocq, M. Bouaboula, J. Marchand M. Rinaldi-Carmona, M. Segui, P. Casellas, The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
Hawkins BL, Roberts JD, Nuclear Magnetic Resonance Spectroscopy: fourier Transform Spectra of Delta-8 and Delta-9 tetrahydrocannabinol
National Institutes of Health, Transcript of the NIH Workshop on the Medical Utility of Marijuana. Tab B, Deliberations of the Ad Hoc Group of Experts;
Eve Conant, A Psychedelic Cure
Jonathan Knight, Buddhism on the brain
F. Rodriguez de Fonseca, M. Navarro, R. Gomez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodriguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gallk & D. Piomelli, An anorexic lipid mediator regulated by feeding
Robert I. Block, Daniel S. OLeary, Richard D. Hichwa, Jean C. Augustinack, Laura L. Boles Ponto, M.M. Ghoneim, Stephan Arndt, Richard R. Hurtig, G. Leonard Watkins, James A. Hall, Peter E. Nathan, Nancy C. Andreasen, Effects of frequent marijuana use on memory-related regional cerebral blood flow
Campbell FA et.al., Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Fiona A Campbell, Martin R Tramèr, Dawn Carroll, D John M Reynolds, R Andrew Moore, Henry J McQuay, Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Fanchamps, A., Some Compounds with Hallucinogenic Activity.
Jacob Michael S, Presti David E, Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine
Stone R, Reefer Madness At FDA
Marcel A.K. Jansen, Victor Gaba and Bruce M. Greenberg, Higher plants and UV-B radiation: balancing damage, repair and acclimation [Review article]
Marcia Barinaga, How Cannabinoids Work in the Brain
Sheldon T, Medicinal marijuana provided at cost price
David Gurwitz, Selective CB 2 cannabinoid antagonists - potential new immune modulators? Emerging molecular targets [Profiles]
MARCIA BARINAGA, Studying the Well-Trained Mind
M King, E Coker, G Leavey, A Hoare, E Johnson-Sabine, Incidence of psychotic illness in London: comparison of ethnic groups
Carlson, L. E., Speca, M., Patel, K. D., et al, Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients.
Kristen Philipkoski, Long Trip for Psychedelic Drugs
Fernando Rodríguez de Fonseca, M. Rocio A. Carrera, Miguel Navarro, George F. Koob, Friedbert Weiss, Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Mullner M, Medical use of cannabis
Zoltan Kiss, Anandamide stimulates phospholipase D activity in PC12 cells but not in NIH 3T3 fibroblasts
Jose Luis Cantero Mercedes Atienza Rosa M. Salas, State-modulation of cortico-cortical connections underlying normal EEG alpha variants
The National Association of Attorneys General, Resolution, Committee on Criminal Law and Law Enforcement XI
W. Poldinger, Zur Pharmakotherapie depressiver und angstlicher Verstimmungszustande
Ferriman A, Regulators accused of bias against cannabis based medicines
MacReady N, Government agents raid the Cannabis Buyers' Club
Mayor S, BMA wants licensing of cannabis to be changed,
M. Beltramo, N. Stella, A. Calignano, S. Y. Lin, A. Makriyannis, D. Piomelli, Functional Role of High Affinity Anandamide Transport, as Revealed by Selective Inhibition
Almaula, N., Ebersole, B. J., Zhang, D., et al, Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
Lehmann, D., Faber, P. L., Gianotti, L. R., et al, Coherence and phase locking in the scalp EEG and between LORETA model sources, and microstates as putative mechanisms of brain temporo-spatial functional organization.
Nutt,David, A tale of two Es.
Khodayar,Mohammad Javad et al, Antinociceptive effect of spinally administered cannabinergic and alfa 2- adrenoceptor drugs on the formalin test in rat: possible interactions.
Wadsworth, E. J. K.; Moss,S. C.; Simpson,S. A.; Smith,A. P., Cannabis use, cognitive performance and mood in a sample of workers.
Nutt,D. J., Alcohol alternatives – a goal for psychopharmacology?
Thornton,Allen E.;Van Snellenberg,Jared X.;Sepehry,Amir A.;Honer,William G., The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review.
Wadsworth, E. J. K.; Moss,S. C.; Simpson,S. A.; Smith,A. P., A community based investigation of the association between cannabis use, injuries and accidents.
Behrendt,Ralf-Peter, Dysregulation of thalamic sensory ‘transmission’ in schizophrenia: neurochemical vulnerability to hallucinations.
Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E, Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex.
Falck RS, Wang J, Carlson RG, Siegal HA, Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R, Ethanol, 3,4-Methylenedioxymethamphetamine (Ecstasy) and Their Combination: Long-Term Behavioral, Neurochemical and Neuropharmacological Effects in the Rat.
Roiser JP, Cook LJ, Cooper JD, Rubinsztein DC, Sahakian BJ, Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users.
Bubeníkova V, Votava M, Horácek J, Pálenícek T, Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA).
Fantegrossi WE, Kiessel CL, De La Garza R, Woods JH, Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Wang X, Baumann MH, Xu H, Morales M, Rothman RB, ({+/-})-3,4-Methylenedioxymethamphetamine (MDMA) Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter its Distribution Between Endosomes and the Plasma Membrane.
Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH, Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Johanson CE, Kilbey M, Gatchalian K, Tancer M, Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA, Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons.
Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA, Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
de la Torre R, Farré M, O Mathúna B, Roset PN, Pizarro N, Segura M, Torrens M, Ortuño J, Pujadas M, Camí J, MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.
Fisk JE, Montgomery C, Wareing M, Murphy PN, Reasoning deficits in ecstasy (MDMA) polydrug users.
Fisk JE, Montgomery C, Wareing M, Murphy PN, Reasoning deficits in ecstasy (MDMA) polydrug users.
Koenig J, Lazarus C, Jeltsch H, Ben Hamida S, Riegert C, Kelche C, Jones BC, Cassel JC, MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females.
O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI, Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX, Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT(2A) and 5-HT(1A) Agonist Psilocybin.
Parrott AC, Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
Rizzo M, Lamers CT, Sauer CG, Ramaekers JG, Bechara A, Andersen GJ, Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users.
Gamma A, Jerome L, Liechti ME, Sumnall HR, Is ecstasy perceived to be safe? A critical survey.
Vollenweider FX, Liechti ME, Paulus MP, MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
Patel MM, Belson MG, Wright D, Lu H, Heninger M, Miller MA, Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: An autopsy study.
Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA, Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR, Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR, Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
Marona-Lewicka D, Thisted RA, Nichols DE, Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Lile JA, Ross JT, Nader MA, A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.
Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN, Syllogistic reasoning performance in MDMA (Ecstasy) users.
Jaehne EJ, Salem A, Irvine RJ, Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
Segura M, Farré M, Pichini S, Peiró AM, Roset PN, Ramírez A, Ortuño J, Pacifici R, Zuccaro P, Segura J, de la Torre R, Contribution of Cytochrome P450 2D6 to 3,4-Methylenedioxymethamphetamine Disposition in Humans : Use of Paroxetine as a Metabolic Inhibitor Probe.
Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J, Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use
McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA, Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [(11)C]McN5652 and [(11)C]DASB.
Connor TJ, Harkin A, Kelly JP, Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10.
Verdejo-García AJ, López-Torrecillas F, Aguilar de Arcos F, Pérez-García M, Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis.
Wareing M, Fisk JE, Murphy P, Montgomery C, Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy').
Passie T, Hartmann U, Schneider U, Emrich, HM,Kruger, THC (2005), Ecstasy (MDMA) mimics the post-orgasmic state: Impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion
Escobedo I, O'shea E, Orio L, Sanchez V, Segura M, de la Torre R, Farre M, Green AR, Colado MI, A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
Duarte JA, Leão A, Magalhães J, Ascensão A, Bastos ML, Amado FL, Vilarinho L, Quelhas D, Appell HJ, Carvalho F, Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.
Arnold, J. C., The role of endocannabinoid transmission in cocaine addiction
Kings County Bar Association, Effective Drug Control: Toward A NEw Legal Framework
Caspi A, Moffit T, Cannon M, McLay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Brathwaite A, Poulton R, Craig I, Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction
Danielle C. Turner, Luke Clark, Jonathan Dowson, Trevor W. Robbins, and Barbara J. Sahakian, Modafinil Improves Cognition and Response Inhibition in Adult Attention-Deficit/Hyperactivity Disorder
Jonathan P. Roiser, Lynnette J. Cook, Jason D. Cooper, David C. Rubinsztein, Barbara J. Sahakian,, Association of a Functional Polymorphism in the Serotonin Transporter Gene With Abnormal Emotional Processing in Ecstasy Users
B. Rael Cahn, John Polich, Meditation States and Traits: EEG, ERP, and Neuroimaging Studies
Igor Grant M.D.,B. Rael Cahn, M.S., Cannabis and endocannabinoid modulators: therapeutic promises and challenges
Bernard Le Foll and Steven R. Goldberg, CANNABINOID CB1 RECEPTOR ANTAGONISTS AS PROMISING NEW MEDICATIONS FOR DRUG DEPENDENCE
Hill, M. N., Patel, S., Carrier, E. J., et al, Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
Beckman, N. J., Zacny, J. P., and Walker, D. J., Within-subject comparison of the subjective and psychomotor effects of a gaseous anesthetic and two volatile anesthetics in healthy volunteers
Dafters, R. I., Impulsivity, inhibition and negative priming in ecstasy users
Medina, K. L., Shear, P. K., and Corcoran, K., Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective.
Patel, M. M., Belson, M. G., Longwater, A. B., et al, Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
Young, R., Khorana, N., Bondareva, T., et al, Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA).
Dietz, B. M., Mahady, G. B., Pauli, G. F., et al, Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
Ludewig, S., Geyer, M. A., Ramseier, M., et al, Information-processing deficits and cognitive dysfunction in panic disorder.
O'sullivan, S. E., Tarling, E. J., Bennett, A. J., et al, Novel time-dependent vascular actions of Delta(9)-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma.
Patton, G. C., Coffey, C., Carlin, J. B., et al, Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence.
Bhat, R., Chari, G., and Rao, R., Effects of prenatal cocaine, morphine, or both on postnatal opioid (A) receptor development
Russo, E. B., Burnett, A., Hall, B., et al, Agonistic Properties of Cannabidiol at 5-HT1a Receptors
Blake, D. R., Robson, P., Ho, M., et al, Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Henry, L. K., Field, J. R., Adkins, E. M., et al, TYR95 and ILE172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high-affinity recognition of antidepressants.
Kuypers, K. P. and Ramaekers, J. G., Transient memory impairment after acute dose of 75 mg 3.4-Methylenedioxymethamphetamine dioxymethamphetamine
Liu, J., Ji, X. Q., and Zhu, X. Z., Comparison of psychic emergence reactions after (~)-ketamine and (+)-ketamine in mice.
Mannila, J., Jarvinen, T., Jarvinen, K., et al, Sublingual administration of Delta(9)-tetrahydrocannabinol,beta-cyclodextrin complex increases the bioavailability of Delta(9)-tetrahydrocannabinol in rabbits.
Pechnick, R. N., Bresee, C. J., and Poland, R. E., The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine.
Piper, B. J. and Meyer, J. S., Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
Rapaka, R., Natureceuticals (natural products), herbal botanicals, psychoactives, hallucinogenics and related products.
Schifano, F., Deluca, P., Agosti, L., et al, New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
Schreckenberger, M., "Ecstasy"-induced neurotoxicity: the contribution of functional brain imaging.
Schwabe, R. F. and Siegmund, S. V., Potential Role of CB2 Receptors in Cannabis Smokers With Chronic Hepatitis C.
, Using In Vitro Models for Expression Profiling Studies on Ethanol and Drugs of Abuse.
Tognolini, M., Barocelli, E., Ballabeni, V., et al, Comparative screening of plant essential oils: Phenylpropanoid moiety as basic core for antiplatelet activity.
Balunas, M. J. and Kinghorn, A. D., Drug discovery from medicinal plants
Buckner, J. D., Schmidt, N. B., Bobadilla, L., et al, Social anxiety and problematic cannabis use: Evaluating the moderating role of stress reactivity and perceived coping.
Carai, M. A., Colombo, G., and Gessa, G. L., Rimonabant: The first therapeutically relevant cannabinoid antagonist.
Casco, C., Forcella, M., Beretta, G., et al, Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
Cheng, J. Y., Chan, D. T., and Mok, V. K., An epidemiological study on alcohol/drugs related fatal traffic crash cases of deceased drivers in Hong Kong between 1996 and 2000.
Cole, J. C., Michailidou, K., Jerome, L., et al, The effects of stereotype threat on cognitive function in ecstasy users.
Craft, R. M., Sex differences in behavioral effects of cannabinoids.
Csomor, P. A., Vollenweider, F. X., Feldon, J., et al, On the feasibility to detect and to quantify prepulse-elicited reaction in prepulse inhibition of the acoustic startle reflex in humans.
Elsohly, M. A. and Slade, D., Chemical constituents of marijuana: The complex mixture of natural cannabinoids.
Erkens, J. A., Janse, A. F., and Herings, R. M., Limited use of medicinal cannabis but for labeled indications after legalization.
Freedman, R. R., Johanson, C. E., and Tancer, M. E., Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Gamma, A., Brandeis, D., Brandeis, R., et al, The P3 in ‘ecstasy’ polydrug users during response inhibition and execution.
Gul, W. and Hamann, M. T., Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.
Gupta, D., Agarwal, A., and Dhiraaj, S., Ketamine for treatment of catheter-related bladder discomfort.
Hall, W. D. and Lynskey, M., Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.
Halpern, J. H. and Sewell, R. A., Hallucinogenic botanicals of America: A growing need for focused drug education and research.
Herning, R. I., Better, W., Tate, K., et al, Neuropsychiatric Alterations in MDMA Users Preliminary Findings.
Hilber, B., Scholze, P., Dorostkar, M. M., et al, Serotonin-transporter mediated efflux: A pharmacological analysis of amphetamines and non-amphetamines.
Howard, J., Anie, K. A., Holdcroft, A., et al, Cannabis use in sickle cell disease: a questionnaire study
Itzhak, Y. and Ali, S. F., Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs.
Jiang, W., Zhang, Y., Xiao, L., et al, Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.
Johansen, S. S. and Jensen, J. L., Liquid chromatography–tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case
Kedzior, K. K. and Martin-Iverson, M., Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans.
Li, C. and Oberlies, N. H., The most widely recognized mushroom: Chemistry of the genus Amanita.
Libiseller, K., Pavlic, M., Grubwieser, P., et al, An announced suicide with ecstasy
Libiseller, K., Pavlic, M., Grubwieser, P., et al, Ecstasy—deadly risk even outside rave parties
Liechti, M. E., Kunz, I., Greminger, P., et al, Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
Lindsay, A. C., Foale, R. A., Warren, O., et al, Cannabis as a precipitant of cardiovascular emergencies.
Lindsay, A. C., Foale, R. A., Warren, O., et al, Cannabis as a precipitant of cardiovascular emergencies.
McCurdy, C. R. and Scully, S. S., Analgesic substances derived from natural products (natureceuticals).
McNamara, R., Kerans, A., O'neill, B., et al, Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (‘‘Ecstasy’’) and MDA (‘‘Love’’).
Morgan, C. J., Rossell, S. L., Pepper, F., et al, Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users.
Murck, H., Spitznagel, H., Ploch, M., et al, Hypericum Extract Reverses S-Ketamine-Induced Changes in Auditory Evoked Potentials in Humans – Possible Implications for the Treatment of Schizophrenia.
Nishiyama, T., Changes in the auditory evoked potentials index by induction doses of four different intravenous anesthetics.
O'connor, K. A. and Roth, B. L., Screening the receptorome for plant-based psychoactive compounds.
Parwani, A., Weiler, M. A., Blaxton, T. A., et al, The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Pijlman, F. T., Rigter, S. M., Hoek, J., et al, Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops.
Bisogno, T., Ligresti, A., and Di, M., V, The endocannabinoid signalling system: Biochemical aspects.
Bruijnzeel, A. W. and Gold, M. S., The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
Cairns, B. E., Svensson, P., Wang, K., et al (, Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males.
Carter, O. L., Presti, D. E., Callistemon, C., et al, Meditation alters perceptual rivalry in Tibetan Buddhist monks.
Castane, A., Berrendero, F., and Maldonado, R., The role of the cannabinoid system in nicotine addiction.
Chalmers, R., Transcendental meditation does not predispose to epilepsy.
Cohen, C., Kodas, E., and Griebel, G., CB1 receptor antagonists for the treatment of nicotine addiction
Colombo, G., Serra, S., Vacca, G., et al, Endocannabinoid system and alcohol addiction: Pharmacological studies.
Curiati, J. A., Bocchi, E., Freire, J. O., et al, Meditation Reduces Sympathetic Activation and Improves the Quality of Life in Elderly Patients with Optimally Treated Heart Failure: A Prospective Randomized Study.
Deng, G. and Cassileth, B. R., Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance.
Di, B. M., D'addario, C., Candeletti, S., et al, Chronic and acute effects of 3,4-methylenedioxy-n-methylamphetamine ('Ecstasy') administration on the dynorphinergic system in the rat brain.
Di, B. M., D'addario, C., Candeletti, S., et al, Neuropsychopharmacology of drug seeking: Insights from studies with second-order schedules of drug reinforcement.
Elliott, S. and Burgess, V., The presence of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic and non-alcoholic beverages.
Fattore, L., Deiana, S., Spano, S. M., et al, Endocannabinoid system and opioid addiction: Behavioural aspects.
Fowler, C. J., Holt, S., Nilsson, O., et al, The endocannabinoid signaling system: Pharmacological and therapeutic aspects.
Gardner, E. L., Endocannabinoid signaling system and brain reward: Emphasis on dopamine.
Ghisolfi, E. S., Schuch, A., Strimitzer, I. M., Jr., et al, Caffeine modulates P50 auditory sensory gating in healthy subjects.
Gonzalez, S., Cebeira, M., and Fernandez-Ruiz, J., Cannabinoid tolerance and dependence: A review of studies in laboratory animals
Grant, J. A. and Rainville, P., Hypnosis and meditation: similar experiential changes and shared brain mechanisms.
Jaseja, H., Meditation may predispose to epilepsy: an insight into the alteration in brain environment induced by meditation.
Johansen, S. S. and Jensen, J. L., Liquid chromatography–tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case.
Jones, A. W., Driving Under the Influence of Drugs in Sweden with Zero Concentration Limits in Blood for Controlled Substances.
Justinova, Z., Goldberg, S. R., Heishman, S. J., et al, Self-administration of cannabinoids by experimental animals and human marijuana smokers.
Kakigi, R., Nakata, H., Inui, K., et al, Intracerebral pain processing in a Yoga Master who claims not to feel pain during meditation.
Kikura-Hanajiri, R., Hayashi, M., Saisho, K., et al, Simultaneous determination of nineteen hallucinogenic tryptamines/-calbolines and phenethylamines using gas chromatography–mass spectrometry and liquid chromatography–electrospray ionisation-mass spectrometry.
Killestein, J. and Uitdehaag, B. M., Cannabinoids in multiple sclerosis: urgent need for long term trials.
Kos, T., Popik, P., Pietraszek, M., et al, Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.
Lundqvist, T., Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions.
Nicholson, P., Does meditation predispose to epilepsy? EEG studies of expert meditators self-inducing simple partial seizures.
Ostroff, R., Gonzales, M., and Sanacora, G., Antidepressant Effect of Ketamine During ECT.
Panchal, V., Taraschenko, O. D., Maisonneuve, I. M., et al, Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.
Pazos, M. R., Nunez, E., Benito, C., et al, Functional neuroanatomy of the endocannabinoid system.
Rippentrop, E. A., Altmaier, E. M., Chen, J. J., et al, The relationship between religion/spirituality and physical health, mental health, and pain in a chronic pain population.
Rohsenow, D. J., Martin, R. A., and Monti, P. M., Urge-specific and lifestyle coping strategies of cocaine abusers: Relationships to treatment outcomes.
Sala, M. and Braida, D., Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
Salzmann, J., Canestrelli, C., Noble, F., et al, Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.
Schneider, R. H., Alexander, C. N., Staggers, F., et al, Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.
Schneider, R. H., Alexander, C. N., Staggers, F., et al, A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year.
Scott, J. A., Kearney, N., Hummerston, S., et al, Use of complementary and alternative medicine in patients with cancer: A UK survey.
Shetty, R. C., Meditation and its implications in non pharmacological management of stress related emotions and cognitions.
Taffe, M. A., Lay, C. C., Von Huben, S. N., et al, Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.
Takahashi, T., Murata, T., Hamada, T., et al, Changes in EEG and autonomic nervous activity during meditation and their association with personality traits.
Vigano, D., Rubino, T., and Parolaro, D., Molecular and cellular basis of cannabinoid and opioid interactions.
Viveros, M. P., Marco, E. M., and File, S. E., Endocannabinoid system and stress and anxiety responses.
Wachholtz, A. B. and Pargament, K. I., Is Spirituality a Critical Ingredient of Meditation? Comparing the Effects of Spiritual Meditation, Secular Meditation, and Relaxation on Spiritual, Psychological, Cardiac, and Pain Outcomes.
Wall, R. B., Tai Chi and mindfulness-based stress reduction in a Boston Public Middle School.
Wilson, C., Cone, K., Kercher, M., et al, Naloxone increases ketamine-induced hyperactivity in the open field in female rats.
Winter, J. C., Kieres, A. K., Zimmerman, M. D., et al, The stimulus properties of LSD in C57BL/6 mice
Yip, J. T. and Lee, T. M., Selective impairment of sadness and disgust recognition in abstinent ecstasy users.
Zajicek, J. P., Sanders, H. P., Wright, D. E., et al, Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Darvesh AS, Yamamoto BK, Gudelsky GA, Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, Maurer HH, Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs 3,4-Methylenedioxyamphetamine, 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine and Its Application to Samples from a Controlled Study with MDMA.
Sumnall HR, Cole JC, Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis.
Saadat KS, O'shea E, Colado MI, Elliott JM, Green AR, The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Bexis S, Docherty JR, Role of alpha(2A)-adrenoceptors in the effects of MDMA on body temperature in the mouse.
Green AR, O'shea E, Saadat KS, Elliott JM, Colado MI, Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.
Hendrickson JC, Gerstein DR, Criminal involvement among young male ecstasy users.
Barrett SP, Gross SR, Garand I, Pihl RO, Patterns of simultaneous polysubstance use in Canadian rave attendees.
M ter Bogt TF, Engels RC, "Partying" hard: party style, motives for and effects of MDMA use at rave parties.
McElrath K, MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk.
Levy KB, O'Grady KE, Wish ED, Arria AM, An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.
Clatts MC, Goldsamt LA, Yi H, Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile.
Banta-Green C, Goldbaum G, Kingston S, Golden M, Harruff R, Logan BK, Epidemiology of MDMA and associated club drugs in the Seattle area.
Degenhardt L, Copeland J, Dillon P, Recent trends in the use of "club drugs": an Australian review.
Maxwell JC, Party drugs: properties, prevalence, patterns, and problems.
Soellner R, Club drug use in Germany.
McCaughan JA, Carlson RG, Falck RS, Siegal HA, From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
Kelly BC, Conceptions of risk in the lives of club drug-using youth.
Ompad DC, Galea S, Fuller CM, Edwards V, Vlahov D, Ecstasy use among Hispanic and black substance users in New York City.
Maxwell JC, Spence RT, Profiles of club drug users in treatment.
Joe Laidler KA, The rise of club drugs in a heroin society: the case of Hong Kong.
Fernández MI, Bowen GS, Varga LM, Collazo JB, Hernandez N, Perrino T, Rehbein A, High rates of club drug use and risky sexual practices among Hispanic men who have sex with men in Miami, Florida.
Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Daumann J, Obradovic M, Kovar KA, Inhibition of Return in the Human 5HT(2A) Agonist and NMDA Antagonist Model of Psychosis.
Clemens KJ, Cornish JL, Li KM, Hunt GE, McGregor IS, MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A, Mental disorders in current and former heavy ecstasy (MDMA) users.
Moskalenko Yu.E., Kravchenko T.I., INTRACRANIAL LIQUORODYNAMICS: FUNDAMENTAL BACKGROUND AND PRACTICAL APPLICATION
Yu. MOSKALENKO, T. KRAVCHENKO, G. WEINSTEIN., COMPARISON OF MANUAL AND INSRTRUMENTAL PRM PARAMETERS DETERMINASTION: SIMILARITIES, DIFFERENCIES, COMTRADICTIONS.
Alex Stevens, Mike Trace and Dave Bewley-Taylor, REDUCING DRUG RELATED CRIME: AN OVERVIEW OF THE GLOBAL EVIDENCE
Marcus Roberts, David Bewley-Taylor and Mike Trace, FACING THE FUTURE: THE CHALLENGE FOR NATIONAL & INTERNATIONAL DRUG POLICY
Paterson, D. S., Belliveau, R. A., Trachtenberg, F., et al, Differential development of 5-HT receptor and the serotonin transporter binding in the human infant medulla.
Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E, Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Carlini EA., The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.
Di Marzo V, Bifulco M, De Petrocellis L., The endocannabinoid system and its therapeutic exploitation.
Butler GK, Montgomery AM, Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
Blessing WW, Clozapine and olanzapine, but not haloperidol, reverse cold-induced and lipopolysaccharide-induced cutaneous vasoconstriction.
Fantegrossi WE, Woods JH, Winger G, Kilbourn M, Sherman P, Woolverton WL, Yuan J, Hatzidimitriou G, Ricaurte GA, Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004).
Parrott AC, MDMA and the Loss of Reinforcement in Fantegrossi et al (2004).
Brvar M, Kozelj G, Osredkar J, Mozina M, Gricar M, Bunc M, Polydipsia as another mechanism of hyponatremia after â€˜ecstasyâ€™ (3,4 methyldioxymethamphetamine) ingestion.
Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgansberger W, Rammes G., Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.
king w, α alex, xyz
king w, γ alex, testing
McFarland MJ, Barker EL., Anandamide transport
Jones DC, Lau SS, Monks TJ, THIOETHER METABOLITES OF MDA AND MDMA INHIBIT hSERT FUNCTION AND SIMULTANEOUSLY STIMULATE DOPAMINE UPTAKE INTO hSERT-EXPRESSING SK-N-MC CELLS.
Sveen ML, Knudsen GM, Aznar S, No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures.
Johnson EA, O'Callaghan JP, Miller DB, Brain concentrations of d-MDMA are increased after stress.
De Micheli D, Formigoni ML, Drug use by Brazilian students: associations with family, psychosocial, health, demographic and behavioral characteristics.
Colado MI, O'Shea E, Green AR, Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.
Parrott AC, Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA, MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice.
Bubar MJ, Pack KM, Frankel PS, Cunningham KA, Effects of dopamine D(1)- or D(2)-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.
Schifano F, A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities.
Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G, Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.
Moyano S, Frechilla D, Del Rí¯ J, NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment.
Green AR, Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI, Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Quate L, McBean DE, Ritchie IM, Olverman HJ, Kelly PA, Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat.
O'Regan MC, Clow A, Decreased pain tolerance and mood in recreational users of MDMA.
Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS, MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C, Chronic MDMA (ecstasy) use, cognition and mood.
Fantegrossi WE, Kiessel CL, Leach PT, Martin CV, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH, Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
Heekeren K, Daumann J, Geyer MA, Gouzoulis-Mayfrank E, Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.
Quednow BB, Kuhn KU, Hoenig K, Maier W, Wagner M, Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
Beveridge TJ, Mechan AO, Sprakes M, Pei Q, Zetterstrom TS, Green AR, Elliott JM, Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.
Curran HV, Rees H, Hoare T, Hoshi R, Bond A, Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users.
Farre M, De La Torre R, O Mathuna B, Roset PN, Peiro AM, Torrens M, Ortuna J, Pujadas M, Cami J, Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.
Lawrence NS, Williams AM, Surguladze S, Giampietro V, Brammer MJ, Andrew C, Frangou S, Ecker C, Phillips ML., Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression.
Lora-Tamayo C, Tena T, Rodríguez A, Moreno D, Sancho JR, Enseñat P, Muela F, The designer drug situation in Ibiza.
Fantegrossi WE, Woods JH, Winger G, Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.
Navarro JF, Rivera A, Maldonado E, Cavas M, de la Calle A, Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala.
Vollenweider S, Lacroix C., 3-Hydroxypropionaldehyde: applications and perspectives of biotechnological production.
De Petrocellis L, Cascio MG, Di Marzo V., The endocannabinoid system: a general view and latest additions.
Alger BE., Endocannabinoids: getting the message across.
Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J, Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
Sprague JE, Brutcher RE, Mills EM, Caden D, Rusyniak DE, Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS, Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.
Bordo DJ, Dorfman MA, Ecstasy overdose: rapid cooling leads to successful outcome.
Saldana SN, Barker EL, Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.
Russo EB., Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Delgado JH, Caruso MJ, Waksman JC, Honigman B, Stillman D, Acute, transient urinary retention from combined ecstasy and methamphetamine use.
Bull EJ, Hutson PH, Fone KC, Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
Hanson KL, Luciana M, Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
Nichols DE., Hallucinogens.
Knight J., Religion and science: Buddhism on the brain.
Knight J., Religion and science: Buddhism on the brain.
Parrott AC, Gouzoulis-Meyfrank E, Rodgers J, Solowij N, Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.
Nicoll RA, Alger BE., The brain's own marijuana.
Connor TJ, Harkin A, Kelly JP, Methylenedioxymethamphetamine (MDMA; "Ecstasy") suppresses production of the pro-inflammatory cytokine tumor necrosis factor-{alpha} independent of a {beta}-adrenoceptor-mediated increase in interleukin-10.
Hrometz SL, Brown AW, Nichols DE, Sprague JE, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.
Heydari A, Rowland Yeo K, Lennard M, Ellis SW, Tucker G, Rostami-Hodjegan A, THE MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE (MDMA).
Xie T, Tong L, McCann UD, Yuan J, Becker KG, Mechan AO, Cheadle C, Donovan DM, Ricaurte GA, Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
Tan B, Foley P, Guttate psoriasis following Ecstasy ingestion.
Robledo P, Mendizabal V, Ortuñ¯ Š, de la Torre R, Kieffer BL, Maldonado R, The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
Hill MN, Froc DJ, Fox CJ, Gorzalka BB, Christie BR., Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.
Simantov R, Peng W, MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission.
Bexis S, Phillis BD, Ong J, White JM, Irvine RJ, Baclofen prevents MDMA-induced rise in core body temperature in rats.
Jiménez A, Jordà EG, Verdaguer E, Pubill D, Sureda FX, Canudas AM, Escubedo E, Camarasa J, Camins A, Pallàs M, Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
Frecska E, White KD, Luna LE, Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation.
Sumnall HR, O'Shea E, Marsden CA, Cole JC, The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS, Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Surguladze SA, Young AW, Senior C, Brebion G, Travis MJ, Phillips ML., Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression.
Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA, Role of the serotonin 5-HT(2A) receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.
Ricaurte GA, MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities. Brendon P. Boot, Annis O. Mechan, Una D. McCann, George A. Ricaurte [Eur. J. Pharmacol. 453 (2002) 239-244].
Parrott AC, MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O'Keeffe M, Thomas SH, A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England.
Gamma A, Lehmann D, Frei E, Iwata K, Pascual-Marqui RD, Vollenweider FX, Comparison of simultaneously recorded [H2(15)O]-PET and LORETA during cognitive and pharmacological activation.
Rusyniak DE, Tandy SL, Kamendulis LM, Sprague JE, Klaunig JE, The effects of ecstasy (MDMA) on rat liver bioenergetics.
Piper BJ, Meyer JS, Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
Mills EM, Rusyniak DE, Sprague JE, The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.
Keizers PH, Lussenburg BM, de Graaf C, Mentink LM, Vermeulen NP, Commandeur JN, Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
Winsauer PJ, Quinton MS, Porter JR, Corll CB, Moerschbaecher JM, Delatte MS, Leonard ST, Stroble SB, Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats.
Gesi M, Ferrucci M, Giusiani M, Lenzi P, Lazzeri G, Alessandrì MG, Salvadorini A, Fulceri F, Pellegrini A, Fornai F, Paparelli A, Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
Fisk JE, Montgomery C, Murphy P, Wareing M, Evidence for executive deficits among users of MDMA (Ecstasy).
Hoshi R, Bisla J, Curran HV, The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings.
Yacoubian GS, Miller S, Pianim S, Kunz M, Orrick E, Link T, Palacios WR, Peters RJ, Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
Kalasinsky KS, Hugel J, Kish SJ, Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Carlson RG, Falck RS, McCaughan JA, Siegal HA, MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
Vorhees CV, Reed TM, Skelton MR, Williams MT, Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning.
Meyer JS, Grande M, Johnson K, Ali SF, Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats.
de la Torre R, Farré M, Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans
Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E, Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
Lyvers M, Hasking P, Have Halpern et al. (2004) detected 'residual neuropsychological effects' of MDMA? Not likely.
Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd DA, Reply to lyvers and hasking (2004).
Gamma A, Keeping a clear head on effects of illicit drugs.
Singer LT, Linares TJ, Ntiri S, Henry R, Minnes S, Psychosocial profiles of older adolescent MDMA users.
Caslavska J, Thormann W, Monitoring of drugs and metabolites in body fluids by capillary electrophoresis with XeHg lamp-based and laser-induced fluorescence detection.
Rusch M, Lampinen TM, Schilder A, Hogg RS, Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role.
Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR, Effect of Repeated ('Binge') Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-HT and Dopamine Neurones.
Sumnall HR, Wagstaff GF, Cole JC, Self-reported psychopathology in polydrug users.
Nair SG, Gudelsky GA, Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
de la Torre R, Farre M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Cami J, Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
Pizarro N, Farré M, Pujadas M, Peiró AM, Roset PN, Joglar J, De La Torre R, Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Daniela E, Brennan K, Gittings D, Hely L, Schenk S, Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats.
Parry CD, Myers B, Morojele NK, Flisher AJ, Bhana A, Donson H, Pl?nn A, Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001).
Ho YJ, Pawlak CR, Guo L, Schwarting RK, Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.
Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI, 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
Darvesh AS, Gudelsky GA, The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Khorana N, Pullagurla MR, Young R, Glennon RA, Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization.
Ootsuka Y, Nalivaiko E, Blessing WW, Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") and its reversal by clozapine.
Milani RM, Parrott AC, Turner JJ, Fox HC, Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
Garcia-Osta A, Del Rí¯ J, Frechilla D, Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis-Mayfrank E, Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
Arrue A, Gó¥º FM, Giralt MT, Effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') on the jaw-opening reflex and on the alpha-adrenoceptors which regulate this reflex in the anesthetized rat.
Connor TJ, Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.
Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M, A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J, Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
Wareing M, Fisk JE, Murphy P, Montgomery C, Verbal working memory deficits in current and previous users of MDMA.
Brown PL, Kiyatkin EA, Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P, MDMA-evoked changes in [(11)C]raclopride and [(11)C]NMSP binding in living pig brain.
Rosa-Neto P, Olsen AK, Gjedde A, Watanabe H, Cumming P, MDMA-evoked changes in cerebral blood flow in living porcine brain: Correlation with hyperthermia.
Robledo P, Balerio G, Berrendero F, Maldonado R, Study of the behavioural responses related to the potential addictive properties of MDMA in mice.
Halpern JH, Pope HG, Sherwood AR, Barry S., Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs
Wang X, Baumann MH, Xu H, Rothman RB, 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G, Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys.
Wareing M, Murphy PN, Fisk JE, Visuospatial memory impairments in users of MDMA ('ecstasy')
Parrott AC, Rodgers J, Buchanan T, Scholey AB, Heffernan T, Ling J, The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)
Sumnall HR, Jerome L, Doblin R, Mithoefer MC, Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450
Falck RS, Carlson RG, Wang J, Siegal HA, Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users
Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset P, Segura J, De La Torre R, Paroxetine Inhibits Acute Effects of MDMA on the Immune System in Humans
Brookhuis KA, De Waard D, Samyn N, Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety
De Win MM, Reneman L, Reitsma JB, Den Heeten GJ, Booij J, Van Den Brink W, Mood disorders and serotonin transporter density in ecstasy users-the influence of long-term abstention, dose, and gender
Hasler F , Grimberg U, Benz MA, Huber T, Vollenweider FX, Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
Dafters RI, Hoshi R, Talbot AC, Contribution of cannabis and MDMA ('ecstasy') to cognitive changes in long-term polydrug users
Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E, Neural Mechanisms of Working Memory in Ecstasy (MDMA) Users Who Continue or Discontinue Ecstasy and Amphetamine Use: Evidence from an 18-Month Longitudinal functional magnetic resonance imaging Study
Roberts, T. B., From Armchair Theology to Experimental Science: Democratizing Primary Religious Experience
Cannon M. Arseneault L. Witton J. Murray RW., Casual Association Between Cannabis and Psychosis: examination of the evidence
Leweke FM, Gerth CW, Klosterkotter J., Cannabis-associated psychosis: current status of research.
Piomelli D., The endogenous cannabinoid system and the treatment of marijuana dependence.
RICHARD J. DAVIDSON JONATHAN C. SMITH JON KABAT-ZINN FREDERICK TRAVIS ALARIK ARENANDER, EEG ASYMMETRY AND MINDFULNESS MEDITATION
Danielle C Turner, Luke Clark, Edith Pomarol-Clotet, Peter McKenna, Trevor W Robbins, Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia
Dale Gieringer, Joseph St. Laurent, Scott Goodrich, Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds
Louise Arseneault, Mary Cannon, Richie Poulton, Robin Murray, Avshalom Caspi, Terrie E Moffitt, Causal association between cannabis and psychosis: examination of the evidence
Sumner H. Bursteina,*,1, Matthias Karstb, Udo Schneiderc, Robert B. Zurier, Ajulemic acid: A novel cannabinoid produces analgesia without a ‘‘high’’
Diana L. Cichewicz, Synergistic interactions between cannabinoid and opioid analgesics
Beat Lutz, On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures
Joep Killestein, Bernard M.J. Uitdehaag and Chris H. Polman, Cannabinoids in Multiple Sclerosis Do They Have a Therapeutic Role?
BASALINGAPPA L. HUNGUND AND BALAPAL S. BASAVARAJAPPA, Role of Endocannabinoids and Cannabinoid CB1 Receptors in Alcohol-Related Behaviors
Maria M Medveczky, Tracy A Sherwood, Thomas W Klein, Herman Friedman, Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro
Boram Park, John M. McPartland, Michelle Glassa, Cannabis, cannabinoids and reproduction
Guillermo Velasco, Ismael Galve-Roperh, Cristina Sa´nchez, Cristina Bla´zquez,, Hypothesis: cannabinoid therapy for the treatment of gliomas?
Xinyu Wang, Diana Dow-Edwards, Virginia Anderson, Howard Minkoff, and Yasmin L. Hurd, In Utero Marijuana Exposure Associated with Abnormal Amygdala Dopamine D2 Gene Expression in the Human Fetus
Wingerchuk,D., Cannabis for medical purposes: cultivating science, weeding out the fiction
Check, E, Psychedelic drugs: the ups and downs of ecstasy.
E. Frecska · K. D. White · L. E. Luna, Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation
John H. Halpern, Hallucinogens and dissociative agents naturally growing in the United States
Jordi Riba, Peter Anderer, Francesc Jané, Bernd Saletu,Manel J. Barbanoj, Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography
Felix Hasler, Ulrike Grimberg, Marco A. Benz, Theo Huber and Franz X. Vollenweider, Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
John W. Muschamp, Meredith J. Reginab, Elaine M. Hull,Jerrold C. Winter, Richard A. Rabin, Lysergic acid diethylamide and []-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
Ivan L. Bonta, Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor
Alex Gamma, Dietrich Lehmann, Edi Frei, Kazuki Iwata,Roberto D. Pascual-Marqui and Franz X. Vollenweider, Comparison of Simultaneously Recorded [H2 15O]-PET and LORETA During Cognitive and Pharmacological Activation
Dennis J. McKenna, Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges
Carrie Peyton Dahlberg, Meditation study aims to leap over mental barriers
David E. Stuckey, EEG GAMMA COHERENCE AND OTHER CORRELATES OF SUBJECTIVE REPORTS DURING AYAHUASCA EXPERIENCES
Cochran, T., Mindful Writing
Bradley E. Alger, Endocannabinoids: Getting the message across
Shahnaz C. Azad, Krisztina Monory, Giovanni Marsicano, Benjamin F. Cravatt, Beat Lutz, Walter Zieglga¨nsberger and Gerhard Rammes, Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling
Yosefa Avraham, Dikla Ben-Shushan, Aviva Breuer, Olga Zolotarev, Avital Okon, Nir Fink, Vered Katz, Elliot M. Berry, Very low doses of D8-THC increase food consumption and alter neurotransmitter levels following weight loss
E.A. Carlini, The good and the bad effects of (2) trans-delta-9- tetrahydrocannabinol (D9-THC) on humans
Vincenzo Di Marzo, Maurizio Bifulco and Luciano De Petrocellis, THE ENDOCANNABINOID SYSTEM AND ITS THERAPEUTIC EXPLOITATION
Emilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, Belen Ferrer, Fadwa El Banoua, Juan A Flores and Beatriz Galan-Rodriguez, Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function
Matthew N. Hill, David J. Froc, Christopher J. Fox, Boris B. Gorzalka and Brian R. Christie, Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo
F. Markus Leweke, Christoph W. Gerth and Joachim Klosterk¨otter, Cannabis-Associated Psychosis Current Status of Research
Matthew J. McFarland, Eric L. Barker, Anandamide transport
Roger A. Nicoll and Bradley N. Alger, The Brain's Own Marijuana
Perrot, S, Cannabis: the analgesic and antiinflammatory medication of the future?
I Tomida, R G Pertwee, A Azuara-Blanco, Cannabinoids and glaucoma
Appel, J. B., West, W. B., and Buggy, J., LSD, 5-HT (serotonin), and the evolution of a behavioral assay
Niblock, M. M., Kinney, H. C., Luce, C. J., et al, The development of the medullary serotonergic system in the piglet.
Ozdemir, D., Kayserili, E., Arslanoglu, S., et al, Ketamine and Midazolam for Invasive Procedures in Children with Malignancy: A Comparison of Routes of Intravenous, Oral, and Rectal Administration.
Rahm, I., Spigset, O., and Mjorndal, T., Dieting and weight loss do not affect on the platelet serotonin 5-HT2A receptor.
Ramaekers, J. G., Berghaus, G., van, L. M., et al, Dose related risk of motor vehicle crashes after cannabis use.
Rex, E., Molitor, S. C., Hapiak, V., et al, Tyramine receptor (SER-2) isoforms are involved in the regulation of pharyngeal pumping and foraging behavior in Caenorhabditis elegans
Spigset, O., Kristoffersson, A., and Mjorndal, T., Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
Thomas, D. R., Larminie, C. G., Lyons, H. R., et al, Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor.
Wihlback, A. C., Sundstrom, P., I, Bixo, M., et al, Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
Zacny, J. P. and Goldman, R. E., Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers.
Esch, T., Guarna, M., Bianchi, E., et al, Commonalities in the central nervous system's involvement with complementary medical therapies: limbic morphinergic processes.
Grossman, P., Niemann, L., Schmidt, S., et al, Mindfulness-based stress reduction and health benefits A meta-analysis.
Grossman, P., Niemann, L., Schmidt, S., et al, Mindfulness-based stress reduction and health benefits A meta-analysis.
Irwin, M., Pike, J., and Oxman, M., Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment.
Kavanagh, D. J., Andrade, J., and May, J., Beating the urge: Implications of research into substance-related desires.
Manzaneque, J. M., Vera, F. M., Maldonado, E. F., et al, Assessment of immunological parameters following a qigong training program.
Peng, C. K., Henry, I. C., Mietus, J. E., et al, Heart rate dynamics during three forms of meditation.
Solberg, E. E., Ekeberg, O., Holen, A., et al, Hemodynamic Changes During Long Meditation
Solberg, E. E., Holen, A., Ekeberg, O., et al, The effects of long meditation on plasma melatonin and blood serotonin.
Walton, K. G., Fields, J. Z., Levitsky, D. K., et al, Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the Transcendental Meditation program.
Armstrong BD, Noguchi KK, The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: an in-vitro autoradiographic study in rats.
Yuri E. Moskalenko, Tamara I. Kravchenko, Wave Phenomena in Movements of Intracranial Liquid Media and the Primary Respiratory Mechanism.
Marcus Roberts, Mike Trace and Axel Klein, LAW ENFORCEMENT AND SUPPLY REDUCTION
Neil Hunt, Mike Trace and Dave Bewley-Taylor, REDUCING DRUG RELATED HARMS TO HEALTH: AN OVERVIEW OF THE GLOBAL EVIDENCE
Phillips ML, Drevets WC, Rauch SL, Lane R., Neurobiology of emotion perception I: The neural basis of normal emotion perception.
Phillips ML, Drevets WC, Rauch SL, Lane R., Neurobiology of emotion perception II: Implications for major psychiatric disorders.
Dumasia MC, Identification of some N-hydroxylated metabolites of (+/-)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry.
Fornai F, Lazzeri G, Lenzi P, Gesi M, Ferrucci M, Soldani P, Pellegrini A, Capobianco L, De Blasi A, Ruggieri S, Paparelli A, Amphetamines induce ubiquitin-positive inclusions within striatal cells.
Yin Foo Lee G, Wooi Kee Gong G, Vrodos N, Patrick Brophy B, 'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication?
Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE, Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J, Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
Piomelli D., The molecular logic of endocannabinoid signalling.
Iversen L., Cannabis and the brain
Mithoefer M, Jerome L, Doblin R, MDMA ("ecstasy") and neurotoxicity.
Olson T., Buddhism, behavior change, and OCD.
Koprich JB, Campbell NG, Lipton JW, Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Ball KT, Budreau D, Rebec GV, Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS, Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats.
Lai TI, Hwang JJ, Fang CC, Chen WJ, Methylene 3, 4 dioxymethamphetamine-induced acute myocardial infarction.
Wakonigg G, Sturm K, Saria A, Zernig G, Methylenedioxymethamphetamine (MDMA, 'ecstasy') serves as a robust positive reinforcer in a rat runway procedure.
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC, Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
Garcia-Repetto R, Moreno E, Soriano T, Jurado C, Gimenez, MP, Menendez M, Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.
Anderson KL, Itzhak Y, Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice.
Fritzsche M., The origin of brain asymmetry and its psychotic reversal.
Peters FT, Samyn N, Wahl M, Kraemer T, De Boeck G, Maurer HH, Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.
O'Suilleabhain P, Giller C, Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.
Verheyden SL, Maidment R, Curran HV, Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health
Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J, Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users
Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott A.C., Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study
Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ, Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance
Fornai F, Lenzi P, Frenzilli G, Gesi M, Ferrucci M, Lazzeri G, Biagioni F, Nigro M, Falleni A, Giusiani M, Pellegrini A, Blandini F, Ruggieri S, Paparelli A, DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)
Yacoubian GS, Boyle C, Harding CA, Loftus EA, It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees
Verheyden SL, Henry JA, Curran HV, Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users
Vallee JN, Crozier S, Guillevin R, Obadia M, Lo D, Barragan-Campos HM, Samson Y, Chiras J, Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy abuser
Vecellio M, Schopper C, Modestin J, Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care
Underwood B, Fox K, Nixon PJ, Alcohol and drug use among vocational dental practitioners
Turner C, Russell A, Brown W, Prevalence of illicit drug use in young Australian women, patterns of use and associated risk factors
Taffe MA, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH, MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys
Schifano F, Leoni M, Martinotti G, Rawaf S, Rovetto F, Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project
Stuerenburg HJ, Petersen K, Buhmann C, Rosenkranz M, Baeumer T, Thomasius R, Plasma amino acids in ecstasy users
Swanston HY, Plunkett AM, O\'Toole BI, Shrimpton S, Parkinson PN, Oates RK, Nine years after child sexual abuse
Saadat KS, Elliott JM, Colado MI, Green AR, Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs
Salzmann J, Marie-Claire C, Le Guen S, Roques BP, Noble F, Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice
Roiser JP, Sahakian BJ, Relationship between ecstasy use and depression: a study controlling for poly-drug use
Reijneveld SA, Crone MR, Verhulst FC, Verloove-Vanhorick SP, The effect of a severe disaster on the mental health of adolescents: a controlled study
Mlinar B, Corradetti R, Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons
Pritchard MJ, Malignant hyperthermia: clinical features and management
Mills EM, Banks ML, Sprague JE, Finkel T, Pharmacology: uncoupling the agony from ecstasy
Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R, Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus)
Lua AC, Lin HR, Tseng YT, Hu AR, Yeh PC, Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse
Koprich JB, Chen EY, Kanaan NM, Campbell NG, Kordower JH, Lipton JW, Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats
Kish SJ, What Is the Evidence That Ecstasy (MDMA) Can Cause Parkinson’s Disease?
Jovanovski D, Zakzanis KK, Donepezil in a chronic drug user--a potential treatment?
Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH, Preliminary evidence of hippocampal dysfunction in adolescent MDMA ('ecstasy') users: possible relationship to neurotoxic effects
Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E, Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (\'ecstasy\') use history: correlation with dopamine receptor sensitivity
Halpern JH, Hallucinogens: an update
Dundes L, DanceSafe and ecstasy: protection or promotion?
Easton N, Fry J, O\'Shea E, Watkins A, Kingston S, Marsden CA, Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy)
Daumann J, Schnitker R, Weidemann J, Schnell K, Thron A, Gouzoulis-Mayfrank E, Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users
de Almeida SP, Silva MT, Ecstasy (MDMA): effects and patterns of use reported by users in SÃ£o Paulo
Dafters RI, Biello SM, The effect of 3,4-methylenedioxymethamphetamine (\'Ecstasy\') on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia
Cowan RL, Lyooa IK,Sunga SM, Ahna KH, Kima MJ, Hwangc J, Hagaa E, Vimala RLP, Lukasb SE, Renshawa PF, Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study
Cleary L, Docherty JR, Actions of amphetamine derivatives and cathinone at the noradrenaline transporter
Carvalho M, Milhazes N, Remiao F, Borges F, Fernandes E, Amado F, Monks TJ, Carvalho F, Bastos ML, Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates
Borg J, AndrÃ©e B, Soderstrom H, Farde L, The serotonin system and spiritual experiences
Bond AJ, Verheyden SL, Wingrove J, Curran HV, Angry cognitive bias, trait aggression and impulsivity in substance users
Tancer M, Johanson CE, Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP
Yacoubian GS, Boyle C, Harding CA, Loftus EA, It\'s a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees
Michael JC, Pak J, Pulido J, de Venecia G, Central serous chorioretinopathy associated with administration of sympathomimetic agents
Zghoul T, Blier P, Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder
Sprague JE, Preston AS, Leifheit M, Woodside B, Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning
Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bar PR, Nicolay K, Di Marzo V, Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases
Schifano F, Oyefeso A, Corkery J, Cobain K, Jambert-Gray R, Martinotti G, Ghodse AH, Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002
Sprague JE, Banks ML, Cook VJ, Mills EM, Hypothalamic-Pituitary-Thyroid axis and Sympathetic Nervous System involvement in the hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)
Ross MW, Mattison AM, Franklin DR, Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men
Pichini S, Navarro M, Pacifici R, Zuccaro P, OrtuÃ±o J, FarrÃ© M, Roset PN, Segura J, de la Torre R, Usefulness of sweat testing for the detection of MDMA after a single-dose administration
Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, GutiÃ©rrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schatz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B, CB1 cannabinoid receptors and on-demand defense against excitotoxicity
Iravani MM, Jackson MJ, Kuoppamaki M, Smith LA, Jenner P, 3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates
Cole JC, Sumnall HR, The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)
Budisavljevic MN, Stewart L, Sahn SA, Ploth DW, Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ('Ecstasy') abuse
Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J, Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users
Boys A, Marsden J, Perceived functions predict intensity of use and problems in young polysubstance users
Stout PR, Klette KL, Wiegand R, Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine
Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD, Retraction
Schneider RC, Kovar KA, Analysis of ecstasy tablets: comparison of reflectance and transmittance near infrared spectroscopy
Preston NJ, Stirling ML, Perera K, Bell RJ, Harrison TJ, Whitworth L, Castle DJ, A statewide evaluation system for early psychosis
Oliveri M, Calvo G, Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study
Huang Z, Zhang S, Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening
Fucci N, De Giovanni N, Chiarotti M, Simultaneous detection of some drugs of abuse in saliva samples by SPME technique
Gordon J, Barnes NM, Lymphocytes transport serotonin and dopamine: agony or ecstasy?
Frishman WH, Del Vecchio A, Sanal S, Ismail A, Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine
Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JR, Robertson MD, Swann P, The incidence of drugs in drivers killed in Australian road traffic crashes
Dams R, De Letter EA, Mortier KA, Cordonnier JA, Lambert WE, Piette MH, Van Calenbergh S, De Leenheer AP, Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study
Blessing WW, Seaman B, Pedersen NP, Ootsuka Y, Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats
Compan V, Scearce-Levie K, Crosson C, Daszuta A, Hen R, Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine
McCabe SE, Boyd C, Hughes TL, d\'Arcy H., Sexual identity and substance use among undergraduate students
Green AR, Mechan AO, Elliott JM, O\'Shea E, Colado MI, The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Descroix S, Varenne A, Geiser L, Cherkaoui S, Veuthey JL, Gareil P., Influence of electrolyte nature on the separation selectivity of amphetamines in nonaqueous capillary electrophoresis: protonation degree versus ion pairing effects
Zhou JF, Zhou YH, Zhang L, Chen HH, Cai D, 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage
Yacoubian GS, Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study
Zhou JF, Chen P, Zhou YH, Zhang L, Chen HH, 3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage
Won M, Minabe Y, Tani K, Suzuki K, Kawai M, Sekine Y, Ashby CR, Takei N, Mori N, The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats
Williams MT, Morford LL, Wood SL, Rock SL, McCrea AE, Fukumura M, Wallace TL, Broening HW, Moran MS, Vorhees CV, Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress
Wilkins C, Bhatta K, Pledger M, Casswell S, Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys
Verbaten MN, Specific memory deficits in ecstasy users? The results of a meta-analysis
Timár J, Gyarmati S, Szabó A, Fürst S, Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives
Setola V, Hufeisen SJ, Grande-Allen KJ, Vesely I, Glennon RA, Blough B, Rothman RB, Roth BL, 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
Schmued LC, Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA
Romanelli F, Smith KM, Pomeroy C, Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men
Schenk S, Gittings D, Johnstone M, Daniela E, Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats
Raikos N, Christopoulou K, Theodoridis G, Tsoukali H, Psaroulis D, Determination of amphetamines in human urine by headspace solid-phase microextraction and gas chromatography
Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ, Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics
Passie T, Karst M, Borsutzky M, Wiese B, Emrich HM, Schneider U, Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man
McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM, Cornish JL, Hunt GE, Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes
McCabe SE, Boyd C, Hughes TL, d'Arcy H, Sexual identity and substance use among undergraduate students
McGregor IS, Clemens KJ, Van Der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ, Increased Anxiety 3 Months after Brief Exposure to MDMA ('Ecstasy') in Rats: Association with Altered 5-HT Transporter and Receptor Density
Lyles J, Cadet JL, Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms
Kuniyoshi SM, Jankovic J, MDMA and Parkinsonism
Kwon C, Zaritsky A, Dharnidharka VR, Transient proximal tubular renal injury following Ecstasy ingestion
Lebsanft HB, Mayerhofer A, Kovar KA, Schmidt WJ, Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Grant I, Gonzalez R, Cary C, Natarajan L, Wolfson T, Non-acute (residual) neurocognitive effects of cannabis use: A meta-analysis study
Forrest AR, Dataset on deaths related to taking ecstasy looks incomplete
Gibbs T, Ross L, Illicit drug use related attendances at accident and emergency services in Aberdeen: a prospective six month survey
Gimeno P, Besacier F, Chaudron-Thozet H, Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets
Descroix S, Varenne A, Geiser L, Cherkaoui S, Veuthey JL, Gareil P, Influence of electrolyte nature on the separation selectivity of amphetamines in nonaqueous capillary electrophoresis: protonation degree versus ion pairing effects
Curran HV, Verheyden SL, Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function
Carter JF, Sleeman R, Parry J, The distribution of controlled drugs on banknotes via counting machines
Boyd CJ, McCabe SE, d\'Arcy H, Ecstasy use among college undergraduates: gender, race and sexual identity
Bogen IL, Haug KH, Myhre O, Fonnum F, Short- and long-term effects of MDMA ("ecstasy") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo
Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD, Ali SF, Frederick DL, Paule MG, Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations
Banjaw MY, Mayerhofer A, Schmidt WJ, Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat
Achat-Mendes C, Anderson KL, Itzhak Y, Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood
Zhou W, Cunningham KA, Thomas ML, Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats
Walters ST, Foy BD, Castro RJ, The agony of ecstasy: responding to growing MDMA use among college students
Weinbroum AA, Importance of early identification of methylenedioxymethamphetamine (\'ecstasy\') ingestion in victims of motor vehicle accidents
Peng W, Simantov R, Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes
Pubill D, Canudas AM, Pallàs M, Camins A, Camarasa J, Escubedo E, Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity
Nordgren HK, Beck O, Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry
Lingford-Hughes A, Nutt D, Neurobiology of addiction and implications for treatment
Greene SL, Dargan PI, O\'connor N, Jones AL, Kerins M, Multiple toxicity from 3,4-methylenedioxymethamphetamine (\"ecstasy\")
Huang YS, Liu JT, Lin LC, Lin CH, Chiral separation of 3,4-methylenedioxymeth- amphetamine and related compounds in clandestine tablets and urine samples by capillary electrophoresis/fluorescence spectroscopy
Goodwin AK, Pynnonen DM, Baker LE, Serotonergic-dopaminergic mediation of MDMA\'s discriminative stimulus effects in a three-choice discrimination
Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E, Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study
Cole JC, Sumnall HR, Altered states: The clinical effects of Ecstasy
Cole JC, Sumnall HR, Altered states: the clinical effects of Ecstasy
Bull EJ, Hutson PH, Fone KC, Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT(2C) receptor responsivity
Brazier WJ, Dhariwal DK, Patton DW, Bishop K, Ecstasy related periodontitis and mucosal ulceration - a case report
Vuori E, Henry JA, OjanperÃ¤ I, Nieminen R, Savolainen T, Wahlsten P, JÃ¤ntti M, Death following ingestion of MDMA (ecstasy) and moclobemide
Thomasius R, Petersen K, Buchert R, Andersen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt, A, Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users
Schifano F, Oyefeso A, Webb L, Pollard M, Corkery J, Ghodse AH, Review of deaths related to taking ecstasy, England and Wales, 1997-2000
Simonsen KW, Kaa E, Nielsen E, Rollmann D, Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000
Sanchez V, Camarero J, O\'Shea E, Green AR, Colado MI, Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats
Pizarro N, Llebaria A, Cano S, Joglar J, FarrÃ© M, Segura J, Torre Rd Rde L, Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry
Peters FT, Maurer HH, Hellstern P, Prevalence of illicit drug use in plasmapheresis donors
Jorm LR, Thackway SV, Churches TR, Hills MW, Watching the Games: public health surveillance for the Sydney 2000 Olympic Games
Itzhak Y, Ali SF, Achat CN, Anderson KL, Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice
Ferrucci M, Gesi M, Lenzi P, Soldani P, Ruffoli R, Pellegrini A, Ruggieri S, Paparelli A, Fornai F, Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls
Inman DS, Greene D, The agony and the ecstasy: acute urinary retention after MDMA abuse
Fernandez F, Porras G, MormÃ¨de P, Spampinato U, Chaouloff F, Effects of 3,4-methylenedioxymethamphetamine on locomotor activity and extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats
De Letter EA, Espeel MF, Craeymeersch ME, Lambert WE, Clauwaert KM, Dams R, Mortier KA, Piette MH, Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland
Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH, Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice
Cole JC, Sumnall HR, O\'Shea E, Marsden CA, Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse
Auer J, Berent R, Weber T, Lassnig E, Eber B, Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult
Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M, Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET
Arrue A, Ruiz-Ortega JA, Ugedo L, Giralt MT, Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat
Surguladze S, Keedwell P, Phillips M., Neural Systems Underlying Affective Disorders
Croxford JL., Therapeutic potential of cannabinoids in CNS disease.
Baer Ruth A., Mindfulness Training as a Clinical Intervention: A Conceptual and Empirical Review
Baer Ruth A, Mindfulness Training as a Clinical Intervention:A Conceptual and Empirical Review
RICHARD J. DAVIDSON JON KABAT-ZINN JESSICA SCHUMACHER MELISSA ROSENKRANZ, Alterations in Brain and Immune Function Produced by Mindfulness Meditation
Danielle C. Turner · Trevor W. Robbins · Luke Clark ·, Cognitive enhancing effects of modafinil in healthy volunteers
Maria-Teresa Samson, Andrea Small-Howard, Lori M. N. Shimoda, Murielle Koblan-Huberson, Alexander J. Stokes, and Helen Turner, Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
Louisa Degenhardt , Wayne Hall, Michael Lynskey, Testing hypotheses about the relationship between cannabis use and psychosis
, Exploring the association between cannabis use and depression
Mahmoud A. ElSohly, Stephen R. Wachtel, Harriet Wit, Cannabis versus THC: response to Russo and McPartland
IGOR GRANT, RAUL GONZALEZ, .S CATHERINE L. CAREY, LOKI NATA'RAJAN, Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
John H. Halpern *, Harrison G. Pope, Jr, Hallucinogen persisting perception disorder: what do we know after 50 years?
Scott Macdonald, Kristin Anglin-Bodrug , Robert E. Mannb,Patricia Erickson Andrew Hathaway ,Mary Chipmanc, Margaret Rylett, Injury risk associated with cannabis and cocaine use
Mario van der Stelt, Vincenzo Di Marzo, The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders
J. Killestein, E.L.J. Hoogervorst, M. Reif, B. Blauw, M. Smits, B.M.J. Uitdehaag,L. Nagelkerken, C.H. Polman, Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis
Leslie Iversen, Cannabis and the brain
Alison J. Drysdale and Bettina Platt, Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Ethan B. Russo · John M. McPartland, Cannabis is more than simply D9-tetrahydrocannabinol
Derick T Wade, Philip Robson, Petra Makela, Julia Aram, A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
J. D. Wilkinson, B. J. Whalley, D. Baker, G. Pryce, A. Constanti, S. Gibbons, Medicinal cannabis: is delta-9 tetrahydrocannabinol necessary for all its effects?
John Zajicek, Patrick Fox, Hilary Sanders, David Wright, Jane Vickery, Andrew Nunn, Alan Thompson, Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
Kathryn M. Abel, Matthew P. G. Allin, Katarzyna Kucharska-Pietura, Anthony David,Chris Andrew, Steve Williams, M. J. Brammer and Mary L. Phillips, Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study
Jacqueline Borg, Bengt Andrée, Henrik Soderstrom, Lars Farde, The Serotonin System and Spiritual Experiences
DONALD G. McNEIL Jr., Research on Ecstasy Is Clouded by Errors
Fadiman James, Grob Charles, Bravo Gary, PSYCHEDELIC RESEARCH REVISITED
Singh, A. N., Barlas, C., Saeedi, H., et al, Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
M. Fritzsche, The origin of brain asymmetry and its psychotic reversal
Piomelli, D., The molecular logic of endocannabinoid signalling.
Gonzalez-Maeso, J., Yuen, T., Ebersole, B. J., et al, Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex
Kathuria, S., Gaetani, S., Fegley, D., et al, Modulation of anxiety through blockade of anandamide hydrolysis
Svenningsson, P., Tzavara, E. T., Carruthers, R., et al, Diverse Psychotomimetics Act Through a Common Signaling Pathway
Back-Madruga, C., Boone, K. B., Chang, L., et al, Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
Ludewig, S., Paulus, M. P., Ludewig, K., et al, D ecision-making strategies by panic disorder subjects are more sensitive to errors.
Pandey, G. N., Pandey, S. C., Ren, X., et al, Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment.
Purohit, A., Herrick-Davis, K., and Teitler, M., Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Sharma, H., Sen, S., Singh, A., et al, Sudarshan Kriya practitioners exhibit better antioxidant status and lower blood lactate levels.
Shoblock, J. R., Maisonneuve, I. M., and Glick, S. D., Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction.
Shoblock, J. R., Sullivan, E. B., Maisonneuve, I. M., et al, Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Marsicano, G., Goodenough, S., Monory, K., et al, CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Refstad, S., Paramethoxyamphetamine (PMA) poisoning; a 'party drug' with lethal effects.
Rickert, V. I., Siqueira, L. M., Dale, T., et al, Prevalence and Risk Factors for LSD Use among Young Women.
Sheffler, D. J. and Roth, B. L., Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor.
Veldhuis, W. B., van der, S. M., Wadman, M. W., et al, Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil against In Vivo Excitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases.
Ludewig, K., Geyer, M. A., and Vollenweider, F. X., Deficits in Prepulse Inhibition and Habituation in Never-Medicated, First-Episode Schizophrenia.
Kumar A, R. and Kurup, P. A., Changes in the isoprenoid pathway with transcendental meditation and Reiki healing practices in seizure disorder.
Finsterer J, Stöllberger C, Steger C, Kroiss A, Long lasting impaired cerebral blood flow after ecstasy intoxication.
Yury Moskalenko, Viola Frymann, Tamara Kravchenko, Gustav Weinstein., Physiological Background of the Cranial Rhythmic Impulse and The Primary Respiratory Mechanism
Moskalenko Yu.E., Kravchenko T.I., Weinstein G.B., The possibility to correct the disorders of intracranial hemo- and liquorodynamics by the metods of cranial osteopathy.
Fride E, Shohami E., The endocannabinoid system: function in survival of the embryo, the newborn and the neuron.
Davies SN, Pertwee RG, Riedel G., Functions of cannabinoid receptors in the hippocampus.
Goodman N., The serotonergic system and mysticism: could LSD and the nondrug-induced mystical experience share common neural mechanisms?
Landry MJ, MDMA: a review of epidemiologic data.
G.J. Molderings, H. Bonisch, R. Hammermann, M. Gothert, M. Bruss, Noradrenaline release-inhibiting receptors on PC12 cells devoid of 2 and CB1 receptors: similarities to presynaptic imidazoline and edg receptors.
Ceng Luo, Eiichi Kumamoto, Hidemasa Furue, Jun Chen, Megumu Yoshimura, Anandamide inhibits excitatory transmission to rat substantia gelatinosa neurones in a manner different from that of apsai in
Tibor Wenger, Ida Gerendai, Filomena Fezza, Sara González, Tiziana Bisogno, Javier Fernandez-Ruiz, Vincenzo Di Marzo, The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats
David W. Carley PhD, Sasa Pavlovic MD, Marika Janelidze, and Miodrag Radulovacki MD PhD, Functional Role for Cannabinoids in Respiratory Stability During Sleep
Jerome Dempsey PhD, Functional Role for Cannabinoids in Respiratory Stability During Sleep by D.W. Carley, et al.
Patrick M. Beardsley, Mario E. Dance, Robert L. Balster, Patrik Munzar, Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys
George E. Da Silva, Reinaldo N. Takahashi, SR 141716A prevents 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice
Jano J. Janoyan, Jennifer L. Crim, Nissar A. Darmani, Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by 9-THC and other cannabinoids
S. A. Varvel, A. H. Lichtman, Evaluation of CB1 Receptor Knockout Mice in the Morris Water Maze
Billy R. Martin, Renee G. Jefferson, Ramona Winckler, Jenny L. Wiley, Brian F. Thomas, Peter J. Crocker, William Williams, Raj K. Razdan, Assessment of structural commonality between tetrahydrocannabinol and anandamide
Jenny L. Wiley, Irina D. Beletskaya, Edward W. Ng, Zongmin Dai, Peter J. Crocker, Anu Mahadevan, Raj K. Razdan, Billy R. Martin, Resorcinol Derivatives: A Novel Template for the Development of Cannabinoid CB1 /CB2 and CB2 -Selective Agonists
Amy C. Porter, John-Michael Sauer, Michael D. Knierman, Gerald W. Becker, Michael J. Berna, Jingqi Bao, George G. Nomikos, Petra Carter, Frank P. Bymaster, Andrea Baker Leese, Christian C. Felder, Characterization of a Novel Endocannabinoid, Virodhamine, with Antagonist Activity at the CB1 Receptor
H. Hermann, G. Marsicano, B. Lutz, Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
A. C. Howlett, F. Barth, T. I. Bonner, G. Cabral, P. Casellas, W. A. Devane, C. C. Felder, M. Herkenham, K. Mackie, B. R. Martin, R. Mechoulam, R. G. Pertwee, International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
S. M. Rawls, Jose Cabassa, Ellen B. Geller, Martin W. Adler, CB1 Receptors in the Preoptic Anterior Hypothalamus Regulate WIN 55212-2 [(4,5-Dihydro-2- methyl-4(4-morpholinylmethyl)-1-(1- naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-Induced Hypothermia.
Billy R. Martin, Identification of the Endogenous Cannabinoid System through Integrative Pharmacological Approaches
Kojoma M et.al., DNA Fingerprinting of Cannabis sativa using intersimple sequence repeat (ISSR) amplification
Rodney S. Berman, Patricia E. M. Martin, W. Howard Evans, Tudor M. Griffith, Relative Contributions of NO and Gap Junctiona Communication to Endothelium-Dependent Relaxations of Rabbit Resistance Arteries Vary with Vessel Size
Somnanth Mukhopadhyay , Barry M. Chapnick, Allyn C. Howlett, Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein- dependent and G protein-independent
Josefa Ros, Joan Claria, Jordi To-Figueras, Anna Planaguma, Pilar Cejudo-Marti, Guillermo Fernandez-Varo, Raul Martin-Ruiz, Vicente Arroyo, Francisca Rivera, Juan Rodes, Wladimiro Jimenez, Endogenous Cannabinoids: A New System Involved in the Homeostasis of Arterial Pressure in Experimental Cirrhosis in the Rat
Sara Gonzalez, Javier Fernandez-Ruiz, Valentina Sparpaglione, Daniela Parolaro, Jose A. Ramos, Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels
Lutz G. Schmidt, Jerzy Samochowiec, Ulrich Finckh, Ewa Fiszer-Piosik, Jan Horodnicki, B. Wendel, Hans Rommelspacher, Margret R. Hoehe, Association of a CB1 Cannabinoid Receptor Gene (CNR 1) polymorphism with severe alcohol dependence
Nissar A. Darmani, The Potent Emetogenic Effects of the Endocannabinoid, 2-AG (2-Arachidonoylglycerol) Are Blocked by 9 -Tetrahydrocannabinol and Other Cannnabinoids
Malcolm Begg, Areles Molleman, Mike Parsons, Modulation of the release of endogenous g-aminobutyric acid by cannabinoids in the guinea pig ileum
Claire M. Williams, Tim C. Kirkham, Reversal of D-9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
R. Cesa, A. Guastalla, E. Cottone, K. Mackie, M. Beltramo, M. F. Franzoni, Relationships between CB1 Cannabinoid Receptors and Pituitary Endocrine Cells in Xenopus laevis: An Immunohistochemical Study. General and Comparative
Brian Gardner, Li X. Zu, Sherven Sharma, Qian Liu, Alexandros Makriyannis, Donald P. Tashkin, Steven M. Dubinett, Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-b
George B. Stefano, Enzo Ottaviani, The biochemical substrate of nitric oxide signaling is present in primitive non-cognitive organisms
Francesca R. Buttarelli, Francesco E. Pontieri, Vito Margotta, Guido Palladini, Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism
I. Lastres-Becker, F. Berrendero, J.J. Lucas, E. Martin-Aparicio, A. Yamamoto, J.A. Ramos, J.J. Fernandez-Ruiz, Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB receptors in the basal ganglia of a transgenic model of Huntington's disease
Milton, Nathaniel G, Anandamide and noladin ether prevent neurotoxicity of the human amyloid-b peptide
G. Grammatikopoulos, M. Pignatelli, F. D'Amico, C. Fiorillo, A. Fresiello, A.G. Sadile, Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability rat
Patrick Dumas, Mohamed Aoud, Ebastien Bouafia, Christel Gutknecht, Rene Ecochard, Jean Dalery, Thierry Rochet, Thierry d'Amato, Cannabis use correlates with schizotypal personality traits in healthy students
Muller-Vahl KR et.al., Treatment of Tourette's syndrome with delta-9-THC): A Randomized Crossover Trial
Natarajan Subramanian, Hans O. Kalkman, Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone
Rey et.al, Mental Health of Teenagers who use cannabis
Alessandra Ottani, Francesca Ferrari, Daniela Giuliani*, Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models
Maccarrone M et.al., Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer
Osama M.H. Habayeb, Stephen C. Bell, Justin C. Konje, Endogenous cannabinoids: Metabolism and their role in reproduction
Doblin R, A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.
Kraemer T, Maurer HH, Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives
Nunez O, Banares R, Barrio J, Menchen L, Diego A, Salinero E, Clemente G, [Variability of the clinical expression of Ecstasy-induced hepatotoxicity]
Lange-Brock N, Berg T, Muller AR, Fliege H, Neuhaus P, Wiedenmann B, Klapp BF, Monnikes H, [Acute liver failure following the use of ecstasy (MDMA)]
Butcher J, MDMA research leaves ravers far from ecstatic
Gonmori K, Yoshioka N, Fatal Ingestin of Magic Mushroom: a case report
Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar KA, Sass H, Spitzer M, Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans
Osterhoudt KC, Experiencing Ecstasy: Is it all the Rave?
Schmidt WJ, Mayerhofer A, Meyer A, Kovar KA, Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
Gudelsky GA, Yamamoto BK, Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine
Krupitsky E, Burakov A, Romanova T, Dunaevsky I, Strassman R, Grinenko A, Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
Yacoubian GS, Assessing the temporal relationship between race and ecstasy use among high school seniors
Yacoubian GS, Arria AM, Fost E, Wish ED, Estimating the Prevalence of Ecstasy Use Among Juvenile Offenders
Winsauer PJ, McCann UD, Yuan J, Delatte MS, Stevenson MW, Ricaurte GA, Moerschbaecher JM, Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration
Piette V, Parmentier F, Analysis of illicit amphetamine seizures by capillary zone electrophoresis
Peng W, Premkumar A, Mossner R, Fukuda M, Lesch KP, Simantov R, Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA)
Indig D, Thackway S, Jorm L, Salmon A, Owen T, Illicit drug-related harm during the Sydney 2000 Olympic Games: implications for public health surveillance and action
Masi G, Mucci M, Floriani C, Acute catatonia after a single dose of ecstasy
Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE, Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity
Heffernan TM, Ling J, Scholey AB, Subjective ratings of prospective memory deficits in MDMA (\'ecstasy\') users
Arnold DH, Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure
Gilhooly TC, Daly AK, CYP2D6 deficiency, a factor in ecstasy related deaths?
Green AR, McGregor IS, On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA
Zagnoni PG, Albano C, Psychostimulants and epilepsy
Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H, Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans
Vandeputte C, Docherty JR, Vascular actions of 3,4-methylenedioxymethamphetamine in alpha(2A/D)-adrenoceptor knockout mice
Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M, Acute psychological and neurophysiological effects of MDMA in humans
Umbricht D, Vollenweider FX, Schmid L, Grubel C, Skrabo A, Huber T, Koller R, Effects of the 5-HT(2A) Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia
Traub SJ, Hoffman RS, Nelson LS, The "Ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine
Thiriet N, Ladenheim B, McCoy MT, Cadet JL, Analysis of ecstasy (MDMA)-induced transcriptional responses in the rat cortex
Sue YM, Lee YL, Huang JJ, Acute hyponatremia, seizure, and rhabdomyolysis after ecstasy use
Taffe MA, Davis SA, Yuan J, Schroeder R, Hatzidimitriou G, Parsons LH, Ricaurte GA, Gold LH, Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge
Stock SL, Goldberg E, Corbett S, Katzman DK, Substance use in female adolescents with eating disorders
Riba J, Rodriguez-Fornells A, Barbanoj MJ, Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively
Riba J, Anderer P, Morte A, Urbano G, JanÃ© F, Saletu B, Barbanoj MJ, Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers
Navarro JF, Maldonado E, Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze
McElrath K, McEvoy K, Negative experiences on ecstasy: The role of drug, set and setting
Kelly PA, Ritchie IM, Quate L, McBean DE, Olverman HJ, Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain
Hayner, GN, MDMA misrepresentation: An unresolved problem for ecstasy users
Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA, The content of ecstasy tablets: implications for the study of their long-term effects
Colbron S, Jones M, Biello SM, MDMA alters the response of the circadian clock to a photic and non-photic stimulus
Zakzanis KK, Young DA, Radkhoshnoud NF, Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users
Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA, Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity.
Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA, Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines
Young R, Glennon RA, The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinoline is similar to that of cocaine but different from that of amphetamine
Won L, Bubula N, Heller A, Fetal exposure to (+/-)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three- dimensional reaggregate tissue culture
Whitworth TL, Herndon LC, Quick MW, Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons
von Sydow K, Lieb R, Pfister H, Hofler M, Wittchen H-U, Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults—a transient phenomenon? Results from a longitudinal community study
Vastag B, What should the public be told about the risks of Ecstasy? (3)
Verheyden SL, Hadfield J, Calin T, Curran HV, Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, 'ecstasy') on mood: evidence of gender differences
Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA, Comparison of (+)-(11)C-McN5652 and (11)C-DASB as Serotonin Transporter Radioligands Under Various Experimental Conditions
Strote J, Increasing MDMA use among college students: results of a national survey
Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, Thomasius R, Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users
Smith KM, Larive LL, Romanelli F, Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate
Skender L,. Karacic VV, Brcic II, Bagaric A., Quantitative determination of amphetamines, cocaine, and opiates in human hair by gas chromatography/mass spectrometry
Simon NG, Mattick RP, The impact of regular ecstasy use on memory function
Samyn N, De Boeck G, Wood M, Lamers C, De Waard D, Brookhuis K, Verstraete A, Riedel W, Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions
Rothman R, Baumann M, Therapeutic and adverse actions of serotonin transporter substrates
Ricaurte GA, Yuan J, Hatzidimitriou G, Cord BJ, McCann UD, Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA (“Ecstasy”)
Reneman L,, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff F, Booij J, The acute and chronic effects of MDMA (“Ecstasy”) on cortical 5-HT 2A receptors in rat and human brain
Reneman L, Majoie CB, Flick H, den Heeten GJ, Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methylenedioxymethamphetamine (Ecstasy) users: preliminary results
Raikos N, Tsoukali H, Psaroulis D, Vassiliadis N, Tsoungas M, Njau S, Amphetamine derivative related deaths in northern Greece
Ramamoorthy Y, Yu A, Suh N, Haining RL, Tyndale RF, Sellers EM, Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W, Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study-- preliminary report
Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA, Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity
Pizarro N, Ortuno J, Farre M, Hernandez-Lopez C, Pujadas M, Llebaria A, Joglar J. Roset PN. Mas M. Segura J. Cami J, de la Torre R, Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
Pompei P, Cavazzuti E, Martarelli D, Pediconi D, Arletti R, Lucas L, Massi M, Preprotachykinin A gene expression after administration of 3,4- methylene dioxymethamphetamine (Ecstasy)
Pichini S, Navarro M, Farre M, Ortuno J, Roset PN, Pacifici R, Zuccaro P, Segura J, de la Torre R, On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in saliva with Drugwipe and Drugread: a controlled study in recreational users
Pellegrini M, Rosati F, Pacifici R, Zuccaro R, Romolo FS, Lopez A, Rapid screening method for determination of Ecstasy and amphetamines in urine samples using gas chromatography-chemical ionisation mass spectrometry
Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J, Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users
Parry CD, Bhana A, Pluddemann A, Myers B, Siegfried N, Morojele NK, Flisher AJ, Kozel NJ, The South African Community Epidemiology Network on Drug Use (SACENDU): description, findings (1997-99) and policy implications
Parrott A, Very real, very damaging
Parrott AC, Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Palmi I, Ortuno J, Menoyo E, Segura J, de la Torre R, Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings
Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R, Specific neurotoxicity of chronic use of ecstasy
O'Shea E, Easton N, Fry JR, Green AR, Marsden CA, Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia
Murphy J, Flynn JJ, Cannon DM, Guiry PJ, McCormack P, Baird AW, McBean GJ, Keenan AK, In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine
Mortier K, Maudens K, Lambert W, Clauwaert K, Van Bocxlaer J, Deforce D, Van Peteghem C, De Leenheer A, Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry
Morgan M, Throwing the baby out with the bathwater?
Morgan MJ, McFie L, Flettwood LH, Robinson JA, Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence?
Morley-Fletcher S, Bianchi M, Gerra G, Laviola G, Acute and carryover effects in mice of MDMA ('ecstasy') administration during periadolescence
Montiel-Duarte C, Varela-Rey M, Oses-Prieto JA, Lopez-Zabalza MJ, Beitia G, Cenarruzabeitia E, Iraburu MJ, 3,4-Methylenedioxymethamphetamine ("Ecstasy") induces apoptosis of cultured rat liver cells
Montoya AG, Sorrentino R, Lukas SE, Price BH, Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review
Moeller MR, Kraemer T, Drugs of abuse monitoring in blood for control of driving under the influence of drugs
Meyer A, Mayerhofer A, Kovar K, Schmidt W, Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine ('ecstasy') and 3,4-methylenedioxyethylamphetamine ('eve') isomers in rat brain and blood
Meyer JS, Ali SF, Serotonergic neurotoxicity of MDMA (ecstasy) in the developing rat brain
Meyer A, Mayerhofer A, Kovar K, Schmidt W, Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats
Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR, The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats
Mechan A, Moran PM, Elliott JM, Young AMJ, Joseph MH, Green AR, A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on the subsequent long-term behavior in the plus maze and open field
Lieb R, Schuetz, CG, Pfister H, von Sydow K, Wittchen H-U, Mental disorders in ecstasy users; A prospective-longitudinal investigation
Matuszewich L, Filon ME, Finn DA, Yamamoto BK, Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine
Leshner AI, What should the public be told about the risks of Ecstasy?
Kupiec T, DeCicco L, Spiehler V, Sneed G, Kemp P, Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine
Klitzman RL, Greenberg JD, Pollack LM, Dolezal C, MDMA ('ecstasy') use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City
Koesters SC, Rogers PD, Rajasingham CR, MDMA ('ecstasy') and other 'club drugs'. The new epidemic
Kish SJ, How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Johnson EA, Shvedova AA, Kisin E, O'Callaghan JP, Kommineni C, Miller DB,, d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity
Kanthasamy A, Sprague J, Shotwell J, Nichols D, Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum
Jiang XR, Dryhurst G, Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione
Johnson EA, O'Callaghan JP, Miller DB., Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse
Hurley RA, Reneman L, Taber KH, Ecstasy in the brain: a model for neuroimaging
Iwata YT, Garcia A, Kanamori T, Inoue H, Kishi T, Lurie IS, The use of a highly sulfated cyclodextrin for the simultaneous chiral separation of amphetamine-type stimulants by capillary electrophoresis
Holden C, Drug find could give ravers the jitters
Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R, 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics
Hess D, DeBoer S, Ecstasy: This designer drug is increasing in popularity and may be coming soon to an ED near you
Hatzidimitriou G, Tsai EH McCann U D, Ricaurte GA, Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine
Gurtman CG, Morley KC, Li KM, Hunt GE, McGregor IS, Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion
Harris DS, Baggott M, Mendelson J, Mendelson JE, Jones RT, Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Hartung TK, Schofield E, Short AI, Parr MJ, Henry JA, Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion
Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J, Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?
Gross SR, Barrett SP, Shestowsky JS, Pihl RO, Ecstasy and drug consumption patterns: a Canadian rave population study
Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, Mennini T, p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro
Goodwin AK, Baker LE, An analysis of the utility of differential outcome procedures in drug discrimination research
Gough B, Imam SZ, Blough B, Slikker W Jr, Ali SF, Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study
Glennon RA, Young R, Rangisetty JB, Further characterization of the stimulus properties of 5,6,7,8- tetrahydro-1,3-dioxolo[4,5-g]isoquinoline
Gijsman HJ, Van Gerven JM, Verkes RJ, Schoemaker RC, Pieters MS, Pennings EJ, Hessing TJ, Cohen AF, Saccadic peak velocity and EEG as end-points for a serotonergic challenge test
Gill JR, Hayes JA, deSouza IS, Marker E, Stajic M, Ecstasy (MDMA) deaths in New York City: a case series and review of the literature
Gesi M, Soldani P, Lenzi P, Ferrucci M, Giusiani A, Fornai F, Paparelli ., Ecstasy during Loud Noise Exposure Induces Dramatic Ultrastructural Changes in the Heart
Gesi M, Lenzi P, Soldani P, Ferrucci M, Giusiani A, Fornai F, Paparelli A, Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure
Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S, Delsignore R, Laviola G, Macchia T, Brambilla F, Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans
Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ, Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ('ecstasy') polydrug users
Fornai F, Gesi M, Lenzi P, Ferrucci M, Pellegrini A, Ruggieri S, Casini A, Paparelli A, Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration
Gentili S, Torresi A, Marsili R, Chiarotti M, Macchia T, Simultaneous detection of amphetamine-like drugs with headspace solid-phase microextraction and gas chromatography-mass spectrometry
Freese T, Miotto K, Reback C, The effects and consequences of selected club drugs
Forsling ML, Fallon JK Shah D, Tilbrook GS, Cowan DA, Kicman AT, Hutt AJ, The effect of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus
Fone KF, Beckett SG, Topham IA, Swettenham J, Ball M, Maddocks L, Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity
Fletcher PJ, Korth KM, Robinson SR,. Baker GB, Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement
Farre M, Roset PN, de la Torre R, Segura M, Ortuno J, Peiro AM, Torrens M, Pacifici R, Zuccaro P, Cami J, Interaction of Paroxetine and MDMA in humans
Fernandez F, Aguerre S, MormÃ¨de P, Chaouloff F, Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats.
Fang C, Chung YL, Liu JT, Lin CH, Rapid analysis of 3,4-methylenedioxymethamphetamine: a comparison of nonaqueous capillary electrophoresis/fluorescence detection with GC/MS
Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G, 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement
Fallon JK, Shah D, Kicman AT, Hutt AJ, Henry JA, Cowan DA, Forsling M., Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release
Falk EM, Cook VJ, Nichols DE, Sprague JE, An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA
De Letter EA, Clauwaert KM, Lambert WE, Van Bocxlaer JF, De Leenheer AP, Piette MHA, CASE REPORT: Distribution Study of 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxy-amphetamine in a Fatal Overdose
Ellison G, Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry
De Letter EA, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, Piette MH, Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rabbitPart I: experimental approach after in vivo intravenous infusion
Darvesh AS, Shankaran M, Gudelsky GA, 3,4-methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain
De Letter EA, Belpaire FM, Clauwaert KM, Lambert WE, Van Bocxlaer JF, Piette MH, Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') in the rabbitPart II: post-mortem infusion in trachea or stomach
Crouch DJ, Hersch RK, Cook RF, Frank JF, Walsh JM, A field evaluation of five on-site drug-testing devices
Cole J, Sumnall H, Grob C, Sorted: Ecstasy facts and fiction
Cole J, Sumnall H, Grob C, Where are the casualties?
Croft RJ, 'Danger' remains best message
Crouch DJ, Hersch RK, Cook RF, Frank JF, Walsh JM, A field evaluation of five on-site drug-testing devices.
Colbron S, Jones M, Biello SM, MDMA alters the response of the circadian clock to a photic and non-photic stimulus.
Cody JT, Valtier S, Differentiation of the 2,3-methylenedioxy regioisomer of 3,4-MDMA (ecstasy) by gas chromatography-mass spectrometry.
Cleary L, Buber R, Docherty JR, Effects of amphetamine derivatives and cathinone on noradrenaline-evoked contractions of rat right ventricle
Cherney DZ, Davids MR, Halperin ML, Acute hyponatraemia and 'ecstasy': insights from a quantitative and integrative analysis
Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks TJ, Fernandes E, Carvalho F, Bastos ML, Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells
Camarero J, Sanchez V, O'Shea E, Green AR, Colado MI, Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum
Carvalho M, Carvalho F, Remiao F, de Lourdes Pereira M, Pires-Das-Neves R, de Lourdes Bastos M, Effect of 3,4-methylenedioxymethamphetamine ('ecstasy') on body temperature and liver antioxidant status in mice: influence of ambient temperature
Caballero F, Lopez-Navidad A, Cotorruelo J, Txoperena G, Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation
Braida D, Pozzi M, Cavallini R, Sala M, 3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats
Brecht M-L, von Mayrhauser C, Differences between ecstasy-using and non-using methamphetamine users
Braida D, Sala M, Role of the endocannabinoid system in MDMA intracerebral self- administration in rats
Bellis MA, Hughes K, Lowey H, Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach
Boire RG, What should the public be told about the risks of Ecstasy? (2)
Boot BP, Mechan AO, McCann UD, Ricaurte GA, MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities
Boatto G, Faedda MV, Pau A, Asproni B, Menconi S, Cerri R, Determination of amphetamines in human whole blood by capillary electrophoresis with photodiode array detection
Bobes J, Saiz PA, Gonzalez MP, Bascaran MT, Bousono M, Ricaurte GA, McCann UD, Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain. a five-year study
Baggott M, Preventing problems in ecstasy users; Reduce use to reduce harm
Bankson MG, Cunningham KA, Pharmacological Studies of the Acute Effects of (+)-3,4- Methylenedioxymethamphetamine on Locomotor Activity. Role of 5- HT(1B/1D) and 5-HT(2) Receptors
Arria AM, Yacoubian GS, Fost E, Wish ED, Ecstasy Use Among Club Rave Attendees
Badaoui R, El Kettani C, Fikri M, Ouendo M, Canova-Bartoli P, Ossart M, Spontaneous cervical and mediastinal air emphysema after ecstasy abuse
Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, Varner KJ, Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited during Binge Administration of Ecstasy
Anonymous, Ecstasy [a brief introduction]
Peet Malcolm, Essential Fatty Acids: theoretical aspects and treatment implications for schizophrenia and depression
University of Oxford, US prize for Alzheimer’s research
Deepak, Neurophysiological mechanisms of induction of meditation: A hypothetico-deductive approach
Gregory T Carter & Patrick Weydt, Cannabis: Old medicine with new promise for neurological disorders
Eliot L. Gardner, Addictive potential of cannabinoids: the underlying neurobiology
Robert J. McKallip, Catherine Lombard, Michael Fisher, Billy R. Martin, Seongho Ryu, Steven Grant,Prakash S. Nagarkatti, and Mitzi Nagarkatti, Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
George C Patton, Carolyn Coffey, John B Carlin, Louisa Degenhardt, MichaelLynskey and Wayne Hall, Cannabis use and mental health in young people:cohort study
Stanley Zammit, Peter Allebeck, Sven Andreasson, Ingvar Lundberg, Glyn Lewis, Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
M.Maccarrone,K. Falciglia,M.Di Rienzo,A.Finazzi-Agro, Endocannabinoids, hormone-cytokine networks and human fertility
R.Mechoulam, Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression
D.Parolaro, P.Massi, T. Rubino, E.Monti, Endocannabinoids in the immune system and cancer
R.G.Pertwee,R.A.Ross, Cannabinoid receptors and their ligands
Michael D. Roth , Gayle C. Baldwin , Donald P. Tashkin, Effects of delta-9-tetrahydrocannabinol on human immune function and host defense
Herbert Schuel , Lani J. Burkman , Jack Lippes , Kent Crickard, Ellyn Forester , Daniele Piomelli , Andrea Giuffrida, N-Acylethanolamines in human reproductive fluids
J.M.Walker,S.M.Huang, Endocannabinoids in pain modulation
Betty Grover Eisner, Remembrances of LSD therapy past
Jordi Riba,Peter Anderer, Adelaida Morte,Gloria Urbano, Francesc Jane´ ,Bernd Saletu & Manel J. Barbanoj, Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers
JOSEF FINSTERER MD PhD,CLAUDIA STÖLLBERGER MD,CHRISTINE STEGER MD AND ALOIS KROISS MD, Long lasting impaired cerebral blood flow after ecstasy intoxication
S.N. Davies, R.G. Pertwee , G. Riedel, Functions of cannabinoid receptors in the hippocampus
Ester Fride and Esther Shohami, The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
Mayberg, H. S., Silva, J. A., Brannan, S. K., et al, The Functional Neuroanatomy of the Placebo Effect
Baggott, M. J., Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm
Borsutzky, M., Passie, T., Paetzold, W., et al, [Hawaiian baby woodrose: (Psycho-) Pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration].
Brecht, M. L. and von, M. C., Differences Between Ecstasy-Using and Nonusing Methamphetamine Users.
Doblin, R., A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.
Gijsman, H. J., Van Gerven, J. M., Verkes, R. J., et al, Saccadic peak velocity and EEG as end-points for a serotonergic challenge test
Hayner, G. N., MDMA misrepresentation: an unresolved problem for Ecstasy users.
Krupitsky, E., Burakov, A., Romanova, T., et al, Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up
McElrath, K. and McEvoy, K., Negative experiences on Ecstasy: the role of drug, set and setting.
Vollenweider, F. X., Liechti, M. E., Gamma, A., et al, Acute psychological and neurophysiological effects of MDMA in humans.
Yacoubian, G. S., Jr., Arria, A. M., Fost, E., et al, Estimating the prevalence of Ecstasy use among juvenile offenders.
Fang, C., Liu, J. T., and Lin, C. H., Optimization of the separation of lysergic acid diethylamide in urine by a sweeping technique using micellar electrokinetic chromatography.
Heil, S. H., Holmes, H. W., Bickel, W. K., et al, Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.
Leumann, L., Feldon, J., Vollenweider, F. X., et al, Effects of Typical and Atypical Antipsychotics on Prepulse Inhibition and Latent Inhibition in Chronic Schizophrenia
Marona-Lewicka, D., Kurrasch-Orbaugh, D. M., Selken, J. R., et al, Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., et al, Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims.
Roth, B. L., Baner, K., Westkaemper, R., et al, Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Mechoulam, R., Panikashvili, D., and Shohami, E., Cannabinoids and brain injury: therapeutic implications
Riordan, M., Rylance, G., and Berry, K., Poisoning in children 5: Rare and dangerous poisons
Schonbachler, R. D., Gucker, P. M., Arigoni, M., et al, PET imaging of dopamine transporters in the human brain using [(11)C]-beta-CPPIT, a cocaine derivative lacking the 2 beta-ester function.
Skopp, G., Potsch, L., Mattern, R., et al, Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry.
Snelders, S. and Kaplan, C., LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets.
Wilcox, H. C., Wagner, F. A., and Anthony, J. C., Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use.
Zagnoni, P. G. and Albano, C., Psychostimulants and epilepsy.
Pascal Derkinderen, Madeleine Toutant, Gress Kadare, Catherine Ledent, Marc Parmentier, Jean-Antoine Girault, Dual Role of Fyn in the Regulation of FAK 6,7 by Cannabinoids in Hippocampus*
Kumar RN, Chambers WA, Pertwee RG., Pharmacological actions and therapeutic uses of cannabis and cannabinoids.
Paria, BC, H. Song, X. Wang, P. C. Schmid, R. J. Krebsbach, H. H. O. Schmid, Tom I. Bonneri, Andreas Zimmer, S. K. Dey, Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation
Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grubler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B, Stalla GK., Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
Di Marzo V, Bisogno T, De Petrocellis L., Anandamide: some like it hot.
Robson P., Therapeutic aspects of cannabis and cannabinoids.
Ashton CH., Pharmacology and effects of cannabis: a brief review.
Johns A., Psychiatric effects of cannabis.
Newberg A, Alavi A, Baime M, Pourdehnad M, Santanna J, d'Aquili E., The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study.
Xavier Bosch Barcelona,, Catalan parliament pushes for legalisation of cannabis as therapy
Eleni T. Tzavara, Kenneth W. Perry, Dana E. Rodriguez, Frank P. Bymaster, George G. Nomikos, The cannabinoid CB receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus
Velasco L et.al., Delta-9-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells: Involvement of CB1 cannabinoid receptor and Raf-1
Takashi Maejima, Takako Ohno-Shosaku, Masanobu Kano, Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals
Justin P. Meschler, Allyn C. Howlett, Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum
Vera Ralevic, David A. Kendall, Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed
Kim D, Thayer SA, Cannabinids Inhibit the Formation of New Synapses between Hippocampal Neurons in Culture
Anatol C. Kreitzer, Wade G. Regehr, Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids
Chiung-Chun Huang, Shiow-Win Lo, Ku i-S n Hsu, Presynaptic echaniss underlying cannabinoid inhibition of excitatory synaptic transission in rat striatal neurons
E. A. Jennings, C. W. Vaughan, M. J. Christie, Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro
H. Daniel, F. Crepel, Rapid Report Control of Ca 2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebelar cortex requires K+ channels
Irina Fedorova, Akihiro Hashimoto, Robert A. Fecik, Michael P. Hedrick, Lumir O. Hanu S, Dale L. Boger, Kenner C. Rice, Anthony S. Basile, Behavioral Evidence for the Interaction of Oleamide with Multiple Neurotransmitter Systems
E. Sylvester Vizi, Istvan Katona, Tamas F. Freund, Evidence for presynaptic cannabinoid CB receptor-mediated inhibition of noradrenaline release in the guinea pig lung
Tibor Wenger, Catherine Ledent, Valer Csernus, Ida Gerendai, The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions
Stig O. P. Jacobsson, Thomas Wallin, Christopher J. Fowler, Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors
Theodore A. Sarafian, Donald P. Tashkin, and Michael D. Roth, Marijuana Smoke and D9-Tetrahydrocannabinol Promote Necrotic Cell Death but Inhibit Fas-Mediated Apoptosis
Boyle MH et.al, Familial Influences on Substance Use by Adolescents and Young Adults
Margery C. Beinfeld, Kelly Connolly, Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids
Brook JS et.al, Risk Factors for Adolescent Marijuana Use Across Cultures and Across Time
Arthur Christopoulos, Kathryn Wilson, Interaction of anandamide with the M1 and M4 muscarinic acetylcholine receptors
Fowler FJ, Stringfellow VL, Learning from experience: estimating teen use of alcohol, cigarettes, and marijuana from three survey protocols
Salvador Huitron-Resendiz, Lhys Gombart, Benjamin F. Cravatt, and Steven J. Henriksen, Effect of Oleamide on Sleep and Its Relationship to Blood Pressure, Body Temperature, and Locomotor Activity in Rats
Jan K Melichar, Mark RC Daglish, David J Nutt, Addiction and withdrawal - current views
F. Nava, G. Carta, G. Colombo, G.L. Gessa, Effects of chronic 9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze
Eric Murillo-Rodriguez, Magda Giordano, Rafael Cabeza, Steve J. Henriksen, Monica Mendez Diaz, Luz Navarro, Oscar Prospero-Garcia, Oleamide modulates memory in rats
Zoltan Sarnyai, Yavin Shaham, Stephen C. Heinrichs, The Role of Corticotropin-Releasing Factor in Drug Addiction
Wendy Swift, Wayne Hall, Maree Teesson, Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing
Kirsten von Sydow, Roselind Lieb, Hildegard Pfister, Michael Hofler, Holger Sonntag, Hans-Ulrich Wittchen, The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults
Jonathon C. Arnold, Ann N. Topple, Paul E. Mallet, Glenn E. Hunt, Iain S. McGregor, The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain
Elio Acquas, Augusta Pisanu, Paola Marrocu, Steven R. Goldberg, Gaetano Di Chiara, D 9 -tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study
Fellermeier M et.al., Biosynthesis of Cannabinoids: Incorporation experiments with 13 C-labeled glucoses
Iwamura H et.al., In Vitro and in Vivo Pharmacological Characterization of JTE- 907, a Novel Selective Ligand for Cannabinoid CB2 Receptor
Daniel T. Malone, David A. Taylor, Involvement of somatodendritic 5-HT1A receptors in D-9-tetrahydrocannabinol-induced hypothermia in the rat
Vera Ralevic, David A. Kendall, Jeffrey C. Jerman, Derek N. Middlemiss, Darren Smart, Cannabinoid activation of recombinant and endogenous vanilloid receptors
Wiley JL et.al., Novel Pyrazole Cannabinoids: Insights into CB1 Receptor Recognition and Activation
A. Al-Hayani, K.N. Wease, R.A. Ross, R.G. Pertwee, S.N. Davies, The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
Theresa A. Day, Fariborz Rakhshan, Dale G. Deutsch, Eric L. Barker, Role of Fatty Acid Amide Hydrolase in the Transport of theEndogenous Cannabinoid Anandamide
Andrea Giuffrida, Massimiliano Beltramo, Daniele Piomelli, Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
Wallace B. Mendelson, M.D., and Anthony S. Basile, Ph.D, The Hypnotic Actions of the Fatty Acid Amide, Oleamide
Maingret F et.al., The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
Victoria E. Mendizabal, Maria Luz Orliac, Edda Adler-Graschinsky, Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed
Nephi Stella, Daniele Piomelli, Receptor-dependent formation of endogenous cannabinoids in cortical neurons
Namita Varma, Gregory C. Carlson, Catherine Ledent, Bradley E. Alger, Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
Christopher S. Breivogel, Graeme Griffin, Vincenzo Di Marzo, Billy R. Martin, Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
Anat Biegon, Ilan A. Kerman, Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain
N. Hajos, C. Ledent, T. F. Freund, A novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
Isabel Matias, Tiziana Bisogno, Dominique Melck, Franck Vandenbulcke, Martine Verger-Bocquet, Luciano De Petrocellis, Christian Sergheraert, Christophe Breton, Vincenzo Di Marzo, Michel Salzet, Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis
Sumi Fong Lee, Catherine Newton, Raymond Widen, Herman Friedman, Thomas W. Klein, Differential expression of cannabinoid CB receptor mRNA in mouse immune cell subpopulations and following B cell stimulation
Anjali Kulkarni-Narla, David R. Brown, Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons
Mukhopadhyay S, Howlett AC, CB1 receptor-G protein association; Subtype selectivity is determined by distinct intracellular domains
A. J. McDonald, F. Mascagni, Localization of the cb1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons
J. Nie, D. L. Lewis, The proximal and distal c-terminal tail domains of the cb1 cannabinoid receptor mediate
Cristina Sanchez, Daniel Rueda, Bruno Segui, Ismael Galve-roperh, Thierry Levade, Manuel Guzman, The CB1 Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through Adaptor Protein Fan
Soderstrom K, Johnson F, Zebra Finch, CB1 Cannabinoid Receptor: Pharmacology and in Vivo and in Vitro Effects of Activation
Timo Wittenberger, H. Chica Schaller, Susanne Hellebrand, An Expressed Sequence Tag (EST) Data Mining Strategy Succeeding in the Discovery of New G- Protein Coupled Receptors
Ashton, CH, Pharmacology and effects of cannabis: a brief review
Aron H. Lichtman, Justin L. Poklis, Alphonse Poklis, David M. Wilson, Billy R. Martin, The pharmacological activity of inhalation exposure to marijuana smoke in mice
Robson P, Therapeutic aspects of cannabis and cannabinoids
T. Lundqvist, S. Jonsson, S. Warkentin, Frontal lobe dysfunction in long-term cannabis users
Garcia N et.al., Systemic and portal hemodynamic effects of anandamide
Maccarrone M et.al., Human Platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor
Jens A. Wagner, Zoltan Jarai, Sandor Batkai, George Kunos, Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB receptors 1
Vanheel B, Van De Voorde J, Regional Differences in Anandamide- and Methanandamide- Induced Membrane Potential Changes in Rat Mesenteric Arteries
Kerrigan S, Phillips WH, Comparison of ELISAs for Opiates, Methamphetamine, Cocaine Metabolite, Benzodiazepines, Phencyclidine, ans Cannabinoids in Whole Blood and Urine
George E. da Silva, Gina S. Morato, Reinaldo N. Takahashi, Rapid tolerance to D 9-tetrahydrocannabinol and cross-tolerance between ethanol and D 9 - tetrahydrocannabinol in mice
Hoffman AF, Lupica CR, Direct Ations of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparrison With Opioids
Francesco E. Pontieri, Paola Monnazzi, Alessandra Scontrini, Francesca R. Buttarelli, Francesca R. Patacchioli, Behavioral sensitization to heroin by cannabinoid pretreatment in the rat
Scott E. Lukas, Sara Orozco, Ethanol increases plasma 9-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers
A. H. Lichtman, S. M. Sheikh, H. H. Loh, B. R. Martin, Opioid and Cannabinoid Modulation of Precipitated Withdrawal in 9-Tetrahydrocannabinol and Morphine-Dependent Mice
S. Lamarque, K. Taghzouti, H. Simon, Chronic treatment with 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction
Taku Yamaguchi, Yumi Hagiwara, Hiroyuki Tanaka, Takayuki Sugiura, Keizo Waku, Yukihiro Shoyama, Shigenori Watanabe, Tsuneyuki Yamamoto, Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
Salvatore Serra, Mauro A.M. Carai, Giuliana Brunetti, Raquel Gomez, Samuele Melis, Giovanni Vacca, Giancarlo Colombo, Gian Luigi Gessa, The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats
Nissar A. Darmani, Ph.D, D 9 -Tetrahydrocannabinol and Synthetic Cannabinoids Prevent Emesis Produced by the Cannabinoid CB1 Receptor Antagonist/ Inverse Agonist SR 141716A
Nissar A. Darmani, The cannabinoid CB receptor antagonist SR 141716A reverses the 1 antiemetic and motor depressant actions of WIN 55, 212-2
Nissar A. Darmani, Delta-9-tetrahydrocannabinol differently suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew
Anna H.V. Soderpalm, Alyson Schuster, Harriet de Wit, Antiemetic efficacy of smoked marijuana Subjective and behavioral effects on nausea induced by syrup of ipecac
Peter Holzer, Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain
Marja D. Van Sickle, Lorraine D. Oland, Winnie Ho, Cecilia J. Hillard, Ken Mackie, Joseph S. Davison, Keith A. Sharkey, Cannabinoids Inhibit Emesis Through CB1 Receptors in the Brainstem of the Ferret
W.D. Stamer, S.F. Golightly, Y. Hosohata, E.P. Ryan, A.C. Porter, E. Varga, R.J. Noecker, C.C. Felder, H.I. Yamamura, Cannabinoid CB receptor expression, activation and detection of 1endogenous ligand in trabecular meshwork and ciliary process tissues
Jose Melena, Neville N. Osborne, Voltage-dependent Calcium Channels in the Rat Retina: Involvement in NMDA-stimulated Influx of Calcium
Veronica A. Campbell, Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation
K.P. DeSanty, M. Saeed Dar, Involvement of the cerebellar adenosine A receptor in cannabinoid- 1 induced motor incoordination in the acute and tolerant state in mice
J.-C. Lievens, B. Woodman, A. Mahal, O. Spasic-Boscovic, D. Samuel, L. Kerkerian-Le Goff, G. P. Bates, Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Melisa J. Wallace, Jenny L. Wiley, Billy R. Martin, Robert J. DeLorenzo, Assessment of the role of CB receptors in cannabinoid anticonvulsant effects
M. A. Silverdale, S. McGuire, A. McInnes, A. R. Crossman, J. M. Brotchie, Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease
Mary E. Abood, Gulrukh Rizvi, Neetha Sallapudi, Sean D. McAllister, Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
Gil Lavie, Angella Teichner, Esther Shohami, Haim Ovadia, Ronen R. Leker, Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia
Michelle Glass, The role of cannabinoids in neurodeoenerative diseases
Antonio Calignano, Giovanna La Rana, Daniele Piomelli, Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
Lisa M. Johanek, Dwayne R. Heitmiller, Michelle Turner, Nicole Nader, Jim Hodges, Donald A. Simone, Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms
Hans Guhring, Johannes Schuster, May Hamza, Mehmet Ates, Carolin Edith Kotalla, Kay Brune, HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test
Alyson Fox, Adam Kesingland, Clive Gentry, Kara McNair, Sadhana Patel, Laszlo Urban, Iain James, The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
V. Chapman, Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats
John E. McKenna, Ronald Melzack, Blocking NMDA Receptors in the Hippocampal Dentate Gyrus with AP5 Produces Analgesia in the Formalin Pain Test
T. Philip Malan Jr, Mohab M. Ibrahim, Hongfeng Deng, Qian Liu, Heriberto P. Mata, Todd Vanderah, Frank Porreca, Alexandros Makriyannis, CB2 cannabinoid receptor-mediated peripheral antinociception
Valerie Morisset, Laszlo Urban, Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord.
John M. McPartland, Ethan B. Russo, Cannabis and Cannabis Ex tracts: Greater Than the Sum of Their Parts?
Angela Siegling, Heiko A. Hofmann, Dirk Denzer, Frank Mauler, Jean De Vry, Cannabinoid CB receptor upregulation in a rat model of chronic neuropathic pain.
Roger G. Pertwee, Cannabinoid receptors and pain
Valerie Morisset, Jatinder Ahluwalia, Istvan Nagy, Laszlo Urban, Possible mechanisms of cannabinoid-induced antinociception in the spinal cord.
Sidney R. Smith, Georgetta Denhardt, Carol Terminelli, The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models
Alan H. Tseng, Rebecca M. Craft, Sex differences in antinociceptive and motoric effects of cannabinoids
Clyde W. Dent, Ph.D., Steve Sussman, Ph.D., Alan W. Stacy, Ph.D, Project Towards No Drug Abuse: Generalizability to a General High School Sample
Farrell M, Ritson B, Cannabis and Health
Halpern, Pain: no medical necessity defense to controlled substances act
Kalso E, Cannabinoids for pain and nausea, some evidence but is there any need
Lydia A. Shrier, M.D., M.P.H., Sion Kim Harris, Ph.D., Maya Sternberg, Ph.D., William R. Beardslee, M.D, Associations of Depression, Self-Esteem, and Substance Use with Sexual Risk among Adolescents
MacCoun R, Reuter P, Evaluating alternative cannabis regimes
B. Dean, S. Sundram, R. BRADBURY, E. SCARR, D. COPOLOV, Studies on [ 3 h]cp-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
Bovaso GB, Cannabis Abuse as a Risk Factor for Depressive Symptoms
Cristina Arevalo, Rosario de Miguel, Rafael Hernandez-Tristan, Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.
K. R. Miller-Vahl, A. Koblenz, M. Jobges, H. Kolbe, H. M. Emrich, U. Schneider, Influence of Treatment of Tourette Syndrome with D 9 -Tetrahydro- cannabinol (D 9 -THC) on Neuropsychological Performance
Johns A, Psychiatric effects of cannabis
D. Peckys and Y. L. Hurd, Prodynorphin and k opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders
M.D. Wood, C. Reavill, B. Trail, A. Wilson, T. Stean, G.A. Kennett, S. Lightowler, T.P. Blackburn, D. Thomas, T.L. Gager, G. Riley, V. Holland, S.M. Bromidge, I.T. Forbes, D.N. Middlemiss, SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety
Lakshmi N.P. Voruganti, Piotr Slomka, Pamela Zabel, Adel Mattar, A. George Awad, Cannabis induced dopamine release: an in-vivo SPECT study
Ester Fride, Yoav Ginzburg, Aviva Breuer, Tiziana Bisogno, Vincenzo Di Marzo, Raphael Mechoulam, Critical role of the endogenous cannabinoid system in mouse pup suckling and growth
P.A. Fried, A.M. Smith, A literature review of the consequences of prenatal marihuana exposure An emerging theme of a deficiency in aspects of executive function
Perrine DM, Visions in the Night: Western medicine meets peyote (1887-1899)
Horgan J, The future of mind-science
Krupitsky EM, Burakov AM, Romanov TN, Grinenko AY, Strassman RJ, Ketamine-Assisted Psychotherapy (KPT) of Heroin Addiction: Immediate Effects and Six Months Follow-Up
Nichols CD, Sanders-Bush E, Serotonin Receptor Signaling and Hallucinogenic Drug Action
Nichols DE, LSD and Its Lysergamide Cousins
Vollenweider FX, Geyer M, Greer G, Acute psychological and neurophysiological effects of MDMA In humans
Gouzoulis-Mayfrank E, Differential actions of an entactogen compared to a stimulant and a hallucinogen in healthy humans
van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart JF, Nicolay K, Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity
Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI, 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose
Krupitsky EM, Burakov AM, Romanova TN, Grinenko NI, Grinenko AY, Fletcher J, Petrakis IL, Krystal JH, Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists
Ramamoorthy Y, Tyndale RF, Sellers EM, Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates
Cannon DM, Keenan AK, Guiry PJ, Buon C, Baird AW, McBean GJ, In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA
Spitzer M, Franke B, Walter H, Buechler J, Wunderlich AP, Schwab M, Kovar KA, Hermle L, GrÃ¶n G, Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans
Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ, Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M, Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET
Zhao H, Brenneisen R, Scholer A, McNally AJ, ElSohly MA, Murphy TP, Salamone SJ, Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS
Zemishlany Z, Aizenberg D, Weizman A, Subjective effects of MDMA ('Ecstasy') on human sexual function
Zakzanis K, Young DA, Executive function in abstinent MDMA ('ecstasy') users
Zakzanis KK, Young DA, Memory impairment in abstinent MDMA (“Ecstasy”) users: A longitudinal investigation
Verkes RJ, Gijsman HJ, Pieters MSM, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJM, de Bruin D, Van de Wijngaart G, Van Gerven JMA, Cohen AF, Cognitive performance and serotonergic function in users of ecstasy
Wallace TL, Gudelsky GA, Vorhees CV, Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine
Vollenweider FX, Jones RT, Baggott MJ, Caveat Emptor: Editors Beware (reply)
Vaiva G, Boss V, Bailly D, Thomas P, Lestavel P, Goudemand M, An 'Accidental' Acute Psychosis with Ecstasy Use
Vastag B, Ecstasy experts want realistic messages
Tossmann P, Boldt S, Tensil MD, The use of drugs within the techno party scene in European metropolitan cities.
Teter CJ, Guthrie SK, A comprehensive review of MDMA and GHB: two common club drugs
Tancer, ME, Johanson, C-E, The subjective effects of MDMA and mCPP in moderate MDMA users
Taylor JR, Jentsch D, Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine ('Ecstasy')
Taffe MA, Weed MR, Davis S, Huitron-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH, Functional Consequences of Repeated (+/-)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys
Soar K, Turner JJD, Parrott AC, Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history
Segura M, Ortuno J, Farre M, McLure JA, Pujadas M, Pizarro N, Llebaria A Juglar, J, Roset PN, Segura J, de la Torre R, 3,4-Dihydroxymethamphetamine (HHMA). A Major in Vivo 3,4- methylenedioxymethamphetamine (MDMA) Metabolite in Humans
Shankaran M, Yamamoto BK, Gudelsky GA, Ascorbic Acid Prevents 3,4- Methylenedioxymethamphetamine (MDMA)-Induced Hydroxyl Radical Formation and the Behavioral and Neurochemical Consequences of the Depletion of Brain 5-HT
Siliquini R, Faggiano F, Geninatti S, Versino E, Mitola B, Ippolito R, Patterns of drug use among young men in Piedmont (Italy)
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS, Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI, The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain
Russell BR, Laverty R, The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity
Rogers, RD & Robbins, TW, Investigating the neurocognitive deficits associated with chronic drug misuse
Rodgers J, Buchanan T, Scholey AB, Heffernan, TM, Ling J, Parrott A, Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study
Riley SCE, James C, Gregory D, Dingle H, Cadger M, Patterns of recreational drug use at dance events in Edinburgh, Scotland
Ricaurte GA, McCann UD, Assessing long-term effects of MDMA (Ecstasy)
Reneman L, Majoie CB, Habraken JB, den Heeten GJ, Effects of ecstasy (mdma) on the brain in abstinent users: initial observations with diffusion and perfusion mr imaging.
Reneman L, Majoie CBLM, Schmand B, van den Brink W, den Heeten GJ, Pre-frontal N-acetylaspartate is strongly associated with memory performance in (abstinent) Ecstasy users: Preliminary report
Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J, Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy'): Preliminary Findings
Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W, Effects of dose, sex and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
Reneman L, Booij J, Majoie CBLM, van den Brink,W, den Heeten GJ, Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach
Ratzenboeck E, Saria A, Kriechbaum N, Zernig G, Reinforcing Effects of MDMA ('Ecstasy') in Drug-Naive and Cocaine-Trained Rats
Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA, PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA
Rajamani K, Leong S, Lavelle A, Docherty JR, Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and a(2A/D)-adrenoceptor knockout mice
Pham JV, Puzantian T, Ecstasy: Dangers and controversies
Pope, HG Jr., Ionescu-Pioggia, M, and Pope, KW, Drug use and life style among college undergraduates: a 30-year longitudinal study
Pentney AR, An exploration of the history and controversies surrounding MDMA and MDA
Pedersen NP, Blessing WW, Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4- methylenedioxymethamphetamine (ecstasy) in conscious rabbits
Pedersen NP, Blessing WW, Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits
Parrott AC, Milani RM, Parmar R, Turner JD, Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems
Parrott AC, Human psychopharmacology of ecstasy; A review of 15 years of empirical research
Pacifici R, Zuccaro P,. Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R, Effects of repeated doses of MDMA ('ecstasy') on cell-mediated immune response in humans
Obergriesser T, Ende G, Braus DF, Henn FA, Hippocampal [1H]-MRSI in ecstasy users
Pacifici R, Zuccaro P, Lopez CH, Pichini S, di Carlo S, Farre M, Roset PN, Ortuno J, Segura J, de la Torre R, Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans
O'Shea E, Esteban B, Camarero J, Green AR, Colabo MI, Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain
Nixdorf WL, Burrows KB, Gudelsky GA, Yamamoto BK, Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate
O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM, Behavioural, hyperthermic and neurotoxic effects of 3,4- methylenedioxymethamphetamine analogues in the Wistar rat
Navarro M, Pichini S, Farre M, Ortuno J, Roset PN, Segura J, de la Torre R, Usefulness of saliva for measurement of 3,4- methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH
Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS, Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ('Ecstasy')
Mortensen OV, Kristensen AS, Wiborg O, Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants
Mendelson J, Dextromethorphan and Ecstasy Pills (reply)
Mechan AO, O'Shea E, Elliott JM, Colado MI, Green AR, A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation
McElrath K, McEvoy K., Fact, fiction, and function: mythmaking and the social construction of ecstasy use
McDaid J, Docherty JR, Vascular actions of MDMA involve alpha(1) and alpha(2)-adrenoceptors in the anaesthetized rat
McCann UD, Ricaurte GA, Molliver MD, 'Ecstasy' and serotonin neurotoxicity: New findings raise more questions
McCann UD, Ricaurte GA, Caveat Emptor: Editors Beware
Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S, The Circuit Party Men's Health Survey: findings and implications for gay and bisexual men
Mayerhofer A, Kovar KA, Schmidt WJ, Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats
Mattison, AM, Ross, MW, Wolfson, T, Franklin, D, Circuit party attendance, club drug use, and unsafe sex in gay men
Mamamoorthy Y, Tyndale R, Sellers EM, Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates
Maldonado E, Navarro JF, Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice
Logan BK, Couper FJ, 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
MacInnes, N, Handley, SL and Harding, GFA, Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users report mild depressive symptoms
Ling LH, Marchant C, Buckley NA, Prior M, Irvine RJ, Poisoning with the recreational drug paramethoxyamphetamine ('death')
Liechti ME, Vollenweider FX, Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
Kavanagh P, Dunne J, Feely J, Maguire R, Corrigan D, Keating JJ, Meegan MJ, Clancy JM, Burdett J, Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland
Liechti ME, Geyer MA, Hell D, Vollenweider FX, Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin
Kalant, H, The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs
Liechti ME, Gamma A, Vollenweider FX, Gender Differences in the Subjective Effects of MDMA
Hong SS, Discriminative stimulus properties of alpha-ethyltryptamine optical isomers
Jones GRN, Causes of Alzheimer’s disease: paracetamol (acetaminophen) today? Amphetamines tomorrow?
Heffernan TM, Jarvis H, Rodgers J , Scholey AB, Ling J, Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy
Ho E, Karimi-Tabesh L, Koren G, Characteristics of pregnant women who use Ecstasy (3, 4- methylenedioxymethamphetamine)
Hansen D, Maycock B, Lower T, 'Weddings, parties, anything…', a qualitative analysis of ecstasy use in Perth, Western Australia
Gold MS, Tabrah H, Frost-Pineda K, Psychopharmacology of MDMA (Ecstasy)
Golub A, Johnson BD, Sifaneck, S J, Chesluk B, Parker H, Is the U.S. experiencing an incipient epidemic of hallucinogen use?
Gervin M, Hughes R, Bamford L, Smyth BP, Keenan E, Heroin smoking by 'chasing the dragon' in young opiate users in Ireland: stability and associations with use to 'come down' off 'Ecstasy'
Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F, Experimentally induced aggressive behavior in subjects with 3,4- methylenedioxy-methamphetamine ('Ecstasy') use history: psychobiological correlat
Gamma A, Buck A, Berthold T, Vollenweider FX, No difference in brain activation during cognitive performance between Ecstasy (MDMA) users and controls: a [H2(15)O]-PET study
Frei E, Gamma A, Pascual-Marqui R, Lehmann D, Hell D, Vollenweider FX, Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)
Fox HC, Toplis AS, Turner JJD, Parrott AC, Auditory verbal learning in drug-free Ecstasy polydrug users
Fox HC, Parrott AC, Turner JJD, Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug
Fornai F, Giorgi FS, Gesi M, Chen K, Alessandri MG, Shih JC, Biochemical Effects of the Monoamine Neurotoxins DSP-4 and MDMA in Specific Brain Regions of MAO-B-Deficient Mice
Forsling, M, Fallon, JK, Kicman, AT, Hutt, AJ, Cowan, DA, Henry, JA, Arginine vasopressin release in response to the administration of 3,4- methylenedioxymethamphetamine ('ecstasy'): is metabolism a contributory factor?
Dughiero G, Schifano F, Forza G, Personality dimensions and psychopathological profiles of Ecstasy users
Fletcher PJ, Robinson SR, Slippoy DL, Pre-Exposure to (+/-)3,4-methylenedioxymethamphetamine (MDMA) Facilitates Acquisition of Intravenous Cocaine Self-Administration in Rats
Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E, Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use
Croft, RJ, Klugman, A, Baldeweg, T, and Gruzelier, JH, Electrophysiological evidence of serotonergic impairment in lonf-term MDMA ('ecstasy') users
Croft RC, Macay AJ, Mills ATD, Gruzelier JGH, The relative contributions of ecstasy and cannabis to cognitive impairment
Cottler LB, Womack SB, Compton WM, Ben-Abdallah A, Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria
Connor TJ, Dennedy MC, Harkin A, Kelly JP, Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin
Connor TJ, Connelly DB, Kelly JP, Methylenedioxymethamphetamine (MDMA, 'Ecstasy') suppresses antigen-specific IgG2a and IFN-Gamma Production
Colfax GN, Mansergh G, Guzman R, Vittinghoff E, Marks G, Rader M, Buchbinder S, Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison
Colado MI, O'Shea E, Esteban B, Green AR, Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ('ecstasy')-induced neurodegeneration in rat brain.
Colado MI, Camarero J, Mechan AO, Sanchez V, Esteban B, Elliott JM, Green AR, A study of the mechanisms involved in the neurotoxic action of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain
Broening HW, Morford LL, Inman-Wood SL, Fukumura M, Vorhees CV, 3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Learning and Memory Impairments Depend on the Age of Exposure during Early Development
Carvalho M, Carvalho F, Bastos ML, Is hyperthermia the triggering factor for the hepatoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy) ? An in vitro study using freshly isolated mouse hepatocytes
Callahan BT, Cord BJ, Ricaurte GA, Long-Term Impairment of Anterograde Axonal Transport Along Fiber Projections Originating in the Rostral Raphe Nuclei After Treatment With Fenfluramine or Methylenedioxymethamphetamine
Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL,. Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK, Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
Braff, DL, Geyer, MA and Swerdlow, NR, Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
Boyer E, Quang L, Woolf A, Shannon M, Magnani B, Dextromethorphan and Ecstasy Pills
Boys A, Marsden J, Strang J, Understanding reasons for drug use amongst young people: A functional perspective.
Biello, SM, Dafters, RI, MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro
Bhattachary S, Powell JH, Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
Bankson MB, Cunningham KA, 3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dopamine Interactions
Baggott M, Jerome L, Stuart R, 3,4-Methylenedioxymethamphetamine (MDMA): A Review of the English-Language Scientific and Medical Literature
Bai F, Jones DC, Lau SS, Monks TJ, Serotonergic Neurotoxicity of 3,4-(+/-)-Methylenedioxyamphetamine and 3,4-(+/-)-Methylenedioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of y-Glutamyl Transpeptidase
Balmelli C, Kupferschmidt H, Rentsch K, Schneemann M, Fatal brain edema after ingestion of ecstasy and benzylpiperazine
Al-Sahli W, Ahmad H, Kheradmand F, Connolly C, Docherty JR, Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery
Aghajanian GK, Liebermann JA, Caveat Emptor: Editors Beware
Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, Di Chiara G, Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo
Baerensten, Klaus B. Hartvig, Niels V. Stodkilde-Jorgensen, Hans. Mammen, Jens., Onset of Meditation Explored with fMRI
Aceto, Adler, Amass, Anderson, Bicket, Bowman, Brady, Bucholz, Chang, Chawda, Chilcoat, Collins, Coop, Craft, Crandall, de Wit, Dennis, Dewey, Dobkin de Rios, Eisenstein, Fiellin, Fillmore, Filligan, Flanzer, Fowler, Fudala, Gage, Problems of Drug Dependence 2001: Proceedings of the 63rd Annual Scientific Meeting
Pete Arambula,1;2 Erik Peper,1 Mitsumasa Kawakami,1and Katherine Hughes Gibney1, The Physiological Correlates of Kundalini Yoga Meditation: A Study of a Yoga Master
Nina P. Azari*, Janpeter Nickel*, Gilbert Wunderlich*t, Michael Niedeggenl, Harald Hefter*, Lutz Tellmann?, Hans Henogt, Petra Stoerigt, Dieter Birnbachers, Riidiger J. Se&*, Emotion & Cognition Religious experience activates a fronto-parietal circuit
Klaus B. Bzerentsen Niels V. Hartvig Hans Stedkilde-Jorgensen Jens Mamment, Onset of Meditation Explored with fMRI
Rodgers,J.,Buchanan,T.,Scholey, A.B. et al, Differential effects of Ecstasy and cannabis on self-reports of memory ability ; a web-based study.
Martin R Tramèr, Dawn Carroll, Fiona A Campbell, D John M Reynolds, R Andrew Moore and Henry J McQuay, Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Al Hussaini, A., Dorvlo, A. S. S., Antony, S. X., et al, Vipassana meditation: a naturalistic, preliminary observation in Muscat.
NANDAN YARDI, Yoga for control of epilepsy
NANDAN YARDI, Yoga for control of epilepsy
Vincenzo Di Marzo, Tiziana Bisogno and Luciano De Petrocellis, Anandamide: some like it hot
U. PAGOTTO, G. MARSICANO, F. FEZZA, M. THEODOROPOULOU, Y. GRU¨ BLER, J. STALLA, T. ARZBERGER, A. MILONE, M. LOSA, V. DI MARZO, B. LUTZ, AND G. K. STALLA, Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., et al, International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
, Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin
Sasaki-Adams, D. M. and Kelley, A. E., Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior
Vollenweider, F. X., Jones, R. T., and Baggott, M. J., Caveat emptor: editors beware.
Bachurin, S. E. R. G., Tkachenko, S. E. R. G., Baskin, I. G. O. R., et al, Neuroprotective and Cognition-Enhancing Properties of MK-801 Flexible Analogs: Structure–Activity Relationships
Berg, K. A., Cropper, J. D., Niswender, C. M., et al, RNA-editing of the 5-HT2C receptor alters agonist-receptor-e€ector coupling specificity
Bixo, M., Allard, P., Backstrom, T., et al, Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
Liechti, M. E. and Vollenweider, F. X., Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.
Vaiva, G., Boss, V., Bailly, D., et al, An "accidental" acute psychosis with ecstasy use.
Canezin, J., Cailleux, A., Turcant, A., et al, Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry
Grailhe, R., Grabtree, G. W., and Hen, R., Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution.
Kopelman, M. D., Reed, L. J., Marsden, P., et al, Amnesic syndrome and severe ataxia following the recreational use of 3,4 methylene-dioxymethamphetamine (MDMA, 'ecstasy') and other substances.
Niswender, C. M., Herrick-Davis, K., Dilley, G. E., et al (2001, RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.
Renault, J., Fabis, F., Dauphin, F., et al, Solid phase synthesis of sulphonamides: novel ligands of 5-HT6 receptors.
, Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation.
Wihlback, A. C., Sundstrom-Poromaa, I., Allard, P., et al, Influence of Postmenopausal Hormone Replacement Therapy on Platelet Serotonin Uptake Site and Serotonin2A Receptor Binding.
Yu.E.Moskalenko, V.Frymann, G.B.Weinstein, V.N.Semernya, T.I.Kravchenko, S.P.Markovets, A.A.Panov, N.F.Maiorova, SLOW RHYTHMIC OSCILLATION WITHIN THE HUMAN CRANIUM: PHENOMENOLOGY, ORIGIN, AND INFORMATIONAL SIGNIFICANCE.
Wayne Hall, Louisa Degenhardt, Michael Lynskey, National Drug and Alcohol Research Centre, University of New South Wales, The Health and Psychological Effects of Canabis Use
Heinrich, Clark; Ruck, Carl; Staples, Blaise, The Apples of Apollo: Pagan and Christian Mysteries of the Eucharist
Maccarrone M, et.al, Anandamide induces Apoptosis in Human Cells via Vanilloid Receptors: evidence for a protective role of cannabinoid receptors
Klein TW, Lane B, Newton CA, Friedman H., The cannabinoid system and cytokine network.
Ismael Galve-Roperh, Cristina Sánchez, María Luisa Cortes, Teresa Gomez del Pulgar, Marta Izquierdo & Manuel Guzman, Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
Nathalie Auclair, Satoru Otani, Philippe Soubrie, and Francis Crepel, Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons
Deborah Josefson San Francisco, US judge approves distribution of marijuana
Chang L, Grob CS, Ernst T, Itti L, Mishkin FS, Jose-Melchor R, Poland RE., Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study.
Hampson RE, Deadwyler SA, Cannabinoids Reveal the Necessity of Hippocampal Neural Encoding for Short-Term Memory in Rats
Williamson EM. Evans FJ., Cannabinoids in Clinical Practice
Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX, Mood state and brain electric activity in ecstasy users.
Christopher W. Vaughan, Mark Connor, Elena E. Bagley, Macdonald J. Christie, Actions of Cannabinoids on Membrane Properties and Synaptic Transmission in Rat Periaqueductal Gray Neurons In Vitro
B. Szabo, I. Wallmichrath, P. Mathonia and C. Pfreundtner, Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata.
Kanji A. Takahashi, David J. Linden, Cannabinoid Receptor Modulation of Synapses Received by Cerebellar Purkinje Cells
Daniel J. Kim, Stanley A. Thayer, Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures
Alexander F. Hoffman and Carl R. Lupica, Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus
Allyn C. Howlett, Somnath Mukhopadhyay, Cellular signal transduction by anandamide and 2-arachidonoylglycerol
Gerdeman G, Lovinger DM, CB1 Cannabinoid Receptor Inhibits Release of Glutamate in Rat Dorsolateral Striatum
Hajos N, et.al., Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
Hampson RE et.al., Cannabinoid and Kappa opioid Receptors Reduce potassium K Current via Activation of G5 Proteins in Cultured Hippocampal Neurons
J. F. Cheer, C. A. Marsden, D. A. Kendall, R. Mason, Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study
Martin K Johnson, Robin P Smith, Douglas Morrison, Gabriel Laszlo, Roger J White, Case reports: Large lung bullae in marijuana smokers
David Cunnington, MB BS, Harry Teichtahl, MB BS(Hons), FCCP; John M. Hunt, MB BS, Chris Dow, MB BS, Renata Valentine, MB,BS, Necrotizing Pulmonary Granulomata in a Marijuana Smoker
Luciano De Petrocellis, Dominique Melck, Tiziana Bisogno, Vincenzo Di Marzo, Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
Ferguson DM, Horwood J, Does cannabis use encourage other forms of illicit drug use?
F. Ferrari, A. Ottani, D. Giuliani, Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour
Giuliani D. et.al, the cannabinoid receptor agonist HU 210 modifies rat behavioral responses to novelty and stress
Shuzhen Hao, Yosefa Avraham, Raphael Mechoulam & Elliot M. Berry, Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
Mark K. Greenwald, Maxine L. Stitzer, Antinociceptive, subjective and behavioral effects of smoked marijuana in humans
Golub A et.al.;, Response Reliablity and the Study of Adolescent Substance Use Progression
Jodie Lawston, Alice Borella, John K. Robinson, Patricia M. Whitaker-Azmitia, Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2
Aron H. Lichtman, SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
Lynsky M, Hall W, The Effects of adolescent cannabis use on educational attainment: a review
L.P. Spear, The adolescent brain and age-related behavioral manifestations
Ken Soderstrom, Frank Johnson, CB1 cannabinoid receptor expression in brain regions associated with zebra finch song control
Wu X, French ED, Effects of chronic delta-9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment
Barbara Costa, Mariapia Colleoni, Changes in rat brain energetic metabolism after exposure to anandamide or 9-tetrahydrocannabinol
Christopher S. Breivogel, Steven R. Childers, Cannabinoid Agonist Signal Transduction in Rat Brain: Comparison of Cannabinoid Agonists in Receptor Binding, G-Protein Activation, and Adenylyl Cyclase Inhibition
Paul Gouldson, Bernard Calandra, Pascale Legoux, Aimee Kerneis, Murielle Rinaldi-Carmona, Francis Barth, Gerard Le Fur, Pascual Ferrara, David Shire,, Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB receptor 2
Allyn C. Howlett, Gerald H. Wilken, J. Jill Pigg, Devin B. Houston, Ruoxi Lan, Qian Liu, and Alexandros Makriyannis, Azido- and Isothiocyanato-Substituted Aryl Pyrazoles Bind Covalently to the CB 1 Cannabinoid Receptor and Impair Signal Transduction
Josef T. Kittler, Elena V. Grigorenko, Chris Clayton, Shou-yuan Zhuang, Sarah C. Bundey, Michael M. Trower, Don Wallace, Robert Hampson, Sam Deadwyler., Large-scale analysis of gene expression changes during acute and chronic exposure to D 9 -THC in rats
Felice Nava, Giovanna Carta, Gian Luigi Gessa, Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by D 9 -Tetrahydrocannabinol in Rats
Billy R. Martin, Irina Beletskaya, Gray Patrick, Rene E Jefferson, Ramona Winckler, Dale G. Deutsch, Vincenzo Di Marzo, Olivier Dasse, Ann Mahadevan, and Raj K. Razdan, Cannabinoid Properties of Methylfluorophosphonate Analogs
Cecilia J. Hillard, Abbas Jarrahian, The movement of N arachidonoylethanolamine (anandamide) across cellular membranes
Abbas Jarrahian, Sukumar Manna, William S. Edgemond, William B. Campbell, Cecilia J. Hillard, Structure-Activity Relationships Among N-Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter
Waldemar Gonsiorek, Charles Lunn, Xuedong Fan, Satwant Narula, Daniel Lundell, R. William Hipkin, Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide
Shanmugam Muthian, Kasem Nithipatikom, William B. Campbell, Cecilia J. Hillard, Synthesis and Characterization of a Fluorescent Substrate for the N-Arachidonoylethanolamine (Anandamide) Transmembrane Carrier
Harald H.O. Schmid, Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?
Fariborz Rakhshan, Theresa A. Day, Randy D. Blakely, Eric L. Barker, Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells
Natsuo Ueda, Robyn A. Puffenbarger, Shozo Yamamoto, Dale G. Deutsch, The fatty acid amide hydrolase (FAAH)
Takayuki Sugiura, Keizo Waku, 2-Arachidonoylglycerol and the cannabinoid receptors
Jean-Marie Derocq, Omar Jbilo, Monsif Bouaboula, Michel Ségui, Christophe Clère, Pierre Casellas, Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60. Possible involvement of the cb2 receptor in cell differentiation
Peter M. Zygmunt, David Julius, Vincenzo Di Marzo Edward D. Högestätt, Anandamide - the other side of the coin [Comment] Trends in Pharmacological
Graeme Griffin, Qing Tao, Mary E. Abood, Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Lucy Lay, James A. Angus, Christine E. Wright, Pharmacological characterisation of cannabinoid CB receptors in the rat and mouse
Atmaram D. Khanolkar, Sonya L. Palmer, Alexandros Makriyannis, Molecular probes for the cannabinoid receptors
Rhee M-H et.al., Differential Superactivation of Adenylyl cyclase isozymes after chronic activation of the CB1 cannabinoid receptor
Paul L. Prather, Nancy A. Martin, Christopher S. Breivogel, Steven R. Childers, Activation of Cannabinoid Receptors in Rat Brain by WIN 55212-2 Produces Coupling to Multiple G Protein-Subunits with Different Potencies
Rueda D et.al, The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rodriguez-Puertas R et.al, Autoradiography of receptor-activated G-proteins in post mortum human brain
Zhao-Hui Song and Miao Zhong, CB1 Cannabinoid Receptor-Mediated Cell Migration
Ken Soderstrom, Mark Leid, Frank L. Moore, Thomas F. Murray, Behavioral, Pharmacological, and Molecular Characterization of an Amphibian Cannabinoid Receptor
Darren Smart, Jeffery C. Jerman, Anandamide: an endogenous activator of the vanilloid receptor [Letters]
Janos Szolcsanyi, Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? [Comment]
Janos Szolcsanyi, Anandamide and the question of its functional role for activation of capsaicin receptors [Letter]
Emilia Nocerino, Marianna Amato, Angelo A. Izzo, Cannabis and cannabinoid receptors
Raphael Mechoulam, Lumir Hanusi, A historical overview of chemical research on cannabinoids
Javier Fernandez-Ruiz, Fernando Berrendero, Mari Luz Hernández and Jose A. Ramos, The endogenous cannabinoid system and brain development [Review]
George Kunos, Zoltan Jarai, Sandor Batkai, Sravan Kumar Goparaju, Edward J.N. Ishac, Jie Liu, Lei Wang, Jens A. Wagner, Endocannabinoids as cardiovascular modulators
Cecilia J. Hillard, Perspectives in Pharmacology, Endocannabinoids and Vascular Function
Skopp G et.al., Stability of Cannabinoids in Hair Samples Exposed to Sunlight
B. L. Hungund, B. S. Basavarajappa, ARE ANANDAMIDE AND CANNABINOID RECEPTORS INVOLVED IN ETHANOL TOLERANCE? A REVIEW OF THE EVIDENCE
Justin P. Meschler, Francis A. Clarkson, Patricia J. Mathews, Allyn C. Howlett, Bertha K. Madras, D2, but Not D1 Dopamine Receptor Agonists Potentiate Cannabinoid-Induced Sedation in Nonhuman Primates
Stephen R. Wachtel, Harriet de Wit, Naltrexone does not block the subjective effects of oral 9-tetrahydrocannabinol in humans
Anthony L, Vaccarino A, Abba J. Kastin, Endogenous opiates: 1999
Daniela Giuliani, Alessandra Ottani, Francesca Ferrari, Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats
Fried PA, Watkinson B, Visuoperceptial functioning differs in 9- to 12- year olds prenatally exposed to cigarettes and marijuana
F. Markus Leweke, Udo Schneider, Maren Radwan, Eike Schmidt, Hinderk M. Emrich, Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man
Buckley NE et.al., Immunomodulation by cannabinoids is absent in mice deficient for cannabinoid CB2 receptor
E.V. Berdyshev, Cannabinoid receptors and the regulation of immune response
Michel Salzet, Invertebrate molecular neuroimmune processes
Klein TW et.al., The cannabinoid system and cytokine network
Massi P et.al., Relative involvement of cannabinoid CB1 and CB2 receptors in the delta-9-tetrahydrocannabinol-induced inhibition of natural killer activity
Sidney R. Smith, Carol Terminelli, Georgetta Denhardt, Effects of Cannabinoid Receptor Agonist and Antagonist Ligands on Production of Inflammatory Cytokines and Anti-Inflammatory Interleukin-10 in Endotoxemic Mice.
Salzet M. et.al., Comparative biology of the endocannabinoid system, Possible role in the immune response
Paola Sacerdote, Paola Massi, Alberto E. Panerai, Daniela Parolaro, In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
Ruth A. Ross, Heather C. Brockie, Roger G. Pertwee, Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
George B. Stefano, Yannick Goumon, Thomas V. Bilinger, Ingeborg D. Welters, Patrick Cadet, Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor
Massimiliano Beltramo, Fernando Rodríguez de Fonseca, Miguel Navarro, Antonio Calignano, Miguel Angel Gorriti, Gerasimos Grammatikopoulos, Adolfo G. Sadile, Andrea Giuffrida, Daniele Piomelli, Reversal of Dopamine D2 Receptor Responses by an Anandamide Transport Inhibitor
Achiron A et.al., Dexabinol (HU-211) effect on experimental auto immune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis
Vincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis, Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?
Dar MS, Cerebellar CB1 receptor mediation of Delta9-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A1 receptor in the mouse
A. Giuffrida, D. Piomelli, The endocannabinoid system: a physiological perspective on its role in psychomotor control
Vincenzo Di Marzok, Michael P. Hill, Tiziana Bisogno, Alan R. Crossman, Jonathan M. Brotchie, Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
M. Clara Sanudo-Pena, Julian Romero, Garrett E. Seale, J. Javier Fernandez-Ruiz, J. Michael Walker, Activational role of cannabinoids on movement
Sanudo-Pena et.al., Role of the superior colliculus in the motor effects of cannabinoids and dopamine
Yanqiu Chen and Jochen Buck, Cannabinoids Protect Cells from Oxidative Cell Death: A Receptor-Independent Mechanism
M. Glass, M. Dragunow and R. L. M. Faull, The pattern of neurodegeneration in huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and gaba a receptor alterations in the human basal ganglia in huntington's disease
E. M. Denovan-Wright and H. A. Robertson, Cannabinoid receptor messenger rna levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic huntington's disease mice
Deon F. Louw, Fang W. Yang, Garnette R. Sutherland, The effect of d-9-tetrahydrocannabinol on forebrain ischemia in rat
Harald S. Hansen, Birthe Moesgaard, Henrik H. Hansen, Gitte Petersen, N-Acylethanolamines and precursor phospholipids - relation to cell injury
Pierre Beaulieu, Tiziana Bisogno, Shahid Punwar, W. Paul Farquhar-Smith, Gerolmina Ambrosino, Vincenzo Di Marzo, Andrew S.C. Rice, Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
Signor AD et.al., Endocannabinoids protect cerebral cortical neurons from in vitro ichemia in rats
Susan J. Houser, Micah Eads, James P. Embrey, Sandra P. Welch, Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, D 9 -THC and anandamide
Drew LJ et.al., Activation of spinal cannabinoid 1 receptors inhibits c-fibre driven hyperaxcitable neuronal responses and increases [35S]GTPyS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats
Mao J et.al., Two distinctive antinociceptive systems in rats with pathological pain
David Baker, Reply: a sanguine approach to cannabis [Comment]
David Gurwitz, Renewed hope for medicinal marijuana?
Hall W, Babor TF, Cannabis use and public health: assessing the burden
David M. Fergusson, L. John Horwood, Does cannabis use encourage other forms of illicit drug use?
Rubenstein H, Reefer Madness Caribbean Style
Nathalie Auclair, Satoru Otani, Philippe Soubrie, Francis Crepel, Cannabinoids Modulate Synaptic Strength and Plasticity at Glutamatergic Synapses of Rat Prefrontal Cortex Pyramidal Neurons
Fritzsche M, Are cannabinoid receptor knockout mice animal models for schizophrenia?
Rob McGee, Sheila Williams, Richie Poulton, Terrie Moffitt, A longitudinal study of cannabis use and mental health from adolescence to early adulthood.
Mariluz Hernandez, Fernando Berrendero, Isabel Suarez , Lucia Garcia-Gil , Maribel Cebeira , Ken Mackie, Jose A. Ramos, Javier Fernandez-Ruiz, Cannabinoid CB receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.
B.C. Paria, S.K. Dey, B.C. Paria, S.K. Dey, Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation.
Mauro Maccarrone, Massimo De Felici, Monica Bari, Francesca Klinger, Gregorio Siracusa, and Alessandro Finazzi-Agro, Down-regulation of anandamide hydrolase in mouse uterus by sex hormones
Alberto Perez-Rosado, Jorge Manzanares, Javier Fernandez-Ruiz, Jose A. Ramos, Prenatal D 9 -tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences
Louw DF, Yang FW, Sutherland GR, The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat
Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Zimny M, Zeggel T, Wagenknecht G, Kaiser HJ, Sass H, Buell U, "Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study
Zenenberg R, Goldfarb DS, Evaluation of hyponatremia associated with the use of methylenedioxymethamphetamine (MDMA)
Wright JD, Pearl L, Experience and knowledge of young people regarding illicit drug use, 1969-99
Weinmann W, Renz M, Vogt S, Pollak S, Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS [In Process Citation]
Winstock AR, Griffiths P, Stewart D, Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK
Weir E, Raves: a review of the culture, the drugs and the prevention of harm
Wareing M, Fisk JE, Murphy PN, Working Memory Deficits in Current and Previous Users of MDMA
Waldo CR, McFarland W, Katz MH, MacKellar D, Valleroy LA, Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II
van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, Baldwin RM, Innis RB, Age-related decline in central serotonin transporter availability with [ 123 I] b-CIT SPECT
Vollenweider FX, Gucker P, Schönbächler R, Kamber E, Vollenweider-Scherpenhuyzen MFI, Schubiger G, Hell D, Effects of MDMA on 5-HT uptake sites using PET and [11C]-McN5652 in humans
Uhl M, Tandem mass spectrometry: a helpful tool in hair analysis for the forensic expert
van Aerts LAGJM, Malleret M, Rigter H, N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks
Tuchtenhagen F, Daumann J, Norra C, Gobbelé R, Becker S, Pelz S, Sass H, Buchner H, Gouzoulis-Mayfrank E, High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users
Turner JJD, Parrott AC, 'Is MDMA a Human Neurotoxin?': Diverse Views from the Discussants
Smart RG, Ogborne AC, Drug use and drinking among students in 36 countries [In Process Citation]
Tagliaro F, Valentini R, Manetto G, Crivellente F, Carli G, Marigo M, Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences
Slotkin TA, Seidler FJ, Ali SF, Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions
Sharma R, Nelson LS, Methylenedioxymethamphetamine (MDMA) induced hyponatremia
Shewan D, Dalgarno P, Reith G, Perceived risk and risk reduction among ecstasy users; the role of drug, set and setting
Shirayama Y, Hashimoto K, Iyo M, Watanabe K, Higuchi T, Minabe Y, 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation [In Process Citation]
Schroeder B, Brieden S, Bilateral sixth nerve palsy associated with MDMA ('ecstasy') abuse
Shannon M, Methylenedioxymethamphetamine (MDMA, 'Ecstasy') [In Process Citation]
Schifano F, Potential Human Neurotoxicity of MDMA (`Ecstasy'): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies
Schatz DS, Kaufmann WA, Schuligoi R, Humpel C, Saria A, 3,4-Methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices
Samyn N, van Haeren C, On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users
Russell BR, Laverty R, Correlation between 5-HT content and uptake site density following (S)- MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021 [In Process Citation]
Rothman RB, Partilla JS, Baumann MH, Dersch CM, Carroll FI, Rice KC, Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse
Rodgers J, Cognitive performance amongst recreational users of 'ecstasy'
Rohrich J, Zorntlein S, Potsch L, Skopp G, Becker J, Effect of the shampoo Ultra Clean on drug concentrations in human hair
Ricaurte GA, McCann UD, Szabo Z, Scheffel U, Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')
Rieder MJ, Some light from the heat: implications of rave parties for clinicians
Ricaurte GA, Yuan J, McCann UD, (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin Neurotoxicity: Studies in Animals
Reneman L, Habraken JBA, Majoie CBL, Booij J, den Heeten GJ, MDMA ('Ecstasy') and its association with cerebrovascular accidents: preliminary findings
Rashed AM, Anderson RA, King LA, Solid-phase extraction for profiling of ecstasy tablets
Reneman L, Booij J, Schmand B, van den Brink W, Gunning B, Memory disturbances in 'Ecstasy' users are correlated with an altered brain serotonin neurotransmission
Rella JG, Nelson LS, Hoffman RS, 7 years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity
Ramseier A, Siethoff C, Caslavska J, Thormann W, Confirmation testing of amphetamines and designer drugs in human urine by capillary electrophoresis-ion trap mass spectrometry
Parrott AC, Human research on MDMA (3,4-Methylene-dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change
Parrott AC, Sisk E, Turner JJD, Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users
O'Neal C, Crouch DJ, Fatah AA, Validation of twelve chemical spot tests for the , detection of drugs of abuse
O'Cain PA, Hletko SB, Ogden BA, Varner KJ, Cardiovascular and Sympathetic Responses and Reflex Changes Elicited by MDMA
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Hernandez Lopez C, Ortuno J, Segura J, Cami J, de la Torre R, Immunomodulating activity of MDMA
Nixon PJ, Youngson CC, Beese A, Tooth surface loss: does recreational drug use contribute?
Nakahara Y, Hanajiri R, Hair analysis for drugs of abuse XXI. Effect of para-substituents on benzene ring of methamphetamine on drug incorporation into rat hair
Nicotra AS, Parvez H, Nitric Oxide and Neuronal and Pancreatic Beta Cell Death
Morley KC, McGregor IS, (+/-)-3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats
Morgan MJ, Ecstasy (MDMA): a review of its possible persistent psychological effects
Mieczkowski T, Newel R, Statistical examination of hair color as a potential biasing factor in hair analysis
Morland J, Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use
McGuire P, Long term psychiatric and cognitive effects of MDMA use
McFee RB, Mofenson HC, Caraccio TR, Dextromethorphan: Another 'Ecstasy'?
McCann UD, Eligulashvili V, Ricaurte GA, (+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin Neurotoxicity: Clinical Studies
Maldonado E, Navarro JF, Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box
Maurer HH, Bickeboeller-Friedrich J, Kraemer T, Peters FT, Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (`Ecstasy')
Liechti ME, Vollenweider FX, Acute psychological and physiological effects of MDMA ('Ecstasy') after haloperidol pretreatment in healthy humans
Liechti ME, Vollenweider FX, The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers
Liechti ME, Baumann C, Gamma A, Vollenweider FX, Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') are Attenuated by the Serotonin Uptake Inhibitor Citalopram
Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX, Psychological and Physiological Effects of MDMA ('Ecstasy') after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans
Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J, Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine. A Double-Blind, Placebo-Controlled Trial
Lewis RJ, Reed D, Service AG, Langford AM, The identification of 2-chloro-4,5-methylenedioxymethylamphetamine in an illicit drug seizure [In Process Citation]
Lee GS, Taylor RC, Dawson M, Kannangara GS, Wilson MA, High-resolution solid state 13C nuclear magnetic resonance spectra of 3,4-methylenedioxyamphetamine hydrochloride and related compounds and their mixtures with lactose [In Process Citation]
Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS, Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user
Kuhn DM, Geddes TJ, Molecular footprints of neurotoxic amphetamine action [In Process Citation]
Kreth KP,Kovar KA, Schwab M, Zanger UM, Identification of the Human Cytochromes P450 Involved in the Oxidative Metabolism of 'Ecstasy'-Related Designer Drugs
Klitzman RL, Pope HG Jr, Hudson JI, MDMA ('Ecstasy') abuse and high-risk sexual behaviors among 169 gay and bisexual men
Kelly PA, Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Kelly P, Does recreational ecstasy use cause long-term cognitive problems?
Kalia M, O'Callaghan JP, Miller DB, Kramer M, Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry
Jurado C, Gimenez MP, et al, Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS
Iravani M, Asari D, Patel J, Wieczorek WJ, and Kruk ZL, Direct Effects of 3,4-Methylenedioxymethamphetamine(MDMA) on Serotonin or Dopamine Release and Uptake in the Caudate Putamen, Nucleus Accumbens, Substantia Nigra Pars Reticulata, and the Dorsal Raphe' Nucleus Slices
Johnson EA, Sharp DS, Miller DB, Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection [In Process Citation]
Horan B, Gardner EL, Ashby CR Jr, Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA)
Hervías I, Lasheras B, and Aguirre N, 2-Deoxy-D-Glucose Prevents and Nicotinamide Potentiates 3,4-Methylenedioxymethamphetamine-Induced Serotonin Neurotoxicity
Henry JA, Metabolic Consequences of Drug Misuse
Heinz A, Jones DW, Serotonin transporters in ecstasy users
Harvey DC, Lacan G, Tanious SP, Melega WP, Recovery from Methamphetamine Induced Long-term Nigrostriatal Dopaminergic Deficits without Substantia Nigra Cell Loss
Harris, D, Baggott, M, Jones, RT, Mendelson, J, MDMA Pharmacokinetics and Physiological and Subjective Effects in Humans
Grob CS, Deconstructing Ecstasy: The Politics of MDMA Research
Griffiths P, Vingoe L, et al, Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?
Graeme KA, New drugs of abuse
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H, Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Gorman EM, Carroll RT, Substance abuse and HIV: considerations with regard to methamphetamines and other recreational drugs for nursing practice and research
Goodwin AK, Baker LE, A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats [In Process Citation]
Gomez-Balaguer M, Pena H, Morillas C, Hernandez A, Syndrome of Inappropriate Antidiuretic Hormone Secretion and 'Designer Drugs' (ecstasy)
Glennon RA, Young R, MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin
Girod C, Staub C, Analysis of drugs of abuse in hair by automated solid-phase extraction, GC/EI/MS and GC ion trap/CI/MS
Geiser L, Cherkaoui S, Veuthey JL, Simultaneous analysis of some amphetamine derivatives in urine by nonaqueous capillary electrophoresis coupled to electrospray ionization mass spectrometry
Ghuran A, Nolan J, Recreational drug misuse: issues for the cardiologist
Gerra G, Zaimovic A, Ferri M, Zambelli U, Timpano M, Neri E, Marzocchi GF, Delsignore R, Brambilla F, Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans
Gamma A, Buck A, Berthold T, Liechti ME, Vollenweider FX, 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H2 15 O]-PET in Healthy Humans
Gamma A, Buck A, Berthold T, Hell D, Vollenweider F, Erratum. 3, 4-methylenedioxymeth-amphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans
Fischer HS, Zernig G, Schatz DS, Humpel C, Saria A, MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum
Ferrie R, Loveland RC, Bilateral gluteal compartment syndrome after 'ecstasy' hyperpyrexia
Erdtmann-Vourliotis M, Mayer P, Riechert U, Hollt V, Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum
Felscher D, Schulz K, Screening of Amphetamine/Methamphetamine and their Derivatives in Urine using FPIA and Triage 8 and the Scope and Limits of a Subsequent Identification by Means of the REMEDi HS system
Dulawa SC, Scearce-Levie KA, Hen R, Geyer MA, Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice
Duflou J, Mark A, Aortic dissection after ingestion of 'ecstasy' (MDMA)
Dulawa SC, Geyer MA, Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice [In Process Citation]
de la Torre R, Farre' M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, Camí J, Non-linear pharmacokinetics of MDMA (`ecstasy') in humans
Dublin NN, Razack AH, Priapism: Ecstasy Related?
de la Torre R, Farre M, Roset PN, Hernandez Lopez C, Mas M, Ortuno J, Menoyo E, Pizarro N, Segura J, Cami J, Pharmacology of MDMA in humans
Daws EC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F, Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat [In Process Citation]
Curran HV, Is MDMA (`Ecstasy') Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research
Cooper GA, Allen DL, Scott KS, Oliver JS, Ditton J, Smith ID, Hair analysis: self-reported use of 'speed' and 'ecstasy' compared with laboratory findings
Connor TJ, Kelly JP, McGee M, Leonard BE, Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1b and TNF-a secretion following an in vivo lipopolysaccharide challenge
Clauwaert KM, Van Bocxlaer JF, De Letter EA, Van Callenbergh S, Lambert WE, De Leenheer AP, Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine
Connor TJ , Kelly JP, Leonard BE, An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats
Christophersen AS, Amphetamine designer drugs - an overview and epidemiology
Chang L, Grob C, Ernst T, Itti L, Mishkin F, Jose-Melchor R, Poland RE, Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study
Carter N, Rutty GN, Milroy CM, Forrest ARW, Deaths Associated with MBDB Misuse
Cami J, Farre M, et al, Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): psychomotor performance and subjective effects
Byrne T, Baker LE, Poling A, MDMA and learning: effects of acute and neurotoxic exposure in the rat
Burrows KB, Gudelsky G, Yamamoto BK, Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration
Borth S, Hansel W, Rosner P, Junge T, Regioisomeric differentiation of 2,3- and 3,4-methylenedioxy ring-substituted phenylalkylamines by gas chromatography/tandem mass spectrometry
Burgess C, O'Donohoe A, Gill M, Agony and ecstasy: a review of MDMA effects and toxicity
Boot BP, McGregor IS, Hall W, MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks
Bogusz MJ, Kruger KD, Maier RD, Analysis of underivatized amphetamines and related phenethylamines with high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
Bogusz MJ, Liquid Chromatography-Mass Spectrometry as a Routine Method in Forensic Sciences: A Proof of Maturity [In Process Citation]
Bellis MA, Hale G, Bennett A, Chaudry M, Kilfoyle M., Ibiza Uncovered: Changes in Substance use and Sexual Behaviour Amongst Young People Visiting an International Night-Life Resort
Bell SEJ, Burns DT, Dennis AC, Speers JS, Rapid Analysis of Ecstasy and Related Phenethylamines in Seized Tablets by Raman Spectroscopy
Bell SEJ, Burns DT, Dennis AC, Matchett LJ, Speers JS, Composition Profiling of Seized Ecstasy Tablets by Raman Spectroscopy [In Process Citation]
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E, Ecstasy-induced Toxicity in Rat Liver
Behan WMH, Madigan M, Clark BJ, Goldberg J, McLellan DR, Muscle changes in the neuroleptic malignant syndrome
Barrionuevo M, Aguirre N, Del Rio JD, Lasheras B, Serotonergic Deficits and Impaired Passive-avoidance Learning in Rats by MDEA: a Comparison with MDMA
Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E, Zehnder J, Chemical analysis of ecstasy pills
Aalberg L, DeRuiter J, Noggle FT, Sippola E, Clark CR, Chromatographic and Mass Spectral Methods of Identification for the Side-chain and Ring Regioisomers of Methylenedioxymethamphetamine
Allen DL, Oliver JS, The use of supercritical fluid extraction for the determination of amphetamines in hair
Darmani NA, Pandya DK., Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
Andresen Jensine, Meditation Meets Behavioural Medicine: The Story of Experimental Research on Meditation
Austin James H., Consciousness Evolves When the Self Dissolves
Grob C S, Deconstructing Ecstasy: The Politics of MDMA Research
Alex Gamma, Edi Frei, Dietrich Lehmann,Roberto D. Pascual-Marqui, Daniel Hell and Franz X. Vollenweider, Mood state and brain electric activity in Ecstasy users
Elizabeth M. Williamson and Fred J. Evans, Cannabinoids in Clinical Practice
Gamma, A., Buck, A., Berthold, T., et al, 3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H 2 15 O]-PET in Healthy Humans
Gardier, A. M., Moratalla, R., Cuellar, B., et al, Interaction Between the Serotoninergic and Dopaminergic Systems in d-Fenfluramine-Induced Activation of c-fos and jun B Genes in Rat Striatal Neurons
Liechti, M. E., Baumann, C., Gamma, A., et al, Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
Liechti, M. E., Saur, M. R., Gamma, A., et al, Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT 2 Antagonist Ketanserin in Healthy Humans
Barrett, S. P., Archambault, J., Engelberg, M. J., et al, Hallucinogenic Drugs Attenuate the Subjective Response to Alcohol in Humans
Liechti, M. E. and Vollenweider, F. X., Acute psychological and physiological effects of MDMA (‘‘Ecstasy’’) after haloperidol pretreatment in healthy humans
Pelaez, J. R., Towards a neural network based therapy for hallucinatory disorders.
Rohrich, J., Zorntlein, S., and Becker, J., Analysis of LSD in human body fluids and hair samples applying ImmunElute columns.
Singha, A. K., Cance-Katz, E. F., Petrakis, I., et al, Sex Differences in Self-Reported and Physiological Response to Oral Cocaine and Placebo in Humans.
Yatham, L. N., Steiner, M., Liddle, P. F., et al, A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans.
Liechti, M. E. and Vollenweider, F. X., The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers.
Pascal Derkinderen, Madeleine Toutant, Ferran Burgaya, Marc Le Bert, Julio C. Siciliano, Vittorio de Franciscis, Michele Gelman, Jean-Antoine Girault, Regulation of a Neuronal Form of Focal Adhesion Kinase by Anandamide
The British Medical Association,, Cannabinoid Medicines Should be Legalized
A. Calignano, I.Katona, F. De sarnaud, A. Giuffrida, G. La Rana, K. Mackie, T. F. Freund, D. Piomelli, Bidirectional control of airway responsiveness by endogenous cannabinoids
Aftanas L I, Golocheikine SA, Non-linear dynamic complexity of the human EEG during meditation
Dajani EZ, Larsen KR, Taylor J, Dajani NE, Shahwan TG, Neeleman SD, Taylor MS, Dayton MT, Mir GN, 1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties
Pertwee RG., Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Andreas Zimmer, Anne M. Zimmer*, Andrea G. Hohmann, Miles Herkenham, and Tom I. Bonner*, Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Lyketsos CG. Garrett E. Liang KY. Anthony JC, Cannabis use and cognitive decline in persons under 65 years of age
Poncelet M, Barnouin MC, Breliere JC, Le Fur G, Soubrie P, Blockade of cannabinoid (CB1) receptors by 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils
Leweke FM, Schneider U, Thies M, Munte TF, Emrich HM., Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man.
Vaughan CW, McGregor IS, Christie MJ, Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro
Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR, Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current
Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD, Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids
Meyer JS, Kunkle R, Behavioral responses to a D1 dopamine agonist in weanling rats treated neonatally with cocaine and delta9-tetrahydrocannabinol.
Tanda G, Loddo P, Di Chiara G, Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol
Bouaboula M. Dussossoy D. Casellas P, Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses
Ameri A, The effects of cannabinoids on the brain. [Review] [223 refs]
Strangman NM, Walker JM, Cannabinoid WIN 55,212-2 inhibits the activity- dependent facilitation of spinal nociceptive responses
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
Gifford AN, Bruneus M, Gatley SJ, Lan R, Makriyannis A, Volkow ND, Large receptor reserve for cannabinoid actions in the central nervous system
Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V, Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors
Misner DL, Sullivan JM, Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons
Chapman V, The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat
Self DW, Anandamide: a candidate neurotransmitter heads for the big leagues. Comment on: Nat Neurosci 1999 Apr;2(4):358-63,
Mechoulam R, Ben-Shabat S., From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis.
V. Di Marzo, D. Melck, T. Bisogno and L. De Petrocellis, Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Paul D Leeson, David C Rees, Next generation therapeutics [Editorial overview]
M. Bouaboula, L. Bianchini, F.R. McKenzie, J. Pouyssegur, P. Casellas, Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi- mediated mitogen activated protein kinase signaling transduction pathways
Stanley S. Davis, Delivery of peptide and non-peptide drugs through the respiratory tract [Research focus]
R. A. Sherwood, J. Keating, V. Kavvadia, A. Greenough , T. J. Peters, neonatology: Substance misuse in early pregnancy and relationship to fetal outcome
Vincenzo Di Marzo, Tiziana Bisogno, Luciano De Petrocellis, Dominique Melck, Pierangelo Orlando, Jens A. Wagner, and George Kunos, Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages
Annette L. Beautrais, Peter R. Joyce, Roger T. Mulder, Cannabis abuse and serious suicide attempts
Alan J. Budney, Pamela L. Novy, John R. Hughes, Marijuana withdrawal among adults seeking treatment for marijuana dependence
Hannelore Ehrenreich, Thomas Rinn, Hanns J. Kunert, Manfred R. Moeller, Wolfgang Poser, Lothar Schilling, Gerd Gigerenzer, Margret R, Hoehe original investigation: Specific attentional dysfunction in adults following early start of cannabis use
M. Haney, Amie S. Ward, Sandra D. Comer, Richard W. Foltin, Marian W. Fischman, Original investigation: Abstinence symptoms following smoked marijuana in humans
Elena M. Kouri, Harrison G. Pope Jr, Scott E. Lukas, original investigation: Changes in aggressive behavior during withdrawal from long-term marijuana use
Reibaud M. et.al, Enhancement of memory in cannabinoid CB 1 receptor knockout mice
Axel Perkonig, Roselind Lieb, Michael Hofler, Peter Schuster, Holger Sonntag, Hans-Ulrich Wittchen, Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents
Claire M. Williams, T. C. Kirkham, rapid communication: Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Graeme Griffin, Emma J. Wray, Billy R. Martin and Mary E. Abood, Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum
J. M. Kirk, Harriet De Wit, Responses to Oral 9-Tetrahydrocannabinol in Frequent and Infrequent Marijuana Users
Emil Pop, Cannabinoids, endogenous ligands and synthetic analogs [Review article]
Ruth A, Ross, T, Michael Gibson, Lesley A, Stevenson, Bijali Saha, Peter Crocker, Raj K, Razdan and Roger G, Pertwee, Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-8-tetrahydrocannabinol at cannabinoid receptors
Sagan S et.al, Anandamide and WIN 55212-2 inhibkt cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes
RA Ross, HC Brockie, LA Stevenson, VL Murphy, F Templeton, A Makriyannis, RG Pertwee, Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630
V. Di Marzo, D. Melck, T. Bisogno and L. De Petrocellis, Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
DePetrocellis D. et.al, Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response
Kunos G, the discovery of endogenous cannabinoids
Mariscano G, Lutz B, Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
Olov Sterner, Arpad Szallasi, Novel natural vanilloid receptor agonists: new therapeutic targets for drug development [Review]
Michael Holland, R. A. John Challiss, Nicholas B. Standen, John P. Boyle,, Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle
Jens A. Wagner, Karoly Varga, Zoltan Jarai, George Kunos, Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
Peter M. Zygmunt et al, Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Jason E. Gallate, I. S. McGregor, original investigation: The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716
Daniel T. Malone, David A. Taylor, Modulation by fluoxetine of striatal dopamine release following 9-tetrahydrocannabinol: a microdialysis study in conscious rats
Jorge Manzanares, Javier Corchero, Julian Romero, Javier J. Fernandez-Ruiz, Jose A. Ramos Jose A. Fuentes, Pharmacological and biochemical interactions between opioids and cannabinoids
Anthony L. Vaccarino, Gayle A. Olson, Richard D. Olson, Abba J. Kastin, Endogenous opiates: 1998
National Academy of Sciences, Institute of Medicine, Marijuana and Medicine: Assessing the Science Base; Executive Summary; recommendation 5
M. A. Garcia, G. Weigert, S. Duk, M. Alarcon, Chromosome Aberrations Study in Human Lymphocytes from Marijuana Smokers
Sumner H. Burstein, The Cannabinoid Acids: Nonpsychoactive Derivatives with Therapeutic Potential
M.-C. Ko, James H. Woods, rapid communication: Local administration of 9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action
Ferron C et.al., Sport activity in adolescence: associations with health perceptions and experimental behaviours
Michael Hofler, Roselind Lieb, Axel Perkonigg, Peter Schuster, Holger Sonntag, Hans-Ulrich Wittchen, Covariates of cannabis use progression in a representative population sample of adolescents: a prospective examination of vulnerability and risk factors
Jonathan Hodgkin, Mice that can't get high
Mockel M et.al., Severe parnarteritis associated with drug use
Christopher B. Nelson, Jurgen Rehm, T. Bedirhan, Bridget Grant; Somnath Chatterji, Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study
Pertwee RG, Medical uses of cannabinoids: the way forward
Smart RG; et.al., An exploratory study of physicians experiences with patients who use marijuana for medical reasons
David Gurwitz, Marihuana and medicine: the debate persists
R. Alonso, B. Voutsinos, M. Fournier, C. Labie, R. Steinberg, J. Souilhac, G. Le Fur, P. Soubrie, Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function
Leweke FM et.al., Elevated endogenous cannabinoids in schizophrenia
Garcia-Gill L. et.al., Perinatal delta-9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA B, but not GABA A, receptor agonists in adult rats
Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, Greenberg DA, Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Bull U, Sass H., Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG
Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H, Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study
J. C. Callaway, D. J. McKenna, C. S. Grob, G. S. Brito, L. P. Raymon, R.E. Poland, E. N. Andrade, E. O. Andrade, D. C. Mash, Pharmacokinetics of Hoasca alkaloids in Healthy Humans
Zinkiewicz L, Davey J, et al, Sin beyond surfers? Young people's risky behaviour during Schoolies Week in three Queensland regions
Young R, Dukat M, Malmusi L, Glennon RA, Stimulus properties of PMMA: effect of optical isomers and conformational restriction
Yeh SY, Dersch C, Rothman R, Cadet JL, Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats
Yeh SY, N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats
Woodrow G, Turney JH, Ecstasy-induced renal vasculitis
Westwood SC, Hanson GR, Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems
Walker TM, Davenport-Jones JE, Fox RM, Atterwill CK, The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture
Vollenweider FX, Remensberger S, Hell D, Geyer MA, Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
Walubo A, Seger D, Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature
Vollenweider FX, Gamma A, Liechti M, Huber T, Is a single dose of MDMA harmless?
Varela-Rey M, Montiel-Duarte C, Beitia G, Cenarruzabeitia E, Iraburu MJ, 3,4-methylenedioxymethamphetamine ('Ecstasy') stimulates the expression of alpha1(I) procollagen mRNA in hepatic stellate cells
Virden TB, Baker LE, Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+-)-MDMA neurotoxicity: Protection by fluoxetine
Ugland HG, Krogh M, Rasmussen KE, Automated determination of 'Ecstasy' and amphetamines in urine by SPME and capillary gas chromatography after propylchloroformate derivatisation
van Heijst A, Ecstasy intoxication and gastric lavage
van de Wijngaart GF, Braam R, de Bruin D, Fris M, Maalste NJM, Verbraeck HT, Ecstasy use at large-scale dance events in the Netherlands.
Topp L, Hando J, Dillon P, Roche A, Solowij N, Ecstasy use in Australia: patterns of use and associated harm
Talwar D, Watson ID, Stewart MJ, Routine analysis of amphetamine class drugs as their naphthaquinone derivatives in human urine by high-performance liquid chromatography
Tagliaro F, De Battisti Z, Groppi A, Nakahara Y, Scarcella D, Valentini R, Marigo M, High sensitivity simultaneous determination in hair of the major constituents of ecstasy (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylene-dioxyethylamphetamine) by high-performance liquid chromatography with direct fluor
Suy K, Gijsenbergh F, Baute L, Emergency medical assistance during a mass gathering
Stumm G, Schlegel J, Schafer T, Wurz C, Mennel HD, Krieg JC, Vedder H, Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons
Sprague JE, Worst T, et al, Effects of antisense oligonucleotide alteration of MAO-B gene expression on MDMA-induced serotonergic neurotoxicity
Spruit IP, Ecstasy use and policy responses in the Netherlands
Stein DJ, Rink J, Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors
Stephenson CP, Hunt GE, Topple AN, McGregor IS, The distribution of 3,4-methylenedioxymethamphetamine 'Ecstasy'-induced c-fos expression in rat brain
Sherlock K, Wolff K, Hay AW, Conner M, Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department
Sondermann N, Kovar KA, Screening experiments of ecstasy street samples using near infrared spectroscopy
Shankaran M, Yamamoto BK, Gudelsky GA, Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum
Shankaran M, Yamamoto BK, Gudelsky GA, Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine
Sexton TJ, McEvoy C, Neumaier JF, (+) 3,4-methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain
Shankaran M, Gudelsky GA, A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration
Sewell RA, Cozzi NV, More about parkinsonism after taking ecstasy
Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC, Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users
Selim K, Kaplowitz N, Hepatotoxicity of psychotropic drugs
Schwab M, Seyringer E, Brauer RB, Hellinger A, Griese EU, Fatal MDMA intoxication
Scearce-Levie K, Chen JP, Gardner E, Hen R, 5-HT receptor knockout mice: pharmacological tools or models of psychiatric disorders
Schirren CA, Berghaus TM, Sackmann M, Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver failure
Scearce-Levie K, Viswanathan SS, Hen R, Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor
Rogers A, McCarthy M, Drugs and drugs education in the inner city: The views of 12-year-olds and their parents
Rochester JA, Kirchner JT, Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology
Rella JG, Nelson LS, Recovery after Ecstasy intoxication
Regenthal R, Kruger M, Rudolph K, Trauer H, Preiss R, Survival after massive 'ecstasy' (MDMA) ingestion
Ramseier A, Caslavska J, Thormann W, Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis
Reed LJ, Winstock A, Cleare AJ, McGuire P, Toxic effect of MDMA on brain serotonin neurons
Ramsey JD, Johnston A, Holt DW, Death rate from use of ecstasy or heroin
Pedersen W, Skrondal A, Ecstasy and new patterns of drug use: A normal population study.
Quin GI, McCarthy GM, Harries DK, Spontaneous pneumomediastinum and ecstasy abuse
Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Segura J, de la Torre R, Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study
Obrocki J, Thomasius R, Ecstasy use and neuropathology [Reply]
Ortuno J, Pizarro N, Farre M, Mas M, Segura J, Cami J, Brenneisen R, de la Torre R, Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection
Obrocki J, Thomasius R, Ecstasy use and neuropathology: Reply
Obrocki J, Buchert R, Vaterlein O, Thomasius R, Beyer W, Schiemann T, Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography
O'Connor A, Cluroe A, Couch R, Galler L, Lawrence J, Synek B, Death from hyponatraemia-induced cerebral oedema associated with MDMA ('Ecstasy') use
O'Connell D, Heffron JJ, Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland
Nishisawa S, Mzengeza S, Diksic M, Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography
Navarro JF, Maldonado E, Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice
Morgan JF, Ecstasy use and neuropathology
Mortensen OV, Kristensen AS, Rudnick G, Wiborg O, Molecular cloning, expression and characterization of a bovine serotonin transporter
Morgan MJ, Memory deficits associated with recreational use of 'ecstasy' (MDMA)
Morgan JF, Toxic effect of MDMA on brain serotonin neurons
Monks TJ, Ghersi-Egea JF, Philbert M, Cooper AJ, Lock EA, Symposium overview: the role of glutathione in neuroprotection and neurotoxicity
Mintzer S, Hickenbottom S, Gilman S, Parkinsonism after taking ecstasy [Comment & Reply]
Milroy CM, Ten years of 'ecstasy'
Mintzer S, Hickenbottom S, Gilman S, Parkinsonism after taking ecstasy
McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH, Congenital anomalies after prenatal ecstasy exposure
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA, Toxic effect of MDMA on brain serotonin neurons
Milosevic A, Agrawal N, Redfearn P, Mair L, The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine)
McCreary AC, Bankson MG, Cunningham KA, Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors
McCann UD, Mertl M, Eligulashvili V, Ricaurte GA, Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users: a controlled study
McCann UD, Szabao Z, Scheffel U, Dannals RF, Ricaurte GA, Positron emission tomography findings in heavy users of MDMA
McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA, Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users
Mas M, Farre M, de la Torre R, Roset PN, Ortuno J, Segura J, Cami J, Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans
Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP, Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat
Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F, Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats
Lieberman JA, Aghajanian GK, Caveat emptor: researcher beware
Lin HQ, Burden PM, Christie MJ, Johnston GA, The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine
Lind J, Oyefeso A, Pollard M, Baldacchino A, Ghodse H, Death rate from use of ecstasy or heroin
Lynskey M, White V, Hill D, Letcher T, Hall W, Prevalence of illicit drug use among youth: results from the Australian School Students' Alcohol and Drugs Survey
Lavelle A, Honner V, Docherty JR, Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens
Laviola G, Adriani W, Terranova ML, Gerra G, Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models
Kuikka JT, Ahonen AK, Toxic effect of MDMA on brain serotonin neurons
Krishnan A, Brown R, Plain abdominal radiography in the diagnosis of the 'body packer'
Jones AL, Volans G, Management of self poisoning
Kintz P, Samyn N, Determination of 'Ecstasy' components in alternative biological specimens
Klugman A, Hardy S, Baldeweg T, Gruzelier J, Toxic effect of MDMA on brain serotonin neurons
Kramer E, Kovar KA, On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine
Jones AL, Simpson KJ, Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications
Jayanthi S, Ladenheim B, Andrews AM, Cadet JL, Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy)
Jansen KL, Forrest AR, Toxic effect of MDMA on brain serotonin neurons
Jansen KL, Ecstasy (MDMA) dependence
Holland J, Positron emission tomography findings in heavy users of MDMA
Holmes SB, Banerjee AK, Alexander WD, Hyponatraemia and seizures after ecstasy use
Hegadoren KM, Baker GB, Bourin M, 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans
Hensley D, Cody JT, Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS
Harrington RD, Woodward JA, Hooton TM, Horn JR, Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate
Hanson GR, Jensen M, Johnson M, White HS, Distinct features of seizures induced by cocaine and amphetamine analogs
Hatzidimitriou G, McCann UD, Ricaurte GA, Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery
Hammersley R, Ditton J, Smith I,Short E, Patterns of ecstasy use by drug users
Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H, Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers
Hamilton J, Balint P, Field M, Sturrock RD, A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis
Gijsman HJ, Verkes RJ, van Gerven JM, Cohen AF, MDMA study
Glennon RA, Arylalkylamine drugs of abuse: an overview of drug discrimination studies
Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR, Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
Gore SM, Drug Survey Investigator's Consortium, Effective monitoring of young people's use of illegal drugs: meta-analysis of UK trends and recommendations
Gore SM, Fatal uncertainty: death-rate from use of ecstasy or heroin
Fineschi V, Centini F, Mazzeo E, Turillazzi E, Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases
Gamma A, Frei E, Lehmann D, PascuaI-Marqui RD, Hell D, Vollenweider FX, Mood state and brain electric activity in ecstasy users
Erdtmann-Vourliotis M, Mayer P, Riechert U, Hollt V, Acute injection of drugs with low addictive potential (delta(9)-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine)
Fallon JK, Kicman AT, Henry JA, Milligan PJ, Cowan DA, Hutt AJ, Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans
Delaforge M, Jaouen M, Bouille G, Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D
Dafters RI, Duffy F, O'Donnell PJ, Bouquet C, Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
de la Torre R, Ortuno J, Mas M, Farre M, Segura J, Fatal MDMA intoxication
Cozzi NV, Sievert MK, Shulgin AT, Jacob P 3rd, Ruoho AE, Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines
Connor TJ, McNamara MG, Kelly JP, Leonard BE, 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) administration produces dose-dependent neurochemical, endocrine, and immune changes in the rat
Colado MI, O'Shea E, Granados R, Esteban B, Martin AB, Green AR, Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration
Colado MI, O'Shea E, Esteban B, Granados R, Green AR, In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism
Colado MI, Granados R, O'Shea E, Esteban B, Green AR, The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, 'eve') on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ('ecstasy')
Borg GJ, More about parkinsonism after taking ecstasy
Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J, Substance use among young people: the relationship between perceived functions and intentions
Colado MI, Esteban B, O'Shea E, Granados R, Green AR, Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration
Chang L, Ernst T, Grob CS, Poland RE, Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users
Bertram M, Egelhoff T, Schwarz S, Schwab S, Toxic leukencephalopathy following 'ecstasy' ingestion
Bogusz MJ, Maier RD, Kruger KD, Webb KS, Romeril J, Miller ML, Poor reproducibility of in-source collisional atmospheric pressure ionization mass spectra of toxicologically relevant drugs
Beijnen JH, Meenhorst PL, Follow-up of ecstasy intoxication
Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E, 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes
Bailly D, Neuropsychiatric disorders induced by MDMA ('Ecstasy')
Bai F, Lau SS, Monks TJ, Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity
Baggott M, Mendelson J, Jones R, More about parkinsonism after taking ecstasy
Alciati A, Scaramelli B, Fusi A, Butteri E, Cattaneo ML, Mellado C, Three cases of delirium after 'ecstasy' ingestion
Appel JB, West WB, Rolandi WG, Alici T, Pechersky K, Increasing the selectivity of drug discrimination procedures
Adolphs R, Social cognition and the human brain
Akram G, Galt M, A profile of harm-reduction practices and co-use of illicit and licit drugs amongst users of dance drugs
Aguirre N, Barrionuevo M, Ramirez MJ, Del Rio J, Lasheras B, Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity
Jonas S., Why the Drug War will Never End
Nicholas M. Barnes , Trevor Sharp, A review of central 5-HT receptors and their function
Arvanov, V. L., Liang, X., Russo, A., et al, LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex
Aghajanian, G. K. and Marek, G. J., Serotonin and Hallucinogens
Luo, Y., Wei, J., and Weekes, B., Effects of musical meditation training on auditory mismatch negativity and P300 in normal children.
Aghajanian, George K., Marek, Gerard J., Serotonin, via 5-HT receptors, increases EPSCs in layer V pyramidal cells 2A of prefrontal cortex by an asynchronous mode of glutamate release
E. Gouzoulis-Mayfrank · B. Thelen · E. Habermeyer · H.J. Kunert,K.-A. Kovar · H. Lindenblatt · L. Hermle · M. Spitzer · H. Sass, Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers
R. G. Pertwee, Cannabis and Cannabinoids: Pharmacology and Rationale for Clinical Use
Fredholm, B. B., Battig, K., Holmen, J., et al, Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
Gijsman, H. J., Verkes, R. J., Van Gerven, J. M., et al, MDMA Study
Lieberman, J. A. and Aghajanian, G. K., Caveat Emptor: Researcher Beware
Pomilio, A. B., Vitale, A. A., Ciprian-Ollivier, J., et al, Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia
Thompson, M. A., Moon, E., Kim, U. J., et al, Human Indolethylamine N-Methyltransferase: cDNA Cloning and Expression, Gene Cloning, and Chromosomal Localization
Alvarez, J. C., Gluck, N., Arnulf, I., et al, Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine
Berk, S. I., LeBlond, R. F., Hodges, K. B., et al, A mesenteric mass in a chronic LSD user.
Mueller, A. L., Artman, L. D., Balandrin, M. F., et al, NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant : Review of Preclinical and Clinical Studies
Cho, R., Kapur, S., Du, L., et al, Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.
Fowler, C. J., Sjoberg, E., and Tiger, G., Serotonin stimulation of calcium mobilisation in human platelets: choice of units of measurement, effects of age and tobacco use, and correlation with serotonin2A receptor density
Fowler, C. J., Vedin, V., and Sjoberg, E., Evidence for Cooperative Binding of (-)Isoproterenol to rat brain beta1-adrenergic receptors
Halpern, J. H. and Pope, H. G., Jr., Do hallucinogens cause residual neuropsychological toxicity?
Kondro, W., Class-action lawsuit threatened by Canadian female prisoners.
Moore, K. A., Werner, C., Zannelli, R. M., et al, Screening postmortem blood and tissues for nine cases of drugs of abuse using automated microplate immunoassay
Poch, G. K., Klette, K. L., Hallare, D. A., et al, Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
Lyketsos, C. G., Garrett, E., Liang, K. Y., et al, Cannabis use and cognitive decline in persons under 65 years of age.
Nagayama, T., Sinor, A. D., Simon, R. P., et al, Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures
Reuschel, S. A., Eades, D., and Foltz, R. L., Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.
Smedh, K., Spigset, O., Allard, P., et al, Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
Spigset, O., Andersen, T., Hagg, S., et al, Enhanced platelet serotonin 5-HT (2A) receptor binding in anorexia nervosa and bulimia nervosa
Young, S. J., Longstaffe, S., and Tenenbein, M., Inhalant Abuse and the Abuse of Other Drugs.
de, B. D., Gijzels, M. J., Bosman, I. J., et al, More data about the new psychoactive drug 2C-B.
Rosenthal, E., Sala, F., Chichmanian, R. M., et al, Ergotism related to concurrent administration of ergotamine tartrate and indinavir.
Periodic Mobility of Cranial Bones in Humans., Yu. E. Moskalenko, T. I. Kravchenko, B. V. Gaidar, G. B. Weinstein, V. N. Semernya, N. F. Maiorova, and V. F. Mitrofanov.
Berrendero F. Romero J. Garcia-Gil L. Suarez I. De la Cruz P. Ramos JA. Fernandez-Ruiz JJ, Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats
Meng ID, Manning BH, Martin WJ, Fields HL, An analgesia circuit activated by cannabinoids
Labit-Le Bouteiller C, Jamme MF, David M, Silve S, Lanau C, Dhers C, Picard C, Rahier A, Taton M, Loison G, Caput D, Ferrara P, Lupker J, Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step
Paton GS, Pertwee RG, Davies SN, Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice
Swaim RC, Bates SC, Chavez EL, Structural equation socialization model of substance use among Mexican-American and white non-Hispanic school dropouts
Shen M, Thayer SA, Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
Mechoulam R, Fride E, Di Marzo V., Endocannabinoids.
Sanudo-Pena MC, Force M, Tsou K, Miller AS, Walker JM, Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system
Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Anandamide modulates sleep and memory in rats
Pestonjamasp VK, Burstein SH, Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system
Aceto MD, Scates SM, Razdan RK, Martin BR, Anandamide, an endogenous cannabinoid, has a very low physical dependence potential
Mallet PE, Beninger RJ, The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide
Stahl SM, Getting stoned without inhaling: anandamide is the brain's natural marijuana
Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes JA, Fernandez-Ruiz JJ, Ramos JA, Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol
Srivastava MD, Srivastava BI, Brouhard B, Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.
Jaggar SI. Hasnie FS. Sellaturay S. Rice AS, The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.
Rubino T, Patrini G, Massi P, Fuzio D, Vigano D, Giagnoni G, Parolaro D, Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression
Russo E, Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. [Review] [51 refs]
Smith FL, Fujimori K, Lowe J, Welch SP, Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats
Pertwee RG, Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors
Skidmore, Mccaffery, Krumm, Glick, Marijuana as a medicine [letter; comment]
Chan PK, Chan SC, Yung WH, Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist
Kaminski NE, Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors. [Review] [61 refs]
Richardson JD, Kilo S, Hargreaves KM, Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
Patel NA, Moldow RL, Patel JA, Wu G, Chang SL, Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain.
Bisogno T. Katayama K. Melck D. Ueda N. De Petrocellis L. Yamamoto S. Di Marzo V, Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation
Di Marzo V, 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance
Chan PK, Yung WH, Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium
Kondo S, Kondo H, Nakane S, Kodaka T, Tokumura A, Waku K, Sugiura T, 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+ -dependent and -independent mechanisms
MacLennan SJ, Reynen PH, Kwan J, Bonhaus DW, Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
Smith FL, Cichewicz D, Martin ZL, Welch SP, The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol
De Petrocellis L. Melck D. Palmisano A. Bisogno T. Laezza C. Bifulco M. Di Marzo V, The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
Calignano A, La Rana G, Giuffrida A, Piomelli D, Control of pain initiation by endogenous cannabinoids
Szabo B, Dorner L, Pfreundtner C, Norenberg W, Starke K, Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
Wallace JM, Lim R, Browdy BL, Hopewell PC, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group
Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W, Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
Porcella A, Casellas P, Gessa GL, Pani L, Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana
Hirst RA, Lambert DG, Notcutt WG, Pharmacology and potential therapeutic uses of cannabis
Sepe N, De Petrocellis L, Montanaro F, Cimino G, Di Marzo V, Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry
Jentsch JD, Wise A, Katz Z, Roth RH, Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex
Sanudo-Pena MC, Walker JM, Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system
Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, Koppel GA, Brownstein M, LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation
Pratt PF, Hillard CJ, Edgemond WS, Campbell WB, N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
Richardson JD, Aanonsen L, Hargreaves KM, Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia
Johnson RA, Gerstein DR, Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919 [see comments]
Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL, SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
Randall MD, Kendall DA, Endocannabinoids: a new class of vasoactive substances
Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM, Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
Howlett AC, The CB1 cannabinoid receptor in the brain
Navarro M, Rodriguez de Fonseca F, The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease
Murphy LL, Munoz RM, Adrian BA, Villanua MA, Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion
Martin BR. Lichtman AH, Cannabinoid transmission and pain perception.
Francisco Molina-Holgado, Eduardo Molina-Holgado, Carmen Guaza, The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway
Mao L, Oh Y, Does Marijuana or Crack Cocaine Cause Cancer?
Klein TW, Newton C, Friedman H, Cannabinoid receptors and immunity. [Review] [76 refs]
Garcia DE, Brown S, Hille B, Mackie K, Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor
Herring AC, Koh WS, Kaminski NE, Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid
Ouyang Y, Hwang SG, Han SH, Kaminski NE, Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down- regulation of the nuclear factor of activated T cells
Diana M et.al, Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
M. Egertova, D. K. Giang, B. F. Cravatt, M. R. Elphick, A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain
Hall W, The respiratory risks of cannabis smoking
SH Barsky, MD Roth, EC Kleerup, M Simmons, DP Tashkin, Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco
D. Carriero, J. Aberman, S. Y. Lin, A. Hill, A. Makriyannis, J. D. Salamone, original investigation: A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing
Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL, Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Golub AL, Johnson BD, Alcohol is not the Gateway to Hard Drug Abuse
T.J. Graceffo, J. K. Robinson, DELTA-9-TETRAHYDROCANNABINOL (THC) FAILS TO STIMULATE CONSUMPTION OF A HIGHLY PALATABLE FOOD IN THE RAT
T. U. C. Jarbe, R. J. Lamb, A. Makriyannis, S. Lin, A. Goutopoulos, original investigation: 9-THC training dose as a determinant for (R)- methanandamide generalization in rats
David Reilly, Peter Didcott, Wendy Swift, Wayne Hall, Long-term cannabis use: characteristics of users in an Australian rural area
Douglas K. Novins, Christina M. Mitchell, Factors associated with marijuana use among American Indian adolescents
Lars Terenius, Rational treatment of addiction
Wendy Swift, Jan Copeland, Wayne Hall, Choosing a diagnostic cut-off for cannabis dependence
Wendy Swift, Wayne Hall, Peter Didcott, David Reilly, Patterns and correlates of cannabis dependence among long-term users in an Australian rural area
Griffin G. et.al., Evaluation of Cannabinoid Receptor Agonists and Antagonists Using the Guanosine-5-0-(3-{35S}thio)-trihosphate Binding Assay in Rat Cerebellar Membranes
Robert S. Landsman, Alexandros Makriyannis*, Hongfeng Deng*, Paul Consroe, William R. Roeske and Henry I. Yamamura, AM630 is an inverse agonist at the human cannabinoid cb1 receptor
Francois Petitet, Bernadette Jeantaud, Michel Reibaud, Assunta Imperato, Marie-Christine Dubroeucq, Complex Pharmacology Of Natural Cannabinoids : Evidence for partial agonist activity of 9 tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors
Porcella A et.al, Delta 9-Tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain
Vincenzo Di Marzo, Dale G. Deutsch, Biochemistry of the Endogenous Ligands of Cannabinoid Receptors
Christian C. Felder, Michelle Glass, Cannabinoid receptors and their endogenous agonists
T Chataigneau, M Feletou, C Thollon, N Villeneuve, JP Vilaine, J Duhault, PM Vanhoutte, Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries
David Gurwitz, Haemorrhagic shock: endogenous cannabinoids to the rescue
AI McCulloch, MD Randall, Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed
Karoly Vargaa, Jens A. Wagnera, D. Troy Bridgena, George Kunosa, Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
Rosanna Di Toro, Gabriele Campana, Vittorio Sciarretta, Giovanna Murari, Santi Spampinato, Regulation of D opioid receptors by d 9-tetrahydrocannabinol in ng108-15 hybrid cells
Vincenzo Di Marzo et.al., Trick or treat from food endocannabinoids?
DT Malone, DA Taylor, Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat
T Croci, L Manara, G Aureggi, F Guagnini, M Rinaldi-Carmona, JP Maffrand, G Le Fur, S Mukenge, G Ferla, In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum
RA Ross, HC Brockie, SR Fernando, B Saha, RK Razdan, RG Pertwee, Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine
AA Izzo, N Mascolo, F Borrelli, F Capasso, Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors
Thomas W. Klein, Cathy Newton, Herman Friedman, Cannabinoid receptors and immunity [Review article]
Klein TW et.al., Cannabinoid receptors and the cytokine network,
Noe SN et.al., Cannabinoid receptor agonists enhance synctia formation in MT-2 cells infected with cell free HIV-1 MN
Friedman et.al. eds, Drugs of Abuse, Immunology, and AIDS
Newton C et.al., The role of macrophages in THC-induced alteration of the cytokine network
Fishman RHB, Cannabinoid is neuroprotective in head trauma
Gruol DL, Cannabinoids alter neurotoxicity produced by interleukin-6 in central nervous system neurons
Kenneth S. Kendler, Carol A. Prescott, Cannabis Use, Abuse, and Dependence in a Population-Based Sample of Female Twins
John W Kozarich, Daniel H Rich, Looking to the horizon [Editorial overview]
Nancy M. Petry; Warren K . Bickel, Polydrug abuse in heroin addicts: a behavioral economic analysis
Schwenk CR, Marijuana and Job Performance: Comparing the Major Streams of Research
J. G. Ramaekers, Emerging Drugs: The Prospect for Improved Medicines (Vol. 3) [Review article]
William Armando Vega, Ethel Alderete, Bohdan Kolody, Sergio Aguilar-Gaxiola, Illicit drug use among Mexicans and Mexican Americans in California: the effects of gender and acculturation
The Royal Society and the Academy of Medical Sciences, London UK, Use of cannabis and its derivatives for medical and recreational purposes
David Gurwitz, Emerging molecular targets
Alfonso Troisi, Augusto Pasini, Michele Saracco, Gianfranco Spalletta, Psychiatric symptoms in male cannabis users not using other illicit drugs
BC Paria, W Ma, DM Andrenyak, PC Schmid, HH Schmid, DE Moody, H Deng, A Makriyannis SK Dey, Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
Shen M, Thayer SA, Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
Gouzoulis-Mayfrank E, Thelen B, Maier S, Habermeyer E, Spitzer M, Sass H, Modulation of semantic priming effects by psilocybin, MDE (ecstasy) and d-methamphetamine; principles and applicaitons of the model psychosis strategy
Lindenblatt H, Kraemer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA, Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction
Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H., Methodological issues of human experimental research with hallucinogens
Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA., Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans
Gouzoulis-Mayfrank E, Hermle L, Thelen B, Sass H., History, rationale and potential of human experimental hallucinogenic drug research in psychiatry
Gouzoulis-Mayfrank E, Habermeyer E, Hermle L, Steinmeyer AM, Kunert HJ, Sass H, Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study
J. C. Callaway, D. J. McKenna, Neurochemistry of psychedelic drugs
Zheng Y, Laverty R, Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats
Woodrow P, The effects of ecstasy
Young R, Glennon RA, Discriminative stimulus properties of (-)ephedrine
Windhaber J, Maierhofer D, Dantendorfer K, Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine
Wollina U, Kammler HJ, Hesselbarth N, Mock B, Bosseckert H, Ecstasy pimples - a new facial dermatosis
Williams A, Segal O, Andrews B, Short gastric artery perforation after use of 'ecstasy'
Williams H, Dratcu L, Taylor R, Roberts M, Oyefeso A, Saturday night fever: ecstasy related problems in a London accident and emergency department
Vollenweider FX, Gamma A, Liechti M, Huber T, Psychological and cardiovascular effects and short-term sequelae of MDMA ('ecstasy') in MDMA-naive healthy volunteers
Webb E, Ashton CH, Kelly P, Kamah F, An update on British medical students' lifestyles
Weinmann W, Bohnert M, Lethal monointoxication by overdosage of MDEA
Tagliaro F, Manetto G, Crivellente F, Scarcella D, Marigo M, Hair analysis for abused drugs by capillary zone electrophoresis with field-amplified sample stacking
Tagliaro F, Manetto G, Bellini S, Scarcella D, Smith FP, Marigo M, Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine, 3-4-methylenedioxyamphetamine, 3,4-methylenedioxyethylam- phetamine, ephedrine, amphetamine and methamphetamine by capillary electrophoresis in uncoated and coated capillaries with nat
Shankaran M, Gudelsky GA, Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin
Sprague JE, Everman SL, Nichols DE, An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine
Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R, MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients
Schuster P, Lieb R, Lamertz C, Wittchen HU, Is the use of ecstasy and hallucinogens increasing? Results from a community study
Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA, In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain
Sabol KE, Seiden LS, Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis
Schechter MD, 'Candyflipping': synergistic discriminative effect of LSD and MDMA
Ros JJ, Pelders MG, Egberts AC, Performance of Abusign drugs-of-abuse slide tests with particluar emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS
Schechter MD, MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats
Redfearn PJ, Agrawal N, Mair LH, An association between the regular use of 3,4 methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth
Ropero-Miller JD, Goldberger BA, Recreational drugs. Current trends in the 90s
Ramcharan S, Meenhorst PL, Otten JM, Koks CH, de Boer D, Maes RA, Beijnen JH, Survival after massive ecstasy overdose
Ramseier A, Caslavska J, Thormann W, Screening for urinary amphetamine and analogs by capillary electrophoretic immunoassays and confirmation by capillary electrophoresis with on-column multiwavelength absorbance detection
Plessinger MA, Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy
Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K, Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits
Obradovic T, Imel KM, White SR, Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin
Parrott AC, The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997
Parrott AC, Lasky J, Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M, MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6
O'Shea E, Granados R, Esteban B, Colado MI, Green AR, The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy')
Nakahara Y, Kikura R, Takahashi K, Hair analysis for drugs of abuse XX. Incorporation and behaviors of seven methamphetamine homologs in the rat hair root
Mueller PD, Korey WS, Death by 'ecstasy': the serotonin syndrome?
Murray MO, Wilson NH, Ecstasy related tooth wear
Nagilla R, Newland MC, Snyder J, Bronson ME, Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats
Morimoto BH, Lovell S, Kahr B, Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
Muck-Seler D, Takahashi S, Diksic M, The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study
Morgan MJ, Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity
Moeller MR, Steinmeyer S, Kraemer T, Determination of drugs of abuse in blood
Metzger RR, Hanson GR, Gibb JW, Fleckenstein AE, 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function
McElhatton PR, Bateman DN, Evans C, Pughe KR, Worsley AJ, Does prenatal exposure to ecstasy cause congenital malformations? A prospective follow-up of 92 pregnancies
Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY, Kupfer DJ, Reynolds CF, Serotonin in Aging, Late-Life Depression, and Alzheimer’s Disease: The Emerging Role of Functional Imaging
McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA, Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings
Magee C, Staunton H, Tormey W, Walshe JJ, Hyponatraemia, seizures and stupor associated with ecstasy ingestion in a female
Malberg JE, Seiden LS, Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat
Matsushima K, Nagai T, Kamiyama S, Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats
Kurova T, Shoubnikova M, Malceva A, Mardh PA, Prostitution in Riga, Latvia--a socio-medical matter of concern
Kramer HK, Poblete JC, Azmitia EC, Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT)
Lauerma H, Wuorela M, Halme M, Interaction of serotonin reuptake inhibitor and 3,4-methylenedioxymethamphetamine?
Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE, Serotonergic basis of antipsychotic drug effects in schizophrenia
Klee H, The love of speed: An analysis of the enduring attraction of amphetamine sulphate for British youth
Kovar KA, Chemistry and pharmacology of hallucinogens, entactogens and stimulants
Kankaanpaa A, Meririnne E, Lillsunde P, Seppala T, The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens
Keller T, Miki A, Regenscheit P, Dirnhofer R, Schneider A, Tsuchihashi H, Detection of designer drugs in human hair by ion mobility spectrometry (IMS)
Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M, Low-dose MDMA ('ecstasy') induces vasopressin secretion
Henry JA, Hill IR, Fatal interaction between ritonavir and MDMA
Jacks AS, Hykin PG, Retinal haemorrhage caused by 'ecstasy'
Kalivas PW, Duffy P, White SR, MDMA elicits behavioral and neurochemical sensitization in rats
Greer GR, Tolbert R, A method of conducting therapeutic sessions with MDMA
Granoff MI, Ashby CR Jr, The Effect of the Repeated Administration of the Compound 3,4-methylenedioxymethamphetamine on the Response of Rats to the 5-HT2A,C Receptor Agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
Gervin M, Smith R, Bamford L, Keenan E, Chasing the dragon: experience in Ireland and association with 'Ecstasy'
Felgate HE, Felgate PD, James RA, Sims DN, Vozzo DC, Recent paramethoxyamphetamine deaths
Frederick DL, Ali SF, Gillam MP, Gossett J, Slikker W, Paule MG, Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment
Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R, Serotonergic function after (+/-)3,4-methylene-dioxymethamphetamine ('Ecstasy') in humans
Davies JP, Evans RO, Newington DP, Ecstasy related trauma
Dulawa SC, Hen R, Scearce-Levie K, Geyer MA, 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice
Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE, Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat
D'Esposito M, Serotonin neurotoxicity: implications for cognitive neuroscience and neurology
Dafters RI, Lynch E, Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') but not fenfluramine
Conner M, Sherlock K, Orbell S, Psychosocial determinants of ecstasy use in young people in the UK.
Colado MI, Granados R, O'Shea E, Esteban B, Green AR, Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR
Byard RW, Gilbert J, James R, Lokan RJ, Amphetamine derivative fatalities in South Australia--is 'Ecstasy' the culprit?
Cadet JL, Brannock C, Free radicals and the pathobiology of brain dopamine systems
Brody S, Krause C, Veit R, Rau H, Cardiovascular autonomic dysregulation in users of MDMA ('Ecstasy')
Bingham C, Beaman M, Nicholls AJ, Anthony PP, Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine
Bolla KI, McCann UD, Ricaurte GA, Memory impairment in abstinent MDMA ('Ecstasy') users
Bhattacharya SK, Bhattacharya A, Ghosal S, Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an experimental study
Bilsky EJ, Montegut MJ, Nichols ML, Reid LD, CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences
Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP, Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ('Ecstasy') in serotonin transporter-deficient mice
Ahmed JM, Salame MY, Oakley GD, Chest pain in a young girl
Ajaelo I, Koenig K, Snoey E, Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use
Andreu V, Mas A, Bruguera M, Salmeron JM, Moreno V, Nogue S, Rodes J, Ecstasy: a common cause of severe acute hepatotoxicity
Aguirre N, Barrionuevo M, Lasheras B, Del Rio J, The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats
Aguirre N, Ballaz S, Lasheras B, Del Rio J, MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion
Berg, K. A., Maayani, S., Goldfarb, J., et al, Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus
Gerard J. MarekU, George K. Aghajanian, Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action
Berg, K. A., Maayani, S., Goldfarb, J., et al, Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus
SMITH, RANDY L., CANTON, HERVÉ , . BARRETT, ROBERT J. AND SANDERS-BUSH, ELAINE, Agonist Properties of N,N -Dimethyltryptamine at Serotonin 5-HT 2A and 5-HT 2C Receptors
Shen, M. and Thayer, S. A., Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity.
Raphael Mechoulam, Ester Fride and Vincenzo Di Marzo, Endocannabinoids
Grella, B., Dukat, M., Young, R., et al, Investigation of hallucinogenic and related beta-carbolines
Jakab, R. L. and Goldman-Rakic, P. S., 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites
Thompson, M. A. and Weinshilboum, R. M., Rabbit Lung Indolethylamine N-Methyltransferase
Boess, F. G., Monsma, F. J., Jr., Bourson, A., et al, Residues in transmembrane regions III and VI contribute to the 5-ht6 receptor ligand binding site.
Boess, F. G., Monsma, F. J., Jr., and Sleight, A. J, Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5-HT6 Receptor.
Sleight, A. J., Boess, F. G., Bos, M., et al, The putative 5-ht6 receptor: localization and function.
Francken, B. J., Jurzak, M., Vanhauwe, J. F., et al, The human 5-ht5A receptor couples to Gi,Go proteins and inhibits adenylate cyclase in HEK 293 cells
Lotz, J., Hafner, G., Rohrich, J., et al, False-positive LSD drug screening induced by a mucolytic medication.
Meehan, S. M. and Schechter, M. D., LSD Produces Conditioned Place Preference in Male But Not Female Fawn Hooded Rats.
Novak, S. J., Second thoughts on psychedelic drugs.
Panigrahy, A., Sleeper, L. A., Assmann, S., et al, Developmental Changes in Heterogeneous Patterns of Neurotransmitter Receptor Binding in the Human Interpeduncular Nucleus.
Hall, W. and Solowij, N., Adverse effects of cannabis.
Schneider, S., Kuffer, P., and Wennig, R., Determination of lysergide (LSD) and phencyclidine in biosamples.
Spigset, O., Allard, P., and Mjorndal, T., Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Stain-Malmgren, R., Kjellman, B. F., and berg-Wistedt, A., Platelet serotonergic functions and light therapy in seasonal affective disorder.
Weiss, H. M., Haase, W., Michel, H., et al, Comparative biochemical and pharmacological characterization of the mouse 5HT5A 5-hydroxytryptamine receptor and the human b2-adrenergic receptor produced in the methylotrophic yeast Pichia pastoris.
Young, T. L. and Zimmerman, R., Clueless: parental knowledge of risk behaviors of middle school students.
Zacny, J. P., Hill, J. L., Black, M. L., et al, Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Pentazocine and Morphine in Normal Volunteers.
Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z, Anandamide may mediate sleep induction
Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC, Production and physiological actions of anandamide in the vasculature of the rat kidney
Brodkin J. Moerschbaecher JM, SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats
Valk PJ, Hol S, Vankan Y, Ihle JN, Askew D, Jenkins NA, Gilbert DJ, Copeland NG, de Both NJ, Lowenberg B, Delwel R, The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11
Fortner N, Fogerson R, Lindman D, Iversen T, Armbruster D, Marijuana-positive urine test results from consumption of hemp seeds in food products
Costantino A, Schwartz RH, Kaplan P, Hemp oil ingestion causes positive urine tests for delta 9-tetrahydrocannabinol carboxylic acid
Fowler CJ, Tiger G, Stenstrom A, Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship
Mathre ML, Medicinal use of marijuana
Voth EA, Schwartz RH, Medicinal applications of delta-9-tetrahydrocannabinol and marijuana
Molina-Holgado F, Lledo A, Guaza C, Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes
Elwan O. Hassan AA. Abdel Naseer M. Elwan F. Deif R. El Serafy O. El Banhawy E. El Fatatry M, Brain aging in a sample of normal Egyptians cognition, education, addiction and smoking
Pugh G Jr, Mason DJ Jr, Combs V. Welch SP, Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord
Glass M, Dragunow M, Faull RL, Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Daaka Y, Zhu W, Friedman H, Klein TW, Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor
Sanudo-Pena MC, Walker JM, Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat
Glass M, Dragunow M, Faull RL., Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.
Lake KD, Compton DR, Varga K, Martin BR, Kunos G, Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors
Glass M, Felder CC, Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1receptor
Willoughby KA. Moore SF. Martin BR. Ellis EF, The biodisposition and metabolism of anandamide in mice
Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ, Atypical location of cannabinoid receptors in white matter areas during rat brain development
Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F, Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
Herzberg U, Eliav E, Bennett GJ, Kopin IJ, The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
Wingert WE, Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results
Wagner JA. Varga K. Ellis EF. Rzigalinski BA. Martin BR. Kunos G, Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
Compton DR. Martin BR, The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity
Stella N, Schweitzer P, Piomelli D, A second endogenous cannabinoid that modulates long-term potentiation
Katayama K, Ueda N, Kurahashi Y, Suzuki H, Yamamoto S, Kato I, Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP, Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco
Sidney S. Beck JE. Tekawa IS. Quesenberry CP. Friedman GD, Marijuana use and mortality
Emrich HM, Leweke FM, Schneider U, Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system
Lily Yeh Jan, Yuh Nung Jan, Receptor-regulated ion channels [Review article]
John Gatley, Ruoxi Lan, Beatrice Pyatt, Andrew N Gifford, Nora D Volkow, Alexandros Makriyannis, Binding of the non-classical cannabinoid cp 55,940, and the diarylpyrazole am251 to rodent brain cannabinoid receptors
Keiko Hosohata, Raymond M. Quock1, Yoshiaki Hosohata, Thomas H. Burkey, Alexandros Makriyannis*, Paul Consroe, William R. Roeske and Henry I. Yamamura, AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain
Kim E-S, Imunnochemical Localization of tetrahydrocannabinol (THC) in cryofixed Glandular trichomes of cannabis (Cannabaceae)
Pop E, Brewster ME, Dimerization of dexabinol by hydrogen bonding accounts for its hydrophobic character
Tiziana Bisogno, Nunzio Sepe, Dominique Melck, Stefano Maurelli, Luciano De Petrocellis, Vincenzo Di Marzo, Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells
Christopher S. Breivogel, Laura J. Sim, Steven R. Childers, Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain
Kristy D. Lake, Billy R. Martin, George Kunos, Karoly Varga, Cardiovascular Effects of Anandamide in Anesthetized and Conscious Normotensive and Hypertensive Rats
PM Zygmunt, ED Hogestatt, K Waldeck, G Edwards, AJ Kirkup, AH Weston, Studies on the effects of anandamide in rat hepatic artery
R White, CR Hiley, A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery
Michèle Arnone, Jeanne Maruani, Frederique Chaperon, Marie-Helene Thiebot, M. Poncelet, Philippe Soubrie, Gerard Le Fur, Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
Anon, Guidance for premarket submissions for kits for screening drugs of abuse to be used by the consumer, Draft guidance- Not for implementation
National Cancer Institute, Marijuana Use in Supportive Care for Cancer Patients
F Lopez-Redondo, GM Lees, RG Pertwee, Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum
Javier Corchero, Matias A. Avila, Jose A. Fuentes, Jorge Manzanares, DELTA-9-TETRAHYDROCANNABINOL INCREASES PRODYNORPHIN AND PROENKEPHALIN GENE EXPRESSION IN THE SPINAL CORD OF THE RAT
Consroe P, Musty R, Rein J, Tillery W, Pertwee R, The perceived effects of smoked cannabis on patients with multiple sclerosis
Ruth Gallily, Aviva Yamin, Yaakov Waksmann, Haim Ovadia, Joseph Weidenfeld, Avi Bar-Joseph, Anat Biegon, Raphael Mechoulam, Esther Shohami, Protection Against Septic Shock and Suppression of Tumor Necrosis Factor and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid
Rick Bell, Henry Wechsler, Lloyd D. Johnston, Correlates of college student marijuana use: results of a US National Survey
Wayne Hall, The recent Australian debate about the prohibition on cannabis use
William V. Fabricius, Craig T. Nagoshi, David P. Mackinnon, Concepts of drugs: differences in conceptual structure across groups with different levels of drug experience
Michael J. Lyons, Rosemary Toomey, Joanne M. Meyer, Alan I. Green, Seth A. Eisen, Jack Goldberg, William R. True, Ming T. Tsuang, How do genes influence marijuana use? The role of subjective effects
Robson P, Cannabis
Volicer L et.al., Effects of Dronabinol on Anorexia and Disturbed Behavior in Patients with Alzheimer's Disease
Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E, Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid
Ensslin HK, Maurer HH, Gouzoulis E, Hermle L, Kovar KA, Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites
Yeh SY, Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats
Zheng Y, Russell B, Schmierer D, Laverty R, The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice
Yau JL, Noble J, Seckl JR, Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: role of corticosterone and serotonin
Wu D, Otton SV, Inaba T, Kalow W, Sellers EM, Interactions of amphetamine analogs with human liver CYP2D6
Williamson S, Gossop M, Powis B, Griffiths P, Fountain J, Strang J, Adverse effects of stimulant drugs in a community sample of drug users
Williams A, Unwin R, Prolonged elevation of serum creatine kinase (CK) without renal failure after ingestion of ecstasy
Watson ID, Serlin M, Moncur P, Tames F, Acute hyponatraemia
White JM, Bochner F, Irvine RJ, The agony of 'ecstasy'
Volz HP, Kieser M, Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
Vorhees CV, Methods for detecting long-term CNS dysfunction after prenatal exposure to neurotoxins
Uhl M, Determination of drugs in hair using GC/MS/MS
Tsatsakis AM, Michalodimitrakis MN, Patsalis AN, MDEA related death in Crete: a case report and literature review
Towers S, [Unknown]
Towers S, Sorted
Taraska T, Finnegan KT, Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine
Tillmann HL, van Pelt FN, Martz W, Luecke T, Welp H, Dorries F, Veuskens A, Fischer M, Manns MP, Accidental intoxication with methylene dianiline p,p'-diaminodiphenylmethane: acute liver damage after presumed ecstasy consumption
Simantov R, Tauber M, The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells
Spatt J, Glawar B, Mamoli B, A pure amnestic syndrome after MDMA ('ecstasy') ingestion
Schechter MD, Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum
Schwartz RH, Miller NS, MDMA (ecstasy) and the rave: a review
Schechter MD, Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats
Rutty GN, Milroy CM, The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethylamphetamine
Sadeghipour F, Veuthey JL, Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection
Schechter MD, Discrete versus cumulative dosing in dose-response discrimination studies
Rothe M, Pragst F, Spiegel K, Harrach T, Fischer K, Kunkel J, Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users
Rees C, Lehane M, Return to Ecstasy
Robson P, Bruce M, A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations?
Rohrich J, Kauert G, Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair
Pittman JA, Pounsford JC, Spontaneous pneumomediastinum and Ecstasy abuse
Poland RE, Lutchmansingh P, McCracken JT, Zhao JP, Brammer GL, Grob CS, Boone KB, Pechnick RN, Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA
Parrott AC, Stuart M, Ecstacy (MDMA), amphetamine, and LSD: Comparative mood profiles in recreational polydrug users
Pereira SP, McCarthy M, Ellis AJ, Wendon J, Portmann B, Rela M, Heaton N, Williams R, Auxiliary partial orthotopic liver transplantation for acute liver failure
No Authors Listed, Helping patients who misuse drugs
Nuvials X, Masclans JR, Peracaula R, de Latorre FJ, Hyponatraemic coma after ecstasy ingestion
Parr MJ, Low HM, Botterill P, Hyponatraemia and death after 'ecstasy' ingestion
Murthy BV, Roberts NB, Wilkes RG, Biochemical implications of ecstasy toxicity
Murthy BV, Wilkes RG, Roberts NB, Creatine kinase isoform changes following Ecstasy overdose
Nakahara Y, Kikura R, Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethamphetamine (MDMA) disposition in hair roots and use in identification of acute MDMA poisoning
Miller RT, Lau SS, Monks TJ, 2,5-bis-(Glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations
Morgan AE, Horan B, Dewey SL, Ashby CR Jr, Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study
Montgomery H, Myerson S, 3,4-methylenedioxymethamphetamine (MDMA, or 'ecstasy') and associated hypoglycemia
Moeller MR, Hartung M, Ecstasy and Related Substances--Serum Levels in Impaired Drivers
Martinez DL, Geyer MA, Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine
Marquet P, Lacassie E, Battu C, Faubert H, Lachatre G, Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography-mass spectrometry
MacConnachie AM, Ecstasy poisoning
Mallick A, Bodenham AR, MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C
Mann H, Ladenheim B, Hirata H, Moran TH, Cadet JL, Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice
Lin LY, Di Stefano EW, Schmitz DA, Hsu L, Ellis SW, Lennard MS, Tucker GT, Cho AK, Oxidation of Methamphetamine and Methylenedioxymethamphetamine by CYP2D6
LeSage M, Poling A, MDMA and d-amphetamine produce comparable effects in pigeons performing under a multiple fixed-ratio interresponse-time-greater-than-t schedule of food delivery
Lin HQ, Jackson DM, Atrens DM, Christie MJ, McGregor IS, Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation
Lenton S, Boys A, Norcross K, Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia
Kua EH, Designer Drugs--the Ecstasy and the Agony
Lanz M, Brenneisen R, Thormann W, Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis
Kramer HK, Poblete JC, Azmitia EC, Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter
Koch S, Galloway MP, MDMA induced dopamine release in vivo: role of endogenous serotonin
Kintz P, Cirimele V, Interlaboratory comparison of quantitative determination of amphetamine and related compounds in hair samples
Kikura R, Nakahara Y, Mieczkowski T, Tagliaro F, Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse
Ho BK, What you need to know: addiction--Ecstasy
Huether G, Zhou D, Ruther E, Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its congeners
Goff ML, Miller ML, Paulson JD, Lord WD, Richards E, Omori AI, Effects of 3,4-methylenedioxymethamphetamine in decomposing tissues on the development of Parasarcophaga ruficornis (Diptera:Sarcophagidae) and detection of the drug in postmortem blood, liver tissue, larvae, and puparia
Granato P, Weill S, Revillon JJ, Ecstasy and dementia in a young subject
Hall AP, Hyponatraemia, water intoxication and 'ecstasy'
Hall AP, Ecstasy: creatinine kinase
Hall AP, Ecstasy and the Anaesthetist
Gerada C, Ashworth M, ABC of mental health. Addiction and dependence--I: Illicit drugs [published erratum appears in BMJ 1997 Aug 30;315(7107):539]
Gibb JW, Johnson M, Elayan I, Lim HK, Matsuda L, Hanson GR, Neurotoxicity of amphetamines and their metabolites
Gillman PK, Ecstasy, serotonin syndrome and the treatment of hyperpyrexia
Glennon RA, Young R, Dukat M, Cheng Y, Initial characterization of PMMA as a discriminative stimulus
Gartside SE, McQuade R, Sharp T, Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems
Frederick DL, Paule MG, Effects of MDMA on complex brain function in laboratory animals
Denborough MA, Hopkinson KC, Dantrolene and 'ecstasy'
Forsyth AJ, Barnard M, McKeganey NP, Musical preference as an indicator of adolescent drug use
Denborough MA, Hopkinson KC, Dantrolene and 'ecstasy'
De Souza I, Kelly JP, Harkin AJ, Leonard BE, An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxymethamphetamine (MDMA) in the rat
de Groot MJ, Bijloo GJ, van Acker FA, Fonseca Guerra C, Snijders JG, Vermeulen NP, Extension of a predictive substrate model for human cytochrome P4502D6
de Boer D, Tan LP, Gorter P, van de Wal RM, Kettenes-van den Bosch JJ, de Bruijn EA, Maes RA, Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry
Davison D, Parrott AC, Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects
Curran HV, Travill RA, Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low
Dal Cason TA, Young R, Glennon RA, Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs
Cunningham M, Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure
Cooper AJ, Egleston CV, Accidental ingestion of Ecstasy by a toddler: unusual cause for convulsion in a febrile child
Crespi D, Mennini T, Gobbi M, Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine
Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR, A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy
Colado MI, O'Shea E, Granados R, Murray TK, Green AR, In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine
Clark AD, Butt N, Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant
Cohen RS, Cocores J, Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: 'Ecstasy')
Caan W, Bitter pill
Capurro A, Reyes-Paroda M, Olazabal D, Perrone R, Silveira R, Macadar O, Aggressive Behavior and Jamming Avoidance Response in Weakly Electric Fish Gymnotus carapo: Effects of Methylenedioxymethamphetamine (MDMA)
Brauer RB, Heidecke CD, Nathrath W, Beckurts KT, Vorwald P, Zilker TR, Schweigart U, Holscher AH, Siewert JR, Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy
Boys A, Lenton S, Norcross K, Polydrug use at raves by a Western Australian sample
Bogusz MJ, Kala M, Maier RD, Determination of phenylisothiocyanate derivatives of amphetamine and its analogues in biological fluids by HPLC-APCI-MS or DAD
Box SA, Prescott LF, Freestone S, Hyponatraemia at a rave
Baker LE, Taylor MM, Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination
Baker LE, Virden TB, Miller ME, Sullivan CL, Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA)
Aguirre N, Frechilla D, Garcia-Osta A, Lasheras B, Del Rio J, Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids
Vollenweider, F. X., Leenders, K. L., Scharfetter, C., et al, Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
M. GLASS, M. DRAGUNOW and R. L. M. FAULL, CANNABINOID RECEPTORS IN THE HUMAN BRAIN: A DETAILED ANATOMICAL AND QUANTITATIVE AUTORADIOGRAPHIC STUDY IN THE FETAL, NEONATAL AND ADULT HUMAN BRAIN
Vaidya, V. A., Marek, G. J., Aghajanian, G. K., et al, 5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex
Bakish, D., Cavazzoni, P., Chudzik, J., et al, Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
Brooks, S. A., Lachno, D. R., and Obermeyer, B. D., Automated high-performance liquid chromatographic method for the analysis of two novel ergoline compounds in human plasma.
Buckland, P. R., Marshall, R., Watkins, P., et al, Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels.
Eisner, B., Set, setting, and matrix
Poland, R. E., Lutchmansingh, P., McCracken, J. T., et al, Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA
Coccaro, E. F., Kavoussi, R. J., Sheline, Y. I., et al, Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding.
Musshoff, F. and Daldrup, T., Gas chromatographic /mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples.
Spigset, O. and Mjorndal, T., Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variability.
Gallily, R., Yamin, A., Waksmann, Y., et al, Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.
Ritter, D., Cortese, C. M., Edwards, L. C., et al, Interference with testing for lysergic acid diethylamide.
Spigset, O. and Mjorndal, T., Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
White, S. A., Catterick, T., Harrison, M. E., et al, Determination of lysergide in urine by high-performance liquid chromatography combined with electrospray ionisation mass spectrometry.
Yui, K., Ishiguro, T., Goto, K., et al, Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
Zacny, J. P., Conley, K., and Marks, S., Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Nalbuphine and Morphine in Healthy Volunteers.
Zacny, J. P., Conley, K., and Marks, S., Comparing the Subjective, Psychomotor and Physiological Effects of Intravenous Nalbuphine and Morphine in Healthy Volunteers.
Martellotta, M. C., Fattore, L., Cossu, G., et al, Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm.
Childers SR, Deadwyler SA, Role of cyclic AMP in the actions of cannabinoid receptors. [Review] [68 refs]
Kaminski NE, Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. [Review] [61 refs]
Poinot-Chazel C, Portier M, Bouaboula M, Vita N, Pecceu F, Gully D, Monroe JG, Maffrand JP, Le Fur G, Casellas P, Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24
Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P, Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression
Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P, Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A
Di Marzo V, De Petrocellis L, Sepe N, Buono A, Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells
Johnson DH Jr, Statement of the American Medical Association, AMA Urges Research on efficacy of Marijuana
Sugiura T. Kondo S. Sukagawa A. Tonegawa T. Nakane S. Yamashita A. Ishima Y, Waku K, Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine
Gerhard A. Wiesbeck, Marc A. Schuckit, Jelger A. Kalmijn, Jayson E. Tipp, Kathleen K. Bucholz, Tom L. Smith, An evaluation of the history of a marijuana withdrawal syndrome in a large population
Irma B. Adams, Billy R. Martin, Cannabis: pharmacology and toxicology in animals and humans
Abood ME, Martin BR, Molecular neurobiology of the cannabinoid receptor
J. H. Williams, N. A. Wellman, J. N. P. Rawlins, Cannabis use correlates with schizotypy in healthy people
Shen M, Piser TM, Seybold VS, Thayer SA, Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F, Increased activation of indirect semantic associations under psilocybin
Dennis J. McKenna, Plant hallucinogens: Springboards for psychotherapeutic drug discovery
J. C. Callaway, L. P. Raymon, W. L. Hearn, D. J. McKenna, C. S. Grob, G. S. Brito, D. C. Mash, Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with Ayahuasca
Wolff K, Hay AW, Vail A, Harrison K, Raistrick D, Non-prescribed drug use during methadone treatment by clinic- and community-based patients
Wickremasinghe M, Commentary. Ecstasy and crack cocaine
Wilkins B, Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake (response): Hyponatraemia must be treated with low water input
Winstock AR, King LA, Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy.
White SR, Obradovic T, Imel KM, Wheaton MJ, The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on monoaminergic neurotransmission in the central nervous system
Stell JM, Ryan JM, Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness
Sultana SR, Byrne DJ, 'Raver's' haematuria
Tucker G, Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, 'Eve') and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain
Webb E, Ashton CH, Kelly P, Kamali F, Alcohol and drug use in UK university students
Smit AA, Wieling W, Voogel AJ, Koster RW, van Zwieten PA, Orthostatic hypotension due to suppression of vasomotor outflow after amphetamine intoxication
Sprague JE, Johnson MP, Schmidt CJ, Nichols DE, Studies on the mechanism of p-chloroamphetamine neurotoxicity
Seymour HR, Gilman D, Quin JD, Severe ketoacidosis complicated by 'ecstasy' ingestion and prolonged exercise
Shewan D, Dalgarno P, Ecstasy and neurodegeneration. ...such as ketamine
Saunders N, Ecstasy and neurodegeneration. No Evidence of Neurotoxicity Exists
Seiden LS, Sabol KE, Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction
Rezvani K, Kurbaan AS, Brenton D, Ecstasy induced pneumomediastinum
Robson P, A guide to non-opiate illicit drugs
Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS, Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations
Pu C, Broening HW, Vorhees CV, Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex
Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA, Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation
Onwudike M, Ecstasy Induced Retropharyngeal Emphysema
Padich RA, McCloskey TC, Kehne JH, 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
Murray TK, Williams JL, Misra A, Colado MI, Green AR, The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine
Obradovic T, Imel KM, White SR, Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine
Milroy CM, Clark JC, Forrest AR, Pathology of deaths associated with 'ecstasy' and 'eve' misuse
Moore KA, Mozayani A, Fierro MF, Poklis A, Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning
Miller RT, Lau SS, Monks TJ, Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats
McCauley JC, Deaths attributed to an 'ecstasy' overdose
Merrill J, Ecstasy and neurodegeneration. Advice is that 'less is more'
Miller DB, O'Callaghan JP, Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system
Maurer HH, On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry
McCann UD, Slate SO, Ricaurte GA, Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy')
Matthai SM, Davidson DC, Sills JA, Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted intake of water [Authors' reply]
Matthai SM, Davidson DC, Sills JA, Alexandrou D, Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted intake of water
Malberg JE, Sabol KE, Seiden LS, Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat
Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE, Reinforcing effects of certain serotonin-releasing amphetamine derivatives
Lin LY, Fujimoto M, Distefano EW, Schmitz DA, Jayasinghe A, Cho AK, Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymethamphetamine
Kunsman GW, Levine B, Kuhlman JJ, Jones RL, Hughes RO, Fujiyama CI, Smith ML, MDA-MDMA concentrations in urine specimens
Lehane M, Rees C, When Ecstasy means agony
Lesch KP, Heils A, Riederer P, The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes
Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS, Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies
Kronstrand R, Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users
Kintz P, Tracqui A, Mangin P, Edel Y, Sweat testing in opioid users with a sweat patch
Kauert G, Rohrich J, Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers
Kehne JH, Padich RA, Ketteler, 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats
Kehne JH, Ketteler HJ, McCloskey TC, Sullivan CK, Dudley MW, Schmidt CJ, Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats
Henry JA, Ecstasy and serotonin depletion
Holden R, Jackson MA, Near-fatal hyponatraemic coma due to vasopressin over-secretion after 'ecstasy' (3,4-MDMA)
Jagust WJ, Eberling JL, Biegon A, Taylor SE, VanBrocklin HF, Jordan S, Hanrahan SM, Roberts JA, Brennan KM, Mathis CA, Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter
Hall AP, Lyburn ID, Spears FD, Riley B, An unusual case of Ecstasy poisoning
Helmlin HJ, Bracher K, Bourquin D, Vonlanthen D, Brenneisen R, Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS
Gudelsky GA, Nash JF, Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions
Gudelsky GA, Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin
Grob CS, Poland RE, Chang L, Ernst T, Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations
Green AR, Goodwin GM, Ecstasy and neurodegeneration
Gifford AN, Minabe Y, Toor A, Wang RY, Ashby CR Jr, Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons
Geyer MA, Serotonergic functions in arousal and motor activity
Frost M, Kohler H, Blaschke G, Analysis of 'Ecstasy' by capillary electrophoresis
Gartside SE, McQuade R, Sharp T, Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo
Finnegan KT, Taraska T, Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo
Finch E, Sell L, Arnold D, Drug workers emphasise that water is not an antidote to drug
Forsyth AJ, Places and patterns of drug use in the Scottish dance scene
Finch E, Sell L, Arnold D, Drug workers emphasise that water is not an antidote to drug
Fineschi V, Masti A, Fatal poisoning by MDMA (ecstasy) and MDEA: a case report
Fidler H, Dhillon A, Gertner D, Burroughs A, Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis
Fay J, Fogerson R, Schoendorfer D, Niedbala RS, Spiehler V, Detection of methamphetamine in sweat by EIA and GC-MS
Elk C, MDMA (Ecstacy): useful information for health professionals involved in drug education programs
Ellis AJ, Wendon JA, Portmann B, Williams R, Acute liver damage and ecstasy ingestion
Dulawa SC, Geyer MA, Psychopharmacology of prepulse inhibition in mice
Ensslin HK, Kovar KA, Maurer HH, Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, 'Eve') and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay
Day M, The bitterest pill
Demirkiran M, Jankovic J, Dean JM, Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome
Dowsett RP, Deaths attributed to 'ecstasy' overdose
Drake WM, Broadhurst PA, QT-interval prolongation with Ecstasy
Dar KJ, McBrien ME, MDMA induced hyperthermia: report of a fatality and review of current therapy
Cox DE, Williams KR, ADAM' or EVE'?--a toxicological conundrum
Crifasi J, Long C, Traffic fatality related to the use of methylenedioxymethamphetamine
Dallakian P, Budzikiewicz H, Brzezinka H, Detection and quantitation of amphetamine and methamphetamine: electron impact and chemical ionization with ammonia--comparative investigation on Shimadzu QP 5000 GC-MS system
Cook TM, Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake. Values for plasma osmolality may have been wrong
Cook TM, Cerebral oedema after MDMA ('ecstasy') and unrestricted water intake
Coore JR, A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity
Chu T, Kumagai Y, DiStefano EW, Cho AK, Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion
Cohen RS, Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; 'Ecstasy')
Centini F, Masti A, Barni Comparini I, Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS
Chenard-Neu MP, Boudjema K, Bernuau J, Degott C, Belghiti J, Cherqui D, Costes V, Domergue J, Durand F, Erhard J, De Hemptinne B, Gubernatis G, Hadengue A, Kemnitz J, McCarthy M, Maschek H, Mentha G, Oldhafer K, Portmann B, Praet M, Ringers J, Rogiers X,, Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study
Campbell DB, Extrapolation from animals to man: the integration of pharmacokinetics, and pharmacodynamics
Burns N, Olverman HJ, Kelly PA, Williams BC, Effects of ecstasy on aldosterone secretion in the rat in vivo and in vitro
Bodenham AR, Mallick A, New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives
Bronson ME, Wages TD, Beddingfield T, Horner JM, et al, Morphine, MDMA, MDA, and nexus produce a conditioned place preference in newly hatched chickens.
Bitsch A, Thiel A, Rieckmann P, Prange H, Acute inflammatory CNS disease after MDMA ('ecstasy')
Bakir AA, Dunea G, Drugs of abuse and renal disease
Baker LE, Makhay MM, Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats
Abraham, H. D., Aldridge, A. M., and Gogia, P, The psychopharmacology of hallucinogens
Strassman, R. J., Human psychopharmacology of N,N-dimethyltryptamine.
Strassman, R. J., Qualls, C. R., and Berg, L. M., Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
McKenna, D. J., Plant hallucinogens: springboards for psychotherapeutic drug discovery
Bonson, K. R., Buckholtz, J. W., and Murphy, D. L., Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans.
Fekkes, D., Bode, W. T., Zijlstra, F. J., et al, ) Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms.
Francis, J. M. and Craston, D. H., Development of a Stand-alone Affinity Clean-up for Lysergic Acid Diethylamide in Urine
Newton, R. A., Phipps, S. L., Flanigan, T. P., et al, Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Nichols, D. E., Monte, A., Huang, X., et al, Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.
Shen, M., Piser, T. M., Seybold, V. S., et al, Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures.
Mackie K., Lai Y., Westenbroek R., Mitchell R, Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor
Zuardi AW, Morais SL, Guimaraes FS, Mechoulam R, Antipsychotic effect of cannabidiol [letter]
Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P, Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells
Welch SP, Thomas C. Patrick GS, Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine
Henry DJ, Chavkin C, Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.
Fan P, Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons
Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P, Cannabinoids enhance human B-cell growth at low nanomolar concentrations
Associated Press, Newark, NJ, Feds bust family drug ring in Bucks County
Facci L. Dal Toso R. Romanello S. Buriani A. Skaper SD. Leon A, Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
Allyn C. Howlett, Pharmacology of Cannabinoid Receptors
Ludmila Belayev, MD; Raul Busto, BS; Weizhao Zhao, PhD; Myron D. Ginsberg, MD, HU-211, a Novel Noncompetitive N-Methyl-D-Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat
Michael Fendrich, Mary Ellen Mackesy-Amiti, Inconsistencies in lifetime cocaine and marijuana use reports: impact on prevalence and incidence
Heinrich, Clark, Strange Fruit: Alchemy, Religion and Magical Foods
Yensen, Richard; Dryer, Donna, Thirty Years of Psychedelic Research: The Spring Grove Experiment and its Sequels.
Sanchez-Ramos, J. R.; Mash, D., Pharmacotherapy of Drug-Dependence with Ibogaine.
Grof, S., Implications of Holotropic Consciousness Research for Psychiatry: Observations from Psychedelic Therapy and Holotropic Breathwork.
Passie, Torsten, Die Psycholyse in den skandinavischen Ländern. Ein historischer Überblick. [Psycholytic Therapy in the Scandinavian Countries. A Historical Review.]
Gasser, P., Die psycholytische Psychotherapie in der Schweiz (1988-1993). Eine katamnestische Erhebung. [Psycholytic Psychotherapy in Switzerland (1988-1993). A Catamnestic Evaluation.]
Bolle, Ralf H., Von der Sucht zur heilenden archetypischen Erfahrung. [From Addiction to HeaLing Archetypical Experiences.]
Yensen, Richard, From Shamans and Mystics to Scientists and Psychotherapists: Interdisciplinary Perspectives on the Interaction of Psychedelic Drugs and Human Consciousness
Snelders, Stephen, The Use of Psychedelics in Dutch Psychiatry 1950-1970: The Problem of Continuity and Discontinuity.
Passie, Torsten, Psilocybin in der modernen Psychotherapie. [Psilocybin in Modern Psychotherapy.]
Grob, C.; Bravo, G. L., Human Research with Hallucinogens: Past Lessons and Current Trends.
Russel B R, Beresford R A, Schmierer D M, McNaughton N, Clark C R, Stimulus properties of some analogs of 4-methylaminorex
Strassman RJ, Hallucinogenic drugs in psychiatric research and treatment: Perspectives and prospects
Pate David W Guide to the scientific literature on potential medical uses of Cannabis and the cannabinoids,
Goldsmith N, The use of hallucinogens with the dying
Yamamoto BK, Nash JF, Gudelsky GA, Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra
Wichems CH, Hollingsworth CK, Bennett BA, Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release
Wolff K, Hay AW, Sherlock K, Conner M, Contents of 'ecstasy'
Woodrow G, Harnden P, Turney JH, Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ('ecstasy')
Wright JD, Pearl L, Knowledge and experience of young people regarding drug misuse, 1969-94 [published erratum appears in BMJ 1995 Jan 21;310(6973):164]
White SR, Harris GC, Imel KM, Wheaton MJ, Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enhanced following cocaine self-administration
Wall SC, Gu H, Rudnick G, Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux
Sprague JE, Nichols DE, Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum
Wake D, Ecstasy overdose: a case study
Squier MV, Jalloh S, Hilton-Jones D, Series H, Death after ecstasy ingestion: neuropathological findings
Selmi F, Davies KG, Sharma RR, Neal JW, Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations
Shulgin A, The new psychotherapy: MDMA and the shadow
Slikker W Jr, Gaylor DW, Biologically based dose-response model for neurotoxicity risk assessment
Sprague JE, Nichols DE, The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits
Sabol KE, Richards JB, Layton K, Seiden LS, Amphetamine analogs have differential effects on DRL 36-s schedule performance
Priori A, Bertolasi L, Berardelli A, Manfredi M, Acute dystonic reaction to ecstasy
Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA, Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation
Premkumar LS, Ahern GP, Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus
Poblete JC, Azmitia EC, Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor
Miller RT, Serrine SL, Monks TJ, Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracerebroventricular Administration to Male Sprague-Dawley Rats
Meehan SM, Gordon TL, Schechter MD, MDMA (Ecstasy) substitutes for the ethanol discriminative cue in HAD but not LAD rats
Miller DB, O'Callaghan JP, The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine
McCann UD, Ricaurte GA, On the neurotoxicity of MDMA and related amphetamine derivatives [letter]
McNamara MG, Kelly JP, Leonard BE, Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats
Lehmann ED, Thom CH, Croft DN, Delayed severe rhabdomyolysis after taking 'ecstasy'
Lewis LA, Ross MW, The gay dance party culture in Sydney: a qualitative analysis
Kramer HK, Poblete JC, Azmitia EC, 3,4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals
Khakoo SI, Coles CJ, Armstrong JS, Barry RE, Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ('ecstasy') usage
Kintz P, Cirimele V, Tracqui A, Mangin P, Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry
House RV, Thomas PT, Bhargava HN, Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy)
Heller A, Won L, Heller B, Hoffmann PC, Examination of developmental neurotoxicity by the use of tissue culture model systems
Hiratsuka A, Chu TY, Distefano EW, Lin LY, Schmitz DA, Cho AK, Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat
Hegadoren KM, Martin-Iverson MT, Baker GB, Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine
Hardern R, Tehan B, Ecstasy toxicity
Hegadoren KM, Baker GB, Coutts RT, Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, 'Eve') and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain
Galloway G, Shulgin AT, Kornfeld H, Frederick SL, Amphetamine, not MDMA, is associated with intracranial hemorrhage
Hanyu S, Ikeguchi K, Imai H, Imai N, Yoshida M, Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse
Green AR, Cross AJ, Goodwin GM, Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy')
Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, Paule MG, Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys
Frederick DL, Ali SF, Slikker W Jr, Gillam MP, Allen RR, Paule MG, Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys
Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte GA, Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
Dyzkuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC, Ecstasy induced hepatitis mimicking viral hepatitis
Farfel GM, Seiden LS, Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX
Dafters RI, Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing
Cook A, Ecstasy (MDMA): alerting users to the dangers
Colado MI, Williams JL, Green AR, The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype
Cohen RS, Subjective reports on the effects of the MDMA ('ecstasy') experience in humans
Colado MI, Green AR, The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones
Cirimele V, Kintz P, Mangin P, Detection of amphetamines in fingernails: an alternative to hair analysis
Cerruti C, Sheng P, Ladenheim B, Epstein CJ, Cadet JL, Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro
Che S, Johnson M, Hanson GR, Gibb JW, Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity
Bryden AA, Rothwell PJ, O'Reilly PH, Urinary retention with misuse of 'ecstasy'
Cadet JL, Ladenheim B, Hirata H, Rothman RB, Ali S, Carlson E, Epstein C, Moran TH, Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice
Campbell DB, The use of toxicokinetics for the safety assessment of drugs acting in the brain
Barrett RL, Wiley JL, Balster RL, Martin BR, Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats
Brown ER, Jarvie DR, Simpson D, Use of drugs at 'raves'
Broening HW, Bowyer JF, Slikker W Jr, Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response
Aguirre N, Galbete JL, Lasheras B, Del Rio J, Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats
Kenakin, T., Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
Hajicek-Dobberstein, S., Soma siddhas and alchemical enlightenment: psychedelic mushrooms in Buddhist tradition.
Hrdina, P. D., Bakish, D., Chudzik, J., et al, Serotonergic Markers in Platelets of Patients with Major Depression: Upregulation of 5-HT2 Receptors
Lew, G. M., D-Lysergic Acid Reduces Microtubule-Associated Tau Protein in SH-SY5Y Human Neuroblastoma Cells
Sheline, Y. I., Black, K. J., Bardgett, M. E., et al, Platelet binding characteristics distinguish placebo responders from nonresponders in depression.
Wright, J. D. and Pearl, L., Knowledge and experience of young people regarding drug misuse, 1969-94.
Kaminski NE, Koh WS, Yang KH, Lee M. Kessler, Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism
Taylor J M, MDMA Frequently Asked Questions List.
Argos E, Castello L, El MDMA es Valioso en Medicina
del Arco M A, La Batalla del Extasis: Su Inventor Convencio al Juez de Que es una Droga Blanda
Devane WA, A New dawn of cannabinoid pharmacology
Dreher MC, Nugent K, Hudgins R, Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study
Harris L S, Woolverton W L, Massey B W, Evaluation of the abuse liability of aminorex
Schuckit M A, MDMA (Ecstasy): An Old Drug with New Tricks.
Schwarz H et.al, Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis
Grof, Stanislav, List of Publications.
Yensen, Richard; Dryer, Donna, Dreißig Jahre psychedelische Forschung: Das Spring Grove Experiment und seine Folgen. [Thirty Years of Psychedelic Research: The Spring Grove Experiment and its Sequels.]
Grof, Stanislav, Das Heilungspotential außergewöhnlicher Bewußtseinszustände. Beobachtungen aus der psychedelischen und holotropen Therapie. [The HeaLing Potential of Non-Ordinary States of Consciousness. Observations from Psychedelic and Holotropic Therapy.]
Widmer, P. Samuel, Das Problem der Verantwortung des Therapeuten und der Selbstverantwortung des Klienten bei der psycholytischen Arbeit. [The Problem of the Responsibility of the Therapist and the Self-Responsibility of the Client in Psycholytic Work.]
Styk, Juraj, Rückblick auf die letzten sieben Jahre der Schweizerischen Ärztegesellschaft für Psycholytische Therapie (SÄPT). [Review of the Last Seven Years of the Swiss Physicans Society for Psycholytic Therapy (SÄPT) .]
Saunders, Nicholas; Walder, Patrick, Psychotherapie mit Ecstasy. [Psychotherapy with Ecstasy.]
Bolle, Ralf H., Übertragung und Gegenübertragung in der psycholytischen Therapie. [Transference and Countertransference in Psycholytic Therapy.]
Yensen, Richard, Perspectives on LSD and Psychotherapy: The Search for a New Paradigm.
Trebes, Stefan; Saum-Aldehoff, Thomas, Psychotherapie mit einer Modedroge? [Psychotherapy with a Fashion Drug?]
Richter, R., Psychotherapeutic Effects.
O'Brien, C. P.; Jones, R. T., Methodological Issues in the Evaluation of a Medication for its Potential Benefits in Enhancing Psychotherapy.
Leuner, Hanscarl, Hallucinogens as an Aid in Psychotherapy: Basic Principles and Results.
Lader, M., Pharmacological Standards for Evaluation of Clinical Effects of Hallucinogens.
Ladewig, Dieter, Conclusions, with Special Regard to Clinical Aspects.
Grob, C., Psychiatric Research with Hallucinogens: What have we learned?
Strassman RJ, Qualls CR, Dose-response study of N,N-dimethyltryptamine in humans I: Neuroendocrine, autonomic, and cardiovascular effects
Strassman RJ, Qualls CR, Uhlenhuth EH, et al, Dose-response study of N,N-dimethyltryptamine in humans. II: Subjective effects and preliminary results of a new rating scale
Strassman RJ, Human psychopharmacology of LSD, DMT and related compounds, Pletscher A (ed)
Strassman RJ, Human psychopharmacology of n,n-dimethyltryptamine
Strassman RJ, Human hallucinogenic drug research: Regulatory, clinical and scientific issues, Lin GC, Glennon RA (eds)
Riedlinger T J, Riedlinger J E, Psychedelic and Entactogenic Drugs in the Treatment of Depression.
Beck J, Rosenbaum M, "Pursuit of Ecstasy: The MDMA Experience."
Schmidt C J, Sullivan C K, Fadayel G M, Blockade of Striatal 5-Hydroxytryptamine(2) Receptors Reduces the Increase in Extracellular Concentrations of Dopamine Produced by the Amphetamine Analogue 3,4-Methylenedioxymethamphetamine.
Romano A G, Harvey J A, MDMA Enhances Associative and Nonassociative Learning in the Rabbit.
Lee J W Y, Catatonic Stupor After Ecstasy.
McCann U D, Ridenour A, Shaham Y, Ricaurte G A, Serotonin Neurotoxicity After (+/-)3,4-Methylenedioxymethamphetamine (MDMA; "Ecstasy"): A Controlled Study in Humans.
Hastings A, Some Observations on MDMA Experiences Induced Through Posthypnotic Suggestion.
Guimares F S, et al., Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
X Huang, D Marona-Lewicka, RC Pfaff, DE Nichols, Drug Discrimination and Receptor Binding Studies of N-isopropyl Lysergamide Derivatives
MH Lewis, JL Gariepy, P Gendreau, DE Nichols, RB Mailman, Social Reactivity and D1 Dopamine Receptors: Studies in Mice Selectively Bred for High and Low Levels of Aggression
NIDA, CPDD-0039: Aminorex HCL
RBI, Inc., #A170: Aminorex; anorectic; 50mg at $20; 250 mg at $70
Batsche K, Ashby C R, Lee C, Schwartz J, Wang R Y, The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat
Lyttle, Tom, Further comments on U4Euh with more recent addenda
Wotherspoon G, Savery D, Priestley JV, Rattray M, Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra
Yau JL, Kelly PA, Sharkey J, Seckl JR, Chronic 3,4-methylenedioxymethamphetamine administration decreases glucocorticoid and mineralocorticoid receptor, but increases 5-hydroxytryptamine1C receptor gene expression in the rat hippocampus
White SR, Duffy P, Kalivas PW, Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo
Ward C, McNally AJ, Rusyniak D, Salamone SJ, 125I radioimmunoassay for the dual detection of amphetamine and methamphetamine
Walsh T, Carmichael R, Chestnut J, A hyperthermic reaction to 'ecstasy'
Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TY, The demethylenation of methylenedioxymethamphetamine ('ecstasy') by debrisoquine hydroxylase (CYP2D6)
Thompson WC, Dasgupta A, Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays
Sprague JE, Huang X, Kanthasamy A, Nichols DE, Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan
Steele TD, McCann UD, Ricaurte GA, 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans
Snape MF, Colado MI, et al, Chlormethiazole and dizocilpine block the behavioural, but not the neurotoxic effects of 5,7-dihydroxytryptamine in mice
Series HG, Cowen PJ, Sharp T, p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo
Series H, Boeles S, et al, Psychiatric complications of 'Ecstasy' use
Schmidt CJ, Sullivan CK, Fadayel GM, Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
Schifano F, Magni G, MDMA ('ecstasy') abuse: psychopathological features and craving for chocolate: a case series
Padkin A, Treating MDMA ('Ecstasy') toxicity
Poole RG, Brabbins CJ, Psychopathology and 'ecstasy'
Romano AG, Harvey JA, MDMA enhances associative and nonassociative learning in the rabbit
Satchell SC, Connaughton M, Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion
Scheffel U, Dannals RF, Suehiro M, Ricaurte GA, Carroll FI, Kuhar MJ, Wagner HN Jr, Development of PET/SPECT ligands for the serotonin transporter
Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA, Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors
Millman RB, Beeder AB, The new psychedelic culture: LSD, ecstasy, 'rave' parties and the Grateful Dead
O'Callaghan JP, Miller DB, Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse
Miller DB, O'Callaghan JP, Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
McGuire PK, Cope H, Fahy TA, Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')
McCoy EP, Renfrew C, Johnston JR, Lavery G, Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser
McDowell DM, Kleber HD, MDMA: Its history and pharmacology
Miczek KA, Haney M, Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice
McCann UD, Ridenour A, Shaham Y, Ricaurte GA, Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'): a controlled study in humans
Marsh JCW, Abboudi ZH, Gibson FM, Scopes J, Daly S, O'Shaunnessy DF, Baughan ASJ, Gordon-Smith EC, Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy')
Marona-Lewicka D, Nichols DE, Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan
Lin HQ, McGregor IS, Atrens DM, Christie MJ, Jackson DM, Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions
Kelly PA, Ritchie IM, Sangra M, Cursham MJA, Dickson EM, Kelly B, Neilson FP, Reidy MJ, Stevens MC, Hyperaemia in rat neocortex produced by acute exposure to methylenedioxymethamphetamine
Kessel B, Hyponatraemia after ingestion of ecstasy
Kramer K, Azmitia EC, Whitaker-Azmitia PM, In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse
Lee JW, Catatonic stupor after 'ecstasy'
Leonardi ETK, Azmitia EC, MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac)
Hooft PJ, van de Voorde HP, Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): apropos of a fatal accident during car-surfing
Gudelsky GA, Yamamoto BK, Nash FJ, Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists
Hastings A, Some observations on MDMA experiences induced through posthypnotic suggestion
Hewitt KE, Green AR, Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats
Gordon CJ, Fogelson L, Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies
George S, Braithwaite RA, Drugs of abuse screening in the West Midlands: a 6 year retrospective survey of results
Forrest ARW, Galloway JH, Marsh ID, Strachan GA, Clark JC, A fatal overdose with 3,4-methylenedioxyamphetamine derivatives
Fitzgerald JL, Reid JJ, Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Rabbit Isolated Cardiovascular Tissues
Dafters RI, Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in rats
Cuomo MJ, Dyment PG, Gammino VM, Increasing Use of 'Ecstasy' (MDMA) and Other Hallucinogens on a College Campus
Connor B, Hazards associated with the recreational drug 'ecstasy'
Colado MI, Green AR, A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds
Bronson ME, Jiang W, Clark CR, DeRuiter J, Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken
Cassidy G, Ballard CG, Psychiatric sequelae of MDMA (ecstasy) and related drugs
Bronson ME, Barrios-Zambrano L, Jiang W, Clark CR, DeRuiter J, Newland MC, Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives
Cadet JL, Ladenheim B, Baum I, Carlson E, Epstein C, CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)
Axt KJ, Mamounas LA, Molliver ME, Structural Features of Amphetamine Neurotoxicity in the Brain. Amphetamine and its analogs: psychopharmacology, toxicology, and abuse
Beck JR, M, In Pursuit of Ecstasy: The MDMA Experience
Broening HW, Bacon L, Slikker W Jr, Age Modulates the Long-Term but not the Acute Effects of the Serotonergic Neurotoxicant 3,4-Methylenedioxymethamphetamine
Hastings, A., Some observations on MDMA experiences induced through posthypnotic suggestion.
Saez, P., Borges, Y., Gonzalez, E., et al, Alpha-adrenergic and 5-HT2-serotonergic effects of some beta-phenylethylamines on isolated rat thoracic aorta.
Krupitsky, Evgeny, Ketamine Psychedelic Therapy (KPT) of Alcoholism and Neurosis.
Yensen, Richard; Dryer, Donna, Thirty Years of Psychedelic Research: The Spring Grove Experiment and its Sequels.
Widmer, Samuel, Kombinationspräparate in der psycholytischen Psychotherapie und Einsatz verschiedener Psycholytika bei verschiedenen Personen in derselben Gruppensitzunmg: Sinnvolle Therapie oder verantwortungsloses Handeln? [Combined Substances in Psycholytic Psychotherapy and Application of Different Substances in Different Persons in the Same Group Session: Pithy Therapy or Responseless Action?.]
Trebes, Stefan, Psychedelische Heilbehandlungen im Kulturvergleich. [Psychedelic Treatments in Transcultural Perspective.]
Conner M, Sherlock K, Attitudes and Ecstasy Use. Paper presented at the European Association of
Helmlin H-J, Bracher K, Salamone S J, Brenneisen R, Analysis of 3,4-Methylenedioxymethamphetamine (MDMA) and its Metabolites in Human Plasma and Urine by HPLC-DAD, GC-MS and Abuscreen-Online.
Fride E. Mechoulam, Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Zhu W, Igarashi T, Qi ZT, Newton C, Widen RE, Friedman H, Klein TW, delta-9-Tetrahydrocannabinol (THC) decreases the number of high and intermediate affinity IL-2 receptors of the IL-2 dependent cell line NKB61A2
Hermle L, Spitzer M, Borchardt D, Kovar KA, Gouzoulis E, Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?
Gouzoulis E, Borchardt D, Hermle L, A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine)
Gouzoulis E, von Bardeleben U, Rupp A, Kovar KA, Hermle L, Neuroendocrine and cardiovascular effects of MDE in healthy volunteers
Yensen, Richard, Towards a Psychedelic Medicine.
Saunders, Nicholas, Psychotherapeutic Use in Switzerland.
Grof, Stanislav, Implications of Consciousness Research for Psychotherapy and Self-Exploration.
Goutarel, Robert; Gollnhofer, Otto; Sillans, Roger, Pharmacodynamics and Therapeutic Applications of Iboga and Ibogaine.
Saunders N, "E for Ecstasy"
Saunders N, MDMA - The View from England.
Newmeyer J A, X at the Crossroads.
Fitzgerald J, MDMA and Harm.
Scanzello C R, Hatzidimitriou G, Martello A L, Katz J L, Ricaurte G A, Serotonergic Recovery after (+/-)3,4-(Methylenedioxy)methamphetamine Injury: Observations in Rats.
LeSage M, Clark R, Poling A, MDMA and Memory: The Acute and Chronic Effects of MDMA in Pigeons Performing under a Delayed-matching-to-sample Procedure.
Krebs K M, Geyer M A, Behavioral Characterization of Alpha-Ethyltryptamine, a Tryptamine Derivative with MDMA-like Properties in Rats.
Jensen K F, Olin J, Haykal-Coates N, O'Callaghan J, Miller D B, de Olmos J S, Mapping Toxicant-Induced Nervous System Damage With Cupric Silver Stain: A Quantitative Analysis of Neural Degeneration Induced by 3,4-Methylenedioxymethamphetamine.
Huang X, Nichols D, 5-HT2 Receptor-Mediated Potentiation of Dopamine Synthesis and Central Serotonergic Deficits.
Hegadoren K M, Baker G B, Coutts R T, The Simultaneous Separation and Quantitation of the Enantiomers of MDMA and MDA using Gas Chromatography with Nitrogen-Phbosphorus Detection.
Hashimoto K, Effects of Benzylpiperazine Derivatives on the Acute Effects of 3,4-Methylenedioxymethamphetamine in Rat Brain.
Hashimoto K, Maeda H, Hirai K, Goromaru T, Drug Effects on Distribution of [3H]3,4-Methylenedioxymethamphetamine in Mice. Eur. J.
Glennon R A, MDMA-Like Stimulus Effects of Alpha-Ethyltryptamine and the Alpha-Ethyl Homolog of DOM.
Finnegan K T, Calder L, Clikeman J, Wei S, Karler R, Effects of L-type Calcium Channel Antagonists on the Serotonin-depleting Actions of MDMA in Rats.
Gibb J W, Johnson M, Stone D M, Hanson G R, Mechanisms Mediating Biogenic Amine Deficits Induced by Amphetamine and its Congeners.
Cho A K, Hiramatsu M, Kumagal Y, Patel N, Pharmacokinetic Approaches to the Study of Drug Action and Toxicity. Ed. Linda Erinoff
Brodkin J, Malyala A, Nash J F, Effect of Acute Monamine Depletion on 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity.
Ricaurte G A, Markowska A L, Wenk G L, Hatzidimitriou G, Wlos J, Olton D S, 3,4-Methylenedioxymethamphetamine, Serotonin, and Memory.
Robinson T E, Castaneda E, Whishaw I Q, Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade.
Schuldiner S, Steiner-Mordoch S, Yelin R, Wall S C, Rudnick G, Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters.
Rempel N L, Callaway C W, Geyer M A, Serotonin-1B Receptor Activation Mimics Behavioral Effects of Presynaptic Serotonin Release.
Wodarz N, Buning J, "Ecstasy" - Induziertes Psychotisches Depersonalisationssyndrom.
Williams H, Meagher D, Galligan P, M.D.M.A. ("Ecstasy"); a Case of Possible Drug-induced Psychosis.
Stone R J, Response to the paper of Singarah and Laviec.
Tehan B, Ecstasy and Dantrolene.
O'Neill D, Dart J K, Methylenedioxyamphetamine (Ecstasy) Associated Keratopathy.
Hughes J C, McCabe M, Evans R J, Intracranial Haemorrhage Associated with Ingestion of 'Ecstasy.'
Keenan E, Gervin M, Dorman A, O'Connor J J, Psychosis and Recreational Use of MDMA ("Ecstasy").
McCann U D, Ricaurte G A, Reinforcing Subjective Effects of (+/-) 3,4-Methylenedioxymethamphetamine ("Ecstasy") May Be Separable from its Neurotoxic Actions: Clinical Evidence.
Bohn M, Bohn G, Blaschke G, Synthesis Markers in Illegally Manufactured 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine.
Elayan I, Gibb J W, Hanson G R, Lim H K, Foltz R L, Johnson M, Short-term Effects of 2,4,5-Trihydroxyamphetamine, 2,4,5-Trihydroxymethamphetamine and 3,4-Dihydroxymethamphetamine on Central Tryptophan Hydroxylase Acticity.
de Man R A, Wilson J H, Tjen H S, Acute Liver Failure Caused by Methylenedioxymethamphetamine ("Ecstasy").
Friedman R, Ecstasy, the Serotonin Syndrome, and Neuroleptic Malignant Syndrome - A Possible Link. Reply.
Gledhill J A, Moore D F, Bell D, Henry J A, Subarachnoid Haemorrage Associated with MDMA Abuse.
Barrett P J, 'Ecstasy' misuse - Overdose or Normal Dose?
Campkin N T A, Davies U M, Treatment of 'Ecstasy' Overdose with Dandrolene.
Cregg M T, Tracey J A, Ecstasy Abuse in Ireland
Verweij A M A, Sprong A G A, A Note About some Impurities in Commercially Available Piperonylmethylketone.
Allen R P, McCann U D, Ricaurte G A, Persistant Effects of (+/-)3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") on Human Sleep.
Ames D, Wirshing W C, Ecstasy, the Serotonin Syndrome, and Neuroleptic Malignant Syndrome - A Possible Link.
Tedeschi L, Frison G, Castagna F, Giorgetti R, Ferrara S D, Simultaneous Identification of Amphetamine and its Derivatives in Urine Using HPLC-UV.
Renton R J, Cowie J S, Oon M C, A Study of the Precursors, Intermediates and Reaction By-Products on the Synthesis of 3,4-Methylenedioxymethylamphetamine and its Application to Forensic Drug Analysis.
Poklis A, Fitzgerald R L, Hall K V, Saady J J Emit-d.a.u., Monoclonal Amphetamine / Methamphetamine Assay. II. Detection of Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA).
Lim H K, Su Z, Foltz R L, Stereoselective Disposition: Enantioselective Quantitation of 3,4-(Methylenedioxy)Methamphetamine and Three of its Metabolites by Gas Chromatography/Electron Capture Negative Ion Chemical Ionization Mass Spectrometry.
Michel R E, Rege A B, George W J, High-Pressure Liquid Chromatography / Electrochemical Detection Method for Monitoring MDA and MDMA in Whole Blood and Other Biological Tissues.
Cody J T, Schwartzhoff R, Fluorescence Polarizatrion Immunoassay Detection of Amphetamine, Methamphetamine, and Illicit Amphetamine Analogues.
Clark C R, Valaer A K, DeRuiter J, Noggle F T, Synthesis, Stability and Analytical Profiles of 3,4-Methylenedioxyamphetamines: Derivatives of "Ecstasy" (MDMA).
Hemming M, Yellowle P M, Effective treatment of Tourette's-Syndrome with marijuana
Zuardi A W, et al., Effects of ipsapirone and cannabidiol on human experimental anxiety
AP Monte, D Marona-Lewicka, NV Cozzi, DE Nichols, Synthesis and Pharmacological Examination of Benzofuran, Indan, and Tetralin Analogues of 3,4-(Methylenedioxy)amphetamine (MDA)
VJ Watts, CP Lawler, JH Gilmore, SB Southerland, DE Nichols, RB Mailman, Dopamine D1 Receptors: Efficacy of Full (Dihydrexidine) vs. Partial (SKF38393) Agonists in Primates vs. Rodents
VJ Watts, CP Lawler, T Knoerzer, MA Mayleben, KA Neve, DE Nichols, RB Mailman, Hexahydrobenzo[a]phenanthridines: Ligands With High Affinity and Selectivity for D3 Dopamine Receptors
X Huang, DE Nichols, 5-HT2 Receptor-Mediated Potentiation of Dopamine Synthesis and Central Serotonergic Deficits
CW Callaway, LL Wing, DE Nichols, MA Geyer, Suppression of Behavioral Activity by Norfenfluramine and Related Drugs is Not Mediated by Serotonin Release
JD Kohli, PT Horn, D Glock, WK Brewster, DE Nichols, Dihydrexidine: A New Potent DA1 (Vascular) Dopamine Agonist
Young R, Glennon R A, Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex
Wodarz N, 'Ecstasy'-induced psychotic depersonalization syndrome
Williams H, Meagher D, Galligan P, M.D.M.A. ('Ecstasy'); a Case of Possible Drug-Induced Psychosis
Webb C, Williams V, Ecstasy intoxication: appreciation of complications and the role of dantrolene
Tirzite D, Tirzitis G, Vigante B, Duburs G, Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentrations and on the increase in stritatal neurotensin and dynorphin A concentrations
Watson JD, Ferguson C, Hinds CJ, Skinner R, Coakley JH, Exertional heat stroke induced by amphetamine analogues: Does dantrolene have a place?
Tehan B, Ecstasy and dantrolene
Tehan B, Hardern R, Bodenham A, Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve')
Tedeschi L, Frison G, Castagna F, Giorgetti R, Ferrara SD, Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV
Stone RJ, Treatment of 'ecstasy' overdose with dantrolene
Shiue CY, Shiue GG, Rysavy JA, Pleus RC, Huang H, Bai LQ, Cornish KG, Sunderland JJ, Frick MP, Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey
Stolaroff MJ, Wells CW, Preliminary Results with New Psychoactive Agents 2C-T-2 AND 2C-T-7
Seiden LS, Woolverton WL, Lorens SA, Williams JEG, Corwin RL, Hata N, Olimski M, Behavioral consequences of partial monoamine depletion in the CNS after methamphetamine-like drugs: the conflict between pharmacology and toxicology
Schwartz RH, Point-counterpoint. A reader writes: speed, ice, and ecstasy
Schuldiner S, Steiner-Mordoch S, Yelin R, Wall SC, Rudnick G, Amphetamine Derivatives Interact with Both Plasma Membrane and Secretory Vesicle Biogenic Amine Transporters
Schmidt CJ, Kehne JH, Carr AA, Fadayel GM, Humphreys TM, Kettler HJ, McCloskey TC, Padich RA, Taylor VL, Sorensen SM, Contribution of serotonin neurotoxins to understanding psychiatric disorders: The role of 5-HT-sub-2 receptors in schizophrenia and antipsychotic activity
Schechter MD, Gordon TL, Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity
Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA, Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats
Rudnick G, Wall SC, Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serotonin Transporters
Rothwell PM, Grant R, Cerebral venous sinus thrombosis induced by 'ecstasy'
Robinson TE, Castaneda E, Whishaw IQ, Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade
Roberts L, Wright H, Survival following intentional massive overdose of 'Ecstasy'
Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS, 3,4-Methylenedioxymethamphetamine, serotonin and memory [published erratum appears in J Pharmacol Exp Ther 1994 Jan;268(1):529]
Rempel NL, Callaway CW, Geyer MA, Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release
Renton RJ, Cowie JS, Oon MCH, A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis
Poklis A, Fitzgerald RL, Hall KV, Saady JJ, EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA)
Palfreyman MG, Schmidt CJ, Sorensen SM, Dudley MW, Kehne JH, Moser P, Gittos MW, Carr AA, Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function
No Author., Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?
O'Callaghan JP, Miller DB, Quantification of reactive gliosis as an approach to neurotoxicity assessment
Michel RE, Rege AB, George WJ, High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues
O'Neill D, Dart JK, Methylenedioxyamphetamine ('Ecstasy') associated keratopathy
Miller DB, O'Callaghan JP, The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection
McCann UD, Ricaurte GA, Strategies for detecting subclinical monoamine depletions in humans
McCann UD, Ricaurte GA, Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ('ecstasy') may be separable from its neurotoxic actions: clinical evidence
Maxwell DL, Polkey MI, Henry JA, Hyponatraemia and catatonic stupor after taking 'ecstasy'
Lin HQ, Atrens DM, Christie MJ, Jackson DM, McGregor IS, Comparison of conditioned taste aversions produced by MDMA and d-amphetamine
Logan AS, Stickle B, O'Keefe N, Hewitson H, Survival following 'Ecstasy' ingestion with a peak temperature of 42 degrees C
Manchanda S, Connolly MJ, Cerebral infarction in association with Ecstasy abuse
Levine AJ, Drew S, Rees GM, 'Ecstasy' induced pneumomediastinum
Lim HK, Su Z, Foltz RL, Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry
Larner AJ, Dantrolene and 'ecstasy' overdose
LeSage M, Clark R, Poling A, MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure
Keenan E, Gervin M, Dorman A, O'Connor JJ, Psychosis and recreational use of MDMA ('Ecstasy')
Krebs KM, Geyer MA, Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats
Johnson M, Bush LG, Hanson GR, Gibb JW, Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations
Hughes JC, McCabe M, Evans RJ, Intracranial haemorrhage associated with ingestion of 'ecstasy'
Ijzermans JN, Tilanus HW, De Man RA, Metselaar HJ, 'Ecstasy' and liver transplantation
Jensen KF, Olin J, Haykal-Coates N, O'Callaghan J, Miller DB, Olmos JS, Mapping toxicant-induced nervous system damage with a cupric silver stain: a quantitative analysis of neural degeneration induced by 3,4-methylenedioxymethamphetamine
Hornbeck CL, Czarny RJ, Retrospective analysis of some L-methamphetamine/L-amphetamine urine data
Huang X, Nichols DE, 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits
Hashimoto K, Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain
Hashimoto K, Maeda H, Hirai K, Goromaru T, Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine in mice
Hermle L, Spitzer M, Borchardt D, Kovar KA, Gouzoulis E, Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?
Harvey JA, McMaster SE, Romano AG, Methylenedioxyamphetamine: Neurotoxic effects on serotonergic projections to brainstem nuclei in the rat
Gu XF, Azmitia EC, Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons
Gledhill JA, Moore DF, Bell D, Henry JA, Subarachnoid haemorrhage associated with MDMA abuse [letter]
Glennon RA, MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM
Fitzgerald JL, Reid JJ, Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices
Elayan I, Gibb JW, Hanson GR, Lim HK, Foltz RL, Johnson M, Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity
Finnegan KT, Calder L, Clikeman J, Wei S, Karler R, Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats
Cregg MT, Tracey JA, Ecstasy abuse in Ireland
Duxbury AJ, Ecstasy--dental implications
Cardier MA, Clarke JA, Ecstasy and Whizz at a rave resulting in a major burn plus complications
Colado MI, Murray TK, Green AR, 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine
Cody JT, Schwarzhoff R, Fluorescence polarization immunoassay detection of amphetamine, methamphetamine, and illicit amphetamine analogues
Cadier MA, Clarke JA, Ecstasy and Whizz at a rave resulting in a major burn plus complications
Campkin NJ, Davies UM, Treatment of 'ecstasy' overdose with dantrolene
Brodkin J, Malyala A, Nash JF, Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity
Bohn M, Bohn G, Blaschke G, Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine
Ames D, Wirshing WC, Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?
Barrett PJ, 'Ecstasy' misuse--overdose or normal dose?
Barrett PJ, Taylor GT, 'Ecstasy' ingestion: a case report of severe complications
Allen RP, McCann UD, Ricaurte GA, Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on human sleep
Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W Jr, Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate
SYED F. ALI, GLENN D. NEWPORT, ANDREW C. SCALLET, et al, Oral Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Produces Selective Serotonergic Depletion in the Nonhuman Primate
Cook, E. H., Jr., Arora, R. C., Anderson, G. M., et al, Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
Erlander, M. G., Lovenberg, T. W., Baron, B. M., et al, Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.
Lovenberg, T. W., Erlander, M. G., Baron, B. M., et al, Molecular cloning and functional expression of 5-HTlE-like rat and human 5-hydroxytryptamine receptor genes
Pandey, S. C., Kim, S. W., Davis, J. M., et al, Platelet serotonin-2 receptors in obsessive-compulsive disorder.
Pandey, S. C., Sharma, R. P., Janicak, P. G., et al, Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
Moody C P Facsimile letter to C.S. Grob concerning FDA approval of human Phase I study application.,
Zheng ZM, Specter S, Friedman H, Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages
Mackie K, Hille B, Cannabinoids Inhibit N-Type Calcium Channels in Neuroblastoma-Glioma Cells
Brewster M E, Davis F T, Appearance of aminorex as a designer analog of methylaminorex;
Sawyer M, Ecstasy.
McDonnell E, One World, One Party.
Robins C, The Ecstatic Cybernetic Amino Acid Test.
Chaudhuri A, Cause and Effect.
Abbott A, Concar D A Trip into the Unknown. New Scientist,
Felder CC et.al, Cannabinoid agonists stimulate both receptor- and non- receptor - mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones
Hermle L, Funfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E, Fehrenbach RA, Spitzer M, Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research
Gouzoulis E, Steiger A, Ensslin M, Kovar A, Hermle L., Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; \"eve\") in healthy volunteers
Leuner, Hanscarl, Psychedelische Therapie. [Psychedelic Therapy.]
Styk, Juraj, Versuch einer Untersuchung der Wirksamkeitsfaktoren der Psycholyse in kombinierter Einzel- und Gruppentherapie. [A Trial to Evaluate Factors of Efficacy in Psycholysis Combined with Individual and Group Therapy.]
Tolbert, Requa; Greer, George, Der klinische Gebrauch von MDMA. [The Clinical Use of MDMA.]
Leuner, Hanscarl, Psycholytische Therapie. [Psycholytic Therapy.]
Leuner, Hanscarl; Mascher, Eckart; Schulz-Wittner, Thomas, Die Effizienz der durch psychoaktive Substanzen gestützten Psychotherapie (Psycholytische Behandlung). Eine orientierende Untersuchung. [Efficiency of Psychoactive Substance Assisted Psychotherapy (Psycholytic Treatment. An Orienting Evaluation.]
Bolle, Ralf H., Zum prä- und periNatalen Erlebnisraum in der Psychotherapie. [About the Pre- and Perinatal Experience-Space in Psychotherapy.]
Benz, Ernst, Halluzinogen-unterstützte Psychotherapie. [Hallucinogen-Assisted Psychotherapy.]
Yensen, Richard, Vom Mysterium zum Paradigma: Die Reise des Menschen von heiligen Pflanzen zu psychedelischen Drogen. [From Mysteries to Paradigms: Humanity's Journey From Sacred Plants to Psychedelic Drugs.]
Trueheart, Trevor, Triplepoint. LSD in Group Therapy.
Leuner, Hanscarl; Schlichting, Michael, Über den derzeitigen Stand der Forschung auf dem Gebiet der psychoaktiven Substanzen. [About the Current Status of Research in Psychoactive Substances.]
Grof, Stanislav, Jenseits des Gehirns: Neue Dimensionen in der Psychologie und Psychotherapie. [Beyond the Brain: New Dimensions in Psychology and Psychotherapy.]
Strassman RJ, Human hallucinogen interactions with drugs affecting serotonergic neurotransmission
Solowij N, Hall W, Lee N, Recreational MDMA Use in Sydney: A Profile of "Ecstasy" Users and their Experiences with the Drug.
Sternbach G L, Varon J, Designer Drugs.
Randall T, Ecstasy-Fuelled 'Rave" Parties Become Dances of Death for English Youths.
Randall T, 'Rave' Scene, Ecstasy Use, Leap Atlantic.
Lyttle T, Montagne M, Drugs, Music, and Ideology: A Social Pharmacological Interpretation of the Acid House Movement.
McGuire P, Fahy T, Flashbacks following MDMA.
Schmidt C J, Fadayel G M, Sullivan C K, Taylor V L, 5-HT2-Receptors Exert a State-Dependent Regulation of Dopaminergic Function - Studies with MDL-100,907 and the Amphetamine Analogue, 3,4-Methylenedioxymethamphetamine.
Paulus M P, Geyer M A, The Effects of MDMA and Other Methylenedioxy-substituted Phenylalkylamines on the Structure of Rat Locomotor Activity.
Rezvani A H, Garges P L, Miller D B, Gordon C J, Attenuation of Alcohol Consumption by MDMA (Ecstasy) in Two Strains of Alcohol-preferring Rats.
Kehne J H, McCloskey T C, Taylor V L, Black C K, Fadayel G M, Schmidt C J, Effects of the Serotonin Releasers 3,4-Methylenedioxymethamphetamine (MDMA), 4-Chloroamphetamine (PCA) and Fenfluramine on Acoustic and Tactile Startle Reflexes in Rats.
Johnson M, Bush L G, Midgley L, Gibb J W, Hanson G R, MK-801 Blocks the Changes in Neurotensin Concentrations Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine, Cocaine, and GBR 12909.
Glennon R A, Higgs R, Young R, Issa H, Further Studies on N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane as a Discriminative Stimulus: Antagonism by 5-Hydroxytryptamine3 Antagonists.
Glennon R A, Higgs R, Investigation of MDMA-Related Agents in Rats Trained to Discriminate MDMA from Saline.
Farfel G M, Vosmer G L, Seiden L S, The N-Methyl-D-Aspartate Antagonist MK-801 Protects Against Serotonin Depletions Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine and p-Chloramphetamine.
Elayan I, Gibb J W, Hanson G R, Foltz R L, Lim H K, Johnson M, Long-term Alteration in the Central Monoaminergic Systems of the Rat by 2,4,5-Trihydroxyamphetamine but not by 2-Hydroxy-4,5-Methylenedioxymethamphetamine or 2-Hydroxy-4,5-Methylenedioxyamphetamine.
Callaway C W, Geyer M A, Stimulant Effects of 3,4-Methylenedioxymethamphetamine in the Nucleus Accumbens of Rat.
Callaway C W, Geyer M A, Tolerance and Cross-Tolerance to the Activating Effects of 3,4-Methylendioxymethamphetamine and a 5-Hydroxytryptamine1B Agonist.
Zhao Z, Castagnoli Jr. N, Ricaurte G A, Steele T, Martello M, Synthesis and Neurotoxicological Evaluation of Putative Metabolites of the Serotoninergic Neurotoxin 2-(Methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(Methylenedioxy)methamphetamine].
Scheffel U, Lever J R, Stathis M, Ricaurte G A, Repeated Administration of MDMA Causes Transient Down-regulation of Serotonin 5-HT2 Receptors.
Ricaurte G A, Marletto A L, Katz J L, Marletto M B, Lasting Effects of (+/-)-3,4-Methylenedioxymethamphetamine (MDMA) on Ventral Serotonergic Neurons in Nonhuman Primates: Neurochemical Observations.
Ricaurte G A, McCann U D, Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans.
Nash J F, Yamamoto B K, Methamphetamine Neurotoxicity and Striatal Glutamate Release: Comparison to 3,4-Methylenedioxymethamphetamine.
Nash J F, Meltzer H Y, Lowy M T, The Effect of Adrenalectomy on MDMA-Induced Dopamine Release in the Striatum as Measured by in vivo Microdialysis and Depletion of Serotonin.
Johnson M, Elayan I, Hanson G R, Foltz R L, Gibbs J W, Lim H K, Effects of 3,4-Dihydroxymethamphetamine and 2,4,5-Trihydroxymethamphetamine, Two Metabolites of 3,4-Methylenedioxymethamphetamine, on Central Serotonergic and Dopaminergic Systems.
Hashimoto K, Maeda H, Goromaru T, Antagonism of 3,4-Methylenedioxymethamphetamine-induced Neurotoxicity in Rat Brain by 1-Piperonylpiperazine.
Hashimoto K, Goromaru T, Study of 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain Using Specific In Vivo Binding of [3H] 6-Nitroquipazine.
Callaway C W, Rempel N, Peng R Y, Geyer M A, Serotonin 5-HT1-Like Receptors Mediate Hyperactivity in Rats Induced by 3,4-Methylenedioxymethamphetamine.
Lin L, Kumagai Y, Cho A K, Enzymatic and Chemical Demethylenation of (Methylenedioxy)amphetamine and (Methylenedioxy)methamphetamine by Rat Brain Microsomes.
Lim H K, Zeng S, Chei D M, Foltz R L, Comparitive Investigation of Disposition of 3,4-(Methylenedioxy)methamphetamine (MDMA) in the Rat and the Mouse by a Capillary Gas Chromatography-Mass Spectrometry Assay based on Perfluorotributylamine-enhanced Ammonia Positive Ion Chemical Ionization.
Rudnick G, Wall S C, The Molecular Mechanism of "Ecstasy" [3,4-Methylenedioxymethamphetamine(MDMA)]: Serotonin Transporters are Targets for MDMA-Induced Serotonin Release.
Berger U V, Gu X F, Azmitia E C, The Substituted Amphetamines 3,4-Methylenedioxymethamphetamine, Methamphetamine, p-Chloroamphetamine and Fenfluramine Induce 5-Hydroxytryptamine Release via a Common Mechanism Blocked by Fluoxetine and Cocaine.
Woods J D, Henry J A, Hyperpyrexia Induced by 3,4-Methylenedioxyamphetamine ("Eve")
Rohrig T P, Prouty R W, Tissue Distribution of Methylenedioxymethamphetamine.
Russell B, Schwartz R H, Dawling S Accidental Ingestion of 'Ecstasy' (3,4-Methylenedioxymethylamphetamine).,
Sawyer J, Stephens W P, Misuse of Ecstasy.
Screaton G R, Cairns H S, Sarner M, Singer M, Thrasher A, Cohen S L, Hyperpyrexia and Rhabdomyolysis after MDMA ("Ecstasy") Abuse.
Shearman J D, Chapman R W G, Satsangi J, Ryley N G, Weatherhead S, Misuse of Ecstasy.
Rittoo D B, Rittoo D, Complications of "Ecstasy" Misuse.
Rittoo D, Rittoo D B, Rittoo D, Misuse of Ecstasy.
Pallanti S, Mazzi D, MDMA (Ecstasy) Precipitation of Panic Disorder.
Larner A J, Complications of "Ecstasy" Misuse.
Krystal J H, Price L H, Opsahl C, Ricaurte G A, Heninger G R, Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?
Gorard D A, Davies S E, Clark M L, Misuse of Ecstasy.
Harries D P, de Silva R N, 'Ecstasy' and Intracerebral Haemorrhage.
Henry J A, Ecstasy and the Dance of Death.
Henry J A, Jeffreys K J, Dawling S, Toxicity and Deaths from 3,4-Methylenedioxymethamphetamine ("Ecstasy").
Ellis S J, Complications of "Ecstasy" Misuse.
Fahal I H, Sallomi D F, Yaqoob M, Bell G M, Acute Renal Failure after Ecstasy.
de Silva R N, Harries D P, Misuse of Ecstasy.
Barrett P J, Ecstasy and Dandrolene.
Campkin N T A, Davies U M, Another Death from Ecstasy.
Liester M B, Grob C S, Bravo G L, Walsh R N, Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use.
McCann U D, Ricaurte G A, MDMA ("Ecstasy") and Panic Disorder: Induction by a Single Dose.
Grob C S, Bravo G L, Walsh R N, Liester M B, Commentary: The MDMA-Neurotoxicity Controversy: Implications for Clinical Research with Novel Psychoactive Drugs.
Kosten T R, Price L H, Commentary: Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use.
Greer G, Ecstasy and the Dance of Death.
Yourspigs U P, The Complete Book of Ecstasy
Johnson M, Mitros K, Stone D M, Zobrist R, Hanson G R, Gibb J W, Effect of Flunarizine and Nimodipine on the Decrease in Tryptophan Hydroxylase Activity Induced by Methamphetamine and 3,4-Methylenedioxymethamphetamine. J. Pharm. Exptl. Therap.
Lim H K, Zeng S, Chei D M, Flotz R L, Comparitive Investigation of Disposition of 3,4-(Methylenedioxy)methamphetamine (MDMA) in the Rat and the Mouse by a Capillary Gas Chromatography-Mass Spectrometry Assay Based on Perfluorotributylamine-enhanced Ammonia Positive Ion Chemical Ionization.
Helmlin H, Brenneisen R, Determination of Psychotropic Phenylalkylamine Derivatives in Biological Matrices by High-Performance Liquid Chromatography with Photodiode-Array Detection.
Helmlin H-J, Brenneisen R, Determination of Psychotropic Phenylalkylamine Derivatives in Biological Matrices by High-performance Liquid Chromatography with Photodiode-array Detection.
Clark C R, DeRuiter J, Noggle F T, GC-MS Identification of Amine-Solvent Condensation Products Formed During Analysis of Drugs of Abuse.
X Huang, D Marona-Lewicka, DE Nichols, Para-methylthioamphetamine is a Potent New Nonneurotoxic Serotonin-releasing Agent
R Oberlender, RC Pfaff, MP Johnson, X Huang, DE Nichols, Stereoselective LSD-Like Activity in d-Lysergic Acid Amides of R- and S2-Aminobutane
Z Tomaszewski, MP Johnson, DE Nichols,, Benzofuran Bioisosteres of Hallucinogenic Tryptamines
DM Mottola, WK Brewster, LL Cook, DE Nichols, RB Mailman, Dihydrexidine, A Novel Full Efficacy D1 Dopamine Receptor Agonist
Eberle W F, McNeish C S, et al, Dopamine release from A9 and A10 neurons induced by administration of 4-methylaminorex and amphetamine
Hanson G R, Bunker C F, et al, Response of monoaminergic and neuropeptide systems to 4-methylaminorex A new drug of abuse
Noggle F T, Clark C R, DeRuiter J, Liquid chromatographic and spectral analysis of the stereoisomers of dimethylaminorex
Young R, Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine
Zhao ZY, Castagnoli N Jr, Ricaurte GA, Steele T, Martello M, Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine]
Sternbach GL, Varon J, 'Designer drugs'. Recognizing and managing their toxic effects
Teggin AF, Ecstasy--a dangerous drug
Thurman EM, Pedersen MJ, Stout RL, Martin T, Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry
Shearman JD, Chapman RW, Satsangi J, Ryley NG, Weatherhead S, Misuse of ecstasy
Singarajah C, Lavies NG, An overdose of ecstasy: A role for dantrolene
Solowij N, Hall W, Lee N, Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug
Steele TD, Katz JL, Ricaurte GA, Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA)
Screaton GR, Singer M, Cairns HS, Thrasher A, Sarner M, Cohen SL, Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse
Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL, 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
Schmidt CJ, Black CK, Taylor VL, Fadayel GM, Humphreys TM, Nieduzak TR, Sorensen SM, The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine
Sawyer J, Stephens WP, Misuse of ecstasy
Scheffel U, Lever JR, Stathis M, Ricaurte GA, Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors
Rudnick G, Wall SC, The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release
Rittoo D, Rittoo DB, Misuse of ecstasy
Rittoo DB, Rittoo D, Complications of 'ecstasy' misuse
Rohrig TP, Prouty RW, Tissue distribution of methylenedioxymethamphetamine
Satyanarayana, M., Rajeswari, K. R., Rani, N. J., et al, Effect of Santhi Kriya on certain psychophysiological parameters: a preliminary study.
Grob, C. S., Bravo, G. L., Walsh, R. N., et al, The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.
Liester, M. B., Grob, C. S., Bravo, G. L., et al, Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
Gouzoulis, E., Steiger, A., Ensslin, M., et al, Sleep EEG Effects of 3,4- Methylenedioxyethamphetamine (MDE; "Eve") in Healthy Volunteers
Polanski, M. and Karnovsky, M. L., Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
Sioufi, A., Sandrenan, N., and Godbillon, J., Determination of 1Oa-Methoxy-9,lOdihydrolysergol, a Nicergoline Metabolite, in Human Urine by High Performance Liquid Chromatography.
Ricaurte GA, McCann UD, Neurotoxic amphetamine analogues: effects in monkeys and implications for humans
Ricaurte GA, Martello AL, Katz JL, Martello MB, Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations
Randall T, 'Rave' Scene, Ecstasy Use, Leap Atlantic
Rezvani AH, Garges PL, Miller DB, Gordon CJ, Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats
Preston A, Pointing out the Risk
Randall T, Ecstasy-Fueled 'Rave' Parties Become Dances of Death For English Youths
Paulus MP, Geyer MA, The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity
Pallanti S, Mazzi D, MDMA (Ecstasy) precipitation of panic disorder
Paris JM, Cunningham KA, Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)
McGuire P, Fahy T, Flashbacks following MDMA
Nash JF, Yamamoto BK, Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine
McCann UD, Ricaurte GA, MDMA ('ecstasy') and panic disorder: induction by a single dose
Lim HK, Zeng S, Foltz RL, Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography-mass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization
Lin LY, Kumagai Y, Cho AK, Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes
Marchant NC, Breen MA, Wallace D, Bass S, Taylor AR, Ings RM, Campbell DB, Williams J, Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man
Liester MB, Grob CS, Bravo GL, Walsh RN, Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use
Larner AJ, Complications of 'ecstasy' misuse
Lehmann J, DeSouza EB, Culp S, Zaczek R, Regional distribution to recovery of 5-HT levels after administration of 'atrophins' MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine
Kumagai Y, Schmitz DA, Cho AK, Aromatic hydroxylation of methylenedioxybenzene (MDB) and methylenedioxymethamphetamine (MDMA) by rabbit liver microsomes
Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR, Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?
Kosten TR, Price LH, Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [Commentary]
Jones C, Dickinson P, Substance abuse. From ecstasy to agony
Kaskey GB, Possible interaction between an MAOI and 'ecstasy'
Kehne JH, McCloskey TC, Taylor VL, Black CK, Faydayel GM, Schmidt CJ, Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats
Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW, Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine
Huang X, Marona-Lewicka D, Nichols DE, p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Releasing Agent
Johnson M, Elayan I, Hanson GR, Foltz RL, Gibb JW, Lim HK, Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems
Herndon JL, Pierson ME, Glennon RA, Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine
Henry JA, Jeffreys KJ, Dawling S, Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy')
Henry JA, Ecstasy and the dance of death
Harries DP, De Silva R, 'Ecstasy' and intracerebral haemorrhage
Hashimoto K, Maeda H, Goromaru T, Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain
Hashimoto K, Maeda H, Goromaru T, Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine
Helmlin HJ, Brenneisen R, Determination of psychotropic phenylalkylamine derivatives in biological matrices by high-performance liquid chromatography with photodiode-array detection
Gorard DA, Davies SE, Clark ML, Misuse of ecstasy
Greer G, Ecstasy and the dance of death
Grob CS, Bravo GL, Walsh RN, Liester MB, The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs
Glennon RA, Higgs R, Young R, Issa H, Further studies on N-methyl-1(3,4-methylenedioxyphenyl)-2-aminopropane as a discriminative stimulus: antagonism by 5-hydroxytryptamine3 antagonists
Glennon RA, Higgs R, Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline
Ellis SJ, Complications of 'ecstasy' misuse
Fahal IH, Sallomi DF, Yaqoob M, Bell GM, Acute renal failure after ecstasy
Farfel GM, Vosmer GL, Seiden LS, The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine
De Silva RN, Harries DP, Misuse of ecstasy
Elayan I, Gibb JW, Hanson GR, Foltz RL, Lim HK, Johnson M, Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine
Callaway CW, Rempel N, Peng RY, Geyer MA, Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine
Callaway CW, Geyer MA, Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat
Callaway CW, Geyer MA, Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist
Broadbent JJ, Appel JB J, Michael EK E, Ricker JHJ, Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA)
Berger UV, Gu XF, Azmitia EC, The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine
Barrett PJ, Ecstasy and dantrolene
Bedford Russell AR, Schwartz RH, Dawling S, Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine)
Abbott A, Concar D, A trip into the unknown
Lichtman AH, Martin BR, Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism
Mandi J, Ecstasy.
Gilbert J, Stone P J, Yegan J, Controlled Substance Analog Law is Not Unconstitutionally Vague. Finding of the Second Appellate District Division Six.
People v. Silver, Statute Defining Controlled Substance Analog as "Substantially Similar" to Controlled Substance not Unconstitutionally Vague.
Shulgin A T, Future Drugs: The next 10 years
Cohen R, Supreme Court to consider Jerseyans challenge to designer drug law Couple disputes officials authority to quickly rule substances illegal
Greenhouse L, Supreme Court Roundup: Designer drugs - (Euphoria: 4-methylaminorex)
Fitzgerald J, MDMA and Harm.
Imade AG, Ebie JC, A retrospective study of symptom patterns of cannabis- induced psychosis
McNeil L, A Woodstock of Their Own.
Grob C, Bravo G, McQuade J, Doblin R Analgesic Efficacy of, 3,4-Methylenedioxymethamphetamine (MDMA) in Modification of Pain and Distress of End-stage Cancer.
Lichtman AH, Martin BR, Spinal and supraspinal components of cannabinoid- induced antinociception
Fromberg E Letter to R. Doblin from the Netherlands Institute for Alcohol and Drugs.,
Doblin RE, Kleiman MA, Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes
Styk, Juraj, LSD-Erfahrung als Höhepunkt der Psychotherapie bei einem terminalen Krebskranken. [LSD-Experience as a Climax of Psychotherapy in a Terminally Ill Cancer Patient.]
Widmer, P. Samuel, Der Therapeut und seine Wirkung im psycholytischen Prozeß. [The Therapist and his Effect in the Psycholytic Process.]
Widmer, P. Samuel, Fallbeispiel einer psycholytischen Psychotherapie: Auflösung des psychotischen Kerns bei einer jungen Frau. [A Case Study in Psycholyrtic Therapy: Dissolution of the Psychotic Core in a Young Woman.]
Schlichting, Michael, Zur Psychodynamik der Erlebnisinhalte einer psycholytischen Sitzung bei einem Patienten mit Zwangsneurose. [About the Psychodynamic Content of a Psycholytic Session with a Compulsive Neurotic.]
Strassman RJ, The pineal gland: Current evidence for its role in consciousness
Strassman RJ, Human hallucinogenic drug research in the United States: a present-day case history and review of the process
Weigle C, Rippchen R, MDMA: Die Psychoaktive Substanz fur Therapie, Ritual und Rekreation.
Solowij N, Lee N, Survey of Ecstasy [MDMA] Users in Sydney.
Rattray M, Ecstasy: Towards an Understanding of the Biochemical Basis of the Action of MDMA.
McKenna D J, Peroutka S J, Serotonin Neurotoxins: Focus on MDMA (3,4-Methylenedioxymethamphetamine, "Ecstasy").
Korf D, Blanken P, Nabben T, Een Nieuwe Wonderpil? Verspreiding, effecten en risico's van ecstasygebruik in Amsterdam.
Adelaars A, Ecstasy: De opkomst van een Bewustzijnsveranderend Middel.
Yeh S Y, Hsu F-L, The Neurochemical and Stimulatory Effects of Putative Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine in Rats.
Schechter M D, Effect of MDMA Neurotoxicity Upon Its Conditioned Place Preference and Discrimination.
Sharkley J, McBean D E, Kelly P A T, Alterations in Hippocampal Function Following Repeated Exposure to the Amphetamine Derivative Methylenedioxymethamphetamine ("Ecstasy").
Nash J F, Nichols D E, Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues.
Park W K, Azmitia E C, 5-HT, MDMA (Ecstasy), and Nimodipine Effects on 45Ca-Uptake into Rat Brain Synaptosomes.
McKenna D J, Guan X -M, Shulgin A T, 3,4-Methylenedioxyamphetamine (MDA) Analogues Exhibit Differential Effects on Synaptosomeal Release of 3H-Dopamine and 3H-5-Hydroxytryptamine.
Nash J F, Brodkin J, Microdialysis Studies on 3,4-Methylenedioxymethamphetamine-induced Dopamine Release: Effect of Dopamine Uptake Inhibitors.
Johnson M, Bush L G, Gibb J W, Hanson G R, Blockade of the 3,4-Methylenedioxymethamphetamine-induced Changes in Neurotensin and Dynorphin A Systems.
Johnson M P, Frescas S P, Oberlender R, Nichols D E, Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindane: Similarities to 3,4-Methylenedioxymeth-amphetamine (MDMA).
Gordon C J, Watkinson W P, O'Callaghan J P, Miller B D, Effects of 3,4-Methylenedioxymethamphetamine on Autonomic Thermoregulatory Responses of the Rat.
Gough B, Ali S F, Slikker W, Holson R R, Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Monoamines in Rat Caudate.
Dragunow M, Logan B, Laverty R, 3,4-Methylenedioxymethamphetamine Induces Fos-like Proteins in Rat Basic Ganglia: Reversal with MK-801.
Bilsky E J, Reid L D, MDL-72222, A Serotonin 5-HT3 Receptor Antagonist, Blocks MDMA's Ability to Establish a Conditioned Place Preference.
Bilsky E J, Hubbell C L, Delconte J D, Reid L D, MDMA Produces a Conditioned Place Preference and Elicits Ejaculation in Male Rats: A Modulatory Role for the Endogenous Opioids.
St. Omer V E V, Ali S F, Holson R R, Duhart H M, Scalzo F M, Slikker W, Behavioural and Neurochemical Effects of Prenatal Methylenedioxymethamphetamine (MDMA) Exposure in Rats.
Steele T D, Brewster W K, Johnson M P, Nichols D E, Yim G K W, Assessment of the Role of alpha-Methylepinine in the Neurotoxicity of MDMA.
Schmidt C J, Black C K, Taylor V L, L-DOPA Potentiation of the Serotoninergic Deficits Due to a Single Administration of 3,4-Methylenedioxymethamphetamine, p-Chloroamphetamine or Methamphetamine to Rats.
Schmidt C J, Vicki L, Taylor G M, Nieduzak T R, 5-HT-2 Antagonist Stereoselectivly Prevents the Neurotoxicity of 3,4-Methylenedioxymethamphetamine by Blocking the Acute Stimulation of Dopamine Synthesis: Reversal by L-DOPA.
Pan H S, Wang R Y, MDMA: Further Evidence that its Action in the Medial Prefrontal Cortex is Mediated by the Serotoninergic System.
Pan H S, Wang R Y, The Action of (+/-)-MDMA on Medial Prefrontal Cortical Neurons is Mediated Through the Serotoninergic System.
Paris J M, Cunningham K A, Lack of Serotonin Neurotoxicity after Intraraphe Microinjection of (+) 3,4-Methylenedioxymethamphetamine (MDMA).
Millan M J, Colpaert F C, Methylenedioxymethamphetamine Induces Spontaneous Tail-flicks in the Rat via 5-HT1a Receptors.
Johnson M P, Conarty P F, Nichols D E, [3H]Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylenedioxymethamphetamine and p-Chloroamphetamine Analogues.
Johnson M P, Huang X, Nichols D E, Serotonin Neurotoxicity in Rats After Combined Treatment with a Dopaminergic Agent Followed by a Nonneurotoxic 3,4-Methylenedioxymethamphetamine (MDMA) Analogue.
Johnson M P, Nichols D E, Combined Administration of a Non-Neurotoxic 3,4-Methylenedioxymethamphetamine Analogue with Amphetamine Produces Serotonin Neurotoxicity in Rats.
Hoffman B J, Mezey E, Brownstein M J, Cloning of a Serotonin Transporter Affected by Antidepressants.
Dornan W A, Katz J L, Ricaurte G A, The Effects of Repeated Administration of MDMA on the Expression of Sexual Behaviour in the Male Rat.
Champney T H, Matthews R T, Pineal Serotonin is Resistant to Depletion by Serotonergic Neurotoxins in Rats.
Callaway C W, Nichols D E, Paulus M P, Geyer M A, Serotonin Release is Responsible for the Locomotor Hyperactivity in Rats Induced by Derivatives of Amphetamine Related to MDMA. Serotonin: Molecular Biology, Receptors and Functional Effects, J R Fozard and PR Saxena, Eds.
Battaglia G, Sharkey J, Kuhar M J, De Souza E B, Neuroanatomic Specificity and Time Course of Alterations in Rat Brain Serotoninergic Pathways Induced by MDMA (3,4-Methylenedioxymethamphetamine): Assessment Using Quantitative Autoradiography.
Lim H K, Foltz R L, In vivo Formation of Aromatic Hydroxylated Metabolites of 3,4-Methylenedioxymethamphetamine in the Rat: Identification by Ion Trap Tandem Mass Spectrometric (MS/MS and MS/MS/MS) Techniques.
Kumagai Y, Lin L Y, Schmitz D A, Cho A K, Hydroxyl Radical Mediated Demethylenation of (Methylenedioxy)phenyl
Fukuto J M, Kumagai Y, Cho A K, Determination of the Mechanism of Demethylenation of (Methylenedioxy)phenyl Compounds by Cytochrome P450 Using Deuterium Isotope Effects.
Hiramatsu M, DiStefano E, Chang A S, Cho A K, A Pharmacokinetic Analysis of 3,4-Methylenedioxymethamphetamine Effects on Monoamine Concentrations in Brain Dialysates.
Bradberry C W, Sprouse J S, Sheldon P W, Aghajanian G K, Roth R H, In Vitro Microdialysis: A Novel Technique for Stimulated Neurotransmitter Release Measurements.
Winstock A R, Chronic Paranoid Psychosis after Misuse of MDMA.
Schifano F, Chronic Atypical Psychosis Associated with MDMA ("Ecstasy") Abuse. Lancet
McGuire P, Fahy T, Chronic Paranoid Psychosis after Misuse of MDMA ("Ecstasy").
McCann U D, Ricaurte G A, Lasting Neuropsychiatric Sequelae of (+/-) Methylenedioxymethamphetamine ("Ecstasy") in Recreational Users.
Chadwick I S, Linsley A, Freemont A J, Doran B, Ecstasy, 3,4-Methylenedioxymethamphetamine (MDMA), a Fatality Associated With Agulopathy and Hyperthermia.
Watson L, Beck J, New Age Seekers: MDMA Use as an Adjunct to Spiritual Pursuit.
Benazzi F, Mazzoli M, Psychiatric Illness Associated with "Ecstasy".
Kumagai Y, Lin L Y, Schmitz D A, Cho A K, Hydroxyl Radical Mediated Demethylenation of (Methylenedioxy)phenyl Compounds.
,
Verweij A M, Contamination of Illegal Amphetamine. Hydrastatinine as a Contaminant in 3,4-(Methylenedioxy)methylamphetamine.
Simpson B J, Simpson T P, Lui R H, Microcrystalline Differentiation of 3,4-Methylenedioxyamphetamine and Related Compounds.
Noggle Jr. F T, Clark C R, DeRuiter J, Gas Chromatographic and Mass Spectrometric Analysis of N-Methyl-1-aryl-2-propanamines Synthesized from the Substituted Allylbenzenes Present in Sassafras Oil.
Noggle Jr. F T, Clark C R, Andurkar S, DeRuiter J, Methods for the Analysis of 1-(3,4-Methylenedioxyphenyl)-2-Butanamine and N-Methyl-1-(3,4-Methylenedioxyphenyl)-2-Propanamine (MDMA).
Noggle Jr. F T, Clark C R, Bouhadir K H, DeRuiter J, Liquid Chromatographic and Mass Spectral Analysis of 1-(3,4-Methylenedioxyphenyl)-3-propanamines: Regioisomers of MDMA.
Noggle F T, Clark C R, Pitts-Monk P, De Ruiter J, Liquid Chromatographic and Mass Spectral Analysis of 1-(3,4-Dimethoxyphenyl)-2-propanamines: Analogs of MDMA.
Noggle F T, Clark C R, DeRuiter J, Liquid Chromatographic and Spectral Methods for the Differentiation of 3,4-Methylenedioxymethamphetamine (MDMA) from Regioisomeric Phenethylamines.
Noggle Jr. F T, Clark C R, DeRuiter J, Identification of Safrole and Bromosafrole in Samples from the Clandestine Synthesis of MDMA from Sassafras Oil.
Noggle Jr. F T, Clark C R, DeRuiter J, Gas Chromatographic and Mass Spectrometric Analysis of Samples from a Clandestine Laboratory Involved in the Synthesis of Ecstasy from Sassafras Oil.
Gan B K, Baugh D, Liu R H, Walia A S, Simultaneous Analysis of Amphetamine, Methamphetamine, and 3,4-Methylenedioxymethamphetamine (MDMA) in Urine Samples by Solid-phase Extraction, Derivatization, and Gas Chromatography/Mass Spectrometry.
Consroe P, et al., Controlled clinical trial of cannabidiol in Huntington's disease
Zuardi A W, et al., Effects of cannabidiol in animal models predictive of antipsychotic activity
JF Nash, DE Nichols, Microdialysis Studies on 3,4-Methylenedioxyamphetamine and Structurally Related Analogues
TW Lovenberg, RH Roth, DE Nichols, RB Mailman, D1 Dopamine Receptors of NS20Y Neuroblastoma Cells Are Functionally Similar to Rat Striatal D1 Receptors
KJ Darney Jr., MH Lewis, WK Brewster, DE Nichols, RB Mailman, Behavioral Effects in the Rat of Dihydrexidine, A High Potency Full Efficacy D1 Dopamine Receptor Agonist
TW Lovenberg, DE Nichols, EJ Nestler, RH Roth, RB Mailman, Guanine Nucleotide Binding Proteins and the Regulation of Cyclic AMP Synthesis in NS20Y Neuroblastoma Cells: Role of Dl Dopamine and Muscarinic Receptors
JD Elsworth, MS Lawrence, RH Roth, JR Taylor, RB Mailman, DE Nichols, MH Lewis, DE Redmond Jr., D1 and D2 Dopamine Receptors Independently Regulate Spontaneous Blink Rate in the Vervet Monkey
MP Johnson, X Huang, DE Nichols, Serotonin Neurotoxicity in Rats After Combined Treatment With a Dopaminergic Agent Followed by a Non-Neurotoxic 3,4-Methylenedioxymethamphetamine (MDMA) Analogue
CW Callaway, MP Johnson, LH Gold, DE Nichols, MA Geyer, Amphetamine Derivatives Induce Locomotor Hyperactivity by Acting as Indirect Serotonin Agonists
JM Witkin, DE Nichols, P Terry, JL Katz, Behavioral Effects of Selective Dopaminergic Compounds in Rats Discriminating Cocaine Injections
MP Johnson, PF Conarty, DE Nichols, [3H]-Monoamine Releasing and Uptake Inhibition Properties of 3,4-Methylene-dioxymethamphetamine and p-Chloroamphetamine Analogues
JR Taylor, MS Lawrence, DE Redmond Jr., JD Elsworth, RH Roth, DE Nichols, RB Mailman, Dihydrexidine, A Full Dopamine Agonist, Reduces MPTP-Induced Parkinsonism in Monkeys
RJ Markovich, XX Qiu, B Invergo, DE Nichols, FM Alvarez, C Pidgeon, End-Capping Immobilized Artificial Membrane Surfaces: Silica Sub-Surface Amines Affect Both the Chemical Stability and Chromotographic Properties of IAM Surfaces
PE Persons, JP Mayer, DE Nichols, JM Cassady, EB Smalstig, JA Clemens, Preliminary Evaluation of 4-(2-N,N-dialkylaminoethyl)indoles as Potential Dopamine Agonists
MP Johnson, SP Frescas, R Oberlender, DE Nichols, Synthesis and Pharmacological Examination of 1-(3-Methoxy-4-methylphenyl)-2-aminopropane and 5-Methoxy-6-methyl-2-aminoindan: Similarities to 3,4-Methylenedioxymethamphetamine (MDMA)
R Oberlender, DE Nichols, Structural Variation and (+)-Amphetamine-like Discriminative Stimulus Properties
TD Steele, WK Brewster, MP Johnson, DE Nichols, GKW Yim, Assessment of the Role of alpha-Methylepinine in the Neurotoxicity of MDMA
DE Nichols, SE Snyder, R Oberlender, M Johnson, X Huang, 2,3-Dihydrobenzofuran Analogues of Hallucinogenic Phenethylamines
X Huang, MP Johnson, DE Nichols, Reduction in Brain Serotonin Markers by alpha-Ethyltryptamine (Monase)
MP Johnson, DE Nichols, Combined Administration of a Non-neurotoxic 3,4-Methylenedioxymethamphetamine Analogue with Amphetamine Produces Serotonin Neurotoxicity in Rats
Vogel C, et al, Effect of 4-methylaminorex on midbrain dopamine cells
McKenna, D. J., Guan, X. M., and Shulgin, A. T., 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.
Watson, L. and Beck, J., New age seekers: MDMA use as an adjunct to spiritual pursuit.
Winstock AR, Chronic paranoid psychosis after misuse of MDMA
Yeh SY, Hsu FL, The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats
Winslow JT, Insel TR, Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists
Watson L, Beck J, New age seekers: MDMA use as an adjunct to spiritual pursuit
Steele TD, Brewster WK, Johnson MP, Nichols DE, Yim GK, Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA
St Omer VEV, Ali SF, Holson RR, Duhart HM, Scalzo FM, Slikker W Jr, Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats
Sharkey J, McBean DE, Kelly PA, Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ('Ecstasy')
Schifano F, Chronic atypical psychosis associated with MDMA ('ecstasy') abuse
Schmidt CJ, Taylor VL, Abbate GM, Nieduzak TR, 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa
Schechter MD, Effect of serotonin depletion by p-chlorophenylalanine upon discriminative behaviours
Schechter MD, Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination
Ruttenber AJ, Stalking the elusive designer drugs: Techniques for monitoring new problems in drug abuse
Rattray M, Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA
Paulus MP, Geyer MA, A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants
Park WK, Azmitia EC, 5-HT, MDMA (ecstasy), and nimodipine effects on 45Ca-uptake into rat brain synaptosomes
Paris JM, Cunningham KA, Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecstasy')
Pan HS, Wang RY, MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system
Pan HS, Wang RY, The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system
Noggle FT Jr, Clark CR, Andukar S, DeRuiter J, Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA)
Nichols DE, Johnson MP, Oberlender R, 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine
Nash JF, Nichols DE, Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues
Nash JF, Brodkin J, Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors
Nash JF, Arora RC, Schreiber MA, Meltzer HY, Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats
Millan MJ, Colpaert FC, Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors
McGuire P, Fahy T, Chronic paranoid psychosis after misuse of MDMA ('ecstasy')
McKenna DJ, Guan XM, Shulgin AT, 3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine
McCann UD, Ricaurte GA, Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons
McCann UD, Ricaurte GA, Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users
Kumagai Y, Wickham KA, Schmitz DA, Cho AK, Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction
Lim HK, Foltz RL, In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques
Kumagai Y, Lin LY, Schmitz DA, Cho AK, Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds
Johnson MP, Huang XM, Nichols DE, Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue
Johnson MP, Frescas SP, Oberlender R, Nichols DE, Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)
Johnson MP, Conarty PF, Nichols DE, [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues
Johnson M, Bush LG, Gibb JW, Hanson GR, Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems
Huang XM, Johnson MP, Nichols DE, Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase)
Hiramatsu M, DiStefano E, Chang AS, Cho AK, A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates
Gough B, Ali SF, Slikker W Jr, Holson RR, Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate
Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB, Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat
Glennon RA, Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs
Glennon RA, Phenylalkylamine stimulants, hallucinogens, and designer drugs
Garrett ER, Seyda K, Marroum P, High performance liquid chromatographic assays of the illicit designer drug 'Ecstasy', a modified amphetamine, with applications to stability, partitioning and plasma protein binding
Gan BK, Baugh D, Liu RH, Walia AS, Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry
Dragunow M, Logan B, Laverty R, 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801
Fukuto JM, Kumagai Y, Cho AK, Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects
Creighton FJ, Black DL, Hyde CE, 'Ecstasy' psychosis and flashbacks
Dornan WA, Katz JL, Ricaurte GA, The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat
Champney TH, Matthews RT, Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats
Chadwick IS, Curry PD, Linsey A, Freemont AJ, Doran B, Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia
Bradberry CW, Sprouse JS, Sheldon PW, Aghajanian GK, Roth RH, In vitro microdialysis: a novel technique for stimulated neurotransmitter release measurements
Callaway CW, Johnson MP, Gold LH, Nichols DE, Geyer MA, Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists
Bilsky EJ, Reid LD, MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference
Benazzi F, Mazzoli M, Psychiatric illness associated with 'ecstasy'
Bilsky EJ, Hubbell CL, Delconte JD, Reid LD, MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids
Battaglia G, Sharkey J, Kuhar MJ, de Souza EB, Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography
Ali SF, Chang LW, Slikker W Jr, Biogenic amines as biomarkers for neurotoxicity
Mansbach R S, Sannerud C A, Griffiths R R, Balster R L, Harris L S, Intravenous self-administration of 4-methylaminorex in primates
Johnson T, Trafic d'Extase.
Baron JA, Folan RD, Kelley ML Jr, Ulcerative colitis and marijuana [letter]
Lim H K, Foltz R L, Application of Ion Trap MS/MS Techniques for Identification of Potentially Neurotoxic Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA).
Goodman R M, Method of decongesting the nose without adverse stimulant effects U.S. Patent Number 4,980,364
Matsuda LA. Lolait SJ. Brownstein MJ. Young AC. Bonner TI, Structure of a cannabinoid receptor and functional expression of the cloned cDNA [see comments]
Chesher G, Some Views on Ecstasy.
Howlett AC, Johnson MR, Melvin LS, Classical and nonclassical cannabinoids: mechanism of action--brain binding
Gerard, Francis, Pain, Death and LSD: A Retrospective of the Work of Dr. Eric Kast.
Hess, Peter, Der therapeutische Einsatz von MDMA. [The Therapeutic Application of MDMA.]
Greer, George R.; Tolbert, Requa, The Therapeutic Use of MDMA.
Bakalar, James B.; Grinspoon, Lester, Testing Psychotherapies and Drug Therapies: The Case of Psychedelic Drugs.
Shulgin A T, History of MDMA, The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka
Rosenbaum M, Doblin R, Why MDMA Should Not Have Been Made Illegal.
Nichols D E, Oberlender R, Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents? The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Nichols D E, Oberlender R, Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs.
Molliver M E, Berger U V, Mamounas L A, Molliver D C, O'Hearn E, Wilson M A, Neurotoxocity of MDMA and Related Compounds: Anatomical Studies.
McKenna D J, Peroutka S J, The Neurochemistry and Neurotoxicity of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Gibb J W, Johnson M, Stone D, Hanson G R, MDMA: Historical Perspectives.
Gibb J W, Stone D, Johnson M, Hanson G R, Neurochemical Effects of MDMA. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka
Gibb J W, Johnson M, Hanson G R, Neurochemical Basis of Neurotoxicity.
Barendregt C, Dutch Conference on MDMA.
Anon, "Ice" and "Ecstasy" Two Dangerous Psychotropic Drugs.
Bakalar J B, Grinspoon L, Testing Psychotherapies and Drug Therapies: The Case of Psychedelic Drugs. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka
Zacny J P, Virus R M, Woolverton W L, Tolerance and Cross-Tolerance to 3,4-Methylenedioxymethamphetamine (MDMA), Methamphetamine and Methylenedioxyamphetamine.
Sprouse J S, Bradberry C W, Roth R H, Aghajanian G K, 3,4-Methylenedioxymethamphetamine-induced Release of Serotonin and Inhibition of Dorsal Raphe Cell Firing: Potentiation by L-Tryptophane.
Winslow J T, Insel T R, Serotonergic Modulation of Rat Pup Ultrasonic Vocal Development: Studies with 3,4-Methylenedioxymethamphetamine.
Schmidt C J, Taylor V L, Reversal of the Acute Effect of 3,4-Methylenedioxymethamphetamine by 5-HT Uptake Inhibitors.
Paulus M P, Geyer M A, Gold L H, Mandell A J, Application of Entropy Measurements Derived from the Ergodic Theory of Dynamical Systems to Rat Locomotor Behaviour.
Oberlender R, Nichols D E, (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-methylenedioxymethamphetamine-Like Behavioural Activity.
Nash J F, Ketanserin Pretreatment Attenuates MDMA-induced Dopamine Release in the Striatum as Measured by in vivo Microdialysis.
Callaway C W, Wing L L, Geyer M A, Serotonin Release Contributes to the Locomotor Stimulant Effects of 3,4-Methylenedioxyamphetamine in Rats.
Bilsky E J, Hui Y, Hubbell C L, Reid L D, Methylenedioxymethamphet-amine's Capacity to Establish Place Preferences and Modify Intake of an Alcohol Beverage.
Zaczek R, Culp S, De Souza E B, Intrasynaptosomal Sequestration of [3H]Amphetamine and [3H]Methylenedioxyamphetamine: Characterization Suggests the Presence of a Factor Responsible for Maintaining Sequestration.
Yeh S Y, Lack of Protective Effect of Chlorpromazine on 3,4-Methylenedioxymethamphetamine Induced Neurotoxicity on Brain Serotonin Neurons in Rats.
Wagner J, Peroutka S J, Neurochemistry and Neurotoxicity of Substituted Amphetamines
Whitaker-Azmitia P M, Azmitia E C, A Tissue Culture Model of MDMA Toxicity. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka
Slikker Jr W, Gaylor D W, Biologically-Based Dose-Response Model for Neurotoxicity Risk Assessment.
Schmidt C J, Taylor V L, Neurochemical Effects of Methylenedioxymethamphetamine in the Rat: Acute versus Long-term Changes. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka
Schmidt C J, Abbate G M, Black C K, Taylor V L, Selective 5-Hydroxytryptamine-2 Receptor Antagonists Protect against the Neurotoxicity of Methylendioxymethamphetamine in Rats.
Schmidt C J, Black C K, Abbate G M, Taylor V L, Methylenedioxymethamphetamine-induced Hyperthermia and Neurotoxicity are Independently Mediated by 5-HT2 Receptors.
Schmidt C J, Black C K, Abbate G M, Taylor V L, Chloral Hydrate Anesthesia Antagonizes the Neurotoxicity of 3,4-Methylenedioxymethamphetamine.
Schmidt C J, Black C K, Taylor V L, Antagonism of the Neurotoxicity due to a Single Administration of Methylenedioxyamphetamine.
Schmidt C J, Kehne J H, Neurotoxicity of MDMA: Neurochemical Effects.
Scheffel U, Ricaurte G A, Paroxetine as an in vivo Indicator of 3,4-Methylenedioxymethamphetamine Neurotoxicity: A Presynaptic Serotonergic Positron Emission Tomography Ligand?
Piercey M F, Lum J T, Palmer J R, Effects of MDMA ("ecstasy") on Firing Rates of Seroronergic, Dopaminergic, and Noradrenergic Neurons in the Rat.
Nichols D E, Brewster W K, Johnson M P, Oberlender R, Riggs R M, Nonneurotoxic Tetralin and Indan Analogues of 3,4-Methylenedioxyamphetamine (MDA).
Nash J F, Meltzer H Y, Gudelsky G A, Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbers
Johnson M P, Huang X, Oberlender R, Nash J F, Nichols D E, Behavioural, Biochemical and Neurotoxicological Actions of the alpha-Ethyl Homologue of p-Chloroamphetamine.
Hiramatsu M, Cho A K, Enantiomeric Differences in the Effects of 3,4-Methylenedioxymethamphetamine on Extracellular Monoamines and Metabolites in the Striatum of Freely-Moving Rats: An in vivo Microdialysis Study
Hashimoto K, Goromaru T, Reduction of [3H] 6-Nitroquipazine-labelled 5-Hydroxytrypatmine Uptake Sites in Rat Brain by 3,4-Methylenedioxymethamphetamine.
Hashimoto K, Goromaru T, Reduction of in vivo Binding of [3H]Paroxetine in Mouse Brain by 3,4-Methylenedioxymeth-amphetamine.
Gaylor D W, Slikker Jr W, Risk Assessment for Neurotoxic Effects.
Defrese G D R, (+/-)-3,4-Methylenedioxymethamphetamine (MDMA): Extending the Debate Regarding Clinical Implications of its Neurotoxicity. Unpublished manuscript
Finnegan K T, Skratt J J, Irwin I, Langston J W, The N-Methyl-D-aspartate (NMDA) Receptor Antagonist, Dextrorphan, Prevents the Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in Rats.
Battaglia G, Zaczek R, De Souza E, MDMA Effects in Brain: Pharmacologic Profile and Evidence of Neurotoxicity from Neurochemical and Autoradiographic Studies. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Yousif M Y, Fitzgerald R L, Narasimhachari N, Rosecrans J A, Blanke R V, Glennon R A, Identification of Metabolites of 3,4-Methylenedioxymethamphetamine in Rats.
Hiramatsu M, Kumagai Y, Unger S E, Cho A K, Metabolism of Methylenedioxymethamphetamine: Formation of Dihydroxymethamphetamine and a Quinone Identified as its Glutathione Adduct.
Fitzgerald R L, Blanke R V, Poklis A, Stereoselective Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in the Rat.
Cho A K, Hiramatsu M, Distefano E W, Chang A S, Jenden D J, Stereochemical Differences in the Metabolism of 3,4-Methylenedioxymethamphetamine in vivo and in vitro: A Pharmacokinetic Analysis.
Shulgin A T, How Similar is Substantially Similar?
Bradberry C W, Sprouse J S, Aghajanian G K, Roth R H, 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Release of Endogenous Serotonin from the Rat Dorsal Raphe Nucleus in vitro: Effects of Fluoxetine and Tryptophan.
Azmitia E C, Murphy R B, Whitaker-Azmitia P M, MDMA (Ecstasy) Effects on Cultured Serotonergic Neurons: Evidence for Ca 2+ -Dependent Toxicity Linked to Release.
Dowling G P, Human Deaths and Toxic Reactions Attributed to MDMA and MDEA. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Anon,
Peroutka S J, Recreational Use of MDMA, Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Price L H, Krystal J H, Heninger G R, Ricaurte G A, In Reply Arch. Gen. Psychiatry
Greer G, Tolbert R, The Therapeutic Use of MDMA. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Grob C, Bravo G, Walsh R, Second Thoughts on 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxicity.
Beck J, The Public Health Implications of MDMA Use. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S J Peroutka
Hashimoto K, Hirai K, Goromaru T, Synthesis of Racemic, S(+)- and R(-)-N-[methyl-3H] 3,4-Methylenedioxymethamphetamine.
Nash J F, Meltzer H Y, Neuroendocrinological Effects of MDMA in the Rat. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka.
Poland R E, Diminished Corticotropin and Enhanced Prolactin Responses to 8-Hydroxy-2-(di-n-propylamino)tetralin in Methylenedioxymethamphetamine Pretreated Rats.
Hanson G R, Merchant K M, Johnson M, Letter A A, Bush L, Gibb J W, Effect of MDMA-like Drugs on CNS Neuropeptide Systems. The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Ed: S.J. Peroutka.
Verweij A, Clandestine Manufacture of 3,4-Methylenedioxymethylamphetamine (MDMA) by low pressure Reductive Amination. A Mass Sectrometric Study of some Reaction Mixtures.
Julian E A, Microcrystalline Identification of Drugs of Abuse: The Psychedelic Amphetamine.
Kunsman G W, Manno J E, Cockerham K R, Manno B R, Application of the Syva EMIT and Abbott TDx Amphetamine Immuniassays to the Detection of 3,4-Methylenedioxmethamphetamine (MDMA) and 3,4-Methylenedioxyethamphetamine (MDEA) in Urine.
Cody J T, Detection of D,L-Amphetamine, D,L-Methamphetamine, and Illicit Amphetamine Analogs Using Diagnostic Products Corporation's Amphetamine and Methamphetamine Radioimmunoassay.
DeRuiter J, Clark C R, Noggle Jr. F T, Liquid Chromatographic and Mass Spectral Analysis of 1-(3,4-Methylenedioxyphenyl)-1-propanamines: Regioisomers of the 3,4- Methylenedioxyamphetamines.
Cody J T, Cross-Reactivity of Amphetamine Analogues with Roche Abuscreen Radioimmunoassay Reagents,
Clark C R, Noggle F T, De Ruiter J, Liquid Chromatographic and Mass Spectal Analysis of N,N-disubstituted 3,4-Methylenedioxyamphetamines.
Greenberg H S, et al., Marijuana and its effect on postural stability in Multiple Sclerosis patients with controls
Mauer M, et al., Delta-9-tetrahydrocannabinol shows anti-spastic and analgesic effects in a single case double-blind trial
Frankel J P, et al., Marijuana for Parkinsonian tremor
Guimares F S, et al., Anxiolytic effect of cannabidiol in the elevated plus-maze
R Oberlender, DE Nichols, (+)-N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a Discriminative Stimulus in Studies of 3,4-Methyenedioxymethamphetamine-like Behavioral Activity
DE Nichols, MP Johnson, R Oberlender, 5-Iodo-2-aminoindan, a Non-neurotoxic Analogue of para-Iodoamphetamine
MP Johnson, X Huang, R Oberlender, JF Nash, DE Nichols, Behavioral, Biochemical, and Neurotoxicological Actions of the alpha-Ethyl Homologue of p-Chloroamphetamine (PCA)
JP Mayer, JM Cassady, DE Nichols, An Improved Synthesis of 6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole
WK Brewster, DE Nichols, RM Riggs, TW Lovenberg, DM Mottola, RC Lee, MH Lewis, RB Mailman, Trans-10,11-Dihydroxy-5,6,6a,7,8,12b-Hexahydroben zo[a]phe-nanthridine: A Highly Potent Selective Dopamine D1 Full Agonist
Bunker C F, Johnson M, Hanson G R, Gibb J W, The acute effects of a single dose of 4-methylaminorex on rat brain neurochemistry
Glennon R A, Misenheimer B, Stimulus properties of a new designer drug: 4-methylaminorex (U4Euh)
Noggle F T, Clark C R, DeRuiter J, Comparative analytical profiles for 4,5-dihydro-5-phenyl-2-oxazolamine (aminorex) and 4,5-dihydro-4-phenyl-2-oxazolamine (rexamine)
White H S, Bunker C F, Gibb J W, Hanson G R, Characterization of seizures induced by i.c.v. administration of cocaine, methamphetamine and 4-methylaminorex (4-MAX)
Bunker C F, Johnson M, Gibb J W, Bush L G, Hanson G R, Neurochemical effects of an acute treatment with 4-methylaminorex, a new stimulant of abuse
Gerard F, Pain, Death and LSD: A Retrospective on the work of Dr. Eric Kast
McKenna, D. J. and Peroutka, S. J., Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Pandey, G. N., Pandey, S. C., Janicak, P. G., et al, Platelet serotonin-2 receptor binding sites in depression and suicide.
Yousif MY, Fitzgerald RL, Narasimhachari N, Rosecrans JA, Blanke RV, Glennon RA, Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats
Zacny JP, Virus RM, Woolverton WL, Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine
Wright JD, Pearl L, Knowledge and experience of young people regarding drug abuse, 1969-89
Verweij AM, Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures
Winslow JT, Insel TR, Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine
Teitler M, Leonhardt S, Appel NM, De Souza EB, Glennon RA, Receptor pharmacology of MDMA and related hallucinogens
Schmidt CJ, Taylor VL, Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors
Seiden LS, MDMA and Related Compounds: Session Summary
Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK, 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan
Schmidt CJ, Kehne JH, Neurotoxicity of MDMA: neurochemical effects
Schmidt CJ, Black CK, Taylor VL, Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine
Schmidt CJ, Black CK, Abbate GM, Taylor VL, Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine
Schmidt CJ, Black CK, Abbate GM, Taylor VL, Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors
Schmidt CJ, Abbate GM, Black CK, Taylor VL, Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats
Scheffel U, Ricaurte GA, Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
Poland RE, Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats
Ricaurte GA, Finnegan KT, Irwin I, Langston JW, Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations
Piercey MF, Lum JT, Palmer JR, Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat
Paulus MP, Geyer MA, Gold LH, Mandell AJ, Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior
Oberlender R, Nichols DE, (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity
Nichols DE, Oberlender R, Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?
Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM, Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)
Nash JF, Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis
Nash JF, Meltzer HY, Gudelsky GA, Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens
Meilman PW, Gaylor MS, Turco JH, Stone JE, Drug use among college undergraduates: current use and 10-year trends
Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA, Neurotoxicity of MDMA and related compounds: anatomic studies
McKenna DJ, Peroutka SJ, Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
Kunsman GW, Manno JE, Cockerham KR, Manno BR, Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine
Kosten TR, Neurobiology of abused drugs. Opioids and stimulants
Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE, Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine
Hiramatsu M, Kumagai Y, Unger SE, Cho AK, Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct
Hekmatpanah CR, Peroutka SJ, 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
Hiramatsu M, Cho AK, Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: an in vivo microdialysis study
Hashimoto K, Goromaru T, Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine
Grob C, Bravo G, Walsh R, Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity
Hashimoto K, Goromaru T, Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine
Greer GR,Tolbert R, The Therapeutic Use of MDMA
Gibb JW, Johnson M, Stone D, Hanson GR, MDMA: historical perspectives
Gibb JW, Johnson M, Hanson GR, Neurochemical basis of neurotoxicity
Gaylor DW, Slikker W Jr, Risk assessment for neurotoxic effects
Fitzgerald RL, Blanke RV, Poklis A, Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine in the rat
Fitzgerald JL, Reid JJ, Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices
Evans SM, Zacny JP, Johanson CE, Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons
Finnegan KT, Skratt JJ, Irwin I, Langston JW, The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats
Cody JT, Cross-reactivity of amphetamine analogues with Roche Abuscreen radioimmunoassay reagents
Davies JB, Ditton J, The 1990s: decade of the stimulants?
De Souza EB, Battaglia G, Insel TR, Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies
Cody JT, Detection of D,L-amphetamine, D,L-methamphetamine, and illicit amphetamine analogs using diagnostic products corporation's amphetamine and methamphetamine radioimmunoassay
Cho AK, Hiramatsu M, Distenfamo EW, Chang AS, Jenden DJ, Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis
Callaway CW, Wing LL, Geyer MA, Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats
Bilsky EJ, Hui YZ, Hubbell CL, Reid LD, Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage
Beck J, Rosenbaum M, The Scheduling of MDMA ('Ecstasy')
Azmitia EC, Murphy RB, Whitaker-Azmitia PM, MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release
Doblin R,
New Age Chemist, A chemical and pharmacological review of U4Euh / Intellex
Zizzo P, MDMA - Aspects of it's Psychopharmacology.
Beck J, Harlow D, McDonnell D, Morgan P A, Rosenbaum M, Watson L, Exploring Ecstasy: A Description of MDMA Users. Report to NIDA
Browne M W, Problems loom in effort to control use of chemicals for illicit drugs
Anon, Deal mit Cadillac (September 4, 1989); Ecstasy und Cadillac
Liester M B, Grob C S, Bravo G L, Walsh R N, A Study of MDMA Use Among Psychiatrists. Poster #NR-62, New Research Poster Session, American
Doblin R, Regulation or Prohibition? MDMA Research in Switzerland and the United States.
Garfinkel S L, The Price of Ecstasy.
Corliss J, Agonizing over Ecstasy.
Rudolph R, Trial starts for Fair Lawn couple accused of making designer drug
Lyman WD, Sonett JR, Brosnan CF, Elkin R, Bornstein MB, Delta 9- tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis
Sterling G, Husband and wife draw jail terms for manufacturing designer drug
Szabo P, MDMA Restrictions too Hasty?
Anon, Mind-bending Drug Could Leave Brains Permanently Warped.
Goldstein R, The Facts about 'Ecstasy' A Talk with Andrew Weil.
Meinck HM, Schonle PW, Conrad B, Effect of cannabinoids on spasticity and ataxia in multiple sclerosis
Beebe D K, Walley E, Update on Street Drugs in Mississippi.
Doblin R, MDMA: Risk Assessment and the FDA.
Hekmatpanah C R, McKenna D J, Peroutka S J, Reserpine does not Prevent 3,4-Methylenedioxyamphetamine-induced Neurotoxicity in the Rat.
Dax EM, Pilotte NS, Adler WH, Nagel JE, Lange WR, The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function
Nadelman EA, Drug Prohibition in the United States: costs, Consequences, and Alternatives
Grossbard, A., Evaluation of a Shamanic Oriented Psychotherapy Process.
Grof, Stanislav, Psychedelische Therapie und Holonomische Integration. Folgerungen aus der modernen Bewußtseinsforschung für die Transpersonale Psychologie. [Psychedelic Therapy and Holonomic Integration. Implications of Modern Consciousness Research for Transpersonal Psychology.]
Schultz-Wittner, Thomas, Mit psychoaktiven Substanzen unterstützte Psychotherapie bei negativ prognostizierten Patienten - Neue katamnestische Ergebnisse. [Psychotherapy with the Aid of Psychoactive Substances in Patients with Negative Prognoses - New Catamnestic Results.]
Naranjo, Claudio, Ayahuasca Imagery and the Therapeutic Property of Harmala Alkaloids.
Ka-Tzetnik 135633, Shivitti; Vision.
Yensen, Richard, From Mysteries to Paradigms: Humanity's Journey from Sacred Plants to Psychedelic Drugs.
Leuner, Hanscarl; Schlichting, Michael, A Report on the SymPosion on the Current State of Research in the Area of Psychoactive Substances.
Grof, Stanislav, Auf der Schwelle zum Leben. Die Geburt: Tor zur Transpersonalität und Spiritualität.
Grof, Stanislav, Beyond the Brain: New Dimensions in Psychology and Psychotherapy.
Greer, George, Using Altered States to Experience Choice.
Benz, Ernst, Halluzinogen-unterstützte Psychotherapie. Erhebung bei der Schweizerischen Aerztegesellschaft für Psycholytische Therapie. [Hallucinogen-Assisted Psychotherapy. An Evaluation at the Swiss Physicans Society of Psycholytic Therapy.]
Bravo, Gary; Grob, Charles, Shamans, Sacraments and Psychiatrists.
Wright W R, XTC, Analyte of the Month
Whitaker-Azmitia P M, Depression to Ecstasy.
Riedlinger T, Riedlinger J, The 'Seven Deadly Sins' of Media Hype in Light of the MDMA Controversy.
Nichols D E, Oberlender R, Structure-Activity Relationships of MDMA-Like Substances
Peroutka S J, 'Ecstasy': A Human Neurotoxin?
Nasmyth P, Laing on Ecstasy.
Laverty R, Logan B J, Ecstasy Abuse.
Doblin R, Risk Assessment: The FDA and MDMA Research.
Edwards G, Blasted with Ennui.
Eisner B, ECSTASY, The MDMA Story.
Farrell M, Ecstasy and the Oxygen of Publicity.
Beebe D K, Walley E, Update on Street Drugs in Mississippi.
Steele T D, Nichols D E, Yim G K, MDMA Transiently Alters Biogenic Amines and Metabolites in Mouse Brain and Heart.
Spanos L J, Yamamoto B K, Acute and Subchronic Effects of Methylenedioxymethamphetamine [(+/-) MDMA] on Locomotion and Serotonin Syndrome Behaviour in the Rat.
Sprouse J S, Bradberry C W, Roth R H, Aghajanian G K, MDMA 3,4-Methylenedioxymeth-amphetamine Inhibits the Firing of Dorsal Raphe Neurons in Brain Slices via Release of Serotonin.
Matthews R T, Champney T H, Frye G D, Effects of (+/-)-Methylenedioxymethamphetamine (MDMA) on Brain Dopaminergic Activity in Rats.
Mansbach R S, Braff D L, Geyer M A, Prepulse Inhibition of the Acoustic Startle Response is Disrupted by N-Ethyl-3,4-methylenedioxyam-phetamine (MDEA) in the Rat.
Li A A, Marek G J, Vosmer G, Seiden L S, Long-Term Central 5-HT Depletions Resulting from Repeated Administration of MDMA Enhances the Effects of Single Administration of MDMA on Schedule-Controlled Behaviour of Rats
Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho A K, The Effect of Optical Isomers of 3,4-Methylenedioxymethamphetamine (MDMA) on Stereotyped Behaviour in Rats.
Gold L H, Koob G F, MDMA Produces Stimulant-like Conditioned Locomotor Activity
Gold L H, Geyer M A, Koob G F, Psychostimulant Properties of MDMA.
Gold L H, Geyer M A, Koob G F, Neurochemical Mechanisms Involved in Behavioural Effects of Amphetamines and Related Designer Drugs.
Gold L H, Hubner C B, Koob G F, A Role for the Mesolimbic Dopamine System in the Psychostimulant Actions of MDMA.
Glennon R A, Misenheimer B R, Stimulus Effects of N-Monoethyl-1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDE) and N-Hydroxy-1-(3,4-Methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in Rats Trained to Discriminate MDMA from Saline.
Gazzara R A, Takeda H, Cho A K, Howard S G, Inhibition of Dopamine Release by Methylenedioxymethamphetamine is Mediated by Serotonin
Dimpfel W, Spuler M, Nichols D E, Hallucinogenic and Stimulatory Amphetamine Derivatives: Fingerprinting DOM, DOI, DOB, MDMA, and MBDB by Spectral Analysis of Brain Field Potentials in the Freely Moving Rat (Tele-Stereo-EEG).
Crisp T, Stafinsky J L, Boja J W, Schechter M D, The Antinociceptive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in the Rat.
Zaczek R, Hurt S, Culp S, DeSouza E B, Characterization of Brain Interactions with Methylenedioxyamphetamine and Methylenedioxymethamphetamine.
Wilson M A, Ricaurte G A, Molliver M E, Distinct Morphologic Classes of Serotoninergic Axons in Primates Exhibit Differential Vulnerability to the Psychotropic Drug 3,4-Methylenedioxymethamphetamine.
Slikker Jr W, Holson R R, Ali S F, Kolta M G, Paule M G, Scallet A C, McMillan D E, Bailey J R, Hong J S, Scalzo F M, Behavioural and Neurochemical Effects of Orally Administered MDMA in the Rodent and Nonhuman Primate.
Schmidt C J, Acute and Long-term Neurochemical Effects of Methylenedioxmethamphetamine in the Rat.
Schlechter M D, Serotonergic-Dopaminergic Mediation of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy").
Nader M A, Hoffmann S M, Barrett J E, Behavioural Effects of (+/-) 3,4-Methylenedioxyamphetamine (MDA) and (+/-) 3,4-Methylenedioxymethamphetamine (MDMA) in the Pigeon: Interactions with Noradrenergic and Serotoninergic Systems.
Molliver M E, Mamounas L A, Wilson M A, Effects of Neurotoxic Amphetamines on Serotonergic Neurons: Immunocytochemical Studies.
Lowe M T, Nash Jr. J F, Meltzer H Y, Selective Reduction of Striatal Type-II Glucocorticoid Receptors in Rats by 3,4-Methylenedioxymethamphetamine (MDMA).
Kelland M D, Freeman A S, Chiodo L A, (+/-)-3,4-Methylenedioxymethamphetamine-induced Changes in the Basal Activity and Pharmacological Responsiveness of Nigrostriatal Dopamine Neurons.
Kleven M S, Woolverton W L, Seiden L S, Evidence that both Intragastric and Subcutaneous Administration of Methylenedioxmethamphetamine (MDMA) Produce Serotonin Neurotoxicity in Rhesus Monkeys.
Johnson M, Stone D M, Bush L G, Hanson G R, Gibb J W, Glucocorticoid and 3,4-Methylenedioxymethamphetamine (MDMA)-induced Neurotoxicity
Johnson M P, Nichols D E, Neurotoxin Effects of the Alpha-Ethyl Homologue of MDMA Following Subacute Administration.
Insel T R, Battaglia G, Johannessen J N, Marra S, De Souza E B, 3,4-Methylenedioxymethamphetamine ("Ecstasy") Selectively Destroys Brain Serotonin Terminals in Rhesus Monkeys.
Gollamudi R, Ali S F, Lipe G, Newport G, Webb P, Lopez M, Leakey J E A, Kolta M, Slikker Jr W, Influence of Inducers and Inhibitors on the Metabolism in vitro and Neurochemical Effects in vivo of MDMA.
Hanson G R, Sonsalla P, Letter A, Merchant K M, Johnson M, Bush L, Gibb J W, Effects of Amphetamine Analogs on Central Nervous System Neuropeptide Systems.
Gold L H, Hubner C B, Koob G F, A Role for the Mesolimbic Dopamine System in the Psychostimulant Actions of MDMA.
De Souza E B, Battaglia G, Effects of MDMA and MDA on Brain Serotonin Neurons: Evidence from Neurochemical and Autoradiographic Studies.
Battaglia G, De Souza E B, Pharmacologic Profile of Amphetamine Derivatives at Various Brain Recognition Sites: Selective Effects on Serotonergic Systems.
Ali S F, Scallet A C, Newport G D, Lipe G W, Holson R R, Slikker Jr. W, Persistent Neurochemical and Structural Changes in Rat Brain after Oral Administration of MDMA.
Lim H K, Foltz R L, Identification of Metabolites of 3,4-Methylenedioxymethamphetamine in Human Urine.
Whitaker-Azmitia P M, Aronson T A, "Ecstasy" (MDMA)-Induced Panic.
Price L H, Ricaurte G A, Krystal J H, Heninger G R, Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users.
Ricaurte G A, Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates: A Basis for Evaluating Long-Term Effects in Humans.
Ellis P, Schimmel P, Ecstasy Abuse.
Widmer S, Ins Herz der Dinge Lauschen, vom Erwachen der Liebe.
Cerveny L, Kozel J, Marhoul A, Synthesis of Heliotropin.
Wilkerson G, London E D, Effects of Methylenedioxymethamphetamine on Local Cerebral Glucose Utilization in the Rat.
Stone D M, Johnson M, Hanson G R, Gibb J W, Acute Inactivation of Tryptophan Hydroxylase by Amphetamine Analogs Involves the Oxidation of Sulfhydryl Sites.
Johnson M, Hanson G R, Gibb J W, Effect of MK-801 on the Decrease in Tryptophan Hydroxylase Induced by Methamphetamine and its Methylenedioxy Analog.
Noggle F T, Clark C R, DeRuiter J, Liquid Chromatorgraphic and Mass Spectral Analysis of 1-(3,4-Methylenedioxyphenyl)-3-Butanamines, Homologues of 3,4-Methylenedioxyamphetamines.
Fitzgerald R L, Blamke R V, Glennon R A, Yousif M Y, Rosecrans J A, Poklis A, Determination of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Enantiomers in Whole Blood.
Dal Cason T, The Characterization of Some 3,4-Methylenedioxyphenylisopropylamine (MDA) Analogs.
Lyman W D, et al., Delta-9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalitis
Meinck H M, et al., Effect of cannabinoids on spasticity and ataxia in Multiple Sclerosis
Moss D E, et al., Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders
Burstein S H, et al., Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid
Formukong E A, et al., The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation.
Karler R, et al., Pentylenetetrazole kindling in mice.
By A W, Dawson B A, Lodge B A, Sy W W, Spectral distinction between cis- and trans- 4-methylaminorex;
Glennon R A, Misenheimer B, Stimulus properties of a new designer drug: 4-methylaminorex (U4Euh)
Klein R F X, Sperling A R, Cooper D A, Kram T C, The stereoisomers of 4-methylaminorex
Hekmatpanah, C. R., McKenna, D. J., and Peroutka, S. J., Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
Carvey, P., Nausieda, P., Weertz, R., et al, LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
Zaczek R, Hurt S, Culp S, De Souza EB, Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine
Wilson MA, Ricaurte GA, Molliver ME, Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine
Wilkerson G, London ED, Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat
Whitaker-Azmitia PM, Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989
Whitaker-Azmitia PM, Aronson TA, 'Ecstasy' (MDMA)-induced panic
Stone DM, Johnson M, Hanson GR, Gibb JW, Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites
Steele TD, Nichols DE, Yim GK, MDMA transiently alters biogenic amines and metabolites in mouse brain and heart
Stone DM, Hanson GR, Gibb JW, In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine
Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK, MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin
Spanos LJ, Yamamoto BK, Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat [published erratum appears in Pharmacol Biochem Behav 1989 Nov;34(3):679]
Seiden LS, Kleven MS, Methamphetamine and related drugs: toxicity and resulting behavioral changes in response to pharmacological probes
Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM, Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate
Schmidt CJ, Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat
Schechter MD, Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, ''ecstasy'')
Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M, Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis
Ricaurte GA, Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans
Price LH, Ricaurte GA, Krystal JH, Heninger GR, Responses to I.V. L-tryptophan in MDMA Users
Price LH, Ricaurte GA, Krystal JH, Heninger GR, Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations
Peroutka SJ, 'Ecstasy': a human neurotoxin?
Nichols DE, Oberlender R, Structure-activity relationships of MDMA-like substances
Nichols DE, Oberlender R, Burris K, Hoffman AJ, Johnson MP, Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues
Molliver ME, Mamounas LA, Wilson MA, Effects of neurotoxic amphetamines on serotonergic neurons: immunocytochemical studies
Nader MA, Hoffmann SM, Barrett JE, Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems
Miczek KA, Tidey JW, Amphetamines: aggressive and social behavior
Matthews RT, Champney TH, Frye GD, Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats
Mansbach RS, Braff DL, Geyer MA, Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat
Lorens SA, Hata N, Cabrera T, Hamilton ME, Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine
Lowy MT, Nash JF Jr, Meltzer HY, Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA)
Lim HK, Foltz RL, Identification of metabolites of 3,4-(methylenedioxy)methamphetamine in human urine
Laverty R, Logan BJ, Ecstasy abuse
Li AA, Marek GJ, Vosmer G, Seiden LS, Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats
Kleven MS, Woolverton WL, Seiden LS, Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys
Kleven MS, Seiden LS, Toxicity of Amphetamine-related Drugs and Resulting Behavioural Changes
Kelland MD, Freeman AS, Chiodo LA, (+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons
Johnson MP, Nichols DE, Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration
Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW, Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity
Johnson M, Hanson GR, Gibb JW, Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog
Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB, 3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys brain serotonin terminals in rhesus monkeys
Hekmatpanah CR, McKenna DJ, Peroutka SJ, Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat
Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho AK, The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats
Hanson GR, Sonsalla P, Letter A, Merchant KM, Johnson M, Bush L, Gibb JW, Effects of amphetamine analogs on central nervous system neuropeptide systems
Gollamudi R, Ali SF, Lipe G, Newport G, Webb P, Lopez M, Leakey JEA, Kolta M, Slicker W Jr, Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA
Gold LH, Koob GF, MDMA produces stimulant-like conditioned locomotor activity
Gold LH, Hubner CB, Koob GF, A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA
Gold LH, Geyer MA, Koob GF, Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs
Gold LH, Geyer MA, Koob GF, Psychostimulant properties of MDMA
Gibb JW, Stone DM, Johnson M, Hanson GR, Role of dopamine in the neurotoxicity induced by amphetamines and related designer drugs
Glennon RA, Misenheimer BR, Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline
Gazzara RA, Takeda H, Cho AK, Howard SG, Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin
Fitzgerald RL, Blanke RV, Rosecrans JA, Glennon RA, Stereochemistry of the metabolism of MDMA to MDA
Ellis P, Schimmel P, Ecstasy abuse
Farrell M, Ecstasy and the oxygen of publicity
Fitzgerald RL, Blanke RV, Glennon RA, Yousif MY, Rosecrans JA, Poklis A, Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood
Dimpfel W, Spuler M, Nichols DE, Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG)
Crisp T, Stafinsky JL, Boja JW, Schechter MD, The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat
De Souza EB, Battaglia G, Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies
Beebe DK, Walley E, Update on street drugs in Mississippi
Battaglia G, De Souza EB, Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems
Harbin H, MDMA. Narcotics, Forfeiture, and Money-Laundering Update, U.S. Department of Justice, Criminal Division.
AT Shulgin, DIPT: the distortion of music
Anon, The Hyping of Ecstasy
Monti J A, Beaton J M, Benington F, Morin R D, Christian S T, MDMA and MBDB Potentiate Phorbol Ester-Stimulated Catecholamine Release from PC-12 Cells.
Meyers M A, Memorandum in Support of Motion to Dismiss In the United States District Court for the Southern District of Texas, Houston Division, The United Sates of America v. A.E. Quarles, CR. No. H-88-83
Yensen R, Toward a Psychedelic Medicine - Helping at the Edge of Life. Perspectives of a Psychedelic Therapist
Hollister LE, Marijuana and immunity. [Review] [42 refs]
Heise K, Dr. Eric Kast, 72, ran free health clinic
Sandyk R, Awerbuch G, Marijuana and Tourette's syndrome [letter]
Formukong EA, Evans AT, Evans FJ, Analgesic and antiinflammatory activity of constituents of Cannabis sativa L
von Hoyer E, The Agony of Ecstasy; A Consumer's Guide. Identified with "WRT 404 / S. Hubbard"
AT Shulgin, THE CONTROLLED SUBSTANCES ACT: A resource manual of the current status of the federal drug laws
Alan J. Budney, Warren K. Bickel, Leslie Amass, Marijuana use and treatment outcome among opioid-dependent patients
Hollister LE, Cannabis
Horowitz, Michael; Walls, Katrin; Smith, Billy, An Annoted Bibliography of Timothy Leary.
Bolle, Ralf H., Am Ursprung der Sehnsucht. Tiefenpsychologische Aspekte veränderter Wachbewußtseinszustände am Beispiel des Anästhetikums KETANEST. [At the Origin of Longing. Depth-Psychological Aspects of Altered States of Waking Consciousness with the Anaesthetic KETANEST.]
Yensen, Richard, From Mysteries to Paradigms: Humanity's Journey From Sacred Plants to Psychedelic Drugs.
Grof, Stanislav, Theoretische und empirische Basis der Transpersonalen Psychotherapie - Beobachtungen aus der LSD-Forschung. [Theoretical and Empirical Foundations of Transpersonal Psychotherapy - Observations from LSD Research.] In: Boorstein, Seymour (ed.): Transpersonale Psychotherapie.
Hansen, Gustav; Jensen, Sven Boel; Chandresh, Lars; Hilden, Thomas, The Psychotropic Effects of Ketamine.
Adamson, Sophia; Metzner, Ralph, The Nature of the MDMA Experience and its Role in HeaLing, Psychotherapy, and Spiritual Practice.
Akihiko Himeno, Dennis J. McKenna, Adil J. Nazarali, Juan M. Saavedra, (±)DOI, a hallucinogenic phenylalkylamine, downregulates 5HT₂ receptors in rat brain
Bost R O, 3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives.
Barnes D M, New Data Intensifies the Agony over Ecstasy.
Stone D M, Johnson M, Hanson G R, Gibb J W, Role of Endogenous Dopamine in the Central Serotonergic Deficits Induced by 3,4-Methylenedioxymethamphetamine.
Schechter M D, Advantages and Disadvantages of a Rapid Method to Train Drug Discrimination. Pharmacol.
Scallet A C, Lipe G W, Ali S F, Holson R R, Frith C H, Slikker Jr W, Neuropathological Evaluation by Combined Immunohistochemistry and Degeneration-Specific Methods: Application to Methylenedioxymethamphetamine.
Nash Jr. J F, Meltzer H Y, Gulesky G A, Elevation of Serum Prolactin and Corticosterone Concentrations in the Rat after the Administration of 3,4-Methylenedioxymethamphetamine.
Nencini P, Woolverton W L, Seidin L S, Enhancement of Morphine-induced Analgesia after Repeated Injections of Methylenedioxymethamphetamine.
Oberlender R, Nichols D E, Drug Discrimination Studies with MDMA and Amphetamine.
Hubner C B, Bird M, Rassnick S, Lornetsky C, The Threshold Lowering Effects of MDMA (Ecstasy) on Brain-stimulating Reward.
Gold L H, Koob G F, Methysegide Potentialtes the Hyperactivity Produced by MDMA in Rats.
Glennon R A, Yousif M, Patrick G, Stimulus Properties of 1-(3,4-Methylenedioxy)-2-Aminopropane (MDA) analogs.
Callahan P M, Appel J B, Differences in the Stimulus Properties of 3,4-Methylenedioxyamphetamine and 3,4- Methylenedioxmethamphetamine in Animals Trained to Discriminate Hallucinogens from Saline.
Yamamoto B K, Spanos L J, The Acute Effects of Methylenedioxymethamphetamine on Dopamine Release in the Awake-behaving Rat.
Slikker Jr W, Ali S F, Scallet A C, Firth C H, Newport G D, Bailey J R, Neurochemical and Neurohistological Alterations in the Rat and Monkey Produced by Orally Administered Methylenedioxmethamphetamine (MDMA).
Schmidt C J, Taylor V L, Direct Central Effects of Acute Methylenedioxymethamphetamine on Serotonergic Neurons.
Ricaurte G A, Forno L S, Wilson M A, DeLanney L E, Irwin I, Moliver M E, Langston J W, (+/-) 3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates.
Ricaurte G A, DeLanney L E, Irwin I, Langston J W, Toxic Effects of MDMA on Central Serotonergic Neurons in the Primate: Importance of Route and Frequency of Drug Application.
Ricaurte G A, DeLanney L E, Wiener S G, Irwin I, Langston J W, 5-Hydroxyindoleacetic acid in Cerebrospinal Fluid Reflects Serotonergic Damage Induced by 3,4-Methylenedioxymethamphetamine in CNS of Non-human Primates.
Peroutka S J, Relative Insensitivity of Mice to 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxocity.
Pierce P A, Peroutka S J, Ring-substituted Amphetamine Interactions with Neurotransmitter Receptor Binding Sites in Human Cortex.
O'Hearn E, Battaglia G, De Souza E B, Kuhar M J, Molliver M E, Methylenedioxyamphetamine (MDA) and Methylenedioxymethamphetamine (MDMA) Cause Selective Ablation of the Serotoninergic Axon Terminals in Forebrain: Immunocytochemical Evidence for Neurotoxicity.
Kalix P, Yousif M Y, Glennon R A, Differential Effects of the Enantiomers of Methylenedioxymethamphetamine (MDMA) on the Release of Radioactivity from (3H)Dopamine-Prelabeled Rat Striatum.
Logan B J, Laverty R, Sanderson W D, Yee Y B, Differences Between Rats and Mice in MDMA (Methylenedioxmethamphetamine) Neurotoxicity.
Johnson M, Hanson G R, Gibb J W, Effects of Dopaminergic and Serotonergic Receptor Blockade on Neurochemical Changes Induced by Acute Administration of Methamphetamine and 3,4-Methylenedioxymethamphetamine.
Johnson M, Letter A A, Merchant K, Hanson G R, Gibb J W, Effects of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Isomers on Central Serotonergic, Dopaminergic and Nigral Neurotensin Systems of the Rat.
Finnigan K T, Ricaurte G A, Ritchie L D, Irwin I, Peroutka S J, Langston J W, Orally Administered MDMA Causes a Long-term Depletion of Serotonin in Rat Brain.
Battaglia G, Yeh S Y, De Souza E B, MDMA-Induced Neurotoxicity: Parameters of Degeneration and Recovery of Brain Serotonin Neurons.
Lim H K, Foltz R L, In Vivo and In Vitro Metabolism of 3,4-Methylenedioxymethamphetamine in the Rat: Identification of Metabolites using an Ion Trap Detecor.
Fitzgerald R L, Blanke R, Narasimhachari N, Glennon R, Rosecrans J, Identification of 3,4-Methylenedioxyamphetamine (MDA) as a Major Urinary Metabolite of 3,4-Methylenedioxymethamphetamine (MDMA). NIDA Research Monograph #81
Lawn J C, Schedules of Controlled Substances; Deletion of 3,4-Methylenedioxymethamphetamine (MDMA) From Schedule I of the Controlled Substances Act.
Lawn J C, Schedules of Controlled Substances; Scheduling of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act; Remand.
Battaglia G, Brooks B P, Kulsakdinum C, De Souza E B, Pharmacologic Profile of MDMA 3,4-Methylenedioxymeth-amphetamine at Various Brain Recognition Sites.
Verebey K, Alrazi J, Jaffe J H, The Complications of "Ecstasy" (MDMA).
Suarez R V, Riemersma R, "Esctasy" and Sudden Cardiac Death.
Peroutka S J, Newman H, Harris H, Subjective Effects of 3,4-Methylenedioxymethamphetamine in Recreational Users.
Sutherland G J, 3,4-Methylenedioxymethamphetamine (MDMA) A Basis for Quantitation by UV Spectrophotometry.
Ruangyuttikarn W, Moody D E, Comparison of Three Commercial Amphetamine Immunoassays for Detection of Methamphetamine, Methylenedioxyamphetamine, Methylenedioxymethamphetmaine, and Methylenedioxyethylamphetamine.
Ramos J M, Johnson S, Poklis A, MDMA and MDA Cross Reactivity Observed with Abbott TDx Amphetamine/Methamphetamine Reagents.
Noggle Jr. R T, Clark C R, Valaer A K, DeRuiter J, Liquid Chromatographic and Mass Spectral Analysis of N-Substituted Analogues of 3,4-Methylenedioxyamphetamine.
Anon, Analytical Profiles of Substituted 3,4-Methylenedioxyamphetamines: Designer Drugs Related to MDA.
Ruchman M C, Role of cannabidiol in the medical treatment of Meige's syndrome
Formukong E A, et al., Analgesic and anti-inflammatory activity of constituents of Cannabis sativa L.
Davis F T, Brewster M E, A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine;
Friendly Stranger, U4Euh also known as Intellex
Suarez RV, Riemersma R, 'Ecstasy' and sudden cardiac death
Verebey K, Alrazi J, Jaffe JH, The complications of 'ecstasy' (MDMA)
Yamamoto BK, Spanos LJ, The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat
Stanford MW, Designer drugs: Medical aspects and clinical management
Stone DM, Johnson M, Hanson GR, Gibb JW, Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine
Slikker W Jr, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR, Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)
Schmidt CJ, Taylor VL, Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons
Schechter MD, Advantages and disadvantages of a rapid method to train drug discrimination
Schechter MD, Use of TFMPP stimulus properties as a model of 5-HT1B receptor activation
Scallet AC, Lipe GW, Ali SF, Holson RR, Frith CH, Slikker W Jr, Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine
Ruangyuttikarn W, Moody DE, Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine
Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW, 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates
Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW, (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates
Ricaurte GA, DeLanney LE, Irwin I, Langston JW, Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration
Pierce PA, Peroutka SJ, Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex
Peroutka SJ, Newman H, Harris H, Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users
Oberlender R, Nichols DE, Drug discrimination studies with MDMA and amphetamine
O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME, Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
Nencini P, Woolverton WL, Seiden LS, Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine
Nash JF Jr, Meltzer HY, Gudelsky GA, Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine
Mamounas LA, Molliver ME, Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA)
Logan BJ, Laverty R, Sanderson WD, Yee YB, Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity
Lim HK, Foltz RL, In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector
Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW, Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat
Hubner CB, Bird M, Rassnick S, Kornetsky C, The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward
Johnson M, Hanson GR, Gibb JW, Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine
Gold LH, Koob GF, Methysergide potentiates the hyperactivity produced by MDMA in rats
Glennon RA, Yousif M, Patrick G, Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs
Finnegan KT, Ricaurte GA, Ritchie LD, Irwin I, Peroutka SJ, Langston JW, Orally administered MDMA causes a long-term depletion of serotonin in rat brain
Callahan PM, Appel JB, Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline
Bost RO, 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives
Buchanan JF, Brown CR, 'Designer drugs'. A problem in clinical toxicology
Battaglia G, Yeh SY, de Souza EB, MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons
Barnes DM, Ecstasy returns to Schedule I
Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB, Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
Sirius R U, May you never know sleep; cognition enhancing drugs
Coffin, Torruella, Pettin, Lester Grinspoon, Petitioner, v. Drug Enforcement Administration, Respondent. United States Court of Appeals for the First Circuit.
Callahan P M, Appel J B, Differences in the Stimulus Properties of 3,4-Methylenedioxyamphetamine (MDA) and N-Methyl-3,4-methylenedioxmethamphetamine (MDMA) in Animals Trained to Discriminate Hallucinogens from Saline.
Straus H, From Crack to Ecstasy; Basement Chemists can Duplicate almost any Over-the-border Drug.
Nakai M, Enomiya T, Process for Producing Phenylacetones.
Doblin R, A Proposal for Orphan Pharmaceuticals, Inc. A Division of Neurobiological Technologies, Inc.
Lawn J C, Schedules of Controlled substances Temporary placement of 2-amino-4-methyl-5-phenyl-2-oxazoline (4-methylaminorex) into Schedule 1, 52FR30174-30175
Murison G, et.al, Cannabinoids Induce Incomplete Maturation of Cultured Human Leukemia Cells
Grof, Stanislav, Psychedelische Therapie und holonome Integration: Therapeutisches Potential außergewöhnlicher Bewußtseinszustände. Beobachtungen bei psychedelischer und holotroper Therapie. [Psychedelic Therapy and Holonomic Integration: Therapeutic Potential of Non-Ordinary States of Consciousness. Observations from Psychedelic and Holotropic Therapy.]
Leuner, Hanscarl, Die Psycholytische Therapie: Durch Halluzinogene unterstützte tiefenpsychologische Psychotherapie. [Psycholytic Therapy: Depth-Psychological Psychotherapy Assisted through Hallucinogens.]
Neill, John R., "More Than Medical Significance": LSD and American Psychiatry 1953 to 1966.
Grof, Stanislav, Psychodynamic Factors in Depression and Psychosis: Observations from Modern Consciousness Research.
Grof, Stanislav, The Adventure of Self-Discovery: Dimensions of Consciousness & a New Perspective in Psychotherapy in Psychotherapy & Inner Exploration.
Grof, Stanislav, The Adventure of Self-Discovery: Dimensions of Consciousness & a New Perspective in Psychotherapy in Psychotherapy & Inner Exploration. [Das Abenteuer der Selbstentdeckung: Heilung durch veränderte Bewußtseinszustände]
Dennis J. McKenna, J. M. Saavedra, Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain
Dennis J. McKenna, C. A. Mathis, A. T. Shulgin, J. M. Saavedra, Hallucinogens bind to common receptors in the rat forebrain: a comparative study using ¹²⁵I-LSD and ¹²⁵I-DOI, a new psychotomimetic radioligand
Dennis J. McKenna, C. A. Mathis, A. T. Shulgin, Thornton Sargent III, J. M. Saavedra, Autoradiographic localization of binding sites for ¹²⁵I-(-)DOI, a new psychotomimetic radioligand, in the rat brain
, Incidence of Recreational Use of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") on an Undergraduate Campus.
Ehrnstein L B, Reflections on Drug Enforcement and Drug Use.
Thompson D M, Winsauer P J, Mastropaolo J, Effects of Phencyclidine, Ketamine and MDMA on Complex Operant Behaviour in Monkeys.
Schechter M D, MDMA as a Discriminative Stimulus: Isomeric Comparisons.
Rosecrans J A, Glennon R A, The Effect of MDA and MDMA ("Ecstasy") Isomers in Combination with Pirenpirone on Operant Responding in Mice.
Kulmala H K, Boja J W, Schechter M D, Behavioural Suppression Following 3,4-Methylenedioxymethamphetamine.
Lamb R J, Griffiths R R, Self-injection of dl-3,4-Methylenedioxymethamphetamine in the Baboon.
Glennon R A, Little P J, Rosecrans J A, Yousif M, The Effects of MDMA ("Ecstasy") and its Optical Isomers on Schedule-Controlled Responding in Mice. Pharmacol.
Yeh S Y, Hsu F-L, Neurotoxicity of Metabolites of MDA and MDMA (Ecstasy) in the Rat.
Beaton J M, Benington F, Christian S T, Monti J A, Morin R D, Analgesic Effects of MDMA and Related Compounds
Wilson M A, Ricaurte G A, Molliver M E, The Psychotropic Drug 3,4-Methylenedioxymethamphetamine (MDMA) Destroys Serotonergic Axons in Primate Forebrain: Regional and Laminar Differences in Vulnerability.
Trulson T J, Trulson M E, 3,4-Methylenedioxymethamphetamine (MDMA) Suppresses Serotonergic Dorsal Raphe Neuronal Activity in Freely Moving Cats and in Midbrain Slices in vitro.
Stone D M, Hanson G R, Gibb J W, Differences in the Central Serotonergic Effects of Methylenedioxymethamphetamine (MDMA) in Mice and Rats.
Stone D M, Merchant K M, Hanson G R, Gibb J W, Immediate and Long Term Effects of 3,4-Methylenedioxymethamphetamine on Serotonin Pathways in Brain of Rat.
Schmidt C J, Levin J A, Loverberg W, In Vitro and In Vivo Neurochemical Effects of Methylenedioxymethamphetamine on Striatal Monoaminergic Systems in the Rat Brain
Schmidt C J, Acute Administration of Methylenedioxymethamphetamine: Comparison with the Neurochemical Effects of its N-Desmethyl and N-Ethyl Analogs.
Schmidt C J, Neurotoxicity of the Psychedelic Amphetamine, Methylenedioxymethamphetamine.
Scallet A C, Ali S F, Holson R R, Lipe G W, Slikker Jr. W, Neurohistological Effects 120 Days after Oral Ecstasy (MDMA): Multiple Antigen Immunohistochemistry and Silver Degeneration Staining.
Ricaurte G A, Finnegan K F, Nichols D E, DeLanney L E, Irwin I, Langston J W, 3,4-Methylenedioxymethamphetamine (MDE), a Novel Analogue of MDMA, Produces Long-lasting Depletion of Serotonin in the Rat
Ricaurte G A, Forno L S, Wilson M A, DeLanney L E, Irwin I, Molliver M E, Langston J W, (+/-) Methylenedioxymethamphetamine (MDMA) Exerts Toxic Effects on Central Serotonergic Neurons in Primates.
Mokler D J, Robinson S E, Rosecrans J A, Differential Depletion of Brain 5-Hydroxytryptamine (5-HT) by (+/-) 3,4-Methylenedioxymethamphetamine (MDMA).
Mokler D J, Robinson S E, Rosecrans J A, (+/-) 3,4-Methylenedioxymethamphetamine (MDMA) Produces Long-term Reductions in Brain 5-Hydroxytryptamine in Rats.
Mokler D J, Robinson S E, Rosecrans J A, A Comparison of the Effects of Repeated Doses of MDMA ("Ecstasy") on Biogenic Amine Levels in Adult and Neonate Rats.
Molliver M E, Serotonergic Neural Systems: What Their Anatomic Organization Tells Us about Function.
Gehlert D R, Schmidt C J, Acute Administration of Methylenedioxymethamphetamine (MDMA) Results in a Persistent and Selective Increase in 5-HT1 Receptor Binding in Rat Brain.
Gold L H, Hubner C B, Koob G F, The Role of Mesolimbic Dopamine in the Stimulant Action of MDMA.
Commins D L, Vosmer G, Virus R M, Woolverton C R, Schuster C R, Seiden L S, Biochemical and Histological Evidence that Methylenedioxmethamphetamine (MDMA) is Toxic to Neurons in Rat Brain.
Bird M P, Svendsen C N, Knapp C, Hrbek C C, Bird E D, Kornetsky C, Evidence for Dopaminergic and Not Serotonergic Mediation of the Threshold Lowering Effects of MDMA on Rewarding Brain Stimulation.
Anon Long-term Effects of "Ecstasy": Study Finds Brain Cell Destruction.,
Battaglia G, Yeh S Y, O'Hearn E, Molliver M E, Kuhar M J, De Souza E B, 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine Destroy Serotonin Terminals in Rat Brain: Quantification of Neurodegeneration by Measurements of [3H] Paroxetine-Labelled Serotonin Uptake Sites.
Ali S F, Scallet A C, Holson R R, Newport G D, Slikker Jr. W, Acute Administration of MDMA (Ecstasy): Neurochemical Changes Persist up to 120 Days in Rat Brain.
Wang S S, Ricaurte G A, Peroutka S J, [3H]3,4 Methylenedioxymethamphetamine (MDMA) Interactions with Brain Membranes and Glass Fiber Filter Paper.
Steele T D, Nichols D E, Yim G K W, Stereochemical Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Related Amphetamine Derivatives on Inhibition of Uptake of [3H]Monoamines into Synaptosomes from Different Regions of Rat Brain.
Smilkstein M J, Smolinske S C, Rumack B H, A Case of MAO Inhibitor / MDMA Interaction: Agony after Ecstasy.
Peroutka S J, Pascoe N, Faull K F, Monoamine Metabolites in the Cerebrospinal Fluid of Recreational Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy").
Davis W M, Hatoum H T, Waters I W, Toxicity of MDA (3,4-Methylenedioxyamphetamine) Considered for Relevancy to Hazards of MDMA (Ecstasy) Abuse.
Dowling G P, McDonough III E T, Bost R O, 'Eve' and 'Ecstasy' A Report of Five Deaths Associated with the Use of MDEA and MDMA.
Brown C, Osterloh J, Multiple Severe Complications from Recreational Ingestion of MDMA (Ecstasy).
Janesko J L, Dal Cason T A, Seizure of a Clandestine Laboratory: The N-Alkyl MDA Analogs. Paper presented at the 39th Annual Meeting of the American Academy of Forensic Sciences, San Diego, CA, Feb. 16-21 1987
Schmidt C J, Taylor V L, Acute Effects of Methylenedioxymethamphetamine (MDMA) on 5-HT Synthesis in the Rat Brain.
Stone D M, Hanson G R, Gibb J W, GABA-Transaminase Inhibitor Protects Against Methylenedioxymethamphetamine (MDMA)-induced Neurotoxicity.
Stone D M, Johnson M, Hanson G R, Gibb J W, A Comparison of the Neurotoxic Potential of Methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated Derivatives.
Johnson M, Bush L G, Stone D M, Hanson G R, Gibb J W, Effects of Adrenalectomy on the 3,4-Methylenedioxymethamphetamine (MDMA)-induced Decrease of Tryptophan Hydroxylase Activity in the Frontal Cortex and Hippocampus.
Frith C H, Chang L W, Lattin D L, Walls R C, Hamm J, Doblin R, Toxicity of Methylenedioxy-methamphetamine (MDMA) in the Dog and the Rat.
Noggle Jr. F T, DeRuiter J, McMillian C L, Clark C R, Liquid Chromatographic Analysis of some N-Alkyl-3,4-Methylenedioxyamphetamines.
Hansson R C, Clandestine Laboratories. Production of MDMA 3,4-Methylenedioxymethamphetamine.
Bateman D N, Delta-9-tetrahydrocannabinol and gastric emptying
Ungerleider J T, et al., Delta-9-tetrahydrocannabinol in the treatment of spasticity associated with Multiple Sclerosis
Elkin R, et al., Delta-9-tetrahydrocannabinol: a novel treatment of inflammatory demyelination
Evans A T, et al., Actions of Cannabis constituents on enzymes or arachidonate metabolism: anti-inflammatory potential.
Formukong E A, et al., Cannabinoids, the active constituents of Cannabis sativa L. inhibit both human and rabbit platelet aggregation.
Green K, McDonald T F, Ocular toxicology of marijuana: an update.
TW Sargent, AT Shulgin, CA Mathis, Rapid brain scanning pharmaceutical
DJ McKenna, CA Mathis, AT Shulgin, T Sargent, JM Saavedra, Autoradiographic localization of binding sites for 125-I-DOI a new psychotomimetic radioligand, in the rat brain
AT Shulgin, The 'social-chemistry' of pharmacological discovery
AT Shulgin, Reference information on MDMA
Wang SS, Ricaurte GA, Peroutka SJ, [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper
Thompson DM, Winsauer PJ, Mastropaolo J, Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys
Stone DM, Johnson M, Hanson GR, Gibb JW, A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives
Stone DM, Merchant KM, Hanson GR, Gibb JW, Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat
Stone DM, Hanson GR, Gibb JW, Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats
Smilkstein MJ, Smolinske SC, Rumack BH, A case of MAO inhibitor/MDMA interaction: agony after ecstasy
Steele TD, Nichols DE, Yim GK, Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain
Schmidt CJ, Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine
Rosecrans JA, Glennon RA, The effect of MDA and MDMA ('Ecstasy') isomers in combination with pirenpirone on operant responding in mice
Schechter MD, MDMA as a discriminative stimulus: isomeric comparisons
Peroutka SJ, Pascoe N, Faull KF, Monoamine metabolites in the cerebralspinal fluid of recreational users of 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy')
Ricaurte GA, Finnegan KF, Nichols DE, DeLanney LE, Irwin I, Langston JW, 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain
Peroutka SJ, Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, 'ecstasy') on an undergraduate campus
Noggle FT Jr, DeRuiter J, et al, Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine
Mokler DJ, Robinson SE, Rosecrans JA, (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats
Kulmala HK, Boja JW, Schechter MD, Behavioral suppression following 3,4-methylenenedioxymethamphetamine
Lamb RJ, Griffiths RR, Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon
Gibb JW, Stone DM, Stahl DC, Hanson GR, The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain
Glennon RA, Little PJ, Rosecrans JA, Yousif M, The effect of MDMA ('Ecstasy') and its optical isomers on schedule-controlled responding in mice
Frith CH, Chang LW, Lattin DL, Walls RC, Hamm J, Doblin R, Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat
Dowling GP, McDonough ET 3rd, Bost RO, 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA
Brown C, Osterloh J, Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') [letter]
Davis WM, Hatoum HT, Waters IW, Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse
Boja JW, Schechter MD, Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE')
Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB, 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites
Omer C. Stewart, A Real Commitment Excerpted from Peyote Religion: A History
Omer C. Stewart, A Real Commitment Excerpted from Peyote Religion: A History
Climko R P, Roehrich H, Sweeney D R, Al-Razi J, Ecstasy: A Review of MDMA and MDA.
Beck J, MDMA: The Popularization and Resulting Implications of a Recently Controlled Psychoactive Substance.
Kane J, Memorandum and Opinion. Case No. 86-CR-153 In the United States District Court for the District of Colorado. Pees and McNeill, Defendants
Nasmyth P, The Agony and the Ecstasy
Seymour R B, Ecstasy on Trial.
Young F L, Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of Administrative Law Judge.
Smith D E, Seymour R B, Abuse Folio: MDMA.
Roberts T B, The MDMA Question. Section on Social Concerns.
Anon, Verordnung des BAG uber die Betaubungsmittel und andere Stoffe und Proparate.
Turkington C, Brain Damage Found with Designer Drugs.
Stone S E, Johnson C A, Government's Exceptions to the Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of the Administrative Law Judge.
Roberts M, Drug Abuse. MDMA: "Madness, not Ecstasy" Crosstalk section
Anon Zweite Verordnung zur Anderung betaubungsmittelrechticher Vorschriften,
Deluca N, Closed Doors/Closed Minds.
McConnell H, MDMA.
Grinspoon L, Bakalar J B, A Potential Psychotherapeutic Drug?
DeSouza E B, Battaglia G, Shu Y Y, Kuhar M J, In Vitro and In Vivo Effects of MDA and MDMA (Ecstasy) on Brain Receptors and Uptake Sites: Evidence for Selective Neurotoxic Actions on Serotonin Terminals.
Lawn J C, Order.
Takeda H, Gazzara R A, Howard S G, Cho A K, Effects of Methylenedioxymethamphetamine (MDMA) on Dopamine (DA) and Serotonin (5-HT) Efflux in the Rat Neostriatum.
Schmidt C J, Lovenberg W, (+/-)Methylenedioxymethamphetamine (MDMA): A Potentially Neurotoxic Amphetamine Analogue.
Nienaber C A, et al, Development of pulmonary aneurysm in primary pulmonary hypertension: a case report
LE Hollister, Health aspects of cannabis
Specter SC, Klein TW, Newton C, Mondragon M, Widen R, Friedman H, Marijuana effects on immunity: suppression of human natural killer cell activity of delta- 9-tetrahydrocannabinol
Grof, Stanislav, Psychedelic Therapy and Holonomic Integration.
Naranjo, Claudio, Drug-Induced States.
Grinspoon, Lester; Bakalar, James B., Can Drugs Be Used to Enhance the Psychotherapeutic Process?
Greer, George; Tolbert, Requa, Subjective Reports of the Effects of MDMA in a Clinical Setting.
Dennis J. McKenna, L. E. Luna, G. H. N. Towers, Biodynamic constituents in Ayahuasca admixture plants: an uninvestigated folk pharmacopoeia
Woolverton W L, A Review of the Effects of Repeated Administration of Selected Phenethylamines.
Shulgin A T, The Background and Chemistry of MDMA.
Seymour R B, "MDMA"
Seymour R B, Wesson D R, Smith D E, Editor's Introduction.
Renfroe C L, MDMA on the Street: Analysis Anonymous.
Nichols D E, Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens.
Newmeyer J A, Some Considerations on the Prevalence of MDMA Use.
Leverant R, MDMA Reconsidered.
Kirsch M M, "Designer Drugs"
Harris L S, The Stimulants and Hallucinogens under Consideration: A Brief Overview of their Chemistry and Pharmacology.
Hollister L E, Clinical Aspects of Use of Phenylalkylamine and Indolealkylamine Hallucinogens.
Grinspoon L, Bakalar J B, Can Drugs be Used to Enhance the Psychotherapeutic Process?
Glennon R A, Discriminative Stimulus Properties of Phenylisopropylamine Derivatives.
Gallagher W, The Looming Menace of Designer Drugs.
Ehrlich B, Understanding Ecstasy: The MDMA Story.
Callaway E, The Biology of Information Processing.
Beck J, Morgan P A, Designer Drug Confusion: A Focus on MDMA.
Barbour J, Cracking Down: What You Must Know About Dangerous Drugs.
Burger A, Drugs and People
Schechter M D, Discriminative Profile of MDMA.
Nichols D E, Hoffman A J, Oberlender R A, Jacob III P, Shulgin A T, Derivatives of 1-(1,3-Benzodioxol-5-yl-2-butanamine: Representatives of a Novel Therapeutic Class.
Li A, Marek G, Vosmer G, Seiden L, MDMA-induced Serotonin Depletion Potentiates the Psychomotor Stimulant Effects of MDMA on Rats Performing on the Differential-Reinforcement-of-Low-Rate (DRL) Schedule.
Kamien J B, Johanson C E, Schuster C R, Woolverton W L, The Effects of (+/-)-Methylenedioxymethamphetamine in Monkeys Trained to Discriminate (+)-Amphetamine from Saline. Drug and Alcohol Dependence
Evans S M, Johanson C E, Discriminative Stimulus Properties of (+/-)-3,4-Methylenedioxymethamphetamine and (+/-)-Methylenedioxyamphetamine in Pigeons.
Bird M, Kornetsky C, Naloxone Antagonism of the Effects of MDMA "Ecstasy" on Rewarding Brain Stimulation.
Beardsley P M, Balster R L, Harris L S, Self-administration of Methylenedioxymethamphetamine (MDMA) by Rhesus Monkeys
Stone D M, Stahl D C, Hanson G R, Gibb J W, The Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) on Monoaminergic Systems in the Rat Brain.
Slikker Jr W, Ali S F, Scallet A C, Frith C H, Methylenedioxymethamphetamine (MDMA) Produces Long Lasting Alterations in the Serotonergic System of Rat Brain.
Spanos L J, Yamamoto B K, Methylenedioxymethamphetamine (MDMA)-induced Efflux of Dopamine and Serotonin in Rat Nucleus Accumbens.
Stone D M, Hanson G R, Gibb J W, Does Dopamine Play a Role in the Serotonergic "Neurotoxicity" Induced by 3,4-Methylenedioxymethamphetamine (MDMA)?
Schmidt C J, Wu L, Lovenberg W, Methylenedioxymethamphetet-amine: A Potentially Neurotoxic Amphetamine Analogue.
Schmidt C J, Lovenberg W, Further Studies on the Neurochemical Effects of 4,5-Methylenedioxymethamphetamine and Related Analogues.
O'Hearn E, Battaglia G, De Souza E B, Kuhar K J, Molliver M E, Systemic MDA and MDMA, Psychotropic Substituted Amphetamines, Produce Serotonin Neurotoxicity.
Molliver M E, O'Hearn E, Battaglia G, De Souza E B, Direct Intracerebral Administration of MDA and MDMA Does Not Produce Serotonin Neurotoxicity.
Lyon R A, Glennon R A, Titeler M, 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective Interactions at Brain 5-HT1 and 5-HT2 Receptors.
Kopajtic T, Battaglia G, De Souza E B, A Pharmacologic Profile of MDA and MDMA on Brain Receptors and Uptake Sites.
Kalix P, A Comparison of the Effects of Some Phenethylamines on the Release of Radioactivity from Isolated Rat Caudate Nucleus Prelabelled with 3H-Dopamine.
Johnson M P, Hoffman A J, Nichols D E, Effects of the Enantiomers of MDA, MDMA, and Related Analogues on [3H]Serotonin and [3H]Dopamine Release from Superfused Rat Brain Slices.
Glennon R A, Titeler M, Lyon R A, Youssif M, MDMA ("Ecstasy"): Drug Discrimination and Brain Binding Properties.
Champney T H, Golden P T, Matthews R T, Reduction of Hypothalamic Serotonin Levels after Acute MDMA Administration.
Battaglia G, Kuhar M J, De Souza E B, MDA and MDMA (Ecstasy) Interactions with Brain Serotonin Receptors and Uptake Sites: In vitro Studies.
Lawn J C, Schedules of Controlled Substances; Scheduling of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act.
Lawn J C, Schedules of Controlled Substances; Extension of Temporary Control of 3,4-Methylenedioxymethamphetamine (MDMA) in Schedule I.
Lyon R A, Glennon R A, Titeler M, 3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective Interactions at Brain 5-HT1 and 5-HT2 Receptors.
Brady J F, Di Stephano E W, Cho A K, Spectral and Inhibitory Interactions of (+/-)-3,4-Methylenedioxyamphetamine (MDA) and (+/-)-3,4-Methylenedioxymethamphetamine (MDMA) with Rat Hepatic Microsomes.
Frye G, Matthews R, Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Contractive Responses in the G. Pig Ileum.
Smilkstein M J, Smolinske S C, Kulig K W, Rumack B H, MAO Inhibitor/MDMA Interaction: Agony after Ecstasy.
Reynolds P C, Personal Communication
Hayner G N, McKinney H, MDMA The Dark Side of Ecstasy.
Wolfson P E, Meetings at the Edge with Adam: A Man for All Seasons.
Brown C R, McKinney H, Osterloh J D, Shulgin A T, Jacob III P, Olson K R, Severe Adverse Reaction to 3,4-Methylenedioxymethamphetamine (MDMA).
Siegel R K, MDMA: Nonmedical Use and Intoxication.
Greer G, Tolbert R, Subjective Reports of the Effects of MDMA in a Clinical Setting.
Nichols D E, Synthesis of 3,4-Methylenedioxymethamphetamine Hydrochloride.
Buffum J, Moser C, MDMA and Human Sexual Function.
Merchant K, Letter A A, Stone D M, Gibb J W, Hanson G R, Responses of Brain Neurotensin-like Immunoreactivity to 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA).
Letter A A, Merchant K, Gibb J W, Hanson G R, Roles of D2 and 5-HT2 Receptors in Mediating the Effects of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and 3,4-Methylenedioxyamphetamine on Striato-Nigral Neurotensin Systems.
Gibb J W, Hanson G R, Johnson M, Effects of (+)-3,4-Methylenedioxymethamphetamine [(+)MDMA] and (-)-3,4-Methylenedioxymethamphetamine [(-)MDMA] on Brain Dopamine, Serotonin, and their Biosynthetic Enzymes.
Hanson G R, Hanson G R, Johnson M, Effects of (+)-3,4-Methylenedioxymethamphetamine [(+)MDMA] and (-)-3,4-Methylenedioxymethamphetamine [(-)MDMA] on Brain Dopamine, Serotonin, and their Biosynthetic Enzymes.
Frith C H, 28-Day Oral Toxicity of Methylenedioxymethamphetamine Hydrochloride (MDMA) in Rats. Project Report.
Frith C H, 28-Day Oral Toxicity of Methylenedioxymethamphetamine Hydrochloride (MDMA) in Dogs. Project Report
Yamauchi T, The Analysis of Stimulant-analogue Compounds (3,4-Methylenedioxymethamphetamine Hydrochloride).
Ruybal R, Microcrystalline Test for MDMA.
Noggle Jr. F T, DeRuiter J, Long M J, Spectrophotometric and Liquid Chromatographic Identification of 3,4-Methylenedioxyphenylisopropylamine and its N-Methyl and N-Ethyl Homologues are presented.
Hearn W L, Hime G, Andollo W, Recognizing Ecstasy: Adam and Eve, the MDA Derivatives - Analytical Profiles.
Holsten D W, Schieser D W, Controls over the Manufacture of MDMA.
Hanigan W C, et al., The effects of delta-9-tetrahydrocannabinol on human spasticity
Truong X T, Hanigan W C, Effect of delta-9-tetrahydrocannabinol on electromyographic measurements in human spasticity
Sandyk R, et al., Cannabidiol in dystonic movement disorders
Consroe P, et al., Open label evaluation of cannabidiol in dystonic movement disorders
Karler R, et al., Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol.
Colasanti B K, Review: Ocular hypotensive affect of marihuana cannabinoids: correlate of central action or separate phenomenon.
Ames F R, Cridland S, Anticonvulsant effect of cannabidiol
Graham J D P, The bronchodilator action of cannabinoids
Patrick Robert Michael, Original chemist who manufactured 4-MAX
Greer G, Tolbert R, Subjective reports of the effects of MDMA in a clinical setting
CA Mathis, T Sargent, AT Shulgin Synthesis of 122-I and, 125-I-labeled-meta-dimethoxy-N,N-dimethyliodophenylisopropylamines
AT Shulgin, LA Shulgin, P Jacob, A protocol for the evaluation of new psychoactive drugs
DE Nichols, AJ Hoffman, RA Oberlender, P Jacob, AT Shulgin, Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class
CA Mathis, AT Shulgin, Y Yano, T Sargent, (18)F-labelled N,N-dimethylamphetamine analogues for brain imaging studies
AT Shulgin, The background and chemistry of MDMA
Greer George, Tolbert Requa, Subjective Reports of the Effects of MDMA in a Clinical Setting
Callaway, E., The biology of human information processing.
Leverant, R., MDMA reconsidered
Newmeyer, J. A., Some considerations on the prevalence of MDMA use
Nichols, D. E., Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.
Renfroe, C. L., MDMA on the street: Analysis Anonymous.
Shulgin, A. T., The Background and Chemistry ofMDMA
Siegel, R. K., MDMA. Nonmedical use and intoxication.
Wolfson, P. E., Meetings at the edge with Adam: a man for all seasons?
Buffum, J. and Moser, C., MDMA and human sexual function.
Downing, J., The psychological and physiological effects of MDMA on normal volunteers.
Ziporyn T, A growing industry and menace: makeshift laboratory's designer drugs
Wolfson PE, Meetings at the edge with Adam: A man for all seasons?
Stone DM, Stahl DC, Hanson GR, Gibb JW, The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain
Siegel RK, MDMA-Nonmedical use and intoxication
Seymour RB, Wesson DR, Smith DE, MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conference. May 17-18, 1986, Oakland, California
Seymour RB, Wesson DR, Smith DE, Editor's Introduction
Shulgin AT, The background and chemistry of MDMA
Schlemmer RF Jr, Nawara C, Heinze WJ, Davis JM, Advokat C, Influence of Environmental Context on Tolerance to LSD-Induced Behavior in Primates
Schmidt CJ, Wu L, Lovenberg W, Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue
Renfroe CL, MDMA on the street: Analysis Anonymous
Schechter MD, Discriminative profile of MDMA
Ransom RW, Asarch KB, Shih JC, [3H] 1-[2-(4-Aminophenyl)Ethyl]-4-(3-Trifluoromethylphenyl)Piperazine: A Selective Radioligand for 5-HT1A Receptors in Rat Brain
Perry DC, [3H]Tryptamine Autoradiography in Rat Brain and Choroid Plexus Reveals Two Distinct Sites
Nichols DE, Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens
Noggle FT Jr, DeRuiter J, Long MJ, Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs
Morgan DG, Finch CE, [3H]Fluphenazine Binding to Brain Membranes: Simultaneous Measurement of D- 1 and D-2 Receptor Sites
Newmeyer JA, Some considerations on the prevalence of MDMA use
McKenney JD, Glennon RA, TFMPP May Produce its Stimulus Effects Via a 5-HT1B Mechanism
Lyon RA, Glennon RA, Titeler M, 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors
Leverant R, MDMA reconsidered
Kamien JB, Johanson CE, Schuster CR, Woolverton WL, The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline
Johnson MP, Hoffman AJ, Nichols DE, Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices
Hayner GN, McKinney H, MDMA. The dark side of ecstasy
Holsten DW, Schieser DW, Controls over the manufacture of MDMA
Grome JJ, Harper AM, Local Cerebral Glucose Utilisation Following Indoleamine- and Piperazine-Containing 5-Hydroxytryptamine Agents
Grinspoon L, Bakalar JB, Can drugs be used to enhance the psychotherapeutic process?
Greer G, Tolbert R, Subjective reports of the effects of MDMA in a clinical setting
Evans SM, Johanson CE, Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons
Downing J, The psychological and physiological effects of MDMA on normal volunteers
Davis WM, Catravas JD, Waters IW, Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) in the dog and antagonism by chlorpromazine
Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS, Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain
Climko RP, Roehrich H, Sweeney DR, Al-Razi J, Ecstacy: a review of MDMA and MDA
Callaway E, The Biology of Human Information Processing
Buffum J, Moser C, MDMA and human sexual function
Beck J, Morgan PA, Designer drug confusion: a focus on MDMA
Brady JF, Di Stefano EW, Cho AK, Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes
Beardsley PM, Balster RL, Harris LS, Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys
Beck J, MDMA: The popularization and resultant implications of a recently controlled psychoactive substance
Greer G, Using MDMA in Psychotherapy
Baum R M, New Variety of Street Drugs Poses Growing Problem.
Smith D E, Wesson D R, Buffum J, MDMA: "Ecstasy" as an Adjunct to Psychotherapy and a Street Drug of Abuse.
Cohen S, They Call It Ecstasy.
Gold M S, Ecstasy, Etc.
Harris L S, Preliminary Report on the Dependence Liability and Abuse Potential of Methylenedioxymethamphetamine (MDMA).
Griffiths R R, Lamb R, Brady J V, A Preliminary Report on the Reinforcing Effects of Racemic 3,4-Methylenedioxymethamphetamine in the Baboon. Document entered into evidence Re: MDMA Scheduling Docket No. 84-48
Seiden L S, Report of Preliminary Results on MDMA. Document entered into evidence Re: MDMA Scheduling Docket No. 84-48
Abramson D M Ecstasy: The New Drug Underground. New Age,
Cohen S, Krippner S, Eds., (LSD Issue) Editors Introduction
Hershkovits D, Esctasy: The Truth About MDMA.
Gertz K R, "HugDrug" Alert: The Agony of Ecstasy.
Tatar A, Naranjo C, MDMA in der Gruppenpsychotherapie.
Klein J, The New Drug They Call 'Ecstasy'
Shafer J, MDMA: Psychedelic Drug Faces Regulation.
Schulman R, The Losing War Against "Designer Drugs."
Toufexis A, A Crackdown on Ecstasy.
Leavy J, Ecstasy: The Lure and the Peril.
Young F L, Opinion and Recommended Decision on Preliminary Issue
Barnett R, DEA: RSVP re MDMA. Editorial from KCBS
Anon, MDMA
Young F L, Memorandum and Order
O'Rourke P J, Tune In. Turn On. Go To The Office Late on Monday.
original authors, A letter to the Editors in response: Holsten D W, Schieser D W Controls over the Manufacture of MDMA. The original authors' reply
Anon, Designer Drugs: A New Concern for the Drug Abuse Community.
Anon, Esctasy of the Eighties
Siegel R K, Chemical Ecstasies.
Dowling C G, The Trouble with Ecstasy.
Adler J, Getting High on 'Ecstasy.'
Anon, Several reports from the Brain/Mind Bulletin: (1) MDMA: Compound raises medical and legal issues.
Kurland, Albert A., LSD in the Supportive Care of the Terminally Ill Cancer Patient.
Greer, George, Using MDMA in Psychotherapy.
Bolle, Ralf, Traumerleben bei einer subnarkotischen Dosis des Anästhetikums KETANEST. Eine orientierende klinische Untersuchung. [Dream Experiences at Subanaesthetic Doses of the Anaesthetic KETANEST. An Orienting Clinical Study.]
Yensen, Richard, LSD and Psychotherapy.
Grof, Stanislav, Beyond the Brain: Birth, Death and Transcendence in Psychotherapy. [Les nouvelles dimensions de la conscience]
Grof, Stanislav, Beyond the Brain: Birth, Death and Transcendence in Psychotherapy. [Oltre il cervello]
Grof, Stanislav, Vorstoß ins Unbewußte. [Thrust into the Unconscious.]
Grof, Stanislav, Beyond the Brain: Birth, Death and Transcendence in Psychotherapy.
Grof, Stanislav, Beyond the Brain: Birth, Death and Transcendence in Psychotherapy. [Geburt, Tod und Transzendenz. Neue Dimensionen in der Psychologie]
Adamson, Sophia (ed.), Through the Gateway of the Heart. Accounts of Experiences with MDMA and other Empathogenic Substances.
Dennis J. McKenna, G. H. N. Towers, On the comparative ethnopharmacology of the Malpighiaceous and Myristicaceous hallucinogens
Shulgin A T, What is MDMA?
Riedlinger J E, The Scheduling of MDMA: A Pharmacist's Perspective.
Grinspoon L, Bakalar J B, What is MDMA?
Hagerty C, "Designer Drug" Enforcement Act Seeks to Attack Problem at Source.
Buchanan J, Ecstasy in the Emergency Department.
Adamson S, "Through the Gateway of the Heart: Accounts of Experiences with MDMA and other Empathogenic Substances." Foreword by R. Metzner Four Trees Publications, San Francisco
Woolverton W L, Virus R M, Kamien J B, Nencini P, Johanson C E, Seiden L S, Schuster C R, Behavioural and Neurotoxic Effects of MDMA and MDA.
Ricaurte G A, Bryan G, Strauss L, Seiden L, Schuster C, Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals.
Anon Request for Information,
Lawn J C, Schedules of Controlled Substances; Temporary Placement of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule I.
Gehlert D R, Schmidt C J, Wu L, Lovenberg W, Evidence for Specific Methylenedioxymethamphetamine (Ecstasy) Binding Sites in the Rat
Greer G, Recommended Protocol for MDMA Sessions.
Greer G, Using MDMA in Psychotherapy. Advances
Goad P T, Acute and Subacute Oral Toxicity Study of Methylenedioxymethamphetamine in Rats. Project Report.
Churchill K T, Identification of 3,4-Methylenedioxymethamphetamine.
Volfe Z, et al., Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients
Snider S R, Consroe P, Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia
Barret M L, et al., Isolation from Cannabis sativa L. of Cannflavon-a novel inhibitor or prostaglandin production.
Gurtner H P, Aminorex and pulmonary hypertension, a review
Yensen R, Adventure at Eagle's Nest
Yensen R, LSD and Psychotherapy
Kurland A A, LSD in the supportive care of the terminally ill patient
Grof S, Beyond the Brain. Birth, Death and Transcendence in Psychotherapy
DB Repke, DB Grotjahn, AT Shulgin, Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents
AT Shulgin, What is MDMA?
D Lemaire, P Jacob, AT Shulgin, Ring substituted beta-methoxyphenethylamines: a new class of psychotomimetic agents active in man
CA Mathis, T Sargent, AT Shulgin, Iodine-122 labeled amphetamine derivatives with potential for PET brain blood-flow studies
Greer, G. and Strassman, R. J., Information on "Ecstasy"
Riedlinger, J. E., The scheduling of MDMA: a pharmacist's perspective.
Weithers S, Larson AA, Desensitization To Intratbecal Substance P-induced Biting And Scratching: Effect Of LSD And Chronic Pain
Trulson ME, Separation of tolerance to the behavioral effects of LSD from changes in seroronin receptor binding in cats
Trulson ME, Crisp T, Henderson LJ, Ascorbic acid antagonizes the behavioural effects of LSD in cats
Stolerman IP, Shine PJ, Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983
Soblosky JS, Jeng I, Influence on 5-3H]Hydroxytryptamine Binding Site Development in Chick Embryo by Serotonergic Compounds
Schindler CW, Harvey JA, Effects of Morphine and LSD on the Classically Conditioned-Nictitating Membrane- Response
Schachter M, Godfrey PP, Minchin MCW, McClue SJ, Young MM, Serotonergic Agonists Stimulate Inositol Lipid Metabolism In Rabbit Platelets
Schachter M, Geaney DP, Grahame-Smith DG, Cowen PJ, Elliott JM, Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment
Robaut C, Fillion MP, Dufois S, Fayole-Bauguen C, Rousselle J-C, Gillet G, Benkirane S, Fillion G, Multiple High Affinity Binding Sites for 5-Hydroxytryptamine: a New Class of Sites Distinct from 5-HT1 and S2
Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C, Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals
Riedlinger JE, The scheduling of MDMA: a pharmacist's perspective
Pazos A, Palacios JM, Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. I. Serotonin-l Receptors
Pazos A, Hoyer D, Palacios JM, The Binding Of Serotonergic Ligands To The Porcine Choroid Plexus: Characterization Of A New Type Of Serotonin Recognition Site
Pazos A, Cortes R, Palacios M, Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. II. Serotonin-2-Receptors
Pawlowski L, Nowak G, Górka Z, Mazela H, Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities
Nathanson JA, Phenyliminoimidazolidines: Characterization of a Class of Potent Agonists of Octopamine-Sensitive Adenylate Cyclase and Their Use in Understanding the Pharmacology of Octopamine Receptors
Nielsen EB, Discriminative Stimulus Properties of Lysergic Acid Diethylamide in the Monkey
Norman AB, Battaglia G, Creese I, [3H]WB4101 Labels the 5-HT1A Serotonin Receptor Subtype in Rat Brain: Guanine Nucleotide and Divalent Cation Sensitivity
Monroe PJ, Smith DJ, Demonstration of an Autoreceptor Modulating the Release of [3h]5-hydroxytrptamine from a Synaptosomal-Rich Spinal Cord Tissue Preparation
Morrow AL, Norman AB, Battaglia G, Loy R, Creese I, Up-Regulatlon of Serotonergic Binding Sites Labeled By [3H]WB4101 Following Fimbrial Transection And 5,7-Dihydroxytryptamine-Induced Lesions
Mack RB, A bit on the Wilde side: MDMA abuse
McNall SJ, Mansour TE, Forskolin Activation Of Serotonin-stimulated Adenylate- Cyclase In The Liver Fluke Fasciola Hepatica
Hoffman BJ, Karpa MD, Lever JR, Hartig PR, N1-Methyl-2-|125|LSD(|128|)MIL), A Preferrred Ligand for Serotonin 5-HT2 Receptors
Kalkman HO, Characterization of serotonin (5-HT) receptors in the isolated guinea-pig ileum
Gillet G, Ammor S, Fillion G, Serotonin Inhibits Acetylcholine Release from Rat Striatum Slices: Evidence for a Presynaptic Receptor-Mediated Effect
Hartig PR, Scheffel U, Frost JJ, Wagner HN Jr, In Vivo Binding Of 125-i-LSD To Serotonin 5-ht2 Receptors In Mouse Brain
Geyer MA, Gordon J, Adams LM, Behavioral Effects of Xylamine-Induced Depletions of Brain Norepinephrine
Fink H, Morgenstern R, Locomotor effects of lisuride: A consequence of dopaminergic and serotonergic actions
Fleming SW, Brown IR, Characterization of a Translational Inhibitor Isolated from Rabbit Brain Following Intravenous Administration of d-Lysergic Acid Diethylamide
Gehlert DR, Schmidt CJ, Wu L, Lovenberg W, Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain
Cotton R, Letter from Dewey, Ballantine, Bushby, Palmer & Wood, 1775 Pennsylvania Avenue, N.W., Washington, D.C. 20006 to F. M. Mullen, Jr., DEA.
Anon., LSD, Yesterday and Today
Anon, DEA Proposal to Ban New Psychedelic Protested.
Doblin R, Murmurs in the Heart of the Beast: MDMA and the DEA, HHS, NIDA, NIMH, ADAMHA, FBI and the WHO.
Lane D C, Science, Mysticism and Dr. Grof
Dansak DA, Brazis K, Deaux ED, Delany HD, Duncan PR,, Report of the Lynn Pierson Therapeutic Research Program, New Mexico State Department of Health, Oral vs. Inhaled Cannabinoids for Nausea/Vomiting from Cancer Chemotherapy, Methodology and Efficacy of Initial Dose
Dennis J. McKenna, G. H. N. Towers, F. S. Abbott, Monoamine oxidase inhibitors in South American hallucinogenic plants Pt. II: Constituents of orally active Myristicaceous hallucinogens
Dennis J. McKenna, G. H. N. Towers, Biochemistry and pharmacology of tryptamine and B-carboline derivatives:
Dennis J. McKenna, G. H. N. Towers, F. S. Abbott, Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and B-carboline constituents of Ayahuasca
Strassman RJ, Adverse reactions to psychedelic drugs. A review of the literature
Nichols D E, Glennon R A, Medicinal Chemistry and Structure-Activity Relationships of Hallucinogens, in Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives Ed. B L Jacobs
Glennon R A, Young R, Further Investigation of the Discriminative Stimulus Properties of MDA.
Davis W M, Borne R F, Pharmacological Investigation of Compounds Related to 3,4-Methylenedioxyamphetamine (MDA)
Mullen F M, Schedules of Controlled Substances. Proposed Placement of 3,4-Methylenedioxymethamphetamine into Schedule I. Hearings.
Randolph W F, International Drug Scheduling; Convention on Psychotropic Substances; Stimulant and/or Hallucinogenic Drugs.
Mullen F M, Schedules of Controlled Substances Proposed Placement of 3,4-Methylenedioxymethamphetamine into Schedule I.
Davis W M, Borne R F, Pharmacologic Investigation of Compounds Related to 3,4-Methylenedioxyamphetamine (MDA).
Burstein S, et al., Stimulation of sphingomyelin hydrolysis by cannabidiol in fibroblasts from a Niemann-Pick patient
Snider S R, Consroe P, Treatment of Meige syndrome with cannabidiol
Karler R, et al., Interaction between delta-9-tetrahydrocannabinol and kindling by electrical and chemical stimulation in mice
Colasanti B K, et al., Ocular hypotension, ocular toxicity, and neurotoxicity in response to marijuana extract and cannabidiol
Colasanti B K, et al., Intraocular pressure, ocular toxicity and neurotoxicity after administration of delta-9-tetrahydrocannabinol or cannabichromene.
Colasanti B K, et al., Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.
Gong H, et al., Acute and subacute bronchial effects of oral cannabinoids
T Sargent, AT Shulgin, CA Mathis, Radiohalogen-labeled imaging agents. 3. Compounds for measurement of brain blood flow by emission tomography
P Jacob, AT Shulgin, Sulfur analogues of psychotomimetic agents. 3. The ethyl homologues of mescaline and their monothio analogues
Strassman, R. J., Adverse Reactions to Psychedelic Drugs A Review of the Literature
Yarbrouch GG, Singh DK, Pettibone DJ, A Comparative Electrophysiological And Biochemical Assessment Of Serotonin (5-ht) And A Novel 5-ht Agonist (mk-212) On Central Serotonergic Receptors
Winter JC, The stimulus properties of para-methoxyamphetamine: A nonessential serotonergic component.
Tegeler J, Der akute Drogen-Patient
Weaver KEC, Letters to the Editor: LSD and Schizophrenia
Smith LAC, Meyerson BJ, Influence of Long-term Zimeldine Treatment on LSD-induced Behavioural Effects
Sethy VH, Mccall JM, High-Affinity (3H)-Dexoxadrol Binding to Rat Brain Membranes
Richardson BP, Engel G, Donatsch P, In Vitro Pharmacology of Neuronal 5-HT Receptor antagonists
Raiteri M, Bonanno G, Marchi M, Maura G, Is There a Functional Linkage Between Neurotransmitter Uptake Mechanisms and Presynaptic Receptors?
Pietzcker A, Rauschdrogenmissbrauch und -abhangigkeit
Poser W, Tranquilizer Missbrauch und -Abhangigkeit
Morgenstern R, Mende T, Gold R, Lemme P, Oelssner W, Drug-Induced Modulation of Locomotor Hyperactivity; Induced by Picrotoxin in Nucleus Accumbens
Nielsen EB, Rolandi W, Appel JB, Drug effects on the repeated generalization of a visual discrimination acquired under one trial per day conditions
Peroutka SJ, Kuhar MJ, Autoradiographic localization of 5-HT1 receptors to human and canine basilar arteries
Mokler DJ, Rech RH, Behavioral Effects of Intracerebroventricular Administration of LSD, DOM, Mescaline or Lisurde
Minnema DJ, Rosecrans JA, Amphetamine and LSD as Discriminative Stimuli: Alterations Following Neonatal Monoamine Reductions
Mokler DJ, Commissaris RL, Henck JW, Rech RH, Naloxone Alters the Effects of LSD, DOM and Quipazine on Operant Behavior of Rats
Meibach RC, Beck SG, Maayani S, Green JP, Regional [Differences in Binding of [3H]LSD and [3H]5-HT in Calf Hippocampal Slices Revealed by Radioautography and Rapid Filtration Studies
McNall SJ, Mansour TE, Desensitization Of Serotonin-stimulated Adenylate Cyclase In The Liver Fluke Fasciola Hepatica
McNall SJ, Mansour TE, Novel Serotonin Receptors In Fasciola: Characterization By Studies On Adenylate Cyclase Activation And [3h]LSD Binding
Luscombe G, Jenner P, Marsden CD, Correlation Of [3h]5-hydroxytryptamine (5ht) Binding To Brain Stem Preparations And The Production And Prevention Of Myoclonus In Guinea Pig By 5ht Agonists And Antagonists
Leysen JE, Gommeren W, Characterization and quantification of serotonin-S2 receptor sites on human blood platelet membranes
Larson AA, Acute And Chronic Effects Of Lsd And 5-MeODMT On Raphe-Evoked Dorsal Root Potentials In The Cat
Leysen JE, De Chaffoy De Courcelles D, De Clerck F, Niemegeers CJE, Van Nueten JM, Serotonin-s2 Receptor Binding Sites And Functional Correlates
Kadan MJ, Krohn AM, Evans MJ, Waltz RL, Hartig PR, Characterization of 125I-Lysergic Acid Diethylamide Binding to Serotonin Receptors in Rat Frontal Cortex
Jarbe TUC, Discriminative Stimulus Properties of Cocaine
Hoffman JA, LSD flashbacks
Glennon RA, Young R, MDA: An Agent That Produces Stimulus Effects Similar to Those of 3,4-DMA, LSD and Cocaine
Hadorn DC, Anistranski JA, Connor JD, Influence Of Naloxone On The Effects Of LSD In Monkeys
Engel G, Müller-Schweinitzer E, Kalkman HO, Hoyer D, Functional correlates to 5HT1 binding sites
Engel G, Müller-Schweinitzer E, Palacios JM, 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors
Engel G, Müuller-Schweinitzer, Göthert M, 5-HT Receptor Subtypes in Periphery and in CNS
Fozard JR, Neuronal 5-HT Receptors in the Periphery
Gandolfi O, Cheney DL, Hong JS, Costa E, On the Neurotoxicity of Chlordecone: A Role for y-Aminobutyric Acid and Serotonin
Geaney DP, Schachter M, Elliot JM, Grahame-Smith DG, Characterisation of [3H]Lysergic Acid Diethylamide Binding to a 5-Hydroxytryptamine Receptor on Human Platelet Membranes
Glennon RA, Titeler M, McKenney JD, Evidence for 5HT-2 Involvement in the Mechanism of Action in Hallucinogenic Agents
Deleers M, Verloes R, Goormaghtigh E, Belgian Society for Fundamental and Clinical Physiology and Phamacology
Engel G, Hoyer D, Kalkman HO, Wick MB, Identification of 5HT-2 Receptors on Longitudinal Muscle of the Guinea Pig Ileum
de Montigny C, Blier P, Chaput Y, Electrophysiologically-identified Serotonin Receptors In The Rat CNS
Bergstrom DA, Bromley SD, Walters JR, Dopamine Agonists Increase Pallidal Unit Activity: Attenuation By Agonist Pretreatment And Anesthesia
Davis WM, Borne RF, Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA)
Burstein S. Hunter SA, Ozman K, Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts
Leuner, Hanscarl, Psycholytic Therapy. Hallucinogenics as an Aid in Psychodynamically Oriented Psychotherapy.
Buckman, John, LSD - Psychiatric Therapy and Research.
Bastiaans, Jan, Mental Liberation Facilitated by the Use of Hallucinogenic Drugs.
Grof, Stanislav, New Perspectives in Psychotherapy: Observations from LSD Research.
Grof, Stanislav, PeriNatale Ursprünge von Kriegen, Revolutionen und Totalitarismus. Beobachtungen aus der LSD-Forschung. [Perinatal Roots of Wars, Revolutions, and Totalitarism. Observations from LSD Research.]
Grinspoon, Lester; Bakalar, James B., Psychedelic Drugs in Psychiatry.
Shulgin A T, Twenty Years on an Ever-changing Quest, Psychedelic Reflections, Eds. Grinspoon L and Bakalar J B
Stafford P, Psychedelics Encyclopedia, Revised Edition
Weil A, Rosen W, Chocolate to Morphine; Understanding Mind-active Drugs
Glennon R A, Rosecrans J A, Young R, Drug-induced Discrimination: A Description of the Paradigm and a Review of its Specific Application to the Study of Hallucinogenic Agents.
Greer G, MDMA: A New Psychotropic Compound and its Effects in Humans.
Clifford David B, Tetrahydrocannabinol for tremor in Multiple Sclerosis
P Jacob, AT Shulgin, Sulfur analogues of psychotomimetic agents. 2. Analogues of (2,5-dimethoxy-4-methylphenyl)- and (2,5-dimethoxy-4-ethylphenyl)-isopropylamine
AT Shulgin, Twenty years on an ever-changing quest. II: L Grinspoon, JB Bakalar [eds.]
Young R, Rosecrans JA, Glennon RA, Behavioral Effects of 5-Methoxy-N,N-Dimethyltryptamine and Dose-Dependent Antagonism by BC-105
White FJ, Wang RY, Comparison Of The Effects Of LSD And Lisuride On A10 Dopamine Neurons In The Rat
White FJ, Wang RY, Comparison Of The Effects-of LSD And Lisuride On A10 Dopamine Neurons In The Rat
White FJ, Holohean AM, Appel JB, Antagonism of a Behavioral Effect of LSD and Lisuride in the Cat
Walker EB, McNall SJ, Mansour TE, Photoreactivity Of Lysergic Acids Diethylamide And Its Possible Utility As A Photoaffinity Labeling Reagent E. B. Walker, S. J. Mcnall, T. E. Mansour
Whipple MR, Reinecke MG, Gage FH, Short Communication: Inhibition of Synaptosomal Neurotransmitter Uptake by Hallucinogens
Waehtel H, Dorow R, Dual Action On Central Dopamine Function Of Transdihydrolisuride, A 9, 10-dihydrogenated Analogue Of The Ergot Dopamine Agonist Lisuride
Trulson ME, Crisp T, Tolerance Develops To LSD While The Drug Is Exerting Its Maximal Behavioral Effects: Implications For The Neural Bases Of Tolerance
Vandermaelen CP, Aghajanian GK, Electrophysiological and Pharmacological Characterization of Serotonergic Dorsal Raphe Neurons Recorded Extracellularly and Intracellularly in Rat Brain Slices
Tran MA, Montastruc JL, Montastruc P, Bases pharmacologiques de l'utilisation thérapeutique des alcaloïdes de l'ergot de seigle
T.A.-Gounh. and P.B. Baker, Identification of Major Drugs of Abuse Using Chromatography:-An Update
Schneider V, Klug E, Unklares Krankheitsbild durch LSD (Beibringung?)
Schotte A, Maloteaux JM, Laduron PM, Characterization and Regional Distribution of Serotonin S2-Receptors in Human Brain
Schmidt MJ, Root MA, Hall JL, Dopamine Agonist Induced Hyperglycemia In Rats: Structure-activity;sRelationships And Mechanisms Of Action .
Ruffing DM, Domino EF, Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly 127623 and FK 33-824 with Indole Hallucinogens: Antagonism of N,N-Dimethyltryptamine- and LSD-Induced Disruption of Food Rewarded Bar Pressing Behavior in the Rat
Potthoff AD, Ellison G, Nelson L, Ethanol Intake Increases during Continuous Administration of Amphetamine and Nicotine, but not Several Other Drugs
Pieri L, Keller HH, Laurent JP, Burkard WP, Pieri M, Bonetti EP, Da Prada M, Behavioral, Neurochemical, and Electrophysiological Effects of Lisuride and LSD In Animals
Palacios JM, Probst A, Cortes R, The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem
Nielsen EB, Appel JB, The Effects of Drugs on the Discrimination of Color Following a Variable Delay Period: A Signal Detection Analysis
Palacios JM, Quantitative Receptor Autoradiography: Application to the Study of Multiple Serotonin Receptors in Rat Cortex
Müller-Schweinitzer E , Engel G, Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery
Morgenstern R, Fink H, Oelssner W, LSD-Potentiated Apomorphine Hypermotility: A Model for Differentiating Antipsychotic Drugs
Monroe PJ, Smith DJ, Characterization of Multiple [3H]5-Hydroxytryptamine Binding Sites in Rat Spinal Cord Tissue
McNall SJ, Mansour TE, A Novel Serotonin Receptor In The Liver Fluke Fasciola Hepatica.
Mccall RB, Schuette MR, Humphrey SJ, Lahti RA, Barsuhn C, Evidence for a Central Sympathoexcitatory Action of Alpha-2 Adrenergic Antagonists
Larsson B, Demonstration of alpha-Adrenoceptors in the Rabbit Bladder Base and Urethra with 3H-Dihydroergocryptine Ligand Binding
Kleven MS, Dwoskin LP, Sparber SB, Pharmacological Evidence for the Existence of Multiple Functional Pools of Brain Serotonin: Analysis Of Brain Perfusate From Conscious Rats
Keller HH, Bonetti EP, Pieri L, Da Prada M, Lisuride-Induced Mounting Behavior and Effects on the Monoaminergic System in Rat Brain
Horowski R, Pharmacological Effects of Lisuride and Their Potential Role in Further Research
Jenner P, Luscombe G, Marsden CD, Interaction Of 5-Ht Agonists With Guinea-Pig Brain Stem 5-Ht
Kalkman HO, Harms YM, Van Gelderen EM, Batink HD, Timmermans WM, Van Zwieten PA, Hypotensive activity of serotonin antagoinists; correlation with alpha1-adrenoceptor and serotonin receptor blockade
Hofmann A, Goodwin DW, LSD: My Problem Child-- Reflections on Sacred Drugs, Mysticism, and Science
Hetey L, Schwitzkowsky R, Oelssner W, Influence Of Psychotomimetics And Lisuride On Synaptosomal Dopamine Release In The Nucleus Accumbens Of Rats
Dwoskin LP, Sparber SB, Behaviorally Inactive Doses of Mianserin Antagonize the Suppressant Effect of Lysergic Acid Diethylamide on a Fixed-Ratio Operant
Engel G, v. Amsterdan F, Palacios JM, 125I-LSD, A New Useful Ligand For The Characterization And Localization Of 5HT2-Receptors
Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA, DOM-Stimulus Generalization to LSD and Other Hallucinogenic Indolealkylamines
HARTIG PR, KADAN MJ, EVANS MJ, KROHN AM, 125-i-LSD: A High Sensitivity Ligand For Serotonin Receptors
Institute of Medice, Division of Heath Sciences Policy, Marijuana and Health: Report of a Study by a committee of the Institute of Medicine, Division of Health Sciences Policy
Gingrich Newt, Legal Status of Marijuana
Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG, Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
Di Leo, Francesco B., The Activation and Experiential Integration of In-Depth Psychic Introjects in Psychedelic-Activated Psychotherapy.
Leuner, Hanscarl, Intensivierung der tiefenpsychologischen Psychotherapie durch Medikamente. [Intensification of Depth-Psychological Psychotherapy through Medicaments.]
Haesler, Walter T., LSD und präNatale Psychologie. [LSD and Prenatal Psychology.]
Shulgin A T, Chemistry of Psychotomimetics, Psychotropic Agents Part III, Alcohol and Psychotomimetics; Psychotropic Effects of Central Acting Drugs Eds. F Hoffmeister, G Stille
Glennon R A, Young R, Rosecrans J A, Anderson G M, Discriminative Stimulus Properties of MDA Analogs.
Anonymous, Request for Information
Nichols D E, Lloyd D H, Hoffman A J, Nichols M B, Yim G K W, Effects of Certain Hallucinogenic Amphetamine Analogues on the Release of [3H] Serotonin from Rat Brain Synaptosomes.
Shulgin A T, Jacob III P, 1-(3,4-Methylenedioxyphenyl)-3-aminobutane: A Potential Toxicological Problem.
Shulgin A T, Jacob III P, Potential Misrepresentation of 3,4-Methylenedioxyamphetamine (MDA). A Toxicological Warning.
O'Brian B A, Bonicamp J M, Jones D W, Differentiation of Amphetamine and its Major Hallucinogen Derivatives using Thinlayer Chromatography.
Gough T A, Baker P B, Identifiction of Major Drugs of Abuse Using Chromatography.
Malec J, et al., Cannabis effect on spasticity in spinal cord injury
ElSohly H N, et al., Synthesis and antimicrobial activity of certain cannabichromene and cannabigerol related compounds.
Merritt J C, et al., Topical delta-9-tetrahydrocannabinol as a potential glaucoma agent
Zuardi A W, et al., Action of cannabidiol on the anxiety and other effects produced by delta-9-THC in normal subjects
Knight Edward H, The Deformed Leg in Pre-Columbian Mexican Mythology
Carrasco David, Quetzalcoatl and the Irony of Empire: Myths and Prophecies in the Aztec Tradition
AT Shulgin, P Jacob, Potential misrepresentation of 3,4-methylenedioxyamphetamine (MDA). A toxicological warning
AT Shulgin, P Jacob, 1-(3,4-methylenedioxyphenyl)-3-aminobutane: a potential toxicological problem
T Sargent, AT Shulgin, CA Mathis, New iodinated amphetamines by rapid synthesis for use as brain blood flow indicators
Young RE, Milroy R, Hutchison S, Kesson CM, The Rising Price Of Mushrooms
Wlikison DM, Hosko MD, The Pharmacologist
Wilikison DM, Hosko MJ, Interactions of Cyproheptadine and Methysergide with LSD on Sensory Evoked Activity.
Williams M, Martin GE, Selectivity of cyproheptadine as assessed by radioligand binding
White FJ, Appel JB, Training Dose as a Factor in LSD-Saline Discrimination
West KB, Hernandez LL, Appel JB, Drugs and Visual Perception: Effects of LSD, Morphine and Chlorpromazine on Accuracy, Bias and Speed
White FJ, Appel JB, Lysergic Acid Diethylarnide (LSD) and Lisuride: Differentiation of Their Neuropharmacological Actions
Trulson ME, Crisp T, Lack of Synergism and Cross Tolerance Between Tactile Stimulus- and LSD-Induced Limb Flicking in the Cat
Trulson ME, Howell GA, Dissociations Between The Behavioral Effects Of LSD And Tolerance Development During Ontogeny In Cats: A Novel Approach To The Study Of Tolerance Mechanisms
Vaupel DB, Morton EC, Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hallucinogens
Stadler PA, Stuetz P, Quelques Aspects Nouveaux De La Chime Des Derives De L'acide Lysergique
Stoff DM, Jeste DV, Moja EA, Stauderman KA, Wyatt RJ, Interaction of Monoamine Blocking Agents with Behavioral Effects of N, N Dimethyltryptamine
Stadler PA, Neuere Ergebnisse der Mutterkornalkaloid-Forschung New Results of Ergot Alkaloid Research
Snyder SH, Peroutka SJ, A Possible Role of Serotonin Receptors in Antidepressant Drug Action
Simon AM, A study of drug abuse in a group of South African university students
Shearman GT, Herz A, Non-opioid Psychotomimetic-like Discriminative Stimulus Properties Of N-allylnormetazocine (skf 10,047) In The Rat
Sakharov DA, Salanki J, Effects of dopamine antagonists on snail locomotion
O'Brien BA, Bonicamp JM, Jones DW, Differentiation of Amphetamine and Its Major Hallucinogenic Derivatives Using Thin-Lager Chromatography
Peden NR, Pringle SD, Hallucinogenic Fungi
Nielsen EB, White FJ, Holohean AM, Callahan PM, Appel JB, Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines
Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW, Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes
Mokler DJ, Commissaris RL, Rech RH, Drugs that influence dopamine function do not alter the disruption of operant behavior by lisuride (LIS), lysergic acid diethylamide (LSD) or d-amphetamine (d-A)
Mishra SK, Raviprakash V, Alpha-Thioglycerol sensitive excitatory oxytocin receptors in fowl rectum
Minnema D, Rosecrans JA, Alterations Of The Discriminative Stimulus Produced By D-amphetamine Or LSD In Rats Neonatally Depleted Of Serotonin Or Dopamine
McCall RB, Humphrey SJ, Involvement of Serotonin in the Central Regulation of Blood Pressure: Evidence for a Facilitating Effect on Sympathetic Nerve Activity
McCall MA, Tieman DG, Hirsch HVB, Chronic Intraventricular Administration of Lysergic Acid Diethylamide (LSD) Affects the Sensitivity of Cortical Cells to Monocular Deprivation
Maj J, Vetulani J, Michaluk J, Rogóz Z, Skuza G, Central Action of Amitriptyline N-oxide
Luscombe G, Jenner P, Marsden CD, Myoclonus In Guinea Pigs Is Induced By Indole-containing But Not Piperazine-containing 5ht Agonists
Lucki I, Frazer A, Prevention of the Serotonin Syndrome in Rats by Repeated Administration of Monoamine Oxidase Inhibitors but not Tricyclic Antidepressants
Langer SZ, Moret C, Citalopram Antagonizes the Stimulation by Lysergic Acid Diethylamide of Presynaptic Inhibitory Serotonin Autoreceptors in the Rat Hypothalamus
Langer SZ, Moret C, Citalopram Antagonizes The Effects Of Lsd On The Presynaptic Serotonin Autoreceptors In Slices Of The Rat Hypothalamus
Ksir C, Slifer B, Drug Effects on Discrimination Performance at Two Levels of Stimulus Control
Koernerl J, Appel JB, Psilocybin as a Discriminative Stimulus: Lack of Specificity in an Animal Behavior Model for 'Hallucinogens'
Kemali M, Milici N, Kemali D, The Pigment Screening (ps) Of The Frog Retina After Administration Of Psychoactive Drugs
Kleven MS, Dwoskin LP, Sparber SB, Lysergic Acid Diethylamide (LSD) attenuates 5-hydroxytryptophan (5-HTP) induced increases in 5-hydroxyindoleacetic acid (5-HIAA) in ventricular perfusate collected during operant behavior
Jarbe TUC, Discriminative Stimulus Properties of d-Amphetamine in Pigeons
Kemali M, Kemali D, Lysergic acid diethylamide (LSD)-induced reversible structural modifications, endogenous psychosis-like experience and CEEG finding. A study in frog and man
Holohean AM, White FJ, Appel JB, Dopaminergic and Serotonergic Mediation of the Discriminable Effects of Ergot Alkaloids
Jacobs BI, Heym J, Rasmussen K, Action of Hallucinogenic Drugs at Postsynaptic Serotonergic Receptors
Hjorthl S, Carlssoni A, Lindberg P, Sanchez D, Wikström H, Arvidsson LE, Hacksell U, Nilsson JLG, 8-Hydroxy-2-(Di-n-Propylamino)Tetralin, 8-OH-DPAT, a Potent and Selective Simplified Ergot Congener with Central 5-HT-Receptor Stimulating Activity
Heym J, Steinfels GF, Jacobs BL, Medullary serotonergic neurons are insensitive to 5-MeoDMT and LSD
Harvey JA, Gormezano I, Cool VA, Effects of d-lysergic Acid Diethylamide, d-2-Bromolysergic Acid Diethylamide, dl-2,5-Dimethoxy-4-Methylamphetamine and d-Amphetamine on Classical Conditioning of the Rabbit Nictitating Membrane Response
Halaris AE, Rosenthal M, DeMet EM, Freedman DX, The Raphe Neuronal System And Serotonergic Effects Of LSD
Domino EF, Ruffing DM, Evidence for Opioids as Partial Antagonists for Indole Hallucinogens
Dong MW, DiCesare JL, Rapid Analysis of Some Commonly Abused Drugs by LC
Glennon RA, Rosecrans JA, Young R, The Use of the Descriminative Stimulus Paradigm for Studying Hallucinogenic Agents: A Review
Gough TA, Baker PB, Identification of Major Drugs of Abuse Using Chromatography
Smith D H, Method of using N-substituted dihydro-2-oxazolamines as analgesics U.S. Patent Number 4,256,755
Ingrasci R, Review of Grof's LSD Psychotherapy
Weissman A, On the definition of cannabinoids: botanical? chemical? pharmacological?
Yaksh TL, The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat
Jones RT, Benowitz NL, Herning RI, Clinical relevance of cannabis tolerance and dependence
Elsohly MA, Harland E, Murphy JC, Wirth P, Waller CW, Cannabinoids in glaucoma: a primary screening procedure
Petro DJ, Ellenberger C Jr, Treatment of human spasticity with delta 9-tetrahydrocannabinol
Turner CE, Elsohly MA, Biological activity of cannabichromene, its homologs and isomers
Ungerleider JT, Andrysiak T, Bias and the cannabis researcher
Schaeffer J et.al., Cognition and Long-Term Use of Ganja (Cannabis)
Jeng I, Harnacker B, Klemm BN, Rieser C, Relationship between 5-hydroxytryptamine and Lysergic Acid Diethylamid
Grof, Stanislav, LSD Psychotherapy.
Roquet, S.; Favreau, P.L., Los alucinogenos de la conception indigena a una nueva psicoterapia.
Leuner, Hanscarl, Halluzinogene. Psychische Grenzzustände in Forschung und Psychotherapie. [Hallucinogens. Psychic Borderline States in Research and Psychotherapy.]
Di Leo, Francesco B., Psychotherapy with Psychedelic Drugs: A Case Report.
Adler, Lothar, Zur analen Erlebnisthematik in der psycholytischen Therapie. [About Experiential Themes of the Anal Phase in Psycholytic Therapy.]
Grof, Stanislav, LSD und das menschliche Unbewußte. Beobachtungen aus der Forschung mit psychedelischen Drogen. [LSD and the Human Unconsciousness. Observations from Research with Psychedelic Drugs.]
Grinspoon, Lester; Bakalar, James B., The Psychedelic Drug Therapies.
Dennis J. McKenna, G. H. N. Towers, Ultra-violet mediated cytotoxic activity of B-carboline alkaloids
Shulgin A T, Hallucinogens. Burger's Medicinal Chemistry, 4th Edition, Part III Ed. M E Wolff
Andrey R E, Moffat A C, Gas-Liquid Chromatographic Retention Indices of 1318 Substances of Toxicological Interest on SE-30 or OV-1 Stationary Phase.
Petro D, Ellenberger C Jr, Treatment of human spasticity with delta-9-tetrahydrocannabinol
Merritt J C, et al., Topical delta-9-tetrahydrocannabinol in hypertensive glaucomas.
Merritt J C, et al., Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma.
Karler R, Turkanis S A, The cannabinoids as potential antiepileptics
Levitt M, et al., Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta-9-tetrahydrocannabinol in cancer chemotherapy: ophthalmologic implications.
Brundage Burr Cartwright, The Phoenix of the Western World Quetzalcoatl and the Sky Religion
Grinspoon L, Bakalar J B, The psychedelic drug therapies
P Jacob, AT Shulgin, Sulfur analogues of psychotomimetic agents. Monothio analogues of mescaline and isomescaline
LN Domelsmith, TA Eaton, KN Houk, GM Anderson, RA Glennon, AT Shulgin, N Castagnoli, PA Kollman, Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogues
AT Shulgin, Chemistry of psychotomimetics. II: F Hoffmeister, G Stille [eds.]
AT Shulgin, Profiles of psychedelic drugs. 11. Bufotenine
AT Shulgin, Hallucinogens. II: ME Wolff [ed.]
AT Shulgin, Profiles of psychedelic drugs. 10. DOB
AT Shulgin, MF Carter, N,N-diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity
Winter JC, Drug-induced stimulus control and the concept of breaking point: LSD and quipazine
White FJ, Holohean AM, Appel JB, Lack of Specificity of an Animal Behavior Model for Hallucinogenic Drug Action
White FJ, Appel JB, A Neuropharmacological Analysis of the Discriminative Stimulus Properties of Fenfluramine
Whitaker PM, Crow TJ, Ferrier IN, Tritiated LSD Binding in Frontal Cortex in Schizophrenia
Weiss S, Drummond GI, Dopamine- And Serotonin-sensitive Adenylate Cyclase In The Gill Of Aplysia
Weinreich P, Seeman P, Binding Of Adrenergic Ligands ([3h]clonidine And [3H]WB-4101) To Multiple Sites In Human Brain
Trulson ME, Brandstetter JW, Jacobs BL, Similarity of the behavioral effects of quipazine and LSD in cats
Wallis D, Nash H, Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells
Stern L, In Vivo Assessment of the Teratogenic Potential of Drugs in Humans
Schlemmer RF, Davis JM, LSD-induced Behavioral Changes In Selected Members Of A Primate Social Colony
Ruffig DM, Domino EF, Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25-Induced Disruption of Food-Rewarded Bar Pressing Behavior in the Rat
Rosenfeld MR, Makman MH, The Interaction of Lisuride, an Ergot Derivative, with Serotonergic and Dopaminergic Receptors in Rabbit Brain
Poller D, Carroll JA, Middlemiss DN, The [3h]5-ht And [3h]spiroperidol Binding Sites In The Rat Frontal Cortex Are Thermally Inactivated At Different Rates
Pope HG Jr, Ionescu-Pioggia M, Cole JO, Drug Use and Life-style Among College Undergraduates: Nine years later
Peroutka SJ, Snyder SH, [3H]Mianserin: Differential Labeling of Serotonin2 and Histamine1 Receptors in Rat Brain
Patel AJ, Barochovsky O, Lewis PD, Psychotropic Drugs And Brain Development: Effects On Cell Replication In Vivo And In Vitro
Nahas GG, A pharmacological classification of drugs of abuse
Neuninger H, Die Biotransformation der Suchtgifte
Oelsner W, Fink H, Hetey L, Drescher K, Action of antipsychotics on LSD-induced neurochemical and behavioral effects in rats
Muggler-Bickel J, Maag F, Drogen und FŸhrertauglichkeit
McNall SJ, Mansour TE, H-LSD Binding To A Serotonin Receptor Coupled To Adenylate Cyclase Activity In The Liver Fluke Fasciola Hepatica
Menon MK, Vivonia CA, Modification Of Apomorphine Hypothermia By Drugs Affecting Brain 5-hydroxytryptamine Function
Maayani S, Meibach RC, Green JP, Heterogeneity of [3H]-5-HT and [3H]-LSD binding in rat brain and calf hippocampus slices
Marini JL, Jacobs BL, Sheard MH, Trulson ME, Activity of a Non-Hallucinogenic Ergoline Derivative, Lisuride, in an Animal Behavior Model for Hallucinogens
Loew DM, Die Wirkung von Mutterkorn-Dervaten auf das Zentralnerensystem: Synaptischetibertragungsmechansmen
Laubscher A, Pletscher A, Noll H, Interaction of D-LSD with Blood Platelets of Rabbits: Shape Change and Specific Binding
Leysen JE, Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro
Larson AA, Chinn C, Proudfit HK, Anderson EG, Dual Actions of Lysergic Acid Diethylamide Tartrate (LSD), 2-Bromo-D-Lysergic Acid Diethylamide Bitartrate (BOL) and Methysergide on Dorsal Root Potentials Evoked by Stimulation of Raphe Nuclei
Konzett H, Halluzinogene: LSD, Psilocybin und Mescalin
Lake CR, Stirba AL, Kinneman RE, Carlson B, Holloway HR, Mania Associated with LSD Ingestion
Keseberg A, Drogenabhangigkeit Heranwachsender
Hirsch JD, Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol
Heinze WJ, Schlemner RF, Javaid JI, Davis JM, The Comparative Effects of d-LSD & d-Amphetamine on Stereotyped Behavior in Rats
Heikkila JJ, Brown IR, Comparison of the Effect of Intravenous Administration of d-Lysergic Acid Diethylamide on Free and Membrane-Bound Polysomes in the Rabbit Brain
Gupta SP, Singh P, Bindal MC, Correlation of Inhibitory Activity of Tryptamine Derivatives on Serotonin Uptake in Thrombocyte with van der Waals Volume
Grinspoon L, LSD Reconsidered: Should clinical research be resumed?
Grillo SA, Effect of dl-amphetamine and d-lysergic acid diethylamide on the slow potentials evoked in the reticular formation
DiSclafani A, Hall RCW, Gardner ER, Drug-induced psychosis: Emergency diagnosis and management
Feltner EJ, Meibach RC, Maayani S, Green JP, Radioautographic Localization of H-5-HT and [2]H-D-LSD Binding Sites on Dopaminergic Nigral-Striatal Neurons
Ferraino R, Feigenson M, Chakrin L, An Animal Model for Predicting Drug-Induced Psychotomimetic Effects in Man
Fink H, Oelssner W, LSD, mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility
Freedman MS, Clark BD, Cruz TF, Gurd JW, Brown IR, Selective Effects of LSD and Hyperthermia on the Synthesis of Synaptic Proteins and Glycoproteins
Commissaris RL, Lyness WH, Rech RH, Effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital (PB), and methaqualone (MQ) on conflict behavior in control and 5,7-dihydroxytryptamine (5,7-DHT)-treated rats
Grof S, LSD Psychotherapy, Emotional distress and physical pain of dying individuals
Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R, Chronic administration of cannabidiol to healthy volunteers and epileptic patients
Strassman RJ, Galanter M, The Abhidharma: a cross-cultural model for the psychiatric application of meditation
Kafkalidis, Athanassios, The Knowledge of the Womb. Autopsychognosia with Psychedelic Drugs.
Grof, Stanislav, Realms of the Human Unconscious.
Strassman RJ, Galanter M, The Abhidharma: A cross-cultural model for the psychiatric application of meditation
Braun U, Shulgin A T, Braun G, Prufung auf zentral Aktivitat und Analgesie von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylenedioxyphenylisopropylamin.
Braun U, Shulgin A T, Braun G, Centrally Active N- Substituted Analogs of 3,4-Methylenedioxyphenylisopropylamine (3,4-Methylenedioxyamphetamine)
Petro D, Marihuana as a therapeutic agent for muscle spasm or spasticity
Blevins R D, Damie M R, The effect of delta-9-THC on Herpes simplex virus replication.
Merritt J C, et al., Effect of marijuana on intraocular and blood pressure in glaucoma.
Merritt J C, et al., Oral delta-9-tetrahydrocannabinol in heterogenous glaucomas.
Cunha J M, et al., Chronic administration of cannabidiol to healthy volunteers and epileptic patients
Davies Nigel, The Toltec Heritage: From the Fall of Tula to the Rise of Tenochtitlan
Furber Louanna, ed., Mayan Texts III. International Journal of American Linguistics, Native American Texts Series, Monograph No. 5
Wollweber A, Stereochemistry studies on drugs, 8
RT Standridge, HG Howell, HA Tilson, JH Chamberlain, HM Holava, JA Gylys, RA Partyka, AT Shulgin, Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes
U Braun, AT Shulgin, G Braun, Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)
RE Kantor, SD Dudlettes, AT Shulgin, 5-methoxy-gamma-methyltryptamine (gamma-O-dimethylserotonine) a hallucinogenic homolog of serotonin
AT Shulgin, Profiles of psychedelic drugs. 8. psilocybin
U Braun, AT Shulgin, G Braun, Prufung auf Aktivitat und Analgesia von N-substituierten Analogen des Amphetamin Derivates 3,4-Methylendioxyphenylisopropylamin
AT Shulgin, Profiles of psychedelic drugs. 9. LSD
Wang RY, Aghajanian GK, Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment
Whitaker PM, Brain receptors for LSD and serotonin
White FJ, Simmons MA, West KB, Holohean AM, Appel JB, The effect of serotonin depletion on the discriminability of LSD
Winter JC, Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus
üArens H, Zenk MH, Radioimmuntests für die Bestimmung von Lysergsaüre und einfachen Lysergsaürederivaten
Young WS, Kuhar MJ, Serotonin receptor localization in rat brain by light microscopic autoradiography
Ögren SO, The effects of chronic treatment with nomifensine and zimelidine on 3H-d-LSD binding in the rat cerebral cortex
Trevor-Roper P, The psychopathic eye
Vanderwolf CH, Robinson TE, Pappas BA, Monamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity
Vetulani J, Bednarczyk B, Reichenberg K, Rokosz A, Head twitches induced by LSD and quipazine: similarities and differences
Wallis DL, Nash HL, The Action Of Methylated Derivatives Of 5-hydroxytryptamine At Ganglionic Receptors
Teal JJ, Holtzman SG, Discriminative Stimulus Effects of Cyclazocine in the Rat
Svensson TH, Effect of Chronic Treatment with Tricyclic Antidepressant Drugs on Identified Brain Noradrenergic and Serotonergic Neurons
Swann AC, Heninger GR, Marini JL, Sheard MH, Maas JW, Lithium effects on high-affinity tryptophan uptake: evidence against a stabilization mechanism
Tang SW, Seeman P, Effect of Antidepressant Drugs on Serotonergic and Adrenergic Receptors
Strahlendorf JCR, Mechanism of Lysergic Acid Diethylamide Influence Upon Optically Evoked Potentials
Sloviter RS, Drust EG, Damiono BP, Connor JB, Serotonergic Mediation Of Behavioral Effects In Rats Of Indoles And Phenethylamine Hallucinogens
Smith JA, Walters G, Johnston D, LSD "flashback" as a cause of diagnostic error
Sloviter RS, Drust EG, Damiano BP, Connor JD, A Common Mechanism for Lysergic Acid, Indolealkylamine and Phenethylamine Hallucinogens: Serotonergic Mediation of Behavioral Effects in Rats
Shannon HE, MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-Like Discriminative Stimuli in the Rat
Sietnieks A, Meyerson BJ, Enhancement By Progesterone Of Lysergic Acid Diethylamide Inhibition Of The Copulatory Response In The Female Rat
Seeman P, Westman K, Coscena D, Warsh J, Serotonin Receptors in Hippocampus and Frontal Cortex
Schorderet M, Sovilla JY, Magistretti PJ, New Findings Related To A Possible Interaction Of Ergolines And Ergopeptines With Pre-synaptic Dopmine Receptors
Sachanska T, Haralanov H, Boaidgieva M, Koicheva V, Genova, Pektova K, Todorov V, Shmarov A, Complex Clinical, Biochemical and Electrophysiological Investigations After The Application Of LSD-25
Ruffing DM, Domino EF, First Dose Behavioral Tolerance to Phencyclidine on Food-Rewarded Bar Pressing Behavior in the Rat
Rech RH, Lyness WH, Moore KE, Commissaris RL, Behavioral Tolerance To The Effects Of LSD In Rats
Pesce VS, L'uso della droga ed i suoi riflessi sull'apparato genitale femminile
Ramabadran K, Jacon J, Systèmes sérotoninergiques et nociception
Peroutka SJ, Snyder SH, Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka SJ, Moskowitz MA, Reinhard JF, Snyder SH, Neurotransmitter Receptor Binding in Bovine Cerebral Microvessels
PARKER RJ, HIROM PC, MILLBURN P, Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat: Hydrolysis of glucuronic acid conjugates in the gut lumen
Oelszner W, Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug
Nielsen EB, Nielsen M, Ellison G, Braestrup C, Decreased Spiroperidol And LSD Binding In Rat Brain After Continuous Amphetamine
North RA, Henderson G, Katayama Y, Johnson SM, Electrophysiological Evidence For Presynaptic Inhibition Of Acetycholine Release By 5-hydroxytryptamine In The Enteric Nervous System
Nielsen EB, Lee TH, Ellison G, Following Several Days of Continuous Administration d-Amphetamine Acquires Hallucinogenlike Properties
Murakami N, Sakata Y, A Possible Role of the Serotonergic System in Thermoregulation in the Rabbit
Morgenstern R, Strutz G, Gold R, Fink H, Zur Beziehung zwischen Neuroleptika-induzierter Hemmung von Spontan-Lokomotion (pD2) and LSD-potenzierter Apomorphin-Lokomotion (pA2) an der Ratte. Einfluss verschiedener Serotoninantagonisten auf die LSD-potenzierte Apomorphin-Lokomotion der Ratte.
Minnema DJ, Rosecrans JA, Discriminative Stimulus Interactions of LSD and d-Amphetamine
Mellett P, Hypnosis. Current views on the psychophysiology of hypnosis
Meibach RC, Maayni S, Green JP, Characterization And Radioautography Of [3H] LSD Binding By Rat Brain Slices In Vitro: The Effect Of 6-hydroxytryptamine
McLellan, AT, Woody GE, O'Brien CP, Psychiatric Illness in Drug Abusers
Mccall RB, Aghajanian GK, Hallucinogens Potentiate Responses To Serotonin And Norepinephrine In The Facial Motor Nucleus
Markó M, Flüeckiger E, Role of Serotonin in the Regulation of Ovulation. Evidence from Pharmacological Studies
Makman MH, Dvorkin B, Horowitz SG, Thal LJ, Properties Of Dopamine Agonist And Antagonist Binding Sites In Mammalian Retina
Maayani S, Weinstein H, "SPECIFIC BINDING" OF 3H-PHENCYCLIDINE: ARTIFACTS OF THE RAPID FILTRATION METHOD
Laubscher A, Pletscher A, Honegger CG, Blood platelets as models for neurons: receptor- and nonreceptor-mediated membrane effects
Lee EHY, Geyer MA, Persistent Effects Of Chronic Administration Of LSD On Intracellular Serotonin Content In Rat Midbrain
Laubscher A, Pletscher A, Increase of cyclic GMP in blood platelets by biogenic amines - a receptor-mediated effect
Kubos KL, Drugs and Seizure Identification by Audio Spectrometry
Kuhn DM, O'Callaghan JP, Juskevich J, Lovenberg W, Activation of Brain Tryptophan Hydroxylase by ATP-Mg2+: Dependence on Calmodulin
Kraus L, Stahl E, Thies W, Quantitative in situ fluorimetry of LSD by HPTLC
Kräuchi K, Feer H, In vivo 3H-d-LSD binding in small punched out rat brain regions
Ksir CJ, Rate-Dependent and Stimulus Control Effects of Drugs
Kenyon CN, Melera A, Use of the Direct Liquid Inlet LC/MS System for the Analysis of Complex Mixtures of Biological Origin
Kemali M, Kemali D, Lysergic Acid Diethylamide: Morphological Study of its Effect on Synapses
Järbe TUC, LSD-25 as a Discriminative Stimulus for Response Selection by Pigeons
Jasinski DR, Interdisciplinary Studies on Phencyclidine at the Addiction Research Cente, Lexington, Kentucky.
Ishii H, Niwaguchi T, Nakahara Y, Hayashi M, Studies on Lysergic Acid Diethylamide and Related Compounds. Part 8. Structural Identification of New Metabolites of Lysergic Acid Diethylamide obtained by Microbial Transformation using Streptomyces roseochromogenes
Ishidate M, Yoshikawa K, Chromosome Aberration Tests with Chinese Hamster Cells in vitro with and without Metabolic Activation - A Comparative study on Mutagens and Carcinogens
Inoue T, Niwaguchi T, Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes
Hetey L, Quiring K, Misselwitz H J, Oelssner W, Bestimmung unterschiedlicher Parameter des cerebralen Dopamin- und Serotonin-Umsatzes nach Psychoharmaka
Hetey L, Quiring K, Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats
Hartung J, Skorka D, The HIT clinical profile of psychedelic drug users
Green JP, Maayani S, Weinstein H, Hough LB, Histamine and Psychotroic Drugs
Gormezano I, Harvey JA, Sensory and Associative Effects of LSD in Classical Conditioning of Rabbit (Oryctolagus cuniculus) Nictitating Membrane Response
Gold R, Morgenstern R, Fink H, Effects of atypical antidepressants on LSD potentiated apomorphine hypermotility in rats
Gormezano I, Harvey JA, Sensory and Associative Effects of LSD on Classical Appetitive Conditioning of the Rabbit Jaw Movement Response
Gillespie JS, The physiology and pharmacology of the anococcygeus muscle
Geyer M A, Both lndoleamine and Phenylethylamine Hallucinogens Increase Serotonin in Both Dorsal and Median Raphe Neurons
Frischknecht HR, Waser PG, Actions of Hallucinogens on Ants (Formica Pratensis)-III. Social Behaviour Under the Influence of LSD and Tetrahydrocannabinol
Gallager DW, Mallorga P, Tallman JF, Interaction Of Diphenylhydantoin And Benzodiazepines In The CNS
Fairchild MD, Jenden DJ, Mickey MR, Yale C, EEG Effects of Hallucinogens and Cannabinoids Using Sleep-Waking Behavior as Baseline
Fink H, Morgenstern R, Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system
Editorial, Tod-geweihte: LSD hilft sterben
Editorial, Wie evoziert das LSD: Halluzinationen und Träume?
Editorial, How is the differential diagnosis made between (a) acute alcohol poisoining, (b) acute lysergide poisoning and (c) acute schizophrenia when there is no history of any previous illness and a patient presents with symptoms of hallucinosis and amnesia?
Editorial, Arguments Heard for Psychedelics Probe
Drummond AH, Bucher F, Levitan IB, d-[3H]Lysergic Acid Diethylamide Binding to Serotonin Receptors in the Molluscan Nervous System
Drummon AH, Benson JA, Levitan IB, Serotonin-induced hyperpolarization of an identified aplysia neuron is mediated by cyclic AMP
Dray A, Fox PC, Hilmy M, Somjen GG, The effects of LSD and some analogues on the responses of single cortical neurons of the cat to optical stimulation
Crow TJ, Bourne R, Cross AJ, Ferrier IN, Owen F, Johnstone EC, Owens DGC, Whitaker PM, Neurotransmitter Enzymes And Receptors In Postmortem Brain In Schizophrenia
Connell DJ, Middlemiss DN, Stone MA, Further evidence for an interaction of propranolol with the central 5-hydroxytryptamine (5-HT) receptor
Ceccarelli P, Ortolani E, Zapponi GA, Loizzo A, Applications of multivariate analysis in the classification of psychotropic drugs: effects of LSD-25 on the EEG of the rabbit
Chiu S, Mishra RK, Effects of dopaminergic and cholinergic drugs, naloxone and 1-prolyl-leucyl-glycynamide on LSD-induced catelepsy
Colpaert FC, In Vivo Evidence Of Mixed Agonist/antagonist Activity Exerted By The Purported 5-hydroxytryptamine Antagonists Mianserin, Methysergide, And Cyproheptadine: A Drug Discrimination Analysis
Commissaris RL, Lyness WH, Moore KE, Rech RH, Antagonism of the Behavioral Effects of Hallucinogens by the 5-Hydroxytryptamine (5 HT) Antagonist Methergoline (MTG)
Abraham HD, Psychiatric illness in drug abusers
Angus JA, Black JW, Pharmacological assay of cardiac H2-receptor blockade by amitripyline and lysergic acid diethylamide
Baraban JM, Aghanjanian GK, Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists
Baumann PA, Presynaptic serotonin autoreceptors in rat cortex slices
Bonetti EP, Bondiolotti G, Backward locomotion in rats, a specific stereotyped behavior
Braun U, Shulgin AT, Braun G, Centrally active N-substituted analogs of 3,4- methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)
Richards, William A., Psychedelic Drug-Assisted Psychotherapy with Persons Suffering from Terminal Cancer.
Berendes, Margret, Formation of Typical, Dynamic Stages in Psychotherapy Before and After Psychodelic Drug Intervention.
Bakalar, James B., Psychedelic Drug Therapy: Cultural Conditions and Obstacles.
Bakalar J B, Psychedelic drug therapy: Cultural conditions and obstacles
Grinspoon, Lester; Bakalar, James B., Psychedelic Drugs Reconsidered.
Richards, William A.; Rhead, John C.; Grof, Stanislav; Goodman, Louisa E.; Di Leo, Francesco; Rush, Lockwood, DPT as an Adjunct in Brief Psychotherapy with Cancer Patients.
Grof, Stanislav, LSD in der Begegnung mit dem Tod - ein Beitrag zur Humanisierung des Sterbens. [LSD in the Human Encounter with Death - A Contribution to the Humanization of Dying.]
Grof, Stanislav, LSD og den kosmiske leg: Skitse fil en psykedelisk kosmologi og ontologi. [LSD and the Cosmic Game: Outline of Psychedelic Cosmology and Ontology.]
Grof, Stanislav, LSD Psychotherapy.
Grof, Stanislav, LSD Psychotherapy. [LSD-Psychotherapie]
Grinspoon, Lester; Bakalar, James B., Therapeutic Uses.
Crawford W, Merritt J C, Effects of tetrahydrocannabinol on arterial and intraocular hypertension
Girard Raphael, Esotericism of the Popol Vuh. Trans. Blair A. Moffett.
Grinspoon L, Bakalar J B, Psychedelic Drugs Reconsidered, Dying: 223-226, Birth and Death: 256-261, Dying: Annotated Bibliography: 366-367
RA Glennon, LB Kier, AT Shulgin, Molecular connectivity analysis of hallucinogenic mescaline analogs
AT Shulgin, Chemistry of phenethylamines related to mescaline
AT Shulgin, Profiles of psychedelic drugs. 6. alpha-O-DMS.
AT Shulgin, Profiles of psychedelic drugs. 7. Mescaline
MacDermot, J., Higashida, H., Wilson, S. P., et al, Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.
Williams JM, Yarbrough GG, Enhancement of in vitro binding and some of the pharmacological properties of diazepam by a novel anthelmintic agent, avermectic B1a
Winter JC, Quipazine-induced stimulus control in the rat
Wong YW, Chiu S, Mishra RK, Effect of d-lysergic acid diethylamide on striatal choline acetyltransferase activity in the rat
Ögren SO, Fuxe K, Agnati LF, Gustafsson JÅ, Jonsson G, Holmt AC, Reevaluation of the Indoleamine Hypothesis of Depression. Evidence for a Reduction of Functional Activity of Central 5-HT Systems by Antidepressant Drugs
Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC, The inhibition of food intake in the dog by LSD, mescaline, psilocin, d-amphetamine and phenyl-isopropylamine derivatives
Vetulani J, Byrska B, Reichenberg K, Head twitches produced by serotonergic drugs and opiates after lesion of the mesotriatal serotonergic system of the rat
Walters JR, Baring MD, Lakoski JM, Effects of ergolines on dopaminergic and serotonergic single unit activity
Wang RY, de Montigny C, Gold BI, Roth RH, Aghajanian GK, Denervation supersensitivity to serotonin in the rat forebrain: single cell studies
Weinstein H, Osman R, Green JP, The molecular basis of structure-activity and relationships: quantum chemical recognition and activation mechanisms in drug receptor interactions
Whitaker PM, Seeman P, Selective labeling of apomorphine receptors by 3H-LSD
White FJ, Appel JB, Kuhn DM, Discriminative stimulus properties of quipazine: direct serotonergic mediation
Williams JM, Distortions of vision and pain: two functional facets of d-lysergic acid diethylamide
Trulson ME, Jacobs BL, Alterations of serotonin and LSD receptor binding following repeated administration of LSD
Trulson ME, Jacobs BL, Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats
Uebelhack R, Belkner J, Seidel K, Einfluss von LSD un 5-Methoxy-N, N-Dimethyltryptamin auf die RNS-Synthese in Zelkernen aus Rattenhirn
Torre E, Pavesi M, Torre C, Azione Dell'LSD-25 Sulle Colinesterasi Del Cervello Di Ratto
Sypniewska M, The Effect of Baclofen on the Hind Limb Flexor Reflex of the Spinal Rat
Sovilla JY, Magistretti P, Schorderet M, Potentiation of Apomorphine-Induced Climbing Behaviour in Mice by d-LSD
Sovilla JY, Schorderet M, Potentiation of apomorphine-induced climbing in mice by d-LSD
Stoney DA, Thornton JI, Solvent-Dependent Photolysis for Identification of Lysergic Acid Diethylamide and Other Indolamines
Sloviter RS, Serotonin Neuropharmacology: Behavior and Hippocampal Electrophysiology
Skett P, Mode A, Eneroth P, Gustafsson JA, The Effect Of Various Centrally-acting Drugs On Hepatic Steroid Metabolism In Male And Female Rats
Sissors DL, Comparison of Mescaline and Lysergic Acid Diethyamide Effects on Lymphocyte Function In Vitro
Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT, The metabolism of lysergic acid diethylamide (LSD) in the isolated perfused rat liver
Silbergeld EK, Hruska RE, Lisuride and LSD: Dopaminergic and Serotonergic Interactions in the "Serotonin Syndrome"
Schlemmer RF, Heinze WJ, Davis JM, Evidence For Serotonin Mediation Of LSD-induced Abnormal Behavior In Monkeys
Siddik ZH, Barnes RD, Dring LG, Smith RL, Williams RT, The fate of lysergic acid di[14C]ethylamide ([14C]LSD) in the rat, guinea pig and rhesus monkey and of [14C]iso-LSD in rat
Schild HO, L'ergot de seigle: des conceptions de dale aux récepteurs
Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML, Severe Aggression in Rats Induced by Mescaline But Not Other Hallucinogens
Przegalinski E, Baran L, Palider W, Siwanowicz J, The central action of pizotifen
Rogawski MA, Aghajanian GK, Response of central monoaminergic neurons to lisuride: comparison with LSD
Ruffing D, Kovacic B, Demetriou S, Domino EF, Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S, m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful Anorexia in Rats
Poklis A, Mackell MA, Drake WK, Fatal intoxication from 3,4-methylenedioxyamphetamine
Polc P, Schneeberger J, Haefely W, Effects of several centrally active drugs on the sleep-wakefulness cycle of cats
Poling AD, White FJ, Appel JB, Discriminative stimulus properties of phencyclidine
Prozialeck WC, Vogel WH, MAO Inhibition and the Effects of Centrally Administered LSD Serotonin, and 5-Methoxytryptamine on the Conditioned Avoidance Response in Rats
Niehoff DL, Palacios JM, Kuhar MJ, In Vivo Receptor Binding: Attempts To Improve Specific/ Non-specific Ratios
Nelson DL, Herbet A, Pichat L, Glowinski J. Hamon M, In vitro and in vivo Disposition of 3H-Methiothepin in Brain Tissues. Relationship to the Effects of Acute Treatment with Methiothepin on Central Serotoninergic Receptors
Natale M, Dahlberg CC, Jaffe J, The Effects Of LSD-25 And Dextroamphetamine On The Use Of Defensive Language
Natale M, Dahlberg CC, Jaffe J, The Effect of Psychotomimetics On Therapist-patient Matching Of Speech "Rhythms"
Miskiewicz M, Rokosz-Pelc A, Vetulani J, The Effect of Quipazine and LSD on Monoamines in the Rat Striatum
Marrazzi AS, Huang CC, Qualitative Identity of Cerebral Neuronal Membrane Actions of 5HT LSD, and CPZ
Marsh A, Visual Hallucinations During Hallucinogenic Experience and Schizophrenia
Marin J, Salaices M, Marco EJ, Gómez B, Lluch S, Analysis of the contractile effect of 5-hydroxytryptamine on the isolated posterior communicating artery of the cat
Mansour TE, Biochemical Effects of Psychopharmacological Agents
Maj J, Palider W, Rawlów A, Trazadone, a Central Serotonin Antagonist and Agonist
Mandel JL, Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy: a Phenomenological Study
Maj J, Lewandowska A, Rawlow A, Central Antiserotonin Action of Amitriptyline
Mahony JB, Brown IR, Fate of mRNA followng disaggregation of brain polysomes after administration of (+)-lysergic acid diethylamide in vivo
Mace S, LSD
MacDermot J, Higashida H, Wilson SP, Matsuzawa H, Minna J, Nirenberg M, Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids
Maayani S, Weinstein H, Green JP, Brain 5-RT And LSD Binding Sites
Macdermot J, Higashida H, Independent Regulation of Receptor-Mediated Cell Depolarization and Adenylate Cyclase by 5-Hydroxytryptamine (Serotonin) in Neuroblastoma Hybrid Cells
Lukaszewski T, 3,4-methylenedioxyamphetamine overdose
Leyland CM, Gwyther RJ, Rylands JM, An Improved Method for Detecting Drug Effects in the Open Field
Laubscher A, Pletscher A, Shape Change And Uptake Of 5-hydroxytryptamine In Human Blood Platelets: Action Of Neuropsychotropic Drugs
Levin RM, Weiss B, Selective Binding of Antipsychotics and Other Psychoactive Agents to the Calcium-Dependent Activator of Cyclic Nucleotide Phosphodiesterase
Lamberts SWJ, Macleod RM, Metergoline and Other Peripheral Serotonin Antagonists Inhibit Prolactin Secretion through Mechanisms Unrelated to Serotonin
Krsiak M, Effects of Drugs on Behaviour of Aggressive Mice
Kräuchi K, M. Lichtsteiner M, Gentsch C, Feer H, In Vivo 3H-d-LSD-binding in punched out brain regions
Kielholz P, Rümmele W, Ladewig D, Hobi V, Auswirkungen von Drogen auf das Verhalten von Motorfahrzeugführern. Ein Gutachten für das Schweizerische Bundesgericht vom 7. April 1978
Kiechel JR, Pharmacocinétique et Métabolisme des Dérives de l'Ergot
Kiechel JR, Pharmacocinétique et métabolisme des dérivés de l'ergot
Kemali M, Kemali D, Observations On Central Nervous System Structures Following The Administration Of A Psychotomimetic Substance
Ishii H, Hayashi M, Niwaguchi T, Nalcahara Y, Studies on Lysergic Acid Diethylamide and Related Compounds. VII. Microbial Transformation of Lysergic Acid Diethylamide and Related Compounds
Hyvaerinen J, Laakso M, Roine R, Leinonen L, Effects of Phencyclidine, LSD and Amphetamine on Neuronal Activity in the Posterior Parietal Association Cortex of the Monkey
Ishii H, Hayashi M, Niwaguchi T, Nakahara Y, Studies on Lysergic Acid Diethylamide and Related Compounds. IX. Microbial Transformation of Amides Related to Lysergic Acid Diethylamide by Streptomyces roseochromogenes
Horowski R, Graef KJ, Neuroendocrine Effects of Neuropsychotropic Drugs and Their Possible Influence On Toxic Reactions in Animals and Man - The Role of the Dopamine-Prolactin System
Horowski R, Wachtel H, Pharmacological Effects Of Lisuride In Rodents Mediated By Dopaminergic Receptors: Mechanism Of Action And Influence Of Chronic Treatment With Lisuride
Holbrook LA, Transient Decrease in Brain Protein Synthesis after in vivo Administration of a Psychotropic Drug: Mechanism and Developmental Effects
Hoffman A, How LSD Originated
Hernandez LL, Appel JB, An analysis of some perceptual effects of morphine, chlorpromazine, and LSD
Héry F, Simonnet G, Bourgoin S, Soubrié P, Artaud F, Hamon M, Glowinski J, Effect Of Nerve Activity On The In Vivo Release Of [3H]serotonin Continuously Formed From L-[3H]tryptophan In The Caudate Nucleus Of The Cat
Heikkila JJ, Brown IR, Disaggregation of brain polysomes after LSD in vivo. Involvement of LSD-induced hyperthermia
Heikkila JJ, Holbrook L, Brown IR, Disaggregation of polysomes in fetal organs and maternal brain after administration of d-lysergic acid diethylamide in vivo
Haigler HJ, Spring DD, Drugs that Antagonize Limb Flick Behavior Induced by D-Lysergic Acid Diethylamide (LSD) in Cats
Greengard P, Cyclic nucleotides, phosphorylated proteins and the nervous system
Graf M, Pletscher A, Shape Change Of Blood Platelets - a Model For Cerebral 5-hydroxytryptamine Receptors?
Glennon RA, Rosecrans JA, Young R, Gaines J, Hallucinogens As A Discriminative Stimuli: Generalizations Of Dom To A 5-methoxy-N, N-dimethyltryptamine Stimulus
Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL, A Characteristic Effect of Hallucinogens on Investigatory Responding in Rats
Gimpl MP, Gormezano I, Harvey JA, Effects on Learning as Measured by Classical Conditioning of the Rabbit Nictitating Membrane Response
Gebhart E, Zur Frage der erbgutschädigenden Nebenwirkungen von psychotropen Substanzen. Teil 2: Rausch- und Suchtdrogen
Geyer MA, Light RK, LSD-Induced Alterations of Investigatory Responding in Rats
Fredrickson PA, Richelson E, Hallucinogens Antagonize Histamine H1 Receptors Of Cultured Mouse Neuroblastoma Cells
Freedman DX, LSD, Psychotogenic Procedures, and Brain Neurohumors
Fox PC, Dray A, Iontophoresis of LSD: effects on responses of single cortical neur